data_2jn8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jn8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.92 -39.41 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.233 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.16 -23.36 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.034 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 25.5 tptp -77.08 -24.25 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.43 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.936 HD13 ' HG2' ' A' ' 60' ' ' ARG . 75.6 mt -63.08 -33.66 75.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.36 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 20.1 t70 -60.77 -40.82 93.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.657 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -67.28 -36.23 81.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.0 mt -71.56 -46.15 64.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.57 75.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.648 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 -170.38 54.77 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.647 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -104.81 -7.01 19.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.793 0.806 . . . . 0.0 108.961 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -132.04 94.87 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.628 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.7 m -80.03 -11.76 59.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.444 . . . . 0.0 111.409 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.186 0.517 . . . . 0.0 110.23 179.101 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 t -103.15 -81.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.492 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.409 ' HE2' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -100.53 -21.48 15.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' HE2' ' A' ' 33' ' ' MET . 12.6 p-10 -77.3 2.72 14.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.602 -172.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -57.63 3.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 109.487 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 1.019 ' HB3' HG13 ' A' ' 89' ' ' ILE . 54.0 m -81.16 -34.96 32.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.88 -174.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -66.06 -36.34 82.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.329 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.33 99.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 36' ' ' SER . 94.2 mttt -58.18 -44.73 88.17 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.999 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.77 -50.01 69.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.226 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 110.861 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.775 HD11 HG22 ' A' ' 52' ' ' VAL . 15.5 tp -62.15 -43.65 98.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 9.9 mtmp? -71.15 -23.4 62.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.259 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -68.39 -40.66 81.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.14 -43.61 97.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.251 0.548 . . . . 0.0 109.816 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.446 ' HB2' HG12 ' A' ' 81' ' ' VAL . 17.9 t-80 -58.0 -41.03 82.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.647 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.08 -38.18 89.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.1 -13.73 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.096 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.96 13.28 25.72 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.351 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.54 93.6 37.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.431 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 98.9 Cg_endo -87.75 114.83 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.504 2.136 . . . . 0.0 111.486 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.775 HG22 HD11 ' A' ' 42' ' ' LEU . 27.4 m -73.64 141.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.293 0.568 . . . . 0.0 111.614 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.653 ' O ' HG21 ' A' ' 56' ' ' VAL . 12.8 m -85.36 138.0 36.55 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.688 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.12 -27.9 67.56 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.0 112.272 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -60.55 -44.62 95.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 53' ' ' SER . 10.3 m -68.18 -24.95 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.808 0.337 . . . . 0.0 110.579 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.89 -51.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.055 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.9 t -61.98 -46.7 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.21 -51.8 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.672 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.936 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.1 tpp180 -70.15 -28.83 65.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -63.3 -41.14 99.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.977 176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 39.4 mt-10 -67.43 -36.16 80.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 110.644 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -68.54 -50.76 49.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.612 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 35.8 mm-40 -84.55 -13.48 51.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.877 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.65 56.51 2.93 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.869 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.424 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 41.7 m0 -87.0 176.51 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.51 126.22 53.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -46.28 -44.5 20.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.937 3.091 . . . . 0.0 114.075 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.69 -37.73 85.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.106 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 74' ' ' VAL . 48.5 t80 -70.09 -47.72 60.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.411 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 25.0 m -58.79 -40.32 83.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.284 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -67.67 -38.09 83.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.849 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.34 -48.15 79.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.633 0.254 . . . . 0.0 110.539 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 70' ' ' PHE . 45.7 t -61.14 -38.31 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.85 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.66 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' GLU . . . -69.51 -32.08 71.27 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.059 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.419 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 24.8 m0 -71.61 -48.97 44.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.67 75.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.493 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 76' ' ' GLY . 10.2 tt0 -48.57 -59.54 3.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.824 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -68.08 -37.91 81.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.053 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 46' ' ' HIS . 41.7 t -58.18 -49.09 82.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.111 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -70.34 -32.23 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.262 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -74.12 -16.1 61.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.591 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 18.1 40.32 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.13 -174.78 3.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -134.0 152.93 52.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.981 0.42 . . . . 0.0 110.509 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.8 pt -126.93 158.83 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.4 tp -91.3 135.97 33.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.21 0.529 . . . . 0.0 110.934 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 1.019 HG13 ' HB3' ' A' ' 36' ' ' SER . 19.2 tt -100.49 131.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.323 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -25.1 34.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 111.25 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.603 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -148.0 93.2 4.51 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.225 0.536 . . . . 0.0 110.373 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HA ' HD13 ' A' ' 89' ' ' ILE . 7.2 Cg_exo -74.03 -16.67 22.72 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.454 2.769 . . . . 0.0 113.348 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.44 -21.92 60.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -80.26 -7.43 59.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -81.23 82.73 7.03 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 m -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.288 1.042 . . . . 0.0 112.074 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -66.33 -36.04 81.9 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.954 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.44 -45.71 87.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.375 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.9 mtm -61.47 -40.07 93.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.065 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.99 -54.98 19.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 10.9 mm-40 -65.28 -24.12 67.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 102' ' ' GLN . 0.9 OUTLIER -63.89 -56.15 17.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.01 -43.68 98.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.259 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 79.7 tttt -57.03 -41.06 77.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.445 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.97 -39.01 79.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 9.9 mp -67.73 -36.27 80.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.808 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.8 t -72.65 -34.96 49.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 110.2 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.1 tp -62.44 -49.9 73.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.569 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -77.43 -7.99 57.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 67.1 t60 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.787 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.685 ' HA ' HD22 ' A' ' 106' ' ' LEU . . . . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.836 0.351 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.16 -56.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.672 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.66 -40.44 96.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.569 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -67.12 -31.85 72.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.677 0.275 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 20' ' ' ILE . . . -64.23 -42.5 96.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.217 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 4.4 mm? -65.56 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.619 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.03 -44.61 96.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.455 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 14.2 m-85 -60.11 -37.53 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 16' ' ' ALA . 75.2 mt -72.78 -65.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.249 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.47 -47.02 53.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.864 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.45 8.69 27.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.271 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt 57.12 31.17 19.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -67.39 111.32 3.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.377 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -76.98 0.89 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.182 -174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.776 -177.144 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.9 p80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.824 0.345 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.7 m -103.5 -80.47 0.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.464 0.65 . . . . 0.0 110.962 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.482 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.4 ttp -83.34 -27.21 29.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.394 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.83 -2.81 22.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.814 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.438 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 10.4 tt0 -102.3 -63.86 1.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.0 110.064 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m -63.53 -46.2 87.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 95' ' ' PHE . 84.2 m -72.5 -29.77 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.01 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.41 79.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.82 -42.16 97.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.251 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 94' ' ' TYR . . . -65.14 -44.07 94.6 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.245 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 36.5 mt -68.14 -40.71 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.95 0.375 . . . . 0.0 111.146 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.855 HD22 HG23 ' A' ' 52' ' ' VAL . 91.7 mt -60.58 -39.37 87.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.171 0.51 . . . . 0.0 110.002 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.839 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.632 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 82.4 t80 -58.3 -55.55 33.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.11 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 48' ' ' LEU . 7.6 mp -63.99 -36.4 83.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.394 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -54.47 -56.3 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.346 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.83 -23.62 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.081 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.7 mt -62.22 -35.33 78.59 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 109.963 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.4 3.61 3.78 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.571 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.4 99.37 45.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.762 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.511 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 64.2 Cg_endo -77.08 117.64 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.125 1.883 . . . . 0.0 111.618 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.855 HG23 HD22 ' A' ' 42' ' ' LEU . 27.4 m -68.03 148.58 11.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.776 -175.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.5 m -94.71 131.71 30.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.298 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 33.5 Cg_exo -58.91 -32.22 96.96 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.267 2.645 . . . . 0.0 113.216 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -55.8 -41.83 74.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 t -61.11 -37.84 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.76 -47.16 86.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.361 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.24 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.675 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.736 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 12.2 tpt180 -68.05 -36.25 79.57 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.07 -45.19 82.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.601 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.96 -46.78 56.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 111.362 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -42.73 80.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.502 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.78 -32.79 23.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.742 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.9 62.58 0.75 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.368 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.496 ' CH2' HD13 ' A' ' 17' ' ' LEU . 39.0 m0 -102.26 152.68 20.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.572 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.68 142.04 94.69 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.7 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -45.81 37.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.934 2.423 . . . . 0.0 111.982 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -58.07 -40.64 81.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.083 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' HG22 ' A' ' 74' ' ' VAL . 75.6 t80 -66.06 -59.63 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.7 m -56.02 -41.94 75.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.57 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.8 -50.59 71.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.67 -43.25 63.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.667 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.6 t -61.69 -38.07 79.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -60.3 -44.19 95.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.604 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.45 ' HA2' ' OE1' ' A' ' 79' ' ' GLU . . . -57.29 -41.01 92.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.401 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.556 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 m0 -65.35 -43.9 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.2 83.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.163 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 53.7 mt-10 -57.06 -48.72 77.88 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.221 0.534 . . . . 0.0 110.519 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.63 -35.59 79.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.6 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 77' ' ' TRP . 66.9 t -62.04 -48.84 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.625 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -62.29 -38.68 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -72.73 -16.63 61.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.741 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.99 29.9 40.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.429 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.496 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -97.47 154.05 17.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -77.82 142.06 38.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.245 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.5 pt -117.25 159.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.809 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tt -87.99 109.23 19.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.294 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -101.53 150.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.438 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 25.1 mtpt -84.68 -58.83 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.514 0.673 . . . . 0.0 109.73 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -111.05 124.3 33.19 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.802 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 93' ' ' GLU . 9.9 Cg_endo -53.32 -30.92 54.36 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.074 2.516 . . . . 0.0 113.02 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 92' ' ' PRO . 1.8 mp0 -63.99 98.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HD2' ' HA2' ' A' ' 40' ' ' GLY . 36.6 m-85 -59.72 -59.29 5.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.364 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.827 ' HB3' HG22 ' A' ' 37' ' ' THR . 26.9 p90 -162.05 172.71 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.692 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -82.68 164.34 20.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 111.705 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -32.86 74.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.484 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -53.78 -44.86 70.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.821 0.82 . . . . 0.0 110.067 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.475 ' HE2' HG21 ' A' ' 37' ' ' THR . 33.1 mtp -75.21 -34.16 61.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.122 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -50.63 70.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.829 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.57 -43.64 84.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -56.02 -56.73 17.18 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 111.081 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.23 -44.36 97.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.644 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -59.71 -43.01 94.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.742 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.48 -48.06 80.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 12' ' ' ALA . 10.0 mp -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.829 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.45 -6.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.31 -42.08 38.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -43.48 54.75 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.498 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.478 0.947 0 C-N-CA 124.154 0.982 . . . . 0.0 112.565 177.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.513 ' HA ' HD23 ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.241 0.543 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.35 -41.08 83.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.586 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -65.28 -47.19 77.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.66 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -64.72 -42.85 94.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.0 82.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.243 0.544 . . . . 0.0 110.652 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD13 ' HZ2' ' A' ' 66' ' ' TRP . 22.8 tp -71.77 -24.06 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.431 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.34 -33.96 37.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.84 -44.46 89.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.443 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.3 mt -84.44 -68.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.611 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.69 45.23 3.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.056 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.52 -6.08 66.37 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.546 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ttt 69.39 105.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.529 0.732 . . . . 0.0 111.937 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -71.8 162.59 29.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.411 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.5 m -52.9 -36.63 59.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.363 0.265 . . . . 0.0 111.582 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.844 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 59.0 m170 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 m -82.96 -79.94 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.461 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.6 ttp -99.41 -24.02 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.759 0.79 . . . . 0.0 108.979 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -78.31 9.54 3.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.048 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 5.9 tt0 -103.05 -72.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.736 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -58.85 -54.33 48.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.542 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.4 m -61.58 -39.93 92.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 111.185 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.04 91.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -58.13 -48.2 80.96 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.477 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.71 82.02 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.571 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.628 HG12 HD11 ' A' ' 103' ' ' LEU . 77.9 mt -62.9 -45.38 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.518 . . . . 0.0 110.715 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.85 -39.29 93.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.2 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HZ1' ' HB3' ' A' ' 43' ' ' LYS . 9.5 mtpm? -69.32 -39.03 78.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.643 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.528 ' CE2' HD11 ' A' ' 48' ' ' LEU . 83.0 t80 -60.23 -44.55 95.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.25 -47.57 85.45 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.34 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 60.7 m80 -65.48 -36.06 82.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.46 -33.17 74.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 44' ' ' TYR . 76.6 mt -66.53 -45.27 79.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.588 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 138.51 4.69 1.62 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.676 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.43 93.29 4.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 90.0 Cg_endo -90.72 88.81 0.3 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.477 2.118 . . . . 0.0 112.924 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.18 123.52 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.7 m -89.09 154.32 49.43 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.612 ' HG3' ' HB2' ' A' ' 79' ' ' GLU . 5.3 Cg_endo -49.86 -37.93 46.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.382 2.721 . . . . 0.0 112.396 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -48.68 -51.57 27.85 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.535 0.522 . . . . 0.0 110.883 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -64.68 -42.1 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.456 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.6 -48.03 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 54' ' ' PRO . 89.6 t -60.99 -52.29 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.34 90.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.359 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.522 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 13.0 tpp180 -67.84 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.457 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.71 -38.53 96.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.934 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.17 -38.93 84.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.591 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.16 -50.5 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.344 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 27.8 mm-40 -65.63 -42.66 91.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.014 0.435 . . . . 0.0 110.258 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.24 50.43 0.5 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.1 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.405 ' HZ2' HD13 ' A' ' 17' ' ' LEU . 30.2 m0 -88.06 163.47 16.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.86 143.52 78.26 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.102 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.23 -55.81 3.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.394 2.729 . . . . 0.0 112.867 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.3 mm-40 -59.01 -37.2 76.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.472 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.443 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 80.2 t80 -64.78 -51.82 60.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -64.86 -45.89 84.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.155 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.04 -41.1 97.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.992 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 13.9 mptt -60.11 -57.53 12.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 48.4 t -58.76 -39.91 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.87 -37.63 85.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.52 86.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.262 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 8.9 m0 -67.19 -36.98 82.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.76 -44.76 89.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.306 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.612 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 2.2 tm-20 -58.17 -46.49 85.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.71 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -52.57 -58.94 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.185 178.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.5 t -67.51 -34.4 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.396 -175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.03 69.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.736 0.303 . . . . 0.0 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -81.94 -14.23 56.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.201 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.46 34.56 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -107.69 169.43 8.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.78 146.46 28.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.772 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.2 pt -128.95 159.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.999 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.074 0.464 . . . . 0.0 110.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -82.8 -12.6 12.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 75.46 -48.12 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.575 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.25 92.12 6.24 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.479 0.657 . . . . 0.0 110.911 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 -10.78 24.66 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.023 2.482 . . . . 0.0 112.424 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -72.59 -15.15 61.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.12 -1.75 58.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.961 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -82.23 84.03 7.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.0 p -71.52 147.43 47.73 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.304 1.049 . . . . 0.0 112.327 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.6 m -49.9 -42.67 48.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.67 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 62.5 t80 -57.39 -42.32 81.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.655 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.443 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 52.8 mtm -73.23 -47.29 44.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.268 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -58.14 9.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -32.34 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.923 -175.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 8.4 tt0 -62.6 -51.17 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.092 0.472 . . . . 0.0 109.811 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.628 HD11 HG12 ' A' ' 41' ' ' ILE . 76.9 mt -57.75 -44.36 86.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.081 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 2.4 ttmp? -53.96 -61.78 2.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.878 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 19.8 mm-40 -57.39 -44.49 84.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.617 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 12' ' ' ALA . 32.5 tp -65.98 -44.14 85.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.697 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.54 -32.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 11.7 tp -61.05 -30.01 70.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.052 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 40.9 mt-10 -60.86 -30.13 69.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.802 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -176.127 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.429 ' O ' HD23 ' A' ' 17' ' ' LEU . 67.8 mt -62.9 -53.23 49.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.814 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -57.44 -39.3 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HD2' HD23 ' A' ' 103' ' ' LEU . 33.6 ttmt -60.99 -53.86 52.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.751 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.12 80.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.661 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 3.6 mm? -66.85 -29.12 68.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.665 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.52 -33.77 67.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.927 0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.22 -42.7 83.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.786 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.92 -69.77 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.014 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.24 53.32 4.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.047 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.49 -146.97 18.63 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.308 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -91.45 36.16 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 110.975 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -82.28 66.8 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.095 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m 67.3 112.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.376 0.608 . . . . 0.0 111.62 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.289 176.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.9 t -96.37 -80.16 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.2 0.524 . . . . 0.0 112.182 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 33' ' ' MET . 28.8 ttp -85.05 -22.43 28.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.307 -172.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.449 ' HB3' ' HE1' ' A' ' 70' ' ' PHE . 2.8 m-20 -54.0 -42.72 69.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.248 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HA ' ' CH2' ' A' ' 77' ' ' TRP . 2.4 tm-20 -50.4 -76.02 0.03 OUTLIER 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.758 0.789 . . . . 0.0 111.54 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -75.74 -37.68 59.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.701 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 33' ' ' MET . 75.0 m -68.99 -47.48 65.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.62 -38.47 89.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.497 ' HD3' HD12 ' A' ' 87' ' ' ILE . 3.9 ttmp? -60.9 -42.16 97.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.199 0.523 . . . . 0.0 110.527 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.12 -45.06 74.02 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.46 -42.85 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.483 0.141 . . . . 0.0 111.003 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 90.0 mt -57.36 -48.02 80.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.697 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HD2' HD13 ' A' ' 87' ' ' ILE . 23.2 mtpp -66.97 -37.34 84.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.297 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 67.7 t80 -65.69 -44.18 86.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.42 -42.24 88.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.828 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.16 -34.02 76.73 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.92 -43.18 79.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.605 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.3 mt -61.81 -42.23 98.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.24 6.68 2.39 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.615 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.97 99.98 51.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.782 0.325 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -88.08 121.8 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.696 2.264 . . . . 0.0 112.709 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.35 108.29 19.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -73.99 138.3 76.1 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.959 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 18.0 Cg_endo -60.05 -25.24 79.2 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.981 2.454 . . . . 0.0 111.96 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.3 -44.67 88.66 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.88 -37.78 69.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.4 t -58.4 -45.24 89.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.017 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 54' ' ' PRO . 71.8 t -63.82 -50.29 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.999 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.83 95.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.661 ' HG2' ' CD1' ' A' ' 17' ' ' LEU . 8.7 tpt180 -66.07 -41.64 90.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.236 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -60.68 -48.75 84.68 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.838 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -68.18 -27.29 66.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -69.85 -56.6 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 60' ' ' ARG . 46.8 mt-10 -73.02 -24.6 60.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.994 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.94 49.68 2.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.006 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.4 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 36.4 m0 -74.69 147.24 41.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -63.3 142.58 97.83 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.248 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.83 -60.91 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.779 2.986 . . . . 0.0 114.432 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 4.9 mm-40 -60.16 -26.32 66.22 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.449 ' HE1' ' HB3' ' A' ' 34' ' ' ASP . 30.4 t80 -66.97 -61.18 2.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 m -57.95 -38.67 76.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.261 0.553 . . . . 0.0 110.782 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -60.28 -49.52 77.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.528 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 53.6 mttm -66.79 -46.08 76.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.924 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.478 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.2 t -61.62 -40.74 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.824 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.39 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.725 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.53 99.58 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.304 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 10.2 m0 -66.82 -50.17 63.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.45 -39.03 72.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.9 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.497 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 32.8 tt0 -54.17 -54.44 39.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.824 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -68.99 -39.64 79.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.211 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 77' ' ' TRP . 92.5 t -69.24 -44.33 80.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.595 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.08 95.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.467 0.175 . . . . 0.0 110.833 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -65.95 -35.2 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.609 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.37 37.1 4.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.002 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -96.72 147.46 23.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.904 0.383 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -67.46 137.76 56.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.625 HD13 ' HD2' ' A' ' 43' ' ' LYS . 30.7 pt -138.44 135.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.547 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.6 pp -69.97 131.13 43.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.849 0.833 . . . . 0.0 112.131 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.49 69.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.998 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.64 13.62 9.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' H ' ' CD ' ' A' ' 92' ' ' PRO . 5.9 m-80 -131.54 -51.25 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.071 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.533 ' CD ' ' H ' ' A' ' 91' ' ' ASN . 50.7 Cg_exo -59.25 -30.45 92.97 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.811 2.341 . . . . 0.0 113.353 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 65.97 17.98 10.94 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.205 0.526 . . . . 0.0 110.65 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 60.24 -95.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.731 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 100' ' ' GLN . 38.1 p90 179.34 177.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.637 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.167 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 98' ' ' TYR . 15.0 t -58.1 -39.61 79.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.585 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 97' ' ' THR . 74.0 t80 -43.93 -54.12 5.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.046 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.5 mtm -75.18 -29.51 60.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.244 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 8.3 tt0 -67.17 -44.55 79.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.217 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.02 -40.43 97.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.43 -51.72 68.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.523 0.678 . . . . 0.0 109.75 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 107' ' ' VAL . 68.1 mt -56.66 -63.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.905 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -57.93 -49.32 77.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.491 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.81 -48.41 80.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.949 0.404 . . . . 0.0 109.977 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.95 2.01 16.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 103' ' ' LEU . 42.7 t -100.14 -33.89 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.41 -31.7 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.365 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -63.6 -63.31 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.412 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 11.4 p80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.467 0.707 . . . . 0.0 110.883 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 120.354 0.121 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.12 -50.95 59.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.46 -41.7 75.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -73.86 -34.89 64.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.49 -33.33 69.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 0.0 109.921 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 60' ' ' ARG . 7.8 tt -62.75 -36.4 82.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.359 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.9 -46.4 89.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.187 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.49 -53.95 47.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.98 -46.24 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.664 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.29 60.89 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.294 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 -119.72 11.42 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.903 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.795 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 2.9 tpt -145.4 81.33 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.405 ' C ' ' HG1' ' A' ' 25' ' ' THR . 79.2 m-20 67.84 -3.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.538 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' MET . 33.4 m -160.15 156.36 26.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.3 m170 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.866 0.365 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -103.48 -80.65 0.52 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.482 0.658 . . . . 0.0 110.238 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.8 ptm -90.5 -9.74 46.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.877 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.56 -22.47 66.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.845 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -102.56 -65.37 1.0 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.739 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.6 m -56.11 -52.3 64.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.986 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 41' ' ' ILE . 23.5 m -66.81 -41.62 87.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.697 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -61.99 -51.37 68.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.171 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.91 -39.86 90.96 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -44.65 97.81 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.15 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.451 ' O ' HD22 ' A' ' 45' ' ' LEU . 80.0 mt -64.38 -47.43 89.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.653 0.264 . . . . 0.0 111.008 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 52' ' ' VAL . 86.0 mt -62.42 -42.75 99.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.024 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -67.45 -40.54 85.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.777 0.322 . . . . 0.0 110.273 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 77.7 t80 -59.15 -47.91 83.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.317 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 41' ' ' ILE . 3.3 mm? -60.03 -45.18 93.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.848 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.91 -42.45 93.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.618 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.52 -37.8 85.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 90.3 mt -56.79 -38.48 72.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.665 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.9 -52.4 0.43 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.801 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -87.23 126.1 63.75 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 121.152 0.501 . . . . 0.0 111.611 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.1 145.75 15.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 42' ' ' LEU . 30.8 m -81.07 140.25 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.176 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.485 ' HB2' HG21 ' A' ' 56' ' ' VAL . 3.6 m -90.55 119.21 69.1 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB3' ' HB1' ' A' ' 78' ' ' ALA . 26.2 Cg_endo -64.1 -38.0 39.12 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.786 2.324 . . . . 0.0 113.462 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -69.98 -39.41 75.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 53' ' ' SER . 27.9 m -67.37 -26.77 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 53' ' ' SER . 86.9 t -68.67 -44.4 82.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 61.3 t -62.29 -42.04 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.09 -39.56 78.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.715 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.8 tpt180 -73.16 -34.34 66.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.296 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -58.42 -48.53 83.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 7.9 pt-20 -72.17 -26.4 62.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -82.12 -54.27 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.17 -25.83 47.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.879 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.28 60.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.391 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.415 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 34.2 m0 -103.01 165.58 10.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -71.91 137.78 82.41 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.695 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.68 -44.62 43.65 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.177 2.585 . . . . 0.0 112.567 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 52.4 mp0 -63.83 -45.8 87.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' O ' HG22 ' A' ' 74' ' ' VAL . 86.9 t80 -61.86 -54.58 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.369 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 23.4 m -58.05 -39.82 79.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.707 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.31 -46.41 73.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.928 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 61.7 mttm -66.94 -43.26 83.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.046 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.87 -36.19 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.822 0.344 . . . . 0.0 110.431 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.83 86.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.353 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.95 96.73 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.091 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.417 ' O ' HG23 ' A' ' 81' ' ' VAL . 28.1 m0 -64.2 -49.19 72.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 54' ' ' PRO . . . -64.29 -35.02 79.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.376 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -59.04 -43.14 91.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.91 0.386 . . . . 0.0 110.138 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.23 -45.46 84.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.07 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 77' ' ' TRP . 85.6 t -58.99 -43.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.63 65.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 p -89.74 -19.88 24.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.01 25.01 9.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.418 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -90.97 162.54 14.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 110.761 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -87.84 145.21 26.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.07 136.52 60.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.934 0.397 . . . . 0.0 110.407 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -86.84 138.54 31.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.888 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.512 HG12 ' N ' ' A' ' 90' ' ' LYS . 6.3 tt -126.45 161.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' N ' HG12 ' A' ' 89' ' ' ILE . 42.9 mmtm -74.42 44.43 0.2 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 171.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.8 OUTLIER 76.23 152.2 0.14 Allowed Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.016 0.926 . . . . 0.0 111.429 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 34.38 0.42 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.695 2.263 . . . . 0.0 112.065 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' ASN . 10.6 tp10 -103.52 161.47 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 74.31 -30.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.264 0.626 . . . . 0.0 111.457 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.66 86.02 3.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 166.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -83.77 172.03 12.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.783 -167.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -25.99 68.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.695 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.2 -53.66 32.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.132 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -68.73 -35.48 77.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 110.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.16 -53.59 42.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.23 -38.17 76.31 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.986 0.179 . . . . 0.0 111.314 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -51.84 -60.69 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.63 0.729 . . . . 0.0 110.506 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.6 -38.17 83.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.111 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.31 -56.62 18.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.381 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.7 tt0 -64.79 -38.34 90.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.462 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -51.26 -43.24 61.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.522 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -83.06 -39.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.594 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.335 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 41.6 mt-10 -62.86 -22.55 66.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.623 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.511 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.901 0.382 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.58 -44.62 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.381 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.55 -33.31 75.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.459 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 10.9 mmpt? -75.45 -26.66 58.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.811 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.38 0.61 . . . . 0.0 109.458 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.5 mm? -74.2 -14.83 61.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 11.9 t70 -69.01 -44.95 71.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.29 -64.29 0.92 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.708 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.744 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 66.5 mt -63.0 -43.14 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 -174.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.15 -9.54 80.62 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.985 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.03 -14.81 71.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.787 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.744 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 65.3 mtm -88.48 75.26 8.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.698 0.761 . . . . 0.0 110.368 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -100.02 10.31 41.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.926 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.96 54.49 1.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.518 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.101 174.568 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -59.25 -67.45 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.254 0.549 . . . . 0.0 111.774 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.574 ' O ' ' HE3' ' A' ' 33' ' ' MET . 0.0 OUTLIER -56.38 -61.82 2.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.618 -176.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.604 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -51.96 -68.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.979 -175.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 36.5 tt0 -62.09 -62.21 1.93 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -169.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -58.99 -47.37 85.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.368 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.462 HG21 ' HE2' ' A' ' 99' ' ' MET . 9.2 m -75.22 -31.27 60.83 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.424 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.5 94.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.038 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.13 -43.4 82.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.078 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.593 ' CA ' ' HA ' ' A' ' 94' ' ' TYR . . . -63.9 -46.53 91.36 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.714 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.66 -47.53 90.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.522 0.201 . . . . 0.0 111.008 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.9 -38.6 86.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 111.208 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -66.59 -42.32 87.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.088 0.471 . . . . 0.0 110.269 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 54.2 t80 -66.16 -45.34 81.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 48' ' ' LEU . 94.7 mt -60.85 -41.59 96.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -50.49 -51.94 42.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.233 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -13.79 59.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.919 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 61.6 mt -73.43 -26.15 60.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 0.0 110.292 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.88 -14.8 10.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.376 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.69 93.17 48.76 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 110.629 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -90.97 146.21 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.091 2.527 . . . . 0.0 112.078 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.71 110.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.872 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 m -66.14 139.54 96.56 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.702 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.54 -28.08 53.47 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.034 2.489 . . . . 0.0 112.743 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.03 -44.41 87.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.211 0.529 . . . . 0.0 110.317 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.32 -38.03 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.307 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.33 -47.76 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.874 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.11 -49.68 83.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.983 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.66 92.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 1.4 tpt85 -69.39 -34.44 74.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.524 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.67 -50.21 68.5 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.275 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.25 -32.07 64.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.407 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -72.09 -45.83 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.439 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 7.3 tp10 -82.75 -48.73 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.25 65.13 0.21 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.19 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.482 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 31.5 m0 -104.56 162.71 13.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.07 148.7 81.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.66 -35.09 66.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.156 2.571 . . . . 0.0 112.411 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 24.4 mm-40 -69.9 -46.74 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.521 ' HZ ' ' HE2' ' A' ' 23' ' ' MET . 54.2 t80 -62.08 -46.6 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.3 m -61.31 -44.78 96.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.191 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.99 -43.22 88.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.239 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 64.0 mttm -62.07 -53.57 53.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.1 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.477 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 53.0 t -59.38 -40.19 80.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.821 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.49 -32.92 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.07 -35.81 64.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.439 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.477 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 14.3 m0 -68.68 -49.35 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.18 -42.52 77.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.0 -58.42 6.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.324 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -66.22 -46.97 75.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.811 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.32 -43.66 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.565 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.49 61.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.579 0.228 . . . . 0.0 111.22 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t -67.25 -35.59 79.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.391 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.14 -3.44 8.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.63 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.28 103.9 16.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 109.759 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -53.41 141.45 24.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.984 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.36 113.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.531 0.681 . . . . 0.0 109.86 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.86 123.86 29.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.021 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.876 HG23 ' HB2' ' A' ' 91' ' ' ASN . 56.2 mt -66.42 -31.03 51.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.101 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HB3' ' HZ2' ' A' ' 90' ' ' LYS . 7.8 mtpm? 62.29 21.55 12.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.271 1.034 . . . . 0.0 109.456 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.988 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 52.4 m-80 -148.43 -160.28 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.988 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 31.6 Cg_exo -43.37 86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.907 2.405 . . . . 0.0 114.14 168.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.543 ' HA ' HD13 ' A' ' 89' ' ' ILE . 19.0 mm-40 -63.99 130.14 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.883 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.593 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 96.8 m-85 64.63 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.94 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.5 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER 169.85 -157.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.161 -172.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 11.3 t -108.14 -175.78 2.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -41.12 88.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -167.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 96' ' ' SER . 0.1 OUTLIER -53.46 -47.56 69.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.462 ' HE2' HG21 ' A' ' 37' ' ' THR . 65.5 mtt -65.1 -45.3 85.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.402 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.5 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -58.68 -45.35 89.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.645 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -60.24 -44.58 95.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.431 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -64.61 -57.41 9.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.07 -46.76 87.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.704 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -65.42 -35.17 80.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.747 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.83 -38.73 91.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 110.821 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -63.55 -34.11 77.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.304 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.93 -50.67 18.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.1 -62.43 1.88 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.394 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -71.42 -59.94 2.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.286 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 . . . . . 0 N--CA 1.471 0.586 0 O-C-N 124.015 0.822 . . . . 0.0 111.569 175.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.39 -37.6 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 14.0 mm-40 -76.72 -25.91 54.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.103 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -81.28 -30.61 33.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.17 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 57.1 tp -58.7 -41.02 85.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.323 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.29 -46.15 86.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.774 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -62.38 -50.74 70.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.868 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.35 -55.86 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.363 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.95 29.3 5.84 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.26 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.05 -70.63 1.1 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.564 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.9 -50.64 10.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 60.49 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.649 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t -89.64 167.35 13.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.313 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 0.0 110.569 -178.133 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.516 0.198 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -95.9 -80.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 0.0 111.911 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.2 ttp -94.32 -17.01 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.544 0.688 . . . . 0.0 109.96 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.14 -21.29 66.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.218 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -93.45 -68.79 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.679 0.275 . . . . 0.0 110.825 -176.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -46.68 88.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -67.21 -36.61 82.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 0.0 111.033 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.94 89.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.525 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 31.7 mmtp -54.74 -48.0 73.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.564 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.12 -44.56 94.71 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.348 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 103' ' ' LEU . 73.9 mt -61.05 -49.97 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.061 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.51 -44.62 93.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.429 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HB3' ' HZ3' ' A' ' 43' ' ' LYS . 9.5 mtpm? -69.42 -27.35 65.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.387 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HH ' ' HB2' ' A' ' 104' ' ' LYS . 68.2 t80 -70.14 -36.52 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.449 . . . . 0.0 110.182 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.15 -40.37 95.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.403 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -72.74 -25.0 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.65 -38.45 89.38 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.24 0.543 . . . . 0.0 109.897 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.44 -40.2 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.767 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.29 -26.81 3.67 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.97 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.91 104.7 54.24 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -92.32 -178.49 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.028 2.486 . . . . 0.0 112.081 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -109.83 121.35 62.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 56' ' ' VAL . 6.4 m -61.65 127.55 88.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' O ' HG22 ' A' ' 58' ' ' VAL . 53.1 Cg_exo -53.02 -32.33 57.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.878 2.386 . . . . 0.0 112.544 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -55.99 -52.52 63.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.664 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 53' ' ' SER . 31.5 m -71.02 -24.19 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 111.015 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.46 -45.49 88.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.126 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 54' ' ' PRO . 65.1 t -61.11 -48.99 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.646 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.57 98.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.949 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.81 -42.49 99.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.207 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.53 -47.63 89.47 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.48 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.9 -12.78 60.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.78 0.324 . . . . 0.0 110.814 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -85.8 -52.4 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -73.88 -27.34 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.959 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.37 48.21 1.45 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.532 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.472 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 40.9 m0 -83.26 153.74 24.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.487 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 67.2 t30 -63.17 127.9 91.6 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 4.9 Cg_endo -47.3 -43.82 25.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.867 . . . . 0.0 113.332 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.3 -37.1 79.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.766 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 74' ' ' VAL . 74.6 t80 -70.45 -53.36 16.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -58.16 -40.03 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.322 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.79 -46.91 88.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.535 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -67.41 -46.19 73.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.545 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 70' ' ' PHE . 69.6 t -60.33 -37.82 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.56 89.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.638 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.27 -35.12 69.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.899 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.535 ' O ' HG21 ' A' ' 81' ' ' VAL . 50.6 m0 -63.1 -54.13 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.36 68.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.056 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.26 -50.29 74.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.162 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -81.27 -21.51 39.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.489 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 77' ' ' TRP . 75.7 t -67.78 -38.27 79.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 109.836 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.41 -44.33 36.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.239 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.3 p -75.55 -34.83 60.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.91 44.36 4.5 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.772 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -111.7 108.52 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 62.13 -141.22 0.44 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.563 0.539 . . . . 0.0 110.671 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 89' ' ' ILE . 37.0 pt 52.76 53.06 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.34 1.056 . . . . 0.0 112.22 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.22 19.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.499 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 87' ' ' ILE . 1.1 tt 79.28 141.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.18 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -71.32 -40.94 70.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.566 0.698 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.459 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.1 OUTLIER -172.19 148.67 2.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.816 175.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 -37.81 93.74 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.453 2.102 . . . . 0.0 111.618 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.33 -97.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.43 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -142.49 24.22 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 111.116 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.25 107.39 4.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.0 m -99.34 159.93 14.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.277 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.3 t -66.79 -28.59 68.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.0 -39.88 63.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.777 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.4 mtt -66.3 -42.23 88.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.086 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.7 -51.65 68.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.586 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' THR . 73.8 mt-10 -59.64 -42.02 91.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.13 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 22.1 mt-30 -56.22 -54.86 40.19 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.698 0.285 . . . . 0.0 111.155 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.0 mt -60.76 -44.67 96.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' HB2' ' HH ' ' A' ' 44' ' ' TYR . 83.8 tttt -63.83 -41.9 97.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.865 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.296 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 96.5 mt -66.54 -21.67 66.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 103' ' ' LEU . 98.6 t -71.8 -40.99 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 109.91 173.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -72.3 -44.3 62.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.77 -23.53 65.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 177.257 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.687 0.28 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -64.13 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.128 0.489 . . . . 0.0 109.889 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.4 -50.64 72.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.15 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 28.1 mmtp -78.85 -18.51 53.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.69 77.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.624 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.1 mt -70.95 -22.41 62.22 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.183 174.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 18.4 t70 -67.48 -36.91 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -65.07 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.488 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.92 -74.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.519 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' ' 66' ' ' TRP . . . -95.36 46.96 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.373 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.08 -58.28 1.41 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.63 95.85 9.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.608 ' CG ' ' HA ' ' A' ' 66' ' ' TRP . 76.6 m-20 -116.21 144.71 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.464 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.4 t -164.54 -178.55 5.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.29 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.503 . . . . 0.0 110.579 -178.21 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.1 m170 . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 121.66 0.743 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -92.56 -49.24 6.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.809 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.599 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.59 -27.71 28.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.332 -170.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.45 -54.17 3.18 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 124.097 0.873 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 33.5 mm-40 -59.09 -63.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -62.14 -55.81 25.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.41 HG21 ' SD ' ' A' ' 99' ' ' MET . 90.9 m -69.14 -52.5 27.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -170.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.48 -44.11 45.71 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.634 ' HZ1' ' HB2' ' A' ' 39' ' ' LYS . 4.2 ttmp? -67.54 -33.59 75.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.799 0.333 . . . . 0.0 110.246 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.7 -50.42 66.3 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.314 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.15 -45.22 96.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.625 0.25 . . . . 0.0 111.102 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.52 -44.83 89.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.941 0.401 . . . . 0.0 111.249 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 43' ' ' LYS . 9.8 mtpm? -69.92 -34.1 73.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.394 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -64.73 -42.2 95.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 110.117 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.43 -42.56 92.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.495 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.61 -35.83 78.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.606 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.56 -43.57 89.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.388 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.472 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.65 16.29 1.67 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.21 94.11 47.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.934 0.397 . . . . 0.0 110.671 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -93.02 152.19 2.63 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.886 2.391 . . . . 0.0 112.253 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 148.26 24.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -83.11 133.37 48.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.601 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 58' ' ' VAL . 45.2 Cg_exo -56.87 -31.42 88.96 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.267 2.645 . . . . 0.0 112.519 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.59 -42.82 64.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.304 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.92 -38.65 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.414 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.43 -46.91 85.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.471 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 85.7 t -60.09 -44.26 94.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.498 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.77 88.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.0 tpt180 -65.38 -39.75 92.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.16 97.86 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.265 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 51.5 mt-10 -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.602 -0.352 . . . . 0.0 111.188 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.84 -46.09 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.4 -9.16 55.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.552 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.3 -65.3 1.58 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.819 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HA ' ' CG ' ' A' ' 24' ' ' ASN . 35.7 m0 55.35 -167.27 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.07 0.548 . . . . 0.0 111.957 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.866 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 54.4 m-80 -93.48 123.4 60.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.45 -38.2 82.78 Favored 'Trans proline' 0 CA--C 1.526 0.106 0 C-N-CA 122.996 2.464 . . . . 0.0 112.628 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -80.45 -33.39 36.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.561 . . . . 0.0 110.015 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.866 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 77.5 t80 -73.27 -43.99 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.535 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.9 m -59.51 -35.62 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -69.59 -40.36 76.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.695 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 63.2 mttt -54.76 -57.6 10.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.475 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.0 t -60.61 -37.46 75.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.06 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.49 73.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.1 51.42 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.15 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.695 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.6 m0 -64.62 -49.25 71.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.979 0.419 . . . . 0.0 110.107 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -34.41 74.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.743 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.6 -45.28 92.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.025 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.56 -49.03 79.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.427 0.632 . . . . 0.0 110.327 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 77' ' ' TRP . 61.9 t -60.77 -44.87 98.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.502 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.1 61.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.64 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -77.45 -9.31 58.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 110.798 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.88 29.01 13.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.098 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -100.12 171.01 8.08 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 86' ' ' ARG . 13.0 ptt180 -119.44 132.83 55.88 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.8 pt -112.73 138.55 41.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.174 0.512 . . . . 0.0 110.901 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.16 116.65 17.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.409 HG21 ' O ' ' A' ' 89' ' ' ILE . 16.8 tt -77.48 89.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 122.502 1.144 . . . . 0.0 110.092 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -67.62 -2.74 7.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.779 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.588 ' ND2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -160.12 88.35 1.88 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -177.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -96.35 29.15 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.523 2.816 . . . . 0.0 112.511 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.2 -55.52 33.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.599 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 20.3 m-85 -99.45 35.67 1.91 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -171.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' HE2' HE21 ' A' ' 100' ' ' GLN . 10.7 t80 -116.1 82.87 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -74.09 160.53 31.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.838 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -30.86 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.734 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.549 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.7 t80 -49.34 -51.64 33.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.546 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.41 ' SD ' HG21 ' A' ' 37' ' ' THR . 68.0 mtm -69.45 -39.14 77.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.467 HE21 ' HE2' ' A' ' 95' ' ' PHE . 73.4 mt-30 -61.88 -46.58 88.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.23 -35.21 79.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.167 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 57.5 mt-30 -59.11 -50.92 72.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 110.37 175.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.48 -45.23 84.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.475 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.44 -42.39 82.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.23 -49.57 55.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.578 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -62.94 -44.51 95.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.942 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.0 -32.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 110.415 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.5 tp -67.51 -59.22 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -32.72 69.99 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.713 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.401 171.13 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 54.6 mt -70.52 -40.4 77.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.215 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.07 -39.77 93.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.91 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 48.4 tptt -68.71 -36.04 77.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.309 . . . . 0.0 110.61 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -41.48 99.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 110.27 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.545 HD13 ' HG2' ' A' ' 60' ' ' ARG . 92.0 mt -66.76 -32.7 74.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.687 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 7.4 t70 -57.49 -44.55 85.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.018 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.49 -41.85 98.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -54.25 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.648 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -54.16 30.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.81 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -111.28 4.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.904 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.6 mtt -109.21 -42.67 4.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 51.1 71.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.902 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -105.28 -78.44 0.57 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.293 0.568 . . . . 0.0 109.796 178.703 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.499 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 5.0 m170 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -104.19 -58.18 1.92 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 110.485 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.485 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -87.4 -58.52 2.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.074 -171.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.36 -5.47 32.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.014 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.675 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 21.0 tt0 -103.19 -62.74 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.09 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.8 m -58.28 -55.78 30.54 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' HE1' ' A' ' 33' ' ' MET . 41.3 m -70.91 -30.17 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.83 0.348 . . . . 0.0 110.868 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.74 99.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HE3' ' CG ' ' A' ' 35' ' ' GLU . 92.3 mttt -58.88 -43.69 90.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.072 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 -44.38 97.87 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.594 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.32 -47.43 93.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.59 HD23 HG13 ' A' ' 52' ' ' VAL . 82.5 mt -64.36 -40.29 95.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 110.916 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.08 -34.23 76.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.461 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.412 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 76.3 t80 -65.62 -39.13 91.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.62 -44.18 96.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 110.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -62.62 -32.52 73.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.575 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.49 -34.46 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.305 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.3 mt -67.65 -41.68 83.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.353 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.25 -50.22 0.47 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.734 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 m -87.47 121.24 71.25 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.224 0.535 . . . . 0.0 112.226 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.8 165.8 8.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.59 HG13 HD23 ' A' ' 42' ' ' LEU . 8.9 p -107.03 147.79 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.45 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 13.8 m -102.16 137.05 19.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 27.0 Cg_exo -62.56 -24.79 75.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.241 2.627 . . . . 0.0 112.545 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -53.36 -45.92 69.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.825 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.84 -36.52 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.62 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.501 HG11 ' HB ' ' A' ' 74' ' ' VAL . 66.8 t -64.0 -49.73 80.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.73 -46.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.06 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HG2' HD13 ' A' ' 17' ' ' LEU . 20.8 tpt180 -66.4 -43.35 86.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -47.08 91.3 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.429 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.13 -33.6 76.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.639 0.257 . . . . 0.0 111.418 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.97 -57.19 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.52 -31.58 68.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.161 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.66 45.03 1.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.964 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -85.65 131.43 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.463 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t30 -65.65 123.45 84.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 26.3 Cg_exo -30.11 -44.67 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.748 4.299 . . . . 0.0 115.918 -176.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.05 -35.19 72.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.096 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 74' ' ' VAL . 57.4 t80 -74.92 -47.54 29.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 m -60.44 -39.8 88.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.879 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -62.41 -43.94 97.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.927 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -56.53 -58.75 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.571 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 31.8 t -59.65 -41.59 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.564 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.07 88.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.438 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.08 -37.98 94.82 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.44 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.675 ' CZ2' ' HG3' ' A' ' 35' ' ' GLU . 11.1 m0 -66.43 -53.78 31.7 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.13 -40.29 64.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.986 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -55.24 -54.57 41.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.796 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 58.5 mttt -73.05 -39.3 66.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -42.21 92.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.541 0.21 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.83 93.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.185 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -78.92 -9.22 59.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.57 39.39 41.54 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.217 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 55.4 m-20 -98.61 152.16 19.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.38 149.72 48.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.152 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 pt -136.39 166.03 27.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.89 102.43 14.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 89' ' ' ILE . 4.0 tt -103.28 -6.94 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.068 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 90' ' ' LYS . 3.8 tptp 66.11 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.0 -169.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.651 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -153.26 126.86 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.21 -59.06 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.279 1.986 . . . . 0.0 111.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' A' ' 91' ' ' ASN . 27.7 mm-40 57.21 -81.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 172.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -85.08 53.44 2.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -111.27 71.15 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -61.01 144.8 52.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.66 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 m -53.55 -38.18 63.6 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.523 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.23 -37.93 78.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.672 0.273 . . . . 0.0 111.231 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.2 mtm -75.56 -41.09 55.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.35 -47.72 82.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.768 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 13.5 tp10 -69.39 -28.0 65.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.675 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -66.24 -49.08 68.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.337 0.589 . . . . 0.0 109.819 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.44 -43.6 98.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.238 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 34.6 tttm -58.86 -37.08 75.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.144 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.561 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.5 tt0 -58.31 -54.67 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 12' ' ' ALA . 6.1 tt -56.13 -45.3 79.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.364 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.73 -42.46 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.3 tp -66.58 -44.91 80.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.992 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 52.7 mt-10 -49.15 -45.46 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.353 -172.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -63.28 -47.62 91.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.104 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.72 -36.76 84.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.495 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -66.85 -46.97 73.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.26 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.476 . . . . 0.0 110.314 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.411 HD13 ' HG2' ' A' ' 60' ' ' ARG . 21.6 tp -66.79 -34.53 78.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.419 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.93 -42.31 97.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.119 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.13 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.42 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.38 -65.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.92 -51.74 55.05 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.903 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.71 -117.17 4.97 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 ptm -165.28 117.87 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.168 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -95.68 93.61 7.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.025 0.441 . . . . 0.0 110.662 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -78.8 83.15 4.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.617 0.722 . . . . 0.0 109.68 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.176 -177.83 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.466 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 26.4 m-70 . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 m -103.3 -80.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.312 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 10.4 ttp -109.34 -17.66 13.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.737 0.779 . . . . 0.0 108.907 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -79.96 -0.25 34.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.307 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' CB ' ' A' ' 31' ' ' HIS . 3.5 tm-20 -102.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.782 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -73.36 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.9 m -62.17 -32.31 72.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.273 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.02 89.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.836 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HD3' HD13 ' A' ' 87' ' ' ILE . 58.4 mttp -57.0 -44.35 82.67 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.79 -49.08 82.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.01 -42.47 88.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.817 0.342 . . . . 0.0 111.061 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.53 -44.51 85.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.46 0.648 . . . . 0.0 110.237 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 57.9 tttp -71.29 -39.38 71.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.511 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.43 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 51.2 t80 -63.24 -38.95 93.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.29 -41.81 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.71 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 51.1 m80 -61.84 -36.05 80.06 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.077 0.465 . . . . 0.0 109.945 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.63 -51.13 68.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 89.4 mt -54.63 -44.06 72.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.429 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.577 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 144.6 -7.29 1.73 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.159 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.15 98.05 6.02 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 121.311 0.577 . . . . 0.0 110.951 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 72.6 Cg_endo -87.74 89.13 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.548 2.166 . . . . 0.0 112.447 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.4 129.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.997 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -92.7 157.82 39.15 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 Cg_endo -52.04 -34.02 55.51 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.31 -50.52 50.48 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.208 0.528 . . . . 0.0 110.878 174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.64 -37.51 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.466 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.46 -47.65 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' PRO . 85.9 t -62.01 -54.27 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.9 tpp180 -65.4 -45.48 83.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.026 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.07 99.52 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.555 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.9 mt-10 -68.57 -26.18 65.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.56 0.219 . . . . 0.0 111.208 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.33 -46.46 11.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 111.14 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -78.35 -26.2 46.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.76 46.29 3.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.004 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -74.93 164.17 26.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.489 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.47 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 57.8 t30 -69.91 127.85 92.18 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 82.4 Cg_exo -45.25 -47.67 12.35 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.15 2.566 . . . . 0.0 113.018 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.62 -34.18 67.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.857 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.414 ' O ' HG23 ' A' ' 74' ' ' VAL . 76.8 t80 -71.34 -59.57 2.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.05 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 24.7 m -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.584 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.54 -49.9 73.48 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -72.73 -40.74 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.613 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.441 HG21 ' CZ3' ' A' ' 77' ' ' TRP . 96.0 t -64.19 -36.07 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.699 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.99 93.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.159 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.266 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.441 ' CZ3' HG21 ' A' ' 74' ' ' VAL . 27.7 m0 -65.98 -48.28 71.76 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.33 82.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.094 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -57.32 -48.53 78.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 0.0 110.763 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.68 -40.5 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.457 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 77' ' ' TRP . 70.5 t -68.47 -35.15 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.589 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.55 80.58 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -69.81 -21.05 63.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.308 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.66 35.53 9.23 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.14 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.3 -178.15 4.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.958 0.409 . . . . 0.0 110.348 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -111.26 138.45 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.513 HD13 ' HD3' ' A' ' 39' ' ' LYS . 39.2 pt -120.43 150.65 23.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 -172.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.26 101.71 9.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.249 0.547 . . . . 0.0 109.723 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.622 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 1.4 tt -89.57 -71.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.076 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 89' ' ' ILE . 43.1 mmtm 175.66 -59.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -172.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -169.52 139.59 1.73 Allowed Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.06 -178.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.79 24.18 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.114 2.543 . . . . 0.0 114.071 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 91' ' ' ASN . 36.2 tt0 -75.0 -26.19 59.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.605 ' HE1' ' HD3' ' A' ' 43' ' ' LYS . 98.4 m-85 67.43 -77.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.939 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 26.0 p90 -170.21 -173.76 1.57 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.651 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 m -75.89 155.06 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.926 0.393 . . . . 0.0 111.465 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -25.82 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.382 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -43.34 -56.43 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.276 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.718 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 2.1 mpt? -64.23 -44.77 90.82 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.063 -174.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.455 ' HG3' ' CE1' ' A' ' 95' ' ' PHE . 24.4 mt-30 -57.62 -49.66 75.71 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 -35.21 75.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.648 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 5.8 tp-100 -61.38 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.601 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 107' ' ' VAL . 10.0 mp -57.26 -39.55 75.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.725 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -57.77 -52.74 64.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.998 0.428 . . . . 0.0 111.482 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.33 65.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 86.5 mt -73.51 -31.65 63.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 103' ' ' LEU . 29.0 t -90.03 -13.66 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 110.482 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.28 -31.78 72.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.395 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.14 86.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.353 175.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.95 0.405 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.4 -30.53 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.588 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.761 ' HG2' HH22 ' A' ' 60' ' ' ARG . 3.6 tm-20 -65.87 -42.63 90.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.626 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 70.5 mmtt -75.08 -20.17 59.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.26 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.08 -39.34 86.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.74 HD12 ' HG2' ' A' ' 60' ' ' ARG . 4.0 mm? -65.61 -33.0 74.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.612 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.14 -36.63 80.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.252 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.2 -43.17 95.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.665 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.87 -56.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.708 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.46 -49.58 30.75 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.602 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 -71.71 2.75 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.998 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.544 ' HG3' ' H ' ' A' ' 24' ' ' ASN . 10.2 tpt -134.53 175.5 9.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -172.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.544 ' H ' ' HG3' ' A' ' 23' ' ' MET . 4.7 p-10 -69.24 168.51 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.069 0.462 . . . . 0.0 111.432 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 3.0 t -58.97 120.48 9.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.607 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.135 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.6 m80 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.9 m -83.69 -52.41 6.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.903 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.498 ' HE2' ' C ' ' A' ' 33' ' ' MET . 0.7 OUTLIER -51.48 -35.47 40.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.949 -175.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.26 -66.14 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 111.58 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 mm-40 -54.12 -64.69 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.472 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 p -67.48 -42.8 82.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' ' SD ' ' A' ' 33' ' ' MET . 33.4 m -79.3 -53.33 7.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.5 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.842 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.714 ' HD3' HG12 ' A' ' 89' ' ' ILE . 87.2 mttt -64.57 -37.91 89.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.066 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.53 -50.28 69.38 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.342 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 47.9 mt -66.66 -45.41 88.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.994 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.478 HD13 HG11 ' A' ' 74' ' ' VAL . 79.4 mt -59.83 -45.85 91.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.627 0.251 . . . . 0.0 111.357 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.12 -44.26 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.893 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 58.4 t80 -61.28 -43.78 98.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.249 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 86.8 mt -62.14 -43.02 99.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.403 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 56.7 m80 -62.6 -37.71 87.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.488 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.95 -38.36 90.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.119 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.2 mt -66.4 -25.16 66.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.11 1.91 14.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.176 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.6 95.75 9.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 77.2 Cg_endo -86.96 94.3 0.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.281 1.987 . . . . 0.0 112.76 -177.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 117.13 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.499 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -99.41 162.06 22.55 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.471 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.2 Cg_exo -53.06 -37.1 78.75 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.186 2.591 . . . . 0.0 112.955 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -56.74 -42.33 79.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.9 -49.81 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.91 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 54' ' ' PRO . 57.7 t -63.06 -47.7 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.76 93.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.761 HH22 ' HG2' ' A' ' 14' ' ' GLU . 5.4 tpp180 -66.16 -42.11 89.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.976 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.78 -36.88 81.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.176 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -71.79 -38.22 70.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.786 0.326 . . . . 0.0 110.672 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -63.32 -50.76 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 111.233 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.563 ' OE2' ' HD2' ' A' ' 60' ' ' ARG . 63.0 mt-10 -87.21 -21.69 25.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' HB ' ' A' ' 25' ' ' THR . . . 82.51 47.12 6.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.159 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -70.35 158.67 35.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.72 135.03 95.43 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.7 -24.69 23.97 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.14 -53.05 62.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.917 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.666 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 51.8 t80 -71.52 -43.52 66.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.124 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 m -58.26 -41.62 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -69.57 -42.26 74.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.666 ' CE ' ' HA ' ' A' ' 70' ' ' PHE . 53.4 mtmt -56.24 -58.71 6.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 42' ' ' LEU . 54.2 t -62.92 -40.05 87.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.543 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.63 88.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 110.516 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -65.19 -40.9 97.06 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.804 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.455 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 43.8 m0 -62.27 -44.59 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.121 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.41 96.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -45.71 88.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HD3' HG22 ' A' ' 87' ' ' ILE . 28.8 mtpp -61.62 -51.73 67.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 77' ' ' TRP . 19.5 t -67.96 -35.53 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.31 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.7 -33.76 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -79.18 -14.18 59.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.373 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.17 26.97 11.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.848 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -111.01 135.11 52.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -62.13 145.92 52.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.627 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.486 HG22 ' HD3' ' A' ' 80' ' ' LYS . 15.9 pt -103.61 129.99 54.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 88' ' ' LEU . 2.5 pt? -68.12 115.37 7.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.484 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.714 HG12 ' HD3' ' A' ' 39' ' ' LYS . 25.1 mt -121.7 137.38 55.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -59.24 -41.26 88.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 153.92 126.39 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 125.401 1.688 . . . . 0.0 109.19 166.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.16 -63.05 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.3 2.0 . . . . 0.0 110.943 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 68.23 -60.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.218 0.949 . . . . 0.0 112.545 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.97 6.89 23.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.812 0.339 . . . . 0.0 110.986 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -73.25 93.47 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m -111.69 -170.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 0.0 112.875 -166.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.5 -54.85 19.11 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.827 -169.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -56.36 -40.37 74.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.341 0.4 . . . . 0.0 111.786 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.3 mtt -66.28 -51.24 59.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.864 0.364 . . . . 0.0 110.743 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.0 -44.42 84.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -65.6 -45.57 82.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.856 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.427 ' O ' HD11 ' A' ' 106' ' ' LEU . 18.3 tp60 -56.46 -53.71 54.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.127 0.489 . . . . 0.0 110.617 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.0 -44.85 94.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.068 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 7.1 ttpm? -67.14 -34.75 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.68 -48.67 73.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.011 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 102' ' ' GLN . 10.1 mp -59.69 -37.22 78.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.2 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.2 t -74.76 -37.87 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 110.69 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.1 tp -58.53 -49.22 78.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.649 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.85 -12.99 61.87 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.917 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.044 0 CA-C-O 121.119 0.485 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.64 -32.31 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.465 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.55 -30.31 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.68 -35.17 76.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.574 HD11 ' HZ2' ' A' ' 66' ' ' TRP . 35.8 tp -61.01 -44.02 98.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.683 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.23 -35.25 79.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.28 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' HE2' ' SD ' ' A' ' 99' ' ' MET . 1.2 m-85 -64.65 -47.18 79.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.59 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -87.97 -59.73 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 111.398 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.77 42.32 1.99 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.28 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.74 78.21 1.05 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.238 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.3 ttt 69.25 10.65 7.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.292 0.637 . . . . 0.0 110.56 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.07 82.4 3.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.843 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.5 t -101.51 -12.5 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.728 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.513 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 p -97.35 -79.86 0.45 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 111.651 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.512 ' HE3' ' HA ' ' A' ' 33' ' ' MET . 2.9 tpt -51.75 -62.28 1.73 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.747 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . 4.0 p-10 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.619 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.4 tt0 -102.62 -73.99 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.601 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.6 p -61.25 -39.18 89.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.508 HG21 ' HE2' ' A' ' 99' ' ' MET . 57.6 m -70.15 -41.11 74.27 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.445 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.12 -36.68 84.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.502 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.18 -43.28 87.44 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.73 96.61 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.906 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 37' ' ' THR . 90.7 mt -59.03 -50.52 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.519 . . . . 0.0 110.455 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.67 -48.88 78.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.532 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -72.11 -29.85 64.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.568 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.77 -48.84 75.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.651 0.262 . . . . 0.0 111.168 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.86 -32.09 72.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.689 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -66.34 -37.13 84.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.22 -36.66 84.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.35 -46.82 84.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.831 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.71 -55.49 0.36 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.369 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.23 113.48 60.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.097 0.475 . . . . 0.0 112.172 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.82 155.22 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.813 2.342 . . . . 0.0 111.772 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.93 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 m -83.44 149.15 57.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.42 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.19 -28.99 64.28 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.088 2.525 . . . . 0.0 112.195 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -46.17 -51.67 13.7 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.718 0.636 . . . . 0.0 110.569 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -63.27 -47.78 90.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.462 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 74' ' ' VAL . 57.8 t -58.04 -53.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.438 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.6 -41.51 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.33 76.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.201 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -68.36 -45.39 72.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.735 0.302 . . . . 0.0 110.285 176.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.71 85.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.834 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.55 -46.01 64.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.218 0.532 . . . . 0.0 110.279 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -69.68 -50.47 43.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.493 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -85.44 -48.09 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.574 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.61 -59.67 0.69 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.574 ' HZ2' HD11 ' A' ' 17' ' ' LEU . 34.7 m0 51.96 -104.57 0.19 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 111.911 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 18.8 t-20 -171.61 131.64 0.77 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.68 -56.87 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.695 2.263 . . . . 0.0 113.275 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.63 -37.99 83.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.703 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 61.1 t80 -64.68 -42.99 94.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.215 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.7 m -63.66 -40.99 98.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.435 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -70.19 -37.49 75.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.25 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -52.58 -60.18 3.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' HB ' HG11 ' A' ' 57' ' ' VAL . 24.2 t -61.45 -39.37 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.261 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.98 85.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.95 -39.62 94.99 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.202 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.449 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 m0 -62.56 -48.34 79.89 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.19 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.992 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.19 -53.04 61.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.091 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.18 -51.52 69.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -39.16 84.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.33 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.48 -33.49 71.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.957 0.408 . . . . 0.0 110.869 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -74.12 -19.39 60.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.387 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.46 32.53 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.127 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 85' ' ' ASN . 0.7 OUTLIER -96.89 164.96 12.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.03 148.04 26.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.158 0.504 . . . . 0.0 110.727 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.53 145.06 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -72.61 129.3 37.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.702 0.763 . . . . 0.0 112.051 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.7 tt -135.26 1.73 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.591 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt 66.05 -70.25 0.1 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.893 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -161.5 136.87 5.66 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.961 -178.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 22.6 Cg_exo -63.84 78.51 0.15 Allowed 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 122.945 2.43 . . . . 0.0 112.715 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -81.82 -38.76 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.486 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -99.8 13.8 32.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.214 -170.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.7 96.03 5.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.46 0.648 . . . . 0.0 109.538 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.9 p -100.72 166.69 10.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.311 1.053 . . . . 0.0 112.197 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -45.89 -40.44 10.05 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.639 -2.073 . . . . 0.0 112.331 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -59.91 -47.36 86.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.939 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.508 ' HE2' HG21 ' A' ' 37' ' ' THR . 14.4 mmt -64.39 -45.25 88.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.205 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -60.34 -58.25 9.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.279 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -31.9 70.42 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.197 0.311 . . . . 0.0 111.788 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -59.8 -58.24 9.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.541 0.686 . . . . 0.0 109.932 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.89 -37.46 87.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.454 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.59 -60.17 3.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.591 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.61 -27.02 66.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.466 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.95 -47.41 80.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.88 0.372 . . . . 0.0 110.596 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -77.75 -24.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.289 0.566 . . . . 0.0 110.54 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.3 tp -67.93 -17.16 64.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.54 -81.57 0.2 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.09 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.663 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mm -60.19 -46.57 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.381 . . . . 0.0 111.544 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.9 -35.44 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.277 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -79.27 -30.97 43.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.73 0.3 . . . . 0.0 110.435 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.33 94.0 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.64 HD12 ' HG2' ' A' ' 60' ' ' ARG . 88.2 mt -68.61 -27.46 66.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.97 -42.02 77.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.886 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.404 ' HZ ' ' OE1' ' A' ' 102' ' ' GLN . 36.9 m-85 -59.62 -53.14 61.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.337 174.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -64.17 -44.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.836 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.33 47.24 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.606 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.57 51.1 4.18 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -87.29 -3.58 59.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.689 0.396 . . . . 0.0 110.595 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t30 66.39 -74.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.252 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -179.09 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.873 -176.801 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 12.0 m170 . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -54.21 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.688 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -24.59 34.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 31' ' ' HIS . 13.9 t70 -53.91 -60.32 3.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.701 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.09 -43.27 91.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -68.06 -50.52 54.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.969 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 41' ' ' ILE . 53.7 m -73.29 -42.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.715 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.41 -48.91 75.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.91 -34.23 77.48 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.727 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.58 92.68 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.575 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 37' ' ' THR . 76.0 mt -59.02 -46.18 91.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.914 0.387 . . . . 0.0 110.488 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 94.3 mt -58.16 -47.93 81.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.527 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.25 -35.84 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.024 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' CE2' HD13 ' A' ' 48' ' ' LEU . 66.1 t80 -65.5 -48.83 71.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.407 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 84.5 mt -61.84 -38.38 87.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.978 0.418 . . . . 0.0 110.715 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -50.97 -51.45 52.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.45 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.0 -7.96 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 HD13 ' CE2' ' A' ' 44' ' ' TYR . 74.5 mt -77.14 -36.24 55.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.56 4.08 13.72 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.347 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 43.9 t -129.42 93.17 36.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 110.773 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.27 162.79 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.198 2.599 . . . . 0.0 111.773 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.81 137.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.743 0.306 . . . . 0.0 110.794 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' VAL . 10.3 m -73.36 127.63 88.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 23.4 Cg_endo -63.1 -29.08 74.32 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.577 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -53.06 -53.36 51.35 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 53' ' ' SER . 29.7 m -69.59 -26.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -176.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.3 -41.01 80.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 54' ' ' PRO . 63.6 t -59.63 -54.19 37.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.187 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.38 86.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.328 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.64 ' HG2' HD12 ' A' ' 17' ' ' LEU . 3.4 tpp180 -63.72 -44.13 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.554 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.448 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -59.28 -47.61 89.97 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.199 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.4 -23.51 61.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.807 0.337 . . . . 0.0 110.807 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -80.04 -45.25 18.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.959 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG2' ' HD3' ' A' ' 60' ' ' ARG . 38.0 mm-40 -75.42 -17.07 60.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 0.0 110.61 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.8 48.38 4.71 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.128 176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 49.5 m0 -70.72 -81.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.606 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 63.2 t30 166.18 130.79 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.606 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 40.7 Cg_exo -35.91 -48.05 1.06 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.932 3.088 . . . . 0.0 114.403 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 22.4 mm-40 -69.85 -38.44 76.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -69.42 -52.29 28.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.735 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 m -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.19 -54.66 44.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.75 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 49.7 mttm -63.81 -47.62 80.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -173.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.12 -39.56 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.81 92.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -38.32 95.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.186 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.6 m0 -65.17 -49.9 68.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.08 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.276 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.531 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 9.2 tp10 -56.83 -51.7 67.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 88.1 mttt -70.21 -29.49 66.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.471 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 77' ' ' TRP . 78.5 t -71.98 -43.13 68.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.651 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -43.86 75.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.045 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -70.13 -31.06 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 111.001 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.74 26.54 19.57 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.998 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -95.33 0.93 54.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.861 0.839 . . . . 0.0 110.333 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.8 mtm-85 64.47 156.6 0.08 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.387 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 80' ' ' LYS . 20.8 pt -119.02 17.63 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.212 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt 46.64 -151.35 0.08 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.975 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 tt -170.99 132.57 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 168.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -95.08 -18.87 20.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.738 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -123.37 102.35 36.59 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.04 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.93 -26.61 58.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.355 2.037 . . . . 0.0 112.856 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.35 118.06 21.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -79.54 -77.7 0.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.24 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -173.23 168.73 4.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.611 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.519 ' HB3' ' HE2' ' A' ' 99' ' ' MET . 40.0 t -54.86 139.99 38.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.378 1.085 . . . . 0.0 111.667 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.8 m -57.92 -21.88 45.91 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.698 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -60.15 -49.52 77.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.519 ' HE2' ' HB3' ' A' ' 96' ' ' SER . 5.4 mpp? -64.96 -28.73 69.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.714 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.09 -51.72 55.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -37.35 74.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.404 ' OE1' ' HZ ' ' A' ' 19' ' ' PHE . 29.6 tt0 -63.39 -53.24 55.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.734 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.47 -42.98 99.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.168 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -52.08 -55.88 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.928 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.71 -32.25 69.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.047 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.01 -46.51 88.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.12 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.9 -41.57 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.619 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.74 -41.2 90.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.217 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.85 5.48 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 112.042 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 110.038 172.876 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.65 -36.86 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.637 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.89 -43.91 67.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.839 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -70.86 -31.42 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.296 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.58 80.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.172 0.51 . . . . 0.0 110.212 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.33 -34.18 75.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -62.26 -41.04 98.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.053 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -73.55 -58.82 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.557 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.0 mt -72.09 -49.18 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.759 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.66 10.63 8.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.263 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 70.89 2.92 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.428 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 22.2 ptp -61.5 -28.82 69.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.306 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t30 64.29 -83.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.771 0.67 . . . . 0.0 111.278 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -99.4 10.5 41.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 42.3 t . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' HE1' ' HD1' ' A' ' 70' ' ' PHE . 5.4 m170 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -95.67 -80.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 110.979 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 37' ' ' THR . 7.1 ptm -102.66 -14.91 16.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.959 0.885 . . . . 0.0 109.007 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -80.35 10.5 4.51 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.827 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.7 tm-20 -103.06 -73.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.479 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -76.37 -52.51 9.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.287 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 33' ' ' MET . 38.6 m -56.14 -46.21 79.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 0.0 111.005 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.95 99.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.04 -38.45 91.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.431 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -37.66 91.5 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.386 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.607 HG22 HD13 ' A' ' 103' ' ' LEU . 63.8 mt -59.12 -46.47 91.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.677 0.275 . . . . 0.0 110.646 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.43 -42.83 92.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -70.41 -36.5 74.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 65.9 t80 -67.97 -37.38 81.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 HD23 HD22 ' A' ' 103' ' ' LEU . 89.0 mt -65.81 -35.05 79.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.792 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -62.0 -36.43 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 18.9 t70 -61.82 -37.96 86.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.484 HD11 HD21 ' A' ' 45' ' ' LEU . 93.2 mt -72.91 -20.27 61.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.99 -32.88 4.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.65 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.9 108.2 33.3 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 0.0 111.867 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 94.4 Cg_endo -88.63 137.01 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -89.22 103.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.856 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -62.05 139.07 95.94 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.338 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' HG21 ' A' ' 58' ' ' VAL . 14.9 Cg_endo -58.43 -27.69 82.59 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -42.41 98.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.232 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -65.48 -36.29 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.88 -47.96 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.189 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 54' ' ' PRO . 74.3 t -62.63 -44.12 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.357 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.95 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.113 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 3.7 mmp_? -67.1 -43.85 81.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -61.77 -32.49 81.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.51 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.74 -27.07 44.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.477 0.18 . . . . 0.0 111.46 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -81.71 -50.48 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.182 0.515 . . . . 0.0 110.602 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -83.68 -23.84 31.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.484 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.33 56.73 2.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.728 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.489 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 44.9 m0 -71.92 175.84 5.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 110.635 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -82.8 154.57 68.01 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.316 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.79 -60.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.184 2.59 . . . . 0.0 112.579 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -60.46 -33.93 73.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.075 0.464 . . . . 0.0 110.96 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.557 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 10.5 t80 -65.55 -57.31 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.475 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 m -61.95 -39.54 92.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 110.819 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -61.34 -57.18 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.554 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.46 -47.44 67.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.073 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.416 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 93.7 t -61.8 -39.66 84.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.609 0.242 . . . . 0.0 110.94 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.09 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.0 110.417 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.53 93.56 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.141 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.464 ' O ' HG21 ' A' ' 81' ' ' VAL . 17.4 m0 -68.93 -44.47 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.47 87.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.43 -53.09 56.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.639 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.63 -37.81 88.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.394 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 77' ' ' TRP . 93.1 t -70.1 -46.04 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.463 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.37 -44.33 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.545 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -67.06 -32.3 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.0 45.79 2.17 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.624 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.18 167.26 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -91.45 132.25 36.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.429 0.633 . . . . 0.0 111.073 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.18 90.49 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.499 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 110.89 5.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.493 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 tt -79.41 98.97 3.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.729 0.776 . . . . 0.0 109.715 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.708 ' HD3' ' H ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -67.1 -13.94 62.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.042 -175.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.95 90.48 5.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.41 0.624 . . . . 0.0 111.663 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.92 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.421 2.08 . . . . 0.0 110.766 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 56.37 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 170.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -86.2 24.49 1.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -98.15 103.9 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' A' ' 99' ' ' MET . 31.4 t -78.38 157.74 28.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.927 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 98' ' ' TYR . 14.3 t -65.97 -44.7 84.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.206 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.419 ' N ' HG23 ' A' ' 97' ' ' THR . 49.4 t80 -62.76 -27.12 69.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.889 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.516 ' HG3' ' HB3' ' A' ' 96' ' ' SER . 61.2 mtt -64.32 -47.72 78.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -62.91 -50.01 72.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.938 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 105' ' ' GLU . 48.0 mt-10 -59.22 -41.96 89.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.366 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.773 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -54.67 -55.95 24.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.502 . . . . 0.0 110.709 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.607 HD13 HG22 ' A' ' 41' ' ' ILE . 71.6 mt -60.62 -45.06 95.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.22 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -64.39 -47.63 78.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 38.8 mm-40 -64.85 -34.1 77.56 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.51 -47.66 83.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.29 -38.73 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.41 -48.15 76.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.39 -29.43 69.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.899 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.8 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.044 172.012 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -64.72 -45.04 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.685 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.752 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -75.18 -33.66 61.48 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.651 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.45 99.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 109.791 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.617 HD13 ' HG2' ' A' ' 60' ' ' ARG . 25.0 tp -64.56 -38.93 92.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.859 175.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.04 -29.82 70.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.026 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.3 -52.0 60.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.691 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.13 -48.29 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.13 31.5 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.936 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.07 28.87 4.89 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.615 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -65.8 -35.98 82.22 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.6 m120 68.57 -44.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.619 0.768 . . . . 0.0 111.771 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.653 HG21 ' H ' ' A' ' 26' ' ' SER . 1.6 m -99.07 -152.45 0.41 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.653 ' H ' HG21 ' A' ' 25' ' ' THR . 15.4 m . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 120.89 0.376 . . . . 0.0 110.041 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.506 0.194 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.5 m -103.58 -80.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.504 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 2.2 tpt -57.48 -52.03 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.044 -175.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -83.91 1.22 44.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.453 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.4 -77.44 0.57 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.387 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -63.3 -48.06 79.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 m -71.17 -30.67 66.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 110.552 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.06 83.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -56.35 -44.64 80.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.384 174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.43 -44.18 97.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.257 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.426 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 67.3 mt -66.2 -44.85 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 110.864 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.55 -37.7 84.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.701 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -66.33 -49.41 67.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.988 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' HD11 ' A' ' 48' ' ' LEU . 71.7 t80 -57.6 -44.75 85.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.575 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 94.4 mt -60.31 -47.98 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.618 0.247 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.529 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m80 -62.17 -36.77 82.86 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.751 177.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.92 -32.83 73.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.114 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 44' ' ' TYR . 81.1 mt -67.68 -16.72 64.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.268 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.37 1.45 35.33 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.109 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.46 98.04 15.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 97.8 Cg_endo -84.0 104.88 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.232 1.954 . . . . 0.0 112.855 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 101.03 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.72 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -66.05 140.54 97.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.336 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 52.3 Cg_exo -55.75 -34.86 92.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.262 2.641 . . . . 0.0 112.506 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.93 -48.72 72.76 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.828 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.77 -38.43 81.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.275 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.88 -45.48 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.823 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.499 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 96.8 t -62.41 -49.08 85.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.944 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.76 94.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.12 0.486 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.617 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.3 tpp180 -66.96 -40.42 87.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.89 -40.7 99.21 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.375 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 36.8 mt-10 -68.14 -31.11 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.581 0.229 . . . . 0.0 111.206 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -76.16 -53.38 8.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 111.267 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.731 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.89 48.71 2.42 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.751 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.644 ' HB3' ' HD2' ' A' ' 70' ' ' PHE . 48.7 m0 -81.13 0.31 36.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 93.1 m-20 72.94 145.05 0.11 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.835 0.454 . . . . 0.0 111.02 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.29 -41.29 79.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.703 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 44.9 mt-10 -63.26 -56.05 19.79 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.657 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HD2' ' HB3' ' A' ' 66' ' ' TRP . 89.7 t80 -60.67 -47.01 88.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.826 0.346 . . . . 0.0 110.631 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 31.1 m -58.78 -41.24 86.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.978 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.98 -43.49 95.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.779 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 67.9 mttm -62.52 -53.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.538 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 46.5 t -59.7 -41.48 85.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.846 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -61.42 -40.82 95.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.388 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -61.48 -42.41 99.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.393 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.538 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 15.2 m0 -62.13 -44.77 95.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.254 0.549 . . . . 0.0 109.572 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.58 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 48.9 mt-10 -59.21 -48.14 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.354 0.409 . . . . 0.0 110.97 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.7 mtpp -60.97 -52.31 65.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 77' ' ' TRP . 62.1 t -61.38 -35.68 68.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.39 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.14 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.1 t -61.76 -48.26 81.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.453 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.77 -10.8 3.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -87.75 107.39 18.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -58.07 156.67 9.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.653 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.54 141.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.75 111.75 24.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 110.763 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 91' ' ' ASN . 14.6 tt -91.78 140.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -94.28 -8.66 38.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.562 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.5 p30 -149.16 76.61 9.35 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.425 0.631 . . . . 0.0 111.297 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.05 -6.24 17.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.512 2.142 . . . . 0.0 112.477 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.55 -10.92 59.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 91' ' ' ASN . 67.1 m-85 -89.72 -18.23 26.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -89.1 91.64 8.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -86.7 173.35 9.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.653 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -66.09 -26.89 67.69 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -45.82 -49.48 15.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.808 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.34 -43.07 87.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -46.45 89.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 97' ' ' THR . 38.2 mm-40 -55.16 -52.08 64.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.504 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 48.2 mt-30 -58.82 -54.04 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.993 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 92.5 mt -59.28 -49.62 77.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.263 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.91 -46.29 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.041 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 6.2 tp10 -65.43 -31.51 72.65 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.54 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 83.3 mt -72.53 -29.71 63.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 103' ' ' LEU . 82.1 t -78.11 -35.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.511 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.64 -42.42 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 2.3 mm-40 -81.99 12.67 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.662 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.25 -56.72 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.989 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.21 -38.34 76.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.393 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -74.24 -34.18 63.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.715 0.293 . . . . 0.0 110.75 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 0.0 110.224 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.9 mm? -64.58 -33.18 75.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.553 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.89 -39.68 87.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.83 -46.92 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.33 -50.05 58.03 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.299 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.67 -8.2 6.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.574 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' MET . 26.8 ttt 63.53 23.62 13.7 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.663 0.744 . . . . 0.0 110.312 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -133.03 163.15 29.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.648 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -125.08 -158.57 0.84 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 25' ' ' THR . 38.3 m . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 123.26 0.624 . . . . 0.0 112.185 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.522 ' HD1' ' CG ' ' A' ' 34' ' ' ASP . 6.4 p80 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 121.378 0.609 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 m -86.38 -14.99 41.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.786 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 4.3 tpt -60.99 -64.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.522 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 11.4 p-10 -79.53 -26.95 41.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.136 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.01 -77.39 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 13.2 m -71.27 -49.82 39.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.9 0.381 . . . . 0.0 111.505 -172.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 33' ' ' MET . 17.5 m -73.18 -55.18 6.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.864 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -68.11 -37.45 81.17 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HZ1' ' HB2' ' A' ' 39' ' ' LYS . 4.4 ttmp? -67.33 -34.97 78.45 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.742 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.23 99.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.473 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -65.89 -47.76 84.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.44 -44.57 92.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.912 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -69.96 -30.97 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.516 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 56.4 t80 -67.07 -46.15 75.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.151 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.89 -41.99 98.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.454 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.481 ' HB2' HG12 ' A' ' 81' ' ' VAL . 41.0 t-80 -50.21 -51.68 42.16 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.81 -2.6 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.472 -175.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 64.3 mt -84.93 -21.83 29.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.218 0.532 . . . . 0.0 109.577 168.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.41 0.95 14.02 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.704 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.24 98.12 47.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.923 0.362 . . . . 0.0 111.106 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.84 157.87 15.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.918 2.412 . . . . 0.0 111.788 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.36 137.98 49.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.62 0.248 . . . . 0.0 110.622 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 24.5 m -85.0 144.43 41.53 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 23.8 Cg_exo -63.41 -32.9 71.24 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.103 2.535 . . . . 0.0 112.771 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -42.35 66.68 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.93 -47.84 91.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.72 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.5 t -64.03 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.497 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.27 -58.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.488 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -30.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.551 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -67.86 -46.84 70.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.77 -34.69 90.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.98 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.05 -29.87 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.749 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -86.1 -49.78 7.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.555 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.07 -28.25 66.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.867 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.5 55.22 1.7 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.028 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 70' ' ' PHE . 44.5 m0 -81.37 -78.34 0.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.451 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 36.1 p30 175.45 160.79 0.41 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.548 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 86.5 Cg_endo -79.89 8.69 3.9 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.046 1.831 . . . . 0.0 112.933 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.33 -69.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.647 -174.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -59.62 -38.23 80.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.423 0.63 . . . . 0.0 110.198 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.882 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.36 -56.81 13.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.329 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.541 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.2 t -59.66 -35.84 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.69 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.62 86.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.93 -37.71 92.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.362 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.541 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 21.9 m0 -66.0 -44.88 83.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.83 75.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.23 -50.29 74.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.423 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -63.55 -39.31 94.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.337 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 46' ' ' HIS . 47.7 t -61.4 -51.14 76.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.313 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.92 93.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.76 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.39 -39.97 92.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.92 6.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.701 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -100.94 -166.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 110.468 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -94.6 154.77 17.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.92 0.391 . . . . 0.0 110.644 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.02 140.89 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -91.4 119.03 31.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.989 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.418 HG13 ' HD2' ' A' ' 39' ' ' LYS . 8.7 tt -112.36 151.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -96.47 -30.03 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.763 0.316 . . . . 0.0 111.081 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 15.0 m-80 -142.0 92.34 7.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -22.52 18.59 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.464 2.11 . . . . 0.0 113.029 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.49 -5.32 59.3 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 91' ' ' ASN . 8.6 m-85 -71.74 -20.06 61.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.0 110.542 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -79.81 88.74 5.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 t -75.92 163.02 27.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.578 -171.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -31.17 69.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.74 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.08 -55.28 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.065 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.472 ' HE3' HG21 ' A' ' 37' ' ' THR . 69.1 mtm -62.63 -36.53 83.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.906 0.384 . . . . 0.0 110.782 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.32 -50.9 71.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.213 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 46.1 mt-10 -73.27 -24.46 60.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.384 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.849 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -65.63 -51.09 62.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 107' ' ' VAL . 98.7 mt -62.52 -42.31 99.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.14 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 83.6 tttt -55.78 -47.36 77.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.213 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.58 -38.62 90.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 0.0 110.878 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 tp -71.59 -44.09 65.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.828 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 103' ' ' LEU . 80.6 t -70.41 -27.38 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.92 -43.67 69.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.528 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -91.77 3.4 55.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 178.539 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 121.067 0.46 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.93 -39.66 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.849 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.67 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.502 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 56.7 mmtt -76.29 -35.44 58.87 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.312 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.34 83.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.588 0.709 . . . . 0.0 109.113 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.74 HD13 ' HZ2' ' A' ' 66' ' ' TRP . 23.4 tp -63.3 -37.12 86.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.252 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.31 -33.76 75.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.332 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.17 -40.51 78.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.471 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -88.15 -76.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.772 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 -4.94 81.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.748 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.13 7.48 77.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.432 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.597 ' HE2' ' HE3' ' A' ' 33' ' ' MET . 26.4 mmt -94.81 111.86 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.12 -156.99 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.06 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -86.96 41.67 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.262 -0.274 . . . . 0.0 110.875 175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 124.648 1.179 . . . . 0.0 112.106 -178.626 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 19.6 m80 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 t -103.38 -80.52 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.084 0.468 . . . . 0.0 110.506 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.597 ' HE3' ' HE2' ' A' ' 23' ' ' MET . 1.3 ttp -97.81 -29.75 13.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.51 0.671 . . . . 0.0 109.305 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 9.2 p-10 -67.81 -8.31 34.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.145 -172.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 39.8 tt0 -102.51 -48.95 3.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 110.658 173.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.8 t -65.41 -48.48 72.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.697 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 m -64.82 -40.24 94.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.359 . . . . 0.0 110.267 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.7 63.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -61.5 -28.88 69.62 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.195 0.521 . . . . 0.0 110.8 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.73 -49.9 52.0 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.382 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 103' ' ' LEU . 63.7 mt -61.84 -43.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.618 0.247 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -54.97 -47.54 74.41 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.658 ' HE3' HD11 ' A' ' 87' ' ' ILE . 9.9 mtmp? -77.9 -25.84 48.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.312 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 53.0 t80 -65.15 -47.81 75.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.13 -40.54 97.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.223 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -50.94 -54.97 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.341 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.12 -18.83 60.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 57.6 mt -68.53 -27.29 65.97 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.6 6.17 10.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.583 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.39 93.19 43.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.758 0.313 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.37 120.75 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.993 2.462 . . . . 0.0 111.838 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.31 138.66 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.299 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.93 147.46 38.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -53.19 -36.0 75.63 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.397 2.731 . . . . 0.0 112.398 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -50.05 -47.3 53.45 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.316 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.0 -40.99 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.607 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' HB ' ' A' ' 74' ' ' VAL . 61.4 t -63.87 -45.92 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.456 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 67.4 t -59.99 -48.28 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.141 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.8 89.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.439 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.736 HH11 HD22 ' A' ' 17' ' ' LEU . 14.6 tpp85 -67.79 -40.42 83.92 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.508 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.83 -37.14 93.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.479 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -62.66 -37.62 87.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.197 0.523 . . . . 0.0 110.574 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -73.03 -44.82 60.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.471 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.86 -30.03 32.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.81 57.28 1.84 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.067 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.74 ' HZ2' HD13 ' A' ' 17' ' ' LEU . 49.4 m0 -84.05 168.43 15.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -61.83 123.58 77.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 167.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.91 -34.23 55.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.502 2.801 . . . . 0.0 113.82 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -64.73 -40.64 95.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 74' ' ' VAL . 73.6 t80 -64.42 -50.97 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.142 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.519 ' HG1' ' HE3' ' A' ' 66' ' ' TRP . 21.4 m -57.27 -41.23 79.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.936 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.44 -40.71 77.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.126 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.62 -50.14 68.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.077 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.587 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 52.1 t -60.22 -40.16 82.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 110.635 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . . . -59.59 -40.18 86.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.684 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.9 -34.79 88.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.078 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.587 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 28.7 m0 -67.23 -47.58 70.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.7 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.95 -44.61 91.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 110.4 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -64.64 -45.79 85.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.635 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 77' ' ' TRP . 75.3 t -63.67 -40.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.37 -41.04 81.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.638 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.7 p -75.03 -16.63 60.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.03 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.53 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -109.98 163.99 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -89.27 156.57 18.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.516 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.658 HD11 ' HE3' ' A' ' 43' ' ' LYS . 21.8 pt -123.94 147.66 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.27 131.74 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 tt -139.32 162.78 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -76.07 -53.18 8.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.723 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.76 140.3 31.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.68 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.2 7.11 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.326 2.017 . . . . 0.0 113.463 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.18 -16.33 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 77.44 -70.6 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.65 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.681 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 40.8 p90 -162.82 -170.85 2.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.772 -173.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 95' ' ' PHE . 16.6 m -85.22 146.62 26.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.771 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 p -50.06 -36.9 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -38.68 57.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.596 0.236 . . . . 0.0 111.623 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.681 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 mmt -65.76 -50.01 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 110.225 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -71.14 -30.77 66.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.085 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.56 -32.74 74.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.358 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 8.6 tp-100 -70.07 -50.54 39.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 109.696 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 41' ' ' ILE . 86.4 mt -52.85 -49.76 65.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.028 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -59.51 -42.26 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 109' ' ' GLU . 35.4 tt0 -63.13 -39.9 96.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.572 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 95.0 mt -62.54 -36.31 82.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.97 -43.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.67 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -78.62 -45.1 22.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 17.6 mm-40 -70.97 -75.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.033 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.835 0.826 . . . . 0.0 110.471 177.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.943 0.402 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.56 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 49.9 mm -65.58 -43.01 94.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.049 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.34 -33.27 75.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.659 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 36.2 mmtt -78.48 -31.07 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.202 177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.86 99.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.275 0.559 . . . . 0.0 109.496 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 13' ' ' ILE . 62.9 mt -72.52 -27.61 62.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.436 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.6 -25.53 67.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.478 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -85.66 -48.25 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.272 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.2 mt -79.12 -37.49 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.32 -11.12 32.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.74 57.33 9.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.775 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.16 91.52 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 69.07 16.85 8.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.682 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 p -99.53 -0.71 40.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.591 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.954 -179.118 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 10.4 m170 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.55 0.214 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 33' ' ' MET . 4.3 m -66.83 -80.18 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.036 0.446 . . . . 0.0 110.166 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.426 ' H ' ' HB2' ' A' ' 32' ' ' SER . 1.8 ppp? -93.1 -16.09 25.33 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 31' ' ' HIS . 7.2 t0 -51.27 -45.57 62.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.913 -1.948 . . . . 0.0 111.315 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -99.9 -40.25 7.78 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.551 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 92' ' ' PRO . 37.0 t -61.89 -62.04 2.07 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.933 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 m -68.62 -36.29 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.915 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.25 -51.81 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.738 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HD3' HG12 ' A' ' 89' ' ' ILE . 95.2 mttt -62.98 -42.98 99.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.56 92.76 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.369 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 52.2 mt -68.91 -47.46 75.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 0.159 . . . . 0.0 111.372 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.18 -40.92 87.17 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.77 -41.34 99.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.939 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.418 ' CE2' HD13 ' A' ' 48' ' ' LEU . 67.6 t80 -73.1 -39.76 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.549 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 92.8 mt -59.36 -46.18 89.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.804 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -64.22 -36.45 84.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.43 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.36 -41.47 97.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.418 HD13 ' CE2' ' A' ' 44' ' ' TYR . 88.5 mt -64.45 -37.86 89.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.803 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.03 2.63 10.14 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.005 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.78 93.39 33.47 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 0.0 109.813 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -91.26 157.13 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.941 2.427 . . . . 0.0 113.072 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.71 141.59 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.939 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB2' HG23 ' A' ' 56' ' ' VAL . 12.8 m -79.81 123.44 83.84 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.473 ' O ' HG21 ' A' ' 58' ' ' VAL . 43.7 Cg_exo -56.08 -38.1 95.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.076 2.517 . . . . 0.0 112.388 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -52.52 -50.66 62.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.155 0.502 . . . . 0.0 110.913 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 53' ' ' SER . 33.3 t -64.18 -35.6 74.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.342 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.33 -40.04 87.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.728 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 54' ' ' PRO . 90.8 t -62.23 -52.94 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.635 0.255 . . . . 0.0 110.458 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.91 -43.76 86.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.2 tpp180 -64.1 -43.76 94.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA3' HG22 ' A' ' 71' ' ' THR . . . -60.53 -48.23 87.23 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.39 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 45.6 mt-10 -59.39 -33.23 70.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.135 0.493 . . . . 0.0 110.854 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -70.25 -48.92 54.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.547 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 60.5 mt-10 -93.48 -3.79 52.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 0.0 111.388 -173.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 67' ' ' ASN . . . 99.32 -70.63 0.54 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.594 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 11.9 m0 56.31 -1.47 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 65' ' ' GLY . 19.4 m-80 69.58 128.97 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 123.322 0.649 . . . . 0.0 110.489 -176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.45 -47.19 23.46 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.693 2.929 . . . . 0.0 114.335 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -69.56 -36.78 76.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB3' ' O ' ' A' ' 66' ' ' TRP . 68.2 t80 -69.94 -49.07 55.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.437 HG22 ' HA3' ' A' ' 61' ' ' GLY . 21.1 m -53.6 -46.62 70.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.22 -46.03 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.067 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -65.06 -40.29 94.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.82 -39.35 83.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.436 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.67 82.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.902 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.21 -40.58 87.7 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.089 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.519 ' O ' HG22 ' A' ' 81' ' ' VAL . 44.9 m0 -60.91 -54.49 44.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.11 73.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.004 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -56.41 -53.95 51.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.239 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 46.0 mtpt -66.65 -35.93 81.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.262 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 77' ' ' TRP . 76.6 t -68.76 -46.17 79.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.052 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.67 69.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 111.173 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.5 t -80.0 -18.12 51.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.747 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.81 45.8 15.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.901 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -95.95 16.3 18.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.032 0.133 . . . . 0.0 111.134 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 47.93 127.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 125.267 1.604 . . . . 0.0 113.953 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.1 pt -115.51 144.13 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.15 112.36 21.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.494 HG21 ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -124.64 -43.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.413 177.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 67.31 -70.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 111.636 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.604 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -165.36 92.2 0.9 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.563 -175.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HD3' HG21 ' A' ' 89' ' ' ILE . 61.1 Cg_endo -80.69 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.436 2.091 . . . . 0.0 112.69 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.8 pt-20 -156.34 24.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.038 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 53.3 m-85 73.25 -21.31 0.26 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.659 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 93' ' ' GLU . 18.1 t80 61.97 83.93 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -169.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -52.63 139.98 24.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.907 -169.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m -53.58 -41.99 67.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 112.329 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 35.5 t80 -61.04 -42.24 98.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.3 mtt -62.15 -50.7 70.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.484 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -59.43 -46.63 88.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.896 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 7.7 mt-10 -72.0 -27.36 62.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 14.0 mm100 -59.01 -48.1 82.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.156 0.503 . . . . 0.0 109.74 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 107' ' ' VAL . 83.1 mt -68.3 -43.51 77.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.402 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 26.9 tttm -60.47 -50.04 75.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.13 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -69.55 -25.46 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.682 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 48.3 tp -70.31 -45.71 65.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 103' ' ' LEU . 59.8 t -71.83 -25.54 24.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.337 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.09 -34.73 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.567 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.65 -70.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 168.233 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.787 0.327 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.484 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 61.0 mt -63.12 -45.61 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.956 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -53.77 -54.83 32.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 94.9 mttt -67.62 -35.71 79.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.462 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.93 85.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 111.077 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.559 HD13 ' HD3' ' A' ' 60' ' ' ARG . 85.5 mt -64.09 -47.22 80.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -13.58 56.79 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.855 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -64.59 -43.12 94.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.32 -39.45 48.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.711 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 70' ' ' PHE . . . -54.79 -47.98 68.74 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.036 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.05 14.96 69.01 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.227 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 67.74 169.97 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.046 0.538 . . . . 0.0 111.455 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.4 108.13 11.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.212 0.529 . . . . 0.0 110.83 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 p -120.98 -171.19 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.707 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.86 -179.09 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.643 0.258 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.7 m -103.98 -80.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.0 110.721 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.4 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 1.2 ppp? -90.35 -12.15 38.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.946 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -15.83 62.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.179 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -92.72 -55.18 3.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.28 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 89' ' ' ILE . 14.3 m -71.27 -53.19 15.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.886 -174.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' HE3' ' A' ' 99' ' ' MET . 53.1 m -62.75 -34.14 76.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.38 90.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.201 0.524 . . . . 0.0 110.132 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -64.0 -27.54 69.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.398 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.08 -55.04 23.96 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.736 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.533 HG23 HD13 ' A' ' 103' ' ' LEU . 66.4 mt -57.27 -43.65 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 110.659 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 78' ' ' ALA . 26.6 tp -56.49 -47.74 78.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.458 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.647 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 9.9 mtmp? -72.83 -30.56 64.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.426 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.462 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 66.3 t80 -63.57 -37.95 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.14 -38.92 89.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.279 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -61.26 -34.54 75.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.07 -24.96 47.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 93.6 mt -75.93 -32.25 59.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.314 0.578 . . . . 0.0 110.411 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.44 -18.11 8.84 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.319 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.83 93.42 48.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -95.37 158.32 1.61 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.065 2.51 . . . . 0.0 111.871 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.92 138.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 110.571 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.422 ' HB2' HG21 ' A' ' 56' ' ' VAL . 23.8 m -83.03 149.24 58.68 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.39 -43.3 44.86 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.322 2.681 . . . . 0.0 112.733 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.17 -43.34 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 53' ' ' SER . 29.4 t -65.0 -36.39 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.174 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.69 -49.05 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.0 -45.55 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.76 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.84 93.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.72 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HD3' HD13 ' A' ' 17' ' ' LEU . 13.2 tpt180 -65.16 -46.12 82.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.409 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.37 99.4 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.035 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -58.51 -39.88 81.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.92 0.39 . . . . 0.0 111.084 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.1 tm0? -83.02 -48.45 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.479 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.33 -25.73 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.876 0.37 . . . . 0.0 111.463 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.81 -76.99 0.34 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.8 m0 54.2 -161.29 0.14 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.832 0.453 . . . . 0.0 111.625 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -124.26 140.23 34.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 -41.73 70.21 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.893 2.395 . . . . 0.0 112.775 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -66.86 -40.66 87.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.582 0.706 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.561 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 31.2 t80 -69.5 -53.06 20.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.409 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -58.29 -43.77 88.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -72.37 -34.44 67.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.741 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -56.91 14.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.806 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.9 -35.47 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.2 86.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.34 -37.83 62.84 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.073 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -61.44 -49.32 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.513 ' HA ' HD23 ' A' ' 42' ' ' LEU . . . -59.14 -38.09 78.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.95 -49.77 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.864 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.97 -37.24 75.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.107 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.47 -38.57 80.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.702 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.09 -30.2 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.082 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . 17.2 m -87.81 -14.61 39.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 31.86 13.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.854 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 12.6 m120 -97.59 -171.65 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -108.95 135.32 50.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -109.0 119.64 58.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.806 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.67 122.61 14.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.054 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 36' ' ' SER . 16.1 tt -129.82 135.56 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.654 ' HG3' ' OD1' ' A' ' 91' ' ' ASN . 17.5 pttm -76.01 -16.72 59.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -171.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.654 ' OD1' ' HG3' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -153.95 114.28 2.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.889 0.376 . . . . 0.0 110.399 177.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.68 80.92 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.138 2.559 . . . . 0.0 113.027 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' HG2' HD21 ' A' ' 91' ' ' ASN . 11.6 pt-20 -138.96 172.45 12.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.927 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -124.23 -80.92 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.723 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.643 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER 175.56 -176.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.951 -172.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 m -84.77 174.63 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.357 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -30.24 68.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.877 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -44.95 -55.08 5.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.622 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.481 ' HE3' HG22 ' A' ' 37' ' ' THR . 52.0 mtt -68.89 -46.32 68.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.171 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.643 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 7.7 tt0 -60.57 -48.38 82.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.261 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.05 -35.18 79.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -54.12 -58.99 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.417 0.627 . . . . 0.0 110.033 175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.533 HD13 HG23 ' A' ' 41' ' ' ILE . 94.3 mt -64.73 -39.68 94.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.911 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.74 -39.38 91.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.304 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.86 -26.56 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.746 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.66 -36.95 81.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 48' ' ' LEU . 55.8 t -77.53 -20.98 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.82 -18.76 64.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.44 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.02 -8.28 47.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.978 0.418 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.49 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 121.355 0.597 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -68.82 -44.23 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.06 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.09 -37.69 86.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.566 ' HZ3' ' HB3' ' A' ' 15' ' ' LYS . 4.2 mmmp? -70.66 -26.35 63.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.838 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.15 86.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.227 0.537 . . . . 0.0 109.718 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 17' ' ' LEU . 4.3 mm? -70.17 -32.33 70.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.088 174.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 24.0 t70 -57.17 -32.66 66.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.718 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -78.7 -63.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.679 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.15 -68.96 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.067 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.95 -8.01 84.48 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.762 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.06 -16.94 80.33 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.332 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' ' 23' ' ' MET . 25.4 ptp -103.59 97.78 7.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.839 0.828 . . . . 0.0 111.118 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.19 49.85 1.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -82.06 -168.94 2.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.133 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.236 -178.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.17 0.51 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -75.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.536 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.445 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 6.8 ttp -96.64 -42.39 8.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -48.19 -45.71 34.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.541 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -50.88 -66.3 0.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.187 0.518 . . . . 0.0 111.135 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HG ' HD12 ' A' ' 89' ' ' ILE . 27.8 t -70.2 -43.1 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.462 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.514 HG23 ' HE3' ' A' ' 99' ' ' MET . 38.6 m -67.41 -42.66 82.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.62 87.08 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.479 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -56.96 -32.5 66.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.916 0.388 . . . . 0.0 110.693 174.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.46 50.61 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.092 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.94 -43.33 92.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 110.736 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.53 -39.56 76.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.142 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.615 ' HB2' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -69.2 -42.33 75.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.009 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -63.64 -48.45 77.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.375 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 103' ' ' LEU . 72.8 mt -61.71 -48.36 81.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.458 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.65 -36.74 77.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.007 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.8 -40.59 88.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.61 HD13 HG23 ' A' ' 107' ' ' VAL . 94.1 mt -61.66 -30.1 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 120.97 -0.09 11.75 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.928 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.05 97.89 9.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 82.1 Cg_endo -83.3 127.12 4.43 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.379 2.053 . . . . 0.0 112.265 -176.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 41.4 t -75.33 101.47 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.857 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 56' ' ' VAL . 22.8 m -70.79 125.94 92.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.49 -23.04 62.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.648 2.232 . . . . 0.0 111.706 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -58.88 -54.08 51.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.14 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 53' ' ' SER . 34.1 m -70.42 -21.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.104 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.98 -49.3 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 69.4 t -62.03 -42.64 95.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.422 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.19 96.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.888 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.54 87.92 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -60.18 -45.62 95.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.911 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 8.4 pt-20 -79.74 -20.41 46.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.82 -53.39 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.899 0.381 . . . . 0.0 110.142 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.73 -38.65 64.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 -173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.91 62.22 0.56 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.973 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.452 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 24.8 m0 -98.52 160.66 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.419 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 26.7 p30 -90.05 153.7 47.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 4.9 Cg_exo -39.23 -60.41 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.613 3.542 . . . . 0.0 114.433 -174.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 4.6 mm-40 -61.21 -39.0 88.59 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.95 -44.76 84.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.0 m -58.45 -48.5 80.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -77.42 -27.14 52.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 tptp -54.4 -66.26 0.43 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.83 -40.94 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.892 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.97 96.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.967 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -66.87 -40.79 93.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.47 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.454 ' O ' HG21 ' A' ' 81' ' ' VAL . 10.6 m0 -63.46 -50.79 68.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -58.91 -39.43 81.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.85 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.5 -49.85 63.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 52.0 mttm -71.98 -41.61 67.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.317 -176.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 77' ' ' TRP . 57.8 t -68.21 -39.65 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.269 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.32 69.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.122 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -65.45 -27.99 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.98 23.04 5.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.863 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.545 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -93.1 -176.27 4.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -136.24 137.88 41.25 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.243 0.544 . . . . 0.0 110.738 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.32 125.48 74.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.613 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.14 110.2 16.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.415 0.626 . . . . 0.0 110.815 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.502 HD12 ' HG ' ' A' ' 36' ' ' SER . 15.8 tt -86.59 -3.24 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.757 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 71.07 -52.05 0.68 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.817 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -161.59 131.71 3.46 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.86 177.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 37.0 Cg_exo -57.62 -66.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.739 2.293 . . . . 0.0 111.902 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.55 -72.5 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -78.15 5.7 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -168.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.18 102.85 14.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p -94.56 169.58 10.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -32.4 71.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.694 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 0.2 OUTLIER -56.19 -44.65 79.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 110.166 -176.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.514 ' HE3' HG23 ' A' ' 37' ' ' THR . 65.0 mtt -66.54 -49.36 66.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.366 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -61.03 -50.9 71.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.781 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.4 -47.96 82.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.445 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -54.49 -56.48 18.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.383 0.611 . . . . 0.0 110.736 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 45' ' ' LEU . 10.4 mp -67.8 -41.08 83.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.357 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -68.96 -34.01 74.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.144 -175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.74 -43.41 89.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.75 -42.9 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.61 HG23 HD13 ' A' ' 48' ' ' LEU . 84.9 t -72.66 -32.19 40.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.121 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.72 -20.56 61.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.01 -18.13 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.775 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -87.85 -23.2 24.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.103 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 t80 75.3 -43.6 0.51 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.0 116.04 4.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.33 111.07 4.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.372 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.65 -66.58 0.29 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.42 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.1 m 65.02 -168.29 0.21 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.92 0.488 . . . . 0.0 110.431 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.3 ttm -156.17 119.07 2.3 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.403 -0.186 . . . . 0.0 110.829 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.45 113.96 2.31 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.575 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 14' ' ' GLU . 35.7 p -75.45 75.22 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.462 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . . . -64.16 -53.0 56.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.21 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.92 -39.41 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.233 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 2.7 mt-10 -77.16 -23.36 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.034 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 25.5 tptp -77.08 -24.25 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.43 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.936 HD13 ' HG2' ' A' ' 60' ' ' ARG . 75.6 mt -63.08 -33.66 75.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.36 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 20.1 t70 -60.77 -40.82 93.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.657 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -67.28 -36.23 81.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.0 mt -71.56 -46.15 64.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.57 75.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.648 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 -170.38 54.77 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.647 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -104.81 -7.01 19.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.793 0.806 . . . . 0.0 108.961 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -132.04 94.87 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.628 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.7 m -80.03 -11.76 59.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.444 . . . . 0.0 111.409 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -79.38 83.62 5.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.186 0.517 . . . . 0.0 110.23 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.59 151.44 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.042 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -152.36 -72.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.738 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.577 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 33.8 t -80.05 -56.89 0.7 Allowed Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.743 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 7.9 Cg_endo -88.73 94.66 0.37 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.434 2.089 . . . . 0.0 112.157 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -104.61 149.44 25.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 t -103.15 -81.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.492 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.409 ' HE2' ' HB3' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -100.53 -21.48 15.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.409 ' HB3' ' HE2' ' A' ' 33' ' ' MET . 12.6 p-10 -77.3 2.72 14.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.602 -172.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -57.63 3.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 109.487 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 1.019 ' HB3' HG13 ' A' ' 89' ' ' ILE . 54.0 m -81.16 -34.96 32.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.88 -174.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -66.06 -36.34 82.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.329 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.33 99.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 36' ' ' SER . 94.2 mttt -58.18 -44.73 88.17 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.999 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.77 -50.01 69.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.226 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 110.861 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.775 HD11 HG22 ' A' ' 52' ' ' VAL . 15.5 tp -62.15 -43.65 98.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 9.9 mtmp? -71.15 -23.4 62.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.259 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -68.39 -40.66 81.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.14 -43.61 97.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.251 0.548 . . . . 0.0 109.816 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.446 ' HB2' HG12 ' A' ' 81' ' ' VAL . 17.9 t-80 -58.0 -41.03 82.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.647 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.08 -38.18 89.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.1 -13.73 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.096 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.96 13.28 25.72 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.351 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.54 93.6 37.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.431 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 98.9 Cg_endo -87.75 114.83 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.504 2.136 . . . . 0.0 111.486 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.775 HG22 HD11 ' A' ' 42' ' ' LEU . 27.4 m -73.64 141.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.293 0.568 . . . . 0.0 111.614 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.653 ' O ' HG21 ' A' ' 56' ' ' VAL . 12.8 m -85.36 138.0 36.55 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.688 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.12 -27.9 67.56 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.0 112.272 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -60.55 -44.62 95.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 53' ' ' SER . 10.3 m -68.18 -24.95 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.808 0.337 . . . . 0.0 110.579 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.89 -51.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.055 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.9 t -61.98 -46.7 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.21 -51.8 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.672 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.936 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.1 tpp180 -70.15 -28.83 65.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -63.3 -41.14 99.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.977 176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 39.4 mt-10 -67.43 -36.16 80.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 110.644 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -68.54 -50.76 49.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.612 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 35.8 mm-40 -84.55 -13.48 51.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.877 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.65 56.51 2.93 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.869 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.424 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 41.7 m0 -87.0 176.51 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.51 126.22 53.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -46.28 -44.5 20.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.937 3.091 . . . . 0.0 114.075 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.69 -37.73 85.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.106 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 74' ' ' VAL . 48.5 t80 -70.09 -47.72 60.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.411 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 25.0 m -58.79 -40.32 83.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.284 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -67.67 -38.09 83.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.849 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.34 -48.15 79.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.633 0.254 . . . . 0.0 110.539 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 70' ' ' PHE . 45.7 t -61.14 -38.31 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.85 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.66 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 79' ' ' GLU . . . -69.51 -32.08 71.27 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.059 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.419 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 24.8 m0 -71.61 -48.97 44.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.67 75.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.493 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 76' ' ' GLY . 10.2 tt0 -48.57 -59.54 3.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.824 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -68.08 -37.91 81.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.053 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 46' ' ' HIS . 41.7 t -58.18 -49.09 82.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.111 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -70.34 -32.23 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.262 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -74.12 -16.1 61.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.591 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 18.1 40.32 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.13 -174.78 3.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -134.0 152.93 52.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.981 0.42 . . . . 0.0 110.509 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.8 pt -126.93 158.83 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.4 tp -91.3 135.97 33.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.21 0.529 . . . . 0.0 110.934 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 1.019 HG13 ' HB3' ' A' ' 36' ' ' SER . 19.2 tt -100.49 131.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.323 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -25.1 34.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 111.25 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.603 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -148.0 93.2 4.51 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.225 0.536 . . . . 0.0 110.373 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HA ' HD13 ' A' ' 89' ' ' ILE . 7.2 Cg_exo -74.03 -16.67 22.72 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.454 2.769 . . . . 0.0 113.348 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.44 -21.92 60.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -80.26 -7.43 59.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -81.23 82.73 7.03 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 m -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.288 1.042 . . . . 0.0 112.074 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -66.33 -36.04 81.9 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.954 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.44 -45.71 87.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.375 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.9 mtm -61.47 -40.07 93.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.065 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.99 -54.98 19.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 10.9 mm-40 -65.28 -24.12 67.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 102' ' ' GLN . 0.9 OUTLIER -63.89 -56.15 17.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.01 -43.68 98.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.259 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.481 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 79.7 tttt -57.03 -41.06 77.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.445 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.97 -39.01 79.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 9.9 mp -67.73 -36.27 80.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.808 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.8 t -72.65 -34.96 49.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 110.2 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.1 tp -62.44 -49.9 73.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.569 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -77.43 -7.99 57.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 67.1 t60 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.787 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.748 0.785 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -131.13 24.09 4.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.244 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -109.39 110.81 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.381 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 25.3 mtpp -137.92 90.32 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.561 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 6.0 t70 160.03 -158.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.778 1.299 . . . . 0.0 108.877 176.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 96.5 mttt -74.95 167.07 22.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -64.57 147.02 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.023 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 70.6 mtm -62.02 147.58 89.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.218 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.83 96.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.005 2.47 . . . . 0.0 112.89 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -117.09 40.33 3.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.049 0.928 . . . . 0.0 109.325 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.685 ' HA ' HD22 ' A' ' 106' ' ' LEU . . . -57.47 -37.51 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.346 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.16 -56.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.672 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.66 -40.44 96.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.569 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -67.12 -31.85 72.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.677 0.275 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 20' ' ' ILE . . . -64.23 -42.5 96.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.217 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 4.4 mm? -65.56 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.619 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.03 -44.61 96.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 14.2 m-85 -60.11 -37.53 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 16' ' ' ALA . 75.2 mt -72.78 -65.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.249 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.47 -47.02 53.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.864 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.45 8.69 27.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.271 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt 57.12 31.17 19.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -67.39 111.32 3.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.377 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -76.98 0.89 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.182 -174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -134.71 18.59 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.776 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.28 90.28 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.477 0.656 . . . . 0.0 110.96 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.8 m -154.89 -45.97 0.08 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.389 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.565 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 67.3 t -120.78 -57.96 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.283 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 74.0 Cg_endo -78.95 95.18 1.06 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.148 1.232 . . . . 0.0 111.604 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -128.43 117.14 20.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.7 m -103.5 -80.47 0.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.464 0.65 . . . . 0.0 110.962 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.482 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.4 ttp -83.34 -27.21 29.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.394 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.83 -2.81 22.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.814 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.438 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 10.4 tt0 -102.3 -63.86 1.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.0 110.064 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m -63.53 -46.2 87.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 95' ' ' PHE . 84.2 m -72.5 -29.77 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.01 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.41 79.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.82 -42.16 97.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.251 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 94' ' ' TYR . . . -65.14 -44.07 94.6 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.245 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 36.5 mt -68.14 -40.71 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.95 0.375 . . . . 0.0 111.146 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.855 HD22 HG23 ' A' ' 52' ' ' VAL . 91.7 mt -60.58 -39.37 87.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.171 0.51 . . . . 0.0 110.002 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.839 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.632 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 82.4 t80 -58.3 -55.55 33.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.11 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 48' ' ' LEU . 7.6 mp -63.99 -36.4 83.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.394 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -54.47 -56.3 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.346 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.83 -23.62 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.081 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.7 mt -62.22 -35.33 78.59 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 109.963 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.4 3.61 3.78 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.571 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.4 99.37 45.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.762 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 64.2 Cg_endo -77.08 117.64 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.125 1.883 . . . . 0.0 111.618 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.855 HG23 HD22 ' A' ' 42' ' ' LEU . 27.4 m -68.03 148.58 11.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.776 -175.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.5 m -94.71 131.71 30.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.298 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 33.5 Cg_exo -58.91 -32.22 96.96 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.267 2.645 . . . . 0.0 113.216 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -55.8 -41.83 74.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 t -61.11 -37.84 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.76 -47.16 86.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.361 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.24 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.675 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.736 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 12.2 tpt180 -68.05 -36.25 79.57 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.07 -45.19 82.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.601 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.96 -46.78 56.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 111.362 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.06 -42.73 80.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.502 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -84.78 -32.79 23.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.742 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.9 62.58 0.75 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.368 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.496 ' CH2' HD13 ' A' ' 17' ' ' LEU . 39.0 m0 -102.26 152.68 20.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.572 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.68 142.04 94.69 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.7 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -45.81 37.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.934 2.423 . . . . 0.0 111.982 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -58.07 -40.64 81.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.083 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' O ' HG22 ' A' ' 74' ' ' VAL . 75.6 t80 -66.06 -59.63 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.7 m -56.02 -41.94 75.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.57 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.8 -50.59 71.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.67 -43.25 63.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.667 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.556 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.6 t -61.69 -38.07 79.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -60.3 -44.19 95.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.604 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.45 ' HA2' ' OE1' ' A' ' 79' ' ' GLU . . . -57.29 -41.01 92.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.401 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.556 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 m0 -65.35 -43.9 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.2 83.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.163 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 53.7 mt-10 -57.06 -48.72 77.88 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.221 0.534 . . . . 0.0 110.519 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.63 -35.59 79.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.6 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 77' ' ' TRP . 66.9 t -62.04 -48.84 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.625 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -62.29 -38.68 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -72.73 -16.63 61.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.741 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.99 29.9 40.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.429 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.496 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -97.47 154.05 17.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -77.82 142.06 38.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.245 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.5 pt -117.25 159.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.809 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tt -87.99 109.23 19.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.294 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -101.53 150.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.438 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 25.1 mtpt -84.68 -58.83 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.514 0.673 . . . . 0.0 109.73 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -111.05 124.3 33.19 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.802 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 93' ' ' GLU . 9.9 Cg_endo -53.32 -30.92 54.36 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.074 2.516 . . . . 0.0 113.02 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 92' ' ' PRO . 1.8 mp0 -63.99 98.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HD2' ' HA2' ' A' ' 40' ' ' GLY . 36.6 m-85 -59.72 -59.29 5.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.364 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.827 ' HB3' HG22 ' A' ' 37' ' ' THR . 26.9 p90 -162.05 172.71 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.692 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -82.68 164.34 20.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 111.705 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -32.86 74.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.484 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -53.78 -44.86 70.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.821 0.82 . . . . 0.0 110.067 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.475 ' HE2' HG21 ' A' ' 37' ' ' THR . 33.1 mtp -75.21 -34.16 61.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.122 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -50.63 70.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.829 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.57 -43.64 84.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -56.02 -56.73 17.18 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 111.081 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.23 -44.36 97.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.644 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -59.71 -43.01 94.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.742 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.48 -48.06 80.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 12' ' ' ALA . 10.0 mp -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.829 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.45 -6.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.31 -42.08 38.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -43.48 54.75 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.498 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.478 0.947 0 C-N-CA 124.154 0.982 . . . . 0.0 112.565 177.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.234 0.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -143.25 -63.09 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -101.72 -43.99 5.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.852 -171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.34 -175.87 4.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.985 0.421 . . . . 0.0 111.66 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.06 162.0 29.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.542 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -118.11 -7.43 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.909 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.0 p -73.6 154.16 39.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.462 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 25.3 mmt -100.22 115.49 65.42 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 2.6 Cg_exo -75.11 84.54 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.789 2.326 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.2 p -99.62 -82.06 0.45 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.772 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' HA ' HD23 ' A' ' 106' ' ' LEU . . . -67.36 -36.73 81.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.72 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.35 -41.08 83.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.586 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -65.28 -47.19 77.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.66 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -64.72 -42.85 94.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.0 82.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.243 0.544 . . . . 0.0 110.652 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD13 ' HZ2' ' A' ' 66' ' ' TRP . 22.8 tp -71.77 -24.06 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.431 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.34 -33.96 37.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.84 -44.46 89.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.443 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.3 mt -84.44 -68.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.611 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.69 45.23 3.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.056 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.52 -6.08 66.37 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.546 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ttt 69.39 105.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.529 0.732 . . . . 0.0 111.937 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 21.5 t-20 -71.8 162.59 29.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.411 172.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.5 m -52.9 -36.63 59.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.363 0.265 . . . . 0.0 111.582 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 p -114.46 -54.29 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . 59.03 17.98 5.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 172.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -132.2 -40.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.913 0.864 . . . . 0.0 109.234 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.59 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.1 m -70.63 -179.04 0.6 Allowed Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.973 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 99.1 Cg_exo -46.26 107.76 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.47 1.447 . . . . 0.0 110.513 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 59.0 m170 -56.63 143.68 35.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.983 -170.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 m -82.96 -79.94 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.461 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.6 ttp -99.41 -24.02 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.759 0.79 . . . . 0.0 108.979 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -78.31 9.54 3.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.048 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.84 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 5.9 tt0 -103.05 -72.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.736 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -58.85 -54.33 48.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.542 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.4 m -61.58 -39.93 92.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 111.185 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.04 91.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -58.13 -48.2 80.96 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.477 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.71 82.02 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.571 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.628 HG12 HD11 ' A' ' 103' ' ' LEU . 77.9 mt -62.9 -45.38 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.518 . . . . 0.0 110.715 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.85 -39.29 93.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.2 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HZ1' ' HB3' ' A' ' 43' ' ' LYS . 9.5 mtpm? -69.32 -39.03 78.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.643 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.528 ' CE2' HD11 ' A' ' 48' ' ' LEU . 83.0 t80 -60.23 -44.55 95.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.25 -47.57 85.45 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.34 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 60.7 m80 -65.48 -36.06 82.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.46 -33.17 74.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 44' ' ' TYR . 76.6 mt -66.53 -45.27 79.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.588 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 138.51 4.69 1.62 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.676 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.43 93.29 4.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 90.0 Cg_endo -90.72 88.81 0.3 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.477 2.118 . . . . 0.0 112.924 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.18 123.52 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.7 m -89.09 154.32 49.43 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.612 ' HG3' ' HB2' ' A' ' 79' ' ' GLU . 5.3 Cg_endo -49.86 -37.93 46.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.382 2.721 . . . . 0.0 112.396 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -48.68 -51.57 27.85 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.535 0.522 . . . . 0.0 110.883 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -64.68 -42.1 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.456 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.6 -48.03 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 54' ' ' PRO . 89.6 t -60.99 -52.29 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.34 90.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.359 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.522 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 13.0 tpp180 -67.84 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.457 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.71 -38.53 96.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.934 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.17 -38.93 84.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.591 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.16 -50.5 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.344 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 27.8 mm-40 -65.63 -42.66 91.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.014 0.435 . . . . 0.0 110.258 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.24 50.43 0.5 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.1 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.405 ' HZ2' HD13 ' A' ' 17' ' ' LEU . 30.2 m0 -88.06 163.47 16.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.86 143.52 78.26 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.102 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.23 -55.81 3.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.394 2.729 . . . . 0.0 112.867 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.3 mm-40 -59.01 -37.2 76.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.472 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.443 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 80.2 t80 -64.78 -51.82 60.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -64.86 -45.89 84.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.155 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.04 -41.1 97.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.992 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 13.9 mptt -60.11 -57.53 12.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 48.4 t -58.76 -39.91 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.87 -37.63 85.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.52 86.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.262 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 8.9 m0 -67.19 -36.98 82.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.76 -44.76 89.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.306 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.612 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 2.2 tm-20 -58.17 -46.49 85.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.71 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.672 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -52.57 -58.94 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.185 178.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.5 t -67.51 -34.4 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.396 -175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.03 69.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.736 0.303 . . . . 0.0 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -81.94 -14.23 56.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.201 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.46 34.56 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -107.69 169.43 8.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.78 146.46 28.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.772 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.2 pt -128.95 159.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.999 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.074 0.464 . . . . 0.0 110.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -82.8 -12.6 12.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 75.46 -48.12 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.575 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.25 92.12 6.24 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.479 0.657 . . . . 0.0 110.911 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 -10.78 24.66 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.023 2.482 . . . . 0.0 112.424 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -72.59 -15.15 61.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.12 -1.75 58.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.961 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -82.23 84.03 7.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.0 p -71.52 147.43 47.73 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.304 1.049 . . . . 0.0 112.327 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.6 m -49.9 -42.67 48.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.67 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 62.5 t80 -57.39 -42.32 81.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.655 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.443 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 52.8 mtm -73.23 -47.29 44.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.268 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -58.14 9.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -32.34 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.923 -175.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 8.4 tt0 -62.6 -51.17 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.092 0.472 . . . . 0.0 109.811 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.628 HD11 HG12 ' A' ' 41' ' ' ILE . 76.9 mt -57.75 -44.36 86.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.081 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 2.4 ttmp? -53.96 -61.78 2.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.878 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 19.8 mm-40 -57.39 -44.49 84.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.617 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 12' ' ' ALA . 32.5 tp -65.98 -44.14 85.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.697 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.54 -32.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 11.7 tp -61.05 -30.01 70.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.052 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 40.9 mt-10 -60.86 -30.13 69.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.802 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -176.127 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.237 0.395 0 CA-C-O 122.165 0.983 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 4' ' ' PHE . 5.5 p-10 -162.1 35.95 0.12 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.134 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 87.3 m-85 72.42 -88.53 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.662 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 4' ' ' PHE . 42.0 tttp 174.79 131.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 123.284 0.365 . . . . 0.0 110.414 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 28.2 t70 174.62 118.29 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.854 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 6' ' ' ASP . 6.6 mmtm -167.05 100.67 0.53 Allowed 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.701 0.625 . . . . 0.0 110.461 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -115.28 148.77 38.77 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ttt 54.63 81.04 0.27 Allowed Pre-proline 0 C--O 1.234 0.273 0 O-C-N 123.832 0.708 . . . . 0.0 110.354 -172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 110' ' ' HIS . 30.2 Cg_endo -62.94 108.66 0.78 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.868 2.379 . . . . 0.0 113.152 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -82.28 74.22 9.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.838 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -40.06 66.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.412 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.429 ' O ' HD23 ' A' ' 17' ' ' LEU . 67.8 mt -62.9 -53.23 49.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.814 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 21.0 tp10 -57.44 -39.3 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.462 ' HD2' HD23 ' A' ' 103' ' ' LEU . 33.6 ttmt -60.99 -53.86 52.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.751 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.12 80.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.661 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 3.6 mm? -66.85 -29.12 68.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.665 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.52 -33.77 67.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.927 0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.22 -42.7 83.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.786 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.92 -69.77 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.014 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.24 53.32 4.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.047 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.49 -146.97 18.63 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.308 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -91.45 36.16 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 110.975 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -82.28 66.8 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.095 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m 67.3 112.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.376 0.608 . . . . 0.0 111.62 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -67.46 89.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.289 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.94 -167.53 2.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.165 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -136.39 -67.39 0.51 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 43.5 t -79.81 -52.97 1.02 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 3.5 Cg_endo -85.72 73.86 3.69 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.23 1.953 . . . . 0.0 111.893 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.54 157.62 18.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.9 t -96.37 -80.16 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.2 0.524 . . . . 0.0 112.182 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 33' ' ' MET . 28.8 ttp -85.05 -22.43 28.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.307 -172.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.449 ' HB3' ' HE1' ' A' ' 70' ' ' PHE . 2.8 m-20 -54.0 -42.72 69.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.248 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HA ' ' CH2' ' A' ' 77' ' ' TRP . 2.4 tm-20 -50.4 -76.02 0.03 OUTLIER 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.758 0.789 . . . . 0.0 111.54 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -75.74 -37.68 59.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.701 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 33' ' ' MET . 75.0 m -68.99 -47.48 65.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.62 -38.47 89.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' HD3' HD12 ' A' ' 87' ' ' ILE . 3.9 ttmp? -60.9 -42.16 97.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.199 0.523 . . . . 0.0 110.527 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.12 -45.06 74.02 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.46 -42.85 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.483 0.141 . . . . 0.0 111.003 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 90.0 mt -57.36 -48.02 80.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.697 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.625 ' HD2' HD13 ' A' ' 87' ' ' ILE . 23.2 mtpp -66.97 -37.34 84.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.297 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 67.7 t80 -65.69 -44.18 86.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.42 -42.24 88.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.828 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.16 -34.02 76.73 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.92 -43.18 79.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.605 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.3 mt -61.81 -42.23 98.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.24 6.68 2.39 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.615 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.97 99.98 51.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.782 0.325 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -88.08 121.8 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.696 2.264 . . . . 0.0 112.709 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.35 108.29 19.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -73.99 138.3 76.1 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.959 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 18.0 Cg_endo -60.05 -25.24 79.2 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.981 2.454 . . . . 0.0 111.96 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.3 -44.67 88.66 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.88 -37.78 69.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.4 t -58.4 -45.24 89.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.017 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 54' ' ' PRO . 71.8 t -63.82 -50.29 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.999 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.83 95.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.661 ' HG2' ' CD1' ' A' ' 17' ' ' LEU . 8.7 tpt180 -66.07 -41.64 90.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.236 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -60.68 -48.75 84.68 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.838 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -68.18 -27.29 66.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -69.85 -56.6 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 60' ' ' ARG . 46.8 mt-10 -73.02 -24.6 60.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.994 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.94 49.68 2.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.006 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.4 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 36.4 m0 -74.69 147.24 41.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -63.3 142.58 97.83 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.248 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.83 -60.91 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.779 2.986 . . . . 0.0 114.432 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 4.9 mm-40 -60.16 -26.32 66.22 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.449 ' HE1' ' HB3' ' A' ' 34' ' ' ASP . 30.4 t80 -66.97 -61.18 2.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 m -57.95 -38.67 76.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.261 0.553 . . . . 0.0 110.782 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -60.28 -49.52 77.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.528 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.598 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 53.6 mttm -66.79 -46.08 76.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.924 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.2 t -61.62 -40.74 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.824 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.39 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.725 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.53 99.58 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.304 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.478 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 10.2 m0 -66.82 -50.17 63.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.45 -39.03 72.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.9 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.497 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 32.8 tt0 -54.17 -54.44 39.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.824 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -68.99 -39.64 79.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.211 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 77' ' ' TRP . 92.5 t -69.24 -44.33 80.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.595 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.08 95.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.467 0.175 . . . . 0.0 110.833 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -65.95 -35.2 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.609 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.37 37.1 4.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.002 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -96.72 147.46 23.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.904 0.383 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -67.46 137.76 56.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.625 HD13 ' HD2' ' A' ' 43' ' ' LYS . 30.7 pt -138.44 135.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.547 ' O ' HD11 ' A' ' 88' ' ' LEU . 2.6 pp -69.97 131.13 43.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.849 0.833 . . . . 0.0 112.131 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.49 69.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.998 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.64 13.62 9.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' H ' ' CD ' ' A' ' 92' ' ' PRO . 5.9 m-80 -131.54 -51.25 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.071 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.533 ' CD ' ' H ' ' A' ' 91' ' ' ASN . 50.7 Cg_exo -59.25 -30.45 92.97 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.811 2.341 . . . . 0.0 113.353 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 65.97 17.98 10.94 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.205 0.526 . . . . 0.0 110.65 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 60.24 -95.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.731 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 100' ' ' GLN . 38.1 p90 179.34 177.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.637 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.167 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 98' ' ' TYR . 15.0 t -58.1 -39.61 79.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.585 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 97' ' ' THR . 74.0 t80 -43.93 -54.12 5.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.046 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.5 mtm -75.18 -29.51 60.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.244 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 8.3 tt0 -67.17 -44.55 79.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.217 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.02 -40.43 97.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.43 -51.72 68.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.523 0.678 . . . . 0.0 109.75 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 107' ' ' VAL . 68.1 mt -56.66 -63.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.905 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -57.93 -49.32 77.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.491 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.81 -48.41 80.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.949 0.404 . . . . 0.0 109.977 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.95 2.01 16.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 103' ' ' LEU . 42.7 t -100.14 -33.89 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.41 -31.7 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.365 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -63.6 -63.31 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.4 p80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.467 0.707 . . . . 0.0 110.883 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -116.69 -150.44 0.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -71.29 -8.26 52.46 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 69.99 100.21 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.58 0.752 . . . . 0.0 112.638 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -167.55 143.3 4.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.96 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -65.47 -45.2 84.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.335 0.588 . . . . 0.0 110.126 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' A' ' 110' ' ' HIS . 4.2 p -152.08 99.68 2.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.162 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.8 ttm -128.03 115.23 20.38 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.958 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.7 94.61 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.568 2.179 . . . . 0.0 112.096 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 p -76.17 5.5 6.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.564 0.697 . . . . 0.0 110.442 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.58 -25.64 68.33 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.263 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.12 -50.95 59.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.46 -41.7 75.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -73.86 -34.89 64.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.49 -33.33 69.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 0.0 109.921 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 60' ' ' ARG . 7.8 tt -62.75 -36.4 82.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.359 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.9 -46.4 89.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.187 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.49 -53.95 47.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.98 -46.24 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.664 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.29 60.89 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.294 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 -119.72 11.42 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.903 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.795 ' HA ' ' HE2' ' A' ' 23' ' ' MET . 2.9 tpt -145.4 81.33 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.405 ' C ' ' HG1' ' A' ' 25' ' ' THR . 79.2 m-20 67.84 -3.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.538 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 23' ' ' MET . 33.4 m -160.15 156.36 26.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -134.03 -163.68 1.4 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.48 166.56 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -132.21 -72.3 0.53 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.543 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 61.0 t -76.86 -57.25 1.21 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.817 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 73.0 Cg_endo -75.89 77.34 3.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.853 1.702 . . . . 0.0 112.164 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -88.43 112.71 23.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -103.48 -80.65 0.52 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.482 0.658 . . . . 0.0 110.238 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.8 ptm -90.5 -9.74 46.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.877 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.56 -22.47 66.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.845 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -102.56 -65.37 1.0 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.739 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.6 m -56.11 -52.3 64.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.986 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.44 ' O ' HG13 ' A' ' 41' ' ' ILE . 23.5 m -66.81 -41.62 87.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.697 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -61.99 -51.37 68.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.171 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.91 -39.86 90.96 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -44.65 97.81 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.15 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.451 ' O ' HD22 ' A' ' 45' ' ' LEU . 80.0 mt -64.38 -47.43 89.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.653 0.264 . . . . 0.0 111.008 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 52' ' ' VAL . 86.0 mt -62.42 -42.75 99.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.024 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -67.45 -40.54 85.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.777 0.322 . . . . 0.0 110.273 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 77.7 t80 -59.15 -47.91 83.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.317 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 41' ' ' ILE . 3.3 mm? -60.03 -45.18 93.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.848 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.91 -42.45 93.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.618 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.52 -37.8 85.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 90.3 mt -56.79 -38.48 72.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.665 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.9 -52.4 0.43 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.801 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -87.23 126.1 63.75 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 121.152 0.501 . . . . 0.0 111.611 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.1 145.75 15.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.611 HG22 HD21 ' A' ' 42' ' ' LEU . 30.8 m -81.07 140.25 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.176 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.485 ' HB2' HG21 ' A' ' 56' ' ' VAL . 3.6 m -90.55 119.21 69.1 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB3' ' HB1' ' A' ' 78' ' ' ALA . 26.2 Cg_endo -64.1 -38.0 39.12 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.786 2.324 . . . . 0.0 113.462 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -69.98 -39.41 75.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 53' ' ' SER . 27.9 m -67.37 -26.77 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 53' ' ' SER . 86.9 t -68.67 -44.4 82.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 61.3 t -62.29 -42.04 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.09 -39.56 78.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.715 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.8 tpt180 -73.16 -34.34 66.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.296 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -58.42 -48.53 83.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 7.9 pt-20 -72.17 -26.4 62.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -82.12 -54.27 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.17 -25.83 47.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.879 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.28 60.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.391 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.415 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 34.2 m0 -103.01 165.58 10.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -71.91 137.78 82.41 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.695 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.68 -44.62 43.65 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.177 2.585 . . . . 0.0 112.567 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 52.4 mp0 -63.83 -45.8 87.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' O ' HG22 ' A' ' 74' ' ' VAL . 86.9 t80 -61.86 -54.58 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.369 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 23.4 m -58.05 -39.82 79.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.707 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.31 -46.41 73.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.928 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 61.7 mttm -66.94 -43.26 83.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.046 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.87 -36.19 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.822 0.344 . . . . 0.0 110.431 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.83 86.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.353 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.95 96.73 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.091 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.417 ' O ' HG23 ' A' ' 81' ' ' VAL . 28.1 m0 -64.2 -49.19 72.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 54' ' ' PRO . . . -64.29 -35.02 79.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.376 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -59.04 -43.14 91.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.91 0.386 . . . . 0.0 110.138 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.23 -45.46 84.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.07 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 77' ' ' TRP . 85.6 t -58.99 -43.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.63 65.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 p -89.74 -19.88 24.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.01 25.01 9.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.418 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -90.97 162.54 14.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 110.761 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -87.84 145.21 26.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.07 136.52 60.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.934 0.397 . . . . 0.0 110.407 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -86.84 138.54 31.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.888 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.512 HG12 ' N ' ' A' ' 90' ' ' LYS . 6.3 tt -126.45 161.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' N ' HG12 ' A' ' 89' ' ' ILE . 42.9 mmtm -74.42 44.43 0.2 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 171.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.8 OUTLIER 76.23 152.2 0.14 Allowed Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.016 0.926 . . . . 0.0 111.429 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 34.38 0.42 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.695 2.263 . . . . 0.0 112.065 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' ASN . 10.6 tp10 -103.52 161.47 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 74.31 -30.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.264 0.626 . . . . 0.0 111.457 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.66 86.02 3.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 166.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -83.77 172.03 12.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.783 -167.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -25.99 68.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.695 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.2 -53.66 32.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.132 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -68.73 -35.48 77.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 110.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.16 -53.59 42.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.23 -38.17 76.31 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.986 0.179 . . . . 0.0 111.314 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -51.84 -60.69 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.63 0.729 . . . . 0.0 110.506 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.6 -38.17 83.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.111 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.31 -56.62 18.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.381 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.7 tt0 -64.79 -38.34 90.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.462 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -51.26 -43.24 61.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.522 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -83.06 -39.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.594 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.335 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 41.6 mt-10 -62.86 -22.55 66.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.623 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 71.2 m-70 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.118 0.485 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.7 106.56 18.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.245 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 89.2 t80 -90.87 96.38 10.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 44.2 tttm 70.19 139.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.898 0.749 . . . . 0.0 109.942 -169.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.68 163.26 22.61 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.901 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -134.74 152.87 52.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 -171.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 p -62.09 111.09 1.8 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.33 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mtp -120.81 125.19 27.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.333 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.53 115.44 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.26 . . . . 0.0 112.293 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -77.23 2.12 16.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.83 92.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.663 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.58 -44.62 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.381 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.55 -33.31 75.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.459 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 10.9 mmpt? -75.45 -26.66 58.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.811 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.38 0.61 . . . . 0.0 109.458 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.5 mm? -74.2 -14.83 61.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 11.9 t70 -69.01 -44.95 71.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.29 -64.29 0.92 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.708 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.744 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 66.5 mt -63.0 -43.14 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 -174.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.15 -9.54 80.62 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.985 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.03 -14.81 71.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.787 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.744 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 65.3 mtm -88.48 75.26 8.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.698 0.761 . . . . 0.0 110.368 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -100.02 10.31 41.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.926 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.96 54.49 1.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.518 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.7 m 57.62 31.22 20.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.101 174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . . . -64.83 112.92 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.141 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 m -165.06 -51.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 31' ' ' HIS . 56.4 t -72.98 139.69 80.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -30.23 96.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.853 3.036 . . . . 0.0 113.351 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.564 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -173.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -59.25 -67.45 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.254 0.549 . . . . 0.0 111.774 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.574 ' O ' ' HE3' ' A' ' 33' ' ' MET . 0.0 OUTLIER -56.38 -61.82 2.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.618 -176.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.604 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -51.96 -68.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.979 -175.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 36.5 tt0 -62.09 -62.21 1.93 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -169.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -58.99 -47.37 85.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.368 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.462 HG21 ' HE2' ' A' ' 99' ' ' MET . 9.2 m -75.22 -31.27 60.83 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.424 -174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.5 94.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.038 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.13 -43.4 82.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.078 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.593 ' CA ' ' HA ' ' A' ' 94' ' ' TYR . . . -63.9 -46.53 91.36 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.714 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.66 -47.53 90.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.522 0.201 . . . . 0.0 111.008 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.9 -38.6 86.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 111.208 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -66.59 -42.32 87.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.088 0.471 . . . . 0.0 110.269 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 54.2 t80 -66.16 -45.34 81.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 48' ' ' LEU . 94.7 mt -60.85 -41.59 96.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -50.49 -51.94 42.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.233 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -13.79 59.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.919 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 61.6 mt -73.43 -26.15 60.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 0.0 110.292 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.88 -14.8 10.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.376 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.69 93.17 48.76 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 110.629 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -90.97 146.21 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.091 2.527 . . . . 0.0 112.078 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.71 110.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.872 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 m -66.14 139.54 96.56 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.702 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.54 -28.08 53.47 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.034 2.489 . . . . 0.0 112.743 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.03 -44.41 87.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.211 0.529 . . . . 0.0 110.317 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.32 -38.03 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.307 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.33 -47.76 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.874 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.11 -49.68 83.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.983 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.66 92.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 1.4 tpt85 -69.39 -34.44 74.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.524 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.67 -50.21 68.5 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.275 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.25 -32.07 64.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.407 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -72.09 -45.83 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.439 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 7.3 tp10 -82.75 -48.73 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.25 65.13 0.21 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.19 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.482 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 31.5 m0 -104.56 162.71 13.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.07 148.7 81.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.66 -35.09 66.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.156 2.571 . . . . 0.0 112.411 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 24.4 mm-40 -69.9 -46.74 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.521 ' HZ ' ' HE2' ' A' ' 23' ' ' MET . 54.2 t80 -62.08 -46.6 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.3 m -61.31 -44.78 96.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.191 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.99 -43.22 88.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.239 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 64.0 mttm -62.07 -53.57 53.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.1 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 53.0 t -59.38 -40.19 80.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.821 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.49 -32.92 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.07 -35.81 64.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.439 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.477 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 14.3 m0 -68.68 -49.35 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.18 -42.52 77.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.0 -58.42 6.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.324 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -66.22 -46.97 75.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.811 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.32 -43.66 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.565 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.49 61.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.579 0.228 . . . . 0.0 111.22 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t -67.25 -35.59 79.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.391 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.14 -3.44 8.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.63 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.28 103.9 16.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 109.759 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -53.41 141.45 24.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.984 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.6 pt -124.36 113.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.531 0.681 . . . . 0.0 109.86 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.86 123.86 29.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.021 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.876 HG23 ' HB2' ' A' ' 91' ' ' ASN . 56.2 mt -66.42 -31.03 51.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.101 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HB3' ' HZ2' ' A' ' 90' ' ' LYS . 7.8 mtpm? 62.29 21.55 12.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.271 1.034 . . . . 0.0 109.456 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.988 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 52.4 m-80 -148.43 -160.28 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.988 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 31.6 Cg_exo -43.37 86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.907 2.405 . . . . 0.0 114.14 168.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.543 ' HA ' HD13 ' A' ' 89' ' ' ILE . 19.0 mm-40 -63.99 130.14 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.883 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.593 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 96.8 m-85 64.63 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.94 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.5 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER 169.85 -157.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.161 -172.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 11.3 t -108.14 -175.78 2.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -41.12 88.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -167.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 96' ' ' SER . 0.1 OUTLIER -53.46 -47.56 69.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.462 ' HE2' HG21 ' A' ' 37' ' ' THR . 65.5 mtt -65.1 -45.3 85.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.402 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.5 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -58.68 -45.35 89.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.645 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -60.24 -44.58 95.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.431 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -64.61 -57.41 9.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.07 -46.76 87.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.704 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -65.42 -35.17 80.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.747 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.83 -38.73 91.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 110.821 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -63.55 -34.11 77.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.304 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.93 -50.67 18.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.1 -62.43 1.88 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.394 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -71.42 -59.94 2.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.286 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 . . . . . 0 N--CA 1.471 0.586 0 O-C-N 124.015 0.822 . . . . 0.0 111.569 175.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -97.38 11.11 37.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -166.9 138.6 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.447 0.165 . . . . 0.0 110.625 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -70.39 122.26 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 175.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.71 170.88 13.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.937 0.398 . . . . 0.0 110.604 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -93.27 19.96 7.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.957 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -125.64 157.13 38.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.057 0.456 . . . . 0.0 110.419 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 ptp -140.96 157.87 66.27 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.0 118.13 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.896 2.397 . . . . 0.0 111.965 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -131.35 148.84 52.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.138 0.494 . . . . 0.0 111.204 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.21 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.39 -37.6 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 14.0 mm-40 -76.72 -25.91 54.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.103 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -81.28 -30.61 33.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.58 -36.17 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 57.1 tp -58.7 -41.02 85.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.323 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.29 -46.15 86.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.774 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -62.38 -50.74 70.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.868 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.35 -55.86 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.363 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.95 29.3 5.84 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.26 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.05 -70.63 1.1 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.564 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.9 -50.64 10.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 60.49 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.649 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t -89.64 167.35 13.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.313 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -71.96 88.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 0.0 110.569 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.614 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . . . -94.01 121.66 35.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.692 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.4 m -130.1 -47.37 1.11 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.508 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 m -74.34 173.62 6.32 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.248 167.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 51.5 Cg_exo -55.34 -19.89 23.6 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.262 1.974 . . . . 0.0 111.553 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.614 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 70.48 -167.17 0.16 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.348 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -95.9 -80.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 0.0 111.911 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.2 ttp -94.32 -17.01 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.544 0.688 . . . . 0.0 109.96 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.14 -21.29 66.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.218 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -93.45 -68.79 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.679 0.275 . . . . 0.0 110.825 -176.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -46.68 88.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -67.21 -36.61 82.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 0.0 111.033 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.94 89.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.525 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 31.7 mmtp -54.74 -48.0 73.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.564 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.12 -44.56 94.71 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.348 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 103' ' ' LEU . 73.9 mt -61.05 -49.97 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.061 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.51 -44.62 93.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.429 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' HZ3' ' HB3' ' A' ' 43' ' ' LYS . 9.5 mtpm? -69.42 -27.35 65.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.387 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HH ' ' HB2' ' A' ' 104' ' ' LYS . 68.2 t80 -70.14 -36.52 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.449 . . . . 0.0 110.182 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.2 mt -64.15 -40.37 95.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.403 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -72.74 -25.0 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.65 -38.45 89.38 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.24 0.543 . . . . 0.0 109.897 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.44 -40.2 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.767 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.29 -26.81 3.67 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.97 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.91 104.7 54.24 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -92.32 -178.49 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.028 2.486 . . . . 0.0 112.081 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -109.83 121.35 62.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 56' ' ' VAL . 6.4 m -61.65 127.55 88.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' O ' HG22 ' A' ' 58' ' ' VAL . 53.1 Cg_exo -53.02 -32.33 57.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.878 2.386 . . . . 0.0 112.544 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -55.99 -52.52 63.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.664 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 53' ' ' SER . 31.5 m -71.02 -24.19 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 111.015 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.46 -45.49 88.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.126 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 54' ' ' PRO . 65.1 t -61.11 -48.99 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.646 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.57 98.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.949 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.81 -42.49 99.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.207 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.53 -47.63 89.47 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.48 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.9 -12.78 60.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.78 0.324 . . . . 0.0 110.814 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -85.8 -52.4 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -73.88 -27.34 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.959 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.37 48.21 1.45 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.532 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.472 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 40.9 m0 -83.26 153.74 24.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.487 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 67.2 t30 -63.17 127.9 91.6 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.487 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 4.9 Cg_endo -47.3 -43.82 25.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.867 . . . . 0.0 113.332 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.3 -37.1 79.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.766 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 74' ' ' VAL . 74.6 t80 -70.45 -53.36 16.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -58.16 -40.03 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.322 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.79 -46.91 88.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.535 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -67.41 -46.19 73.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.545 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 70' ' ' PHE . 69.6 t -60.33 -37.82 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.56 89.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.638 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.27 -35.12 69.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.899 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.535 ' O ' HG21 ' A' ' 81' ' ' VAL . 50.6 m0 -63.1 -54.13 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.36 68.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.056 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.26 -50.29 74.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.162 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -81.27 -21.51 39.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.489 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 77' ' ' TRP . 75.7 t -67.78 -38.27 79.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 109.836 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.41 -44.33 36.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.239 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.3 p -75.55 -34.83 60.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.91 44.36 4.5 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.772 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -111.7 108.52 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 62.13 -141.22 0.44 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.563 0.539 . . . . 0.0 110.671 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 89' ' ' ILE . 37.0 pt 52.76 53.06 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.34 1.056 . . . . 0.0 112.22 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.22 19.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.499 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 87' ' ' ILE . 1.1 tt 79.28 141.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.18 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -71.32 -40.94 70.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.566 0.698 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.459 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.1 OUTLIER -172.19 148.67 2.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.816 175.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 -37.81 93.74 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.453 2.102 . . . . 0.0 111.618 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.33 -97.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.43 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -142.49 24.22 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 111.116 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.25 107.39 4.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.0 m -99.34 159.93 14.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.277 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.3 t -66.79 -28.59 68.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.0 -39.88 63.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.777 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.4 mtt -66.3 -42.23 88.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.086 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.7 -51.65 68.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.586 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' THR . 73.8 mt-10 -59.64 -42.02 91.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.13 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 22.1 mt-30 -56.22 -54.86 40.19 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.698 0.285 . . . . 0.0 111.155 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.0 mt -60.76 -44.67 96.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' HB2' ' HH ' ' A' ' 44' ' ' TYR . 83.8 tttt -63.83 -41.9 97.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.865 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.296 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 96.5 mt -66.54 -21.67 66.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 103' ' ' LEU . 98.6 t -71.8 -40.99 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 109.91 173.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -72.3 -44.3 62.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.77 -23.53 65.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 177.257 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.02 -2.99 56.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 t80 71.29 -105.52 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.676 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.422 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 86.5 tttt 177.73 168.2 0.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.422 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 14.5 m-20 -56.58 109.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 169.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -75.55 -76.29 0.15 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -126.07 109.6 12.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.6 ttm -84.42 114.67 56.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.646 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.07 137.14 64.89 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.797 2.331 . . . . 0.0 112.114 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -77.52 85.35 3.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.563 0.697 . . . . 0.0 110.681 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.4 88.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.583 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -64.13 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.128 0.489 . . . . 0.0 109.889 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.4 -50.64 72.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.15 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 28.1 mmtp -78.85 -18.51 53.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.69 77.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.624 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.1 mt -70.95 -22.41 62.22 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.183 174.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 18.4 t70 -67.48 -36.91 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -65.07 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.488 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.92 -74.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.519 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CE2' ' A' ' 66' ' ' TRP . . . -95.36 46.96 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.373 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.08 -58.28 1.41 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.63 95.85 9.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.608 ' CG ' ' HA ' ' A' ' 66' ' ' TRP . 76.6 m-20 -116.21 144.71 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.464 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.496 HG21 ' CG2' ' A' ' 29' ' ' VAL . 12.4 t -164.54 -178.55 5.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.29 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -85.98 45.93 1.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.503 . . . . 0.0 110.579 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' A' ' 67' ' ' ASN . . . -170.86 -151.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.385 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.4 t -137.5 56.8 1.76 Allowed 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.496 ' CG2' HG21 ' A' ' 25' ' ' THR . 31.3 t -46.09 -44.59 37.24 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.056 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 81.6 Cg_exo -50.16 -37.95 49.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.462 1.441 . . . . 0.0 111.343 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.1 m170 68.18 -69.86 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.558 1.143 . . . . 0.0 111.968 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -92.56 -49.24 6.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.809 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.599 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.59 -27.71 28.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.332 -170.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -41.45 -54.17 3.18 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 124.097 0.873 . . . . 0.0 110.632 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 33.5 mm-40 -59.09 -63.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.9 m -62.14 -55.81 25.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.41 HG21 ' SD ' ' A' ' 99' ' ' MET . 90.9 m -69.14 -52.5 27.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -170.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.48 -44.11 45.71 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.634 ' HZ1' ' HB2' ' A' ' 39' ' ' LYS . 4.2 ttmp? -67.54 -33.59 75.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.799 0.333 . . . . 0.0 110.246 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.7 -50.42 66.3 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.314 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.15 -45.22 96.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.625 0.25 . . . . 0.0 111.102 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.52 -44.83 89.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.941 0.401 . . . . 0.0 111.249 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.721 ' HZ3' ' HB3' ' A' ' 43' ' ' LYS . 9.8 mtpm? -69.92 -34.1 73.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.394 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -64.73 -42.2 95.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 110.117 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.43 -42.56 92.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.495 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.61 -35.83 78.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.606 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.56 -43.57 89.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.388 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.472 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.65 16.29 1.67 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.21 94.11 47.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.934 0.397 . . . . 0.0 110.671 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -93.02 152.19 2.63 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.886 2.391 . . . . 0.0 112.253 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 148.26 24.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -83.11 133.37 48.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.601 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' HG22 ' A' ' 58' ' ' VAL . 45.2 Cg_exo -56.87 -31.42 88.96 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.267 2.645 . . . . 0.0 112.519 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.59 -42.82 64.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.304 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.92 -38.65 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.414 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.43 -46.91 85.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.471 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 85.7 t -60.09 -44.26 94.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.498 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.77 88.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.0 tpt180 -65.38 -39.75 92.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.16 97.86 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.265 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 51.5 mt-10 -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.602 -0.352 . . . . 0.0 111.188 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.84 -46.09 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.4 -9.16 55.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.552 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.3 -65.3 1.58 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.819 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HA ' ' CG ' ' A' ' 24' ' ' ASN . 35.7 m0 55.35 -167.27 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.07 0.548 . . . . 0.0 111.957 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.866 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 54.4 m-80 -93.48 123.4 60.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.45 -38.2 82.78 Favored 'Trans proline' 0 CA--C 1.526 0.106 0 C-N-CA 122.996 2.464 . . . . 0.0 112.628 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -80.45 -33.39 36.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.561 . . . . 0.0 110.015 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.866 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 77.5 t80 -73.27 -43.99 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.535 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.9 m -59.51 -35.62 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -69.59 -40.36 76.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.695 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 63.2 mttt -54.76 -57.6 10.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.475 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.0 t -60.61 -37.46 75.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.06 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.49 73.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.1 51.42 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.15 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.695 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.6 m0 -64.62 -49.25 71.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.979 0.419 . . . . 0.0 110.107 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -34.41 74.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.743 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.6 -45.28 92.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.025 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.56 -49.03 79.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.427 0.632 . . . . 0.0 110.327 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 77' ' ' TRP . 61.9 t -60.77 -44.87 98.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.502 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.1 61.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.64 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -77.45 -9.31 58.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 110.798 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.88 29.01 13.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.098 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.606 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -100.12 171.01 8.08 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 86' ' ' ARG . 13.0 ptt180 -119.44 132.83 55.88 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.8 pt -112.73 138.55 41.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.174 0.512 . . . . 0.0 110.901 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.16 116.65 17.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.409 HG21 ' O ' ' A' ' 89' ' ' ILE . 16.8 tt -77.48 89.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 122.502 1.144 . . . . 0.0 110.092 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -67.62 -2.74 7.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.779 -176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.588 ' ND2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -160.12 88.35 1.88 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -177.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -96.35 29.15 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.523 2.816 . . . . 0.0 112.511 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.2 -55.52 33.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.599 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 20.3 m-85 -99.45 35.67 1.91 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -171.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' HE2' HE21 ' A' ' 100' ' ' GLN . 10.7 t80 -116.1 82.87 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -74.09 160.53 31.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.838 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -30.86 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.734 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.549 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.7 t80 -49.34 -51.64 33.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.546 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.41 ' SD ' HG21 ' A' ' 37' ' ' THR . 68.0 mtm -69.45 -39.14 77.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.467 HE21 ' HE2' ' A' ' 95' ' ' PHE . 73.4 mt-30 -61.88 -46.58 88.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.23 -35.21 79.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.167 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 57.5 mt-30 -59.11 -50.92 72.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 110.37 175.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.48 -45.23 84.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.475 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.44 -42.39 82.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.23 -49.57 55.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.578 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -62.94 -44.51 95.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.942 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.0 -32.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 110.415 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.5 tp -67.51 -59.22 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -32.72 69.99 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.713 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.401 171.13 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -140.48 112.52 7.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.303 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.25 105.61 17.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.522 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -76.89 104.18 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.01 -166.04 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.337 -173.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -116.76 99.83 7.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.094 -179.008 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.2 m -128.39 178.51 6.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.249 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -87.52 109.18 24.22 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 121.099 0.476 . . . . 0.0 110.025 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.76 -60.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.154 2.569 . . . . 0.0 114.401 -170.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.2 p -78.06 -6.57 55.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -171.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 106' ' ' LEU . . . -64.35 -46.62 82.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.2 0.524 . . . . 0.0 110.401 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 54.6 mt -70.52 -40.4 77.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.215 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.07 -39.77 93.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.91 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 48.4 tptt -68.71 -36.04 77.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.309 . . . . 0.0 110.61 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -41.48 99.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 110.27 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.545 HD13 ' HG2' ' A' ' 60' ' ' ARG . 92.0 mt -66.76 -32.7 74.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.687 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 7.4 t70 -57.49 -44.55 85.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.018 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.49 -41.85 98.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -54.25 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.648 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -54.16 30.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.81 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -111.28 4.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.904 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.6 mtt -109.21 -42.67 4.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 51.1 71.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.902 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -105.28 -78.44 0.57 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 t -102.04 4.25 39.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.293 0.568 . . . . 0.0 109.796 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.24 111.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.734 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 60.8 m -154.41 -52.57 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.18 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.569 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 51.3 t -109.15 -47.86 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.305 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 18.9 Cg_exo -67.68 110.54 2.13 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.415 1.41 . . . . 0.0 109.785 165.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.499 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 5.0 m170 -131.21 103.3 6.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.614 -172.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -104.19 -58.18 1.92 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 110.485 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.485 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -87.4 -58.52 2.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.074 -171.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.36 -5.47 32.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.014 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.675 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 21.0 tt0 -103.19 -62.74 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.09 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.8 m -58.28 -55.78 30.54 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' HE1' ' A' ' 33' ' ' MET . 41.3 m -70.91 -30.17 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.83 0.348 . . . . 0.0 110.868 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.74 99.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HE3' ' CG ' ' A' ' 35' ' ' GLU . 92.3 mttt -58.88 -43.69 90.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.072 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 -44.38 97.87 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.594 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.32 -47.43 93.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.042 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.59 HD23 HG13 ' A' ' 52' ' ' VAL . 82.5 mt -64.36 -40.29 95.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 110.916 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.08 -34.23 76.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.461 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.412 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 76.3 t80 -65.62 -39.13 91.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.62 -44.18 96.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 110.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -62.62 -32.52 73.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.575 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.49 -34.46 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.305 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.3 mt -67.65 -41.68 83.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.353 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.25 -50.22 0.47 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.734 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 m -87.47 121.24 71.25 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.224 0.535 . . . . 0.0 112.226 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.8 165.8 8.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.59 HG13 HD23 ' A' ' 42' ' ' LEU . 8.9 p -107.03 147.79 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.45 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 13.8 m -102.16 137.05 19.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 27.0 Cg_exo -62.56 -24.79 75.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.241 2.627 . . . . 0.0 112.545 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -53.36 -45.92 69.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.825 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.84 -36.52 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.62 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.501 HG11 ' HB ' ' A' ' 74' ' ' VAL . 66.8 t -64.0 -49.73 80.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.73 -46.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.06 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HG2' HD13 ' A' ' 17' ' ' LEU . 20.8 tpt180 -66.4 -43.35 86.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -47.08 91.3 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.429 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.13 -33.6 76.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.639 0.257 . . . . 0.0 111.418 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.97 -57.19 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.52 -31.58 68.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.161 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.66 45.03 1.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.964 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -85.65 131.43 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.463 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t30 -65.65 123.45 84.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 26.3 Cg_exo -30.11 -44.67 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.748 4.299 . . . . 0.0 115.918 -176.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 1.4 mp0 -59.05 -35.19 72.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.096 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 74' ' ' VAL . 57.4 t80 -74.92 -47.54 29.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 m -60.44 -39.8 88.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.879 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -62.41 -43.94 97.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.927 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -56.53 -58.75 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.571 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 31.8 t -59.65 -41.59 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.564 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.07 88.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.438 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.08 -37.98 94.82 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.44 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.675 ' CZ2' ' HG3' ' A' ' 35' ' ' GLU . 11.1 m0 -66.43 -53.78 31.7 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.13 -40.29 64.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.986 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -55.24 -54.57 41.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.796 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 58.5 mttt -73.05 -39.3 66.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -42.21 92.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.541 0.21 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.83 93.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.185 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -78.92 -9.22 59.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.57 39.39 41.54 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.217 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 55.4 m-20 -98.61 152.16 19.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.38 149.72 48.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.152 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 pt -136.39 166.03 27.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.89 102.43 14.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 89' ' ' ILE . 4.0 tt -103.28 -6.94 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.068 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 90' ' ' LYS . 3.8 tptp 66.11 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.0 -169.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.651 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -153.26 126.86 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.21 -59.06 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.279 1.986 . . . . 0.0 111.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' A' ' 91' ' ' ASN . 27.7 mm-40 57.21 -81.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 172.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -85.08 53.44 2.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -111.27 71.15 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -61.01 144.8 52.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.66 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 m -53.55 -38.18 63.6 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.523 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.23 -37.93 78.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.672 0.273 . . . . 0.0 111.231 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.2 mtm -75.56 -41.09 55.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.35 -47.72 82.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.768 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 13.5 tp10 -69.39 -28.0 65.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.675 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -66.24 -49.08 68.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.337 0.589 . . . . 0.0 109.819 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.44 -43.6 98.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.238 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 34.6 tttm -58.86 -37.08 75.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.144 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.561 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.5 tt0 -58.31 -54.67 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 12' ' ' ALA . 6.1 tt -56.13 -45.3 79.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.364 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.73 -42.46 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.3 tp -66.58 -44.91 80.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.992 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 52.7 mt-10 -49.15 -45.46 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.353 -172.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.515 0.198 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.05 -59.25 0.57 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.516 0.727 . . . . 0.0 111.811 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -114.75 109.98 19.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.259 0.552 . . . . 0.0 110.877 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -152.16 165.47 34.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.51 106.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.144 0.497 . . . . 0.0 110.595 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 7' ' ' LYS . 23.1 ttpp -88.53 141.67 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.203 -172.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 m 65.73 102.5 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.969 0.793 . . . . 0.0 111.436 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' THR . 72.3 mtm -138.1 126.27 14.11 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.695 -177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 10.5 Cg_exo -71.44 29.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.201 2.601 . . . . 0.0 112.832 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' MET . 9.0 t -78.44 -1.17 32.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.589 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.27 -38.17 82.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -63.28 -47.62 91.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.104 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.72 -36.76 84.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.495 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -66.85 -46.97 73.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.26 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.476 . . . . 0.0 110.314 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.411 HD13 ' HG2' ' A' ' 60' ' ' ARG . 21.6 tp -66.79 -34.53 78.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.419 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.93 -42.31 97.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.119 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.13 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.42 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.38 -65.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.92 -51.74 55.05 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.903 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.71 -117.17 4.97 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 ptm -165.28 117.87 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.168 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -95.68 93.61 7.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.025 0.441 . . . . 0.0 110.662 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -78.8 83.15 4.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.617 0.722 . . . . 0.0 109.68 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t 70.41 -6.12 1.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.176 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.81 114.39 5.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.254 0.55 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 3.3 p -141.11 -57.18 0.5 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.436 -175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.578 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 60.6 t -83.07 -54.83 0.53 Allowed Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 90.6 Cg_endo -81.41 131.83 7.71 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.578 1.518 . . . . 0.0 111.462 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.466 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 26.4 m-70 -131.38 152.64 50.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 m -103.3 -80.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.312 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 10.4 ttp -109.34 -17.66 13.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.737 0.779 . . . . 0.0 108.907 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -79.96 -0.25 34.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.307 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' CB ' ' A' ' 31' ' ' HIS . 3.5 tm-20 -102.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.782 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -73.36 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.9 m -62.17 -32.31 72.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.273 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.02 89.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.836 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.513 ' HD3' HD13 ' A' ' 87' ' ' ILE . 58.4 mttp -57.0 -44.35 82.67 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.79 -49.08 82.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.01 -42.47 88.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.817 0.342 . . . . 0.0 111.061 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.53 -44.51 85.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.46 0.648 . . . . 0.0 110.237 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.605 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 57.9 tttp -71.29 -39.38 71.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.511 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.43 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 51.2 t80 -63.24 -38.95 93.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.29 -41.81 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.71 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.489 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 51.1 m80 -61.84 -36.05 80.06 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.077 0.465 . . . . 0.0 109.945 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.63 -51.13 68.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 89.4 mt -54.63 -44.06 72.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.429 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.577 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 144.6 -7.29 1.73 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.159 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.15 98.05 6.02 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 121.311 0.577 . . . . 0.0 110.951 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 72.6 Cg_endo -87.74 89.13 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.548 2.166 . . . . 0.0 112.447 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.4 129.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.997 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -92.7 157.82 39.15 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 Cg_endo -52.04 -34.02 55.51 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.31 -50.52 50.48 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.208 0.528 . . . . 0.0 110.878 174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.64 -37.51 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.466 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.46 -47.65 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' PRO . 85.9 t -62.01 -54.27 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.9 tpp180 -65.4 -45.48 83.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.026 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.07 99.52 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.555 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.9 mt-10 -68.57 -26.18 65.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.56 0.219 . . . . 0.0 111.208 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.33 -46.46 11.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 111.14 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -78.35 -26.2 46.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.76 46.29 3.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.004 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -74.93 164.17 26.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.489 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.47 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 57.8 t30 -69.91 127.85 92.18 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 82.4 Cg_exo -45.25 -47.67 12.35 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.15 2.566 . . . . 0.0 113.018 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 3.7 mm-40 -56.62 -34.18 67.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.857 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.414 ' O ' HG23 ' A' ' 74' ' ' VAL . 76.8 t80 -71.34 -59.57 2.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.05 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 24.7 m -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.584 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.54 -49.9 73.48 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -72.73 -40.74 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.613 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.441 HG21 ' CZ3' ' A' ' 77' ' ' TRP . 96.0 t -64.19 -36.07 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.699 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.99 93.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.159 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.266 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.441 ' CZ3' HG21 ' A' ' 74' ' ' VAL . 27.7 m0 -65.98 -48.28 71.76 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.33 82.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.094 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -57.32 -48.53 78.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 0.0 110.763 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.68 -40.5 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.457 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 77' ' ' TRP . 70.5 t -68.47 -35.15 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.589 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.55 80.58 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -69.81 -21.05 63.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.308 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.66 35.53 9.23 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.14 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.3 -178.15 4.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.958 0.409 . . . . 0.0 110.348 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -111.26 138.45 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.513 HD13 ' HD3' ' A' ' 39' ' ' LYS . 39.2 pt -120.43 150.65 23.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 -172.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.26 101.71 9.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.249 0.547 . . . . 0.0 109.723 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.622 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 1.4 tt -89.57 -71.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.076 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 89' ' ' ILE . 43.1 mmtm 175.66 -59.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -172.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -169.52 139.59 1.73 Allowed Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.06 -178.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.79 24.18 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.114 2.543 . . . . 0.0 114.071 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 91' ' ' ASN . 36.2 tt0 -75.0 -26.19 59.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.605 ' HE1' ' HD3' ' A' ' 43' ' ' LYS . 98.4 m-85 67.43 -77.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.939 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.718 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 26.0 p90 -170.21 -173.76 1.57 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.651 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 m -75.89 155.06 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.926 0.393 . . . . 0.0 111.465 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -25.82 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.382 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -43.34 -56.43 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.276 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.718 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 2.1 mpt? -64.23 -44.77 90.82 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.063 -174.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.455 ' HG3' ' CE1' ' A' ' 95' ' ' PHE . 24.4 mt-30 -57.62 -49.66 75.71 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 -35.21 75.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.648 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 5.8 tp-100 -61.38 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.601 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.513 ' O ' HG21 ' A' ' 107' ' ' VAL . 10.0 mp -57.26 -39.55 75.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.725 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -57.77 -52.74 64.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.998 0.428 . . . . 0.0 111.482 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.33 65.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 86.5 mt -73.51 -31.65 63.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 103' ' ' LEU . 29.0 t -90.03 -13.66 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 110.482 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.28 -31.78 72.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.395 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.14 86.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.353 175.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.8 t . . . . . 0 C--O 1.233 0.222 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -64.99 137.97 58.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 112.64 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -98.37 104.48 16.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.811 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -87.05 -160.61 0.6 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -67.37 -174.64 0.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.36 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -76.57 75.95 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 110.652 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -101.66 106.67 17.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.264 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.3 mtp -141.21 71.39 27.52 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -96.2 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.263 2.642 . . . . 0.0 112.7 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 14' ' ' GLU . 21.7 p 49.95 76.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.608 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.73 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.514 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.4 -30.53 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.588 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.761 ' HG2' HH22 ' A' ' 60' ' ' ARG . 3.6 tm-20 -65.87 -42.63 90.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.626 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 70.5 mmtt -75.08 -20.17 59.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.26 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.08 -39.34 86.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.74 HD12 ' HG2' ' A' ' 60' ' ' ARG . 4.0 mm? -65.61 -33.0 74.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.612 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.14 -36.63 80.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.252 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.2 -43.17 95.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.665 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.87 -56.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.708 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.46 -49.58 30.75 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.602 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 -71.71 2.75 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.998 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.544 ' HG3' ' H ' ' A' ' 24' ' ' ASN . 10.2 tpt -134.53 175.5 9.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -172.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.544 ' H ' ' HG3' ' A' ' 23' ' ' MET . 4.7 p-10 -69.24 168.51 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.069 0.462 . . . . 0.0 111.432 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 3.0 t -58.97 120.48 9.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.607 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -157.16 -50.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.54 -161.91 1.04 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.123 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.699 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 15.5 t -96.98 25.51 5.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 28' ' ' SER . 45.7 t 85.03 157.92 0.11 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 113.467 -1.697 . . . . 0.0 106.522 -165.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HD2' ' CG1' ' A' ' 29' ' ' VAL . 34.4 Cg_exo -30.53 -14.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.075 3.85 . . . . 0.0 116.847 173.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 29' ' ' VAL . 42.6 m80 86.78 -47.78 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.278 1.031 . . . . 0.0 110.871 168.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.9 m -83.69 -52.41 6.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.903 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.498 ' HE2' ' C ' ' A' ' 33' ' ' MET . 0.7 OUTLIER -51.48 -35.47 40.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.949 -175.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.26 -66.14 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 111.58 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.614 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 mm-40 -54.12 -64.69 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.472 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 p -67.48 -42.8 82.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' ' SD ' ' A' ' 33' ' ' MET . 33.4 m -79.3 -53.33 7.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.5 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.842 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.714 ' HD3' HG12 ' A' ' 89' ' ' ILE . 87.2 mttt -64.57 -37.91 89.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.066 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.53 -50.28 69.38 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.342 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 47.9 mt -66.66 -45.41 88.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.994 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.478 HD13 HG11 ' A' ' 74' ' ' VAL . 79.4 mt -59.83 -45.85 91.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.627 0.251 . . . . 0.0 111.357 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.12 -44.26 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.893 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.475 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 58.4 t80 -61.28 -43.78 98.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.249 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 86.8 mt -62.14 -43.02 99.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.403 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.61 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 56.7 m80 -62.6 -37.71 87.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.488 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.95 -38.36 90.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.119 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.2 mt -66.4 -25.16 66.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.11 1.91 14.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.176 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.6 95.75 9.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.61 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 77.2 Cg_endo -86.96 94.3 0.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.281 1.987 . . . . 0.0 112.76 -177.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 117.13 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.499 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -99.41 162.06 22.55 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.471 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.2 Cg_exo -53.06 -37.1 78.75 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.186 2.591 . . . . 0.0 112.955 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -56.74 -42.33 79.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.9 -49.81 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.91 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 54' ' ' PRO . 57.7 t -63.06 -47.7 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.76 93.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.761 HH22 ' HG2' ' A' ' 14' ' ' GLU . 5.4 tpp180 -66.16 -42.11 89.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.976 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.78 -36.88 81.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.176 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -71.79 -38.22 70.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.786 0.326 . . . . 0.0 110.672 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -63.32 -50.76 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 111.233 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.563 ' OE2' ' HD2' ' A' ' 60' ' ' ARG . 63.0 mt-10 -87.21 -21.69 25.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' HB ' ' A' ' 25' ' ' THR . . . 82.51 47.12 6.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.159 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -70.35 158.67 35.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.72 135.03 95.43 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.7 -24.69 23.97 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.14 -53.05 62.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.917 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.666 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 51.8 t80 -71.52 -43.52 66.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.124 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 m -58.26 -41.62 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -69.57 -42.26 74.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.666 ' CE ' ' HA ' ' A' ' 70' ' ' PHE . 53.4 mtmt -56.24 -58.71 6.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 42' ' ' LEU . 54.2 t -62.92 -40.05 87.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.543 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.63 88.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 110.516 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -65.19 -40.9 97.06 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.804 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.455 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 43.8 m0 -62.27 -44.59 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.121 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.41 96.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -45.71 88.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HD3' HG22 ' A' ' 87' ' ' ILE . 28.8 mtpp -61.62 -51.73 67.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 77' ' ' TRP . 19.5 t -67.96 -35.53 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.31 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.7 -33.76 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -79.18 -14.18 59.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.373 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.17 26.97 11.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.848 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -111.01 135.11 52.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -62.13 145.92 52.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.627 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.486 HG22 ' HD3' ' A' ' 80' ' ' LYS . 15.9 pt -103.61 129.99 54.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 88' ' ' LEU . 2.5 pt? -68.12 115.37 7.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.484 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.714 HG12 ' HD3' ' A' ' 39' ' ' LYS . 25.1 mt -121.7 137.38 55.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -59.24 -41.26 88.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 153.92 126.39 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 125.401 1.688 . . . . 0.0 109.19 166.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.16 -63.05 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.3 2.0 . . . . 0.0 110.943 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 68.23 -60.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.218 0.949 . . . . 0.0 112.545 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.97 6.89 23.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.812 0.339 . . . . 0.0 110.986 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -73.25 93.47 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m -111.69 -170.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 0.0 112.875 -166.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.5 -54.85 19.11 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.827 -169.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -56.36 -40.37 74.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.341 0.4 . . . . 0.0 111.786 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.3 mtt -66.28 -51.24 59.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.864 0.364 . . . . 0.0 110.743 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.0 -44.42 84.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -65.6 -45.57 82.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.856 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.427 ' O ' HD11 ' A' ' 106' ' ' LEU . 18.3 tp60 -56.46 -53.71 54.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.127 0.489 . . . . 0.0 110.617 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.0 -44.85 94.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.068 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HB3' ' HZ2' ' A' ' 104' ' ' LYS . 7.1 ttpm? -67.14 -34.75 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 -176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.68 -48.67 73.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.011 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 HD11 ' O ' ' A' ' 102' ' ' GLN . 10.1 mp -59.69 -37.22 78.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.2 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.2 t -74.76 -37.87 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 110.69 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.1 tp -58.53 -49.22 78.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.649 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.85 -12.99 61.87 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.917 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.713 0.292 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -70.93 138.23 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -150.61 -41.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.28 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 71.53 165.64 0.29 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.054 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.85 26.48 13.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.573 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.75 106.34 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.754 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -140.4 111.09 6.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.476 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.3 mmt -95.95 131.67 28.57 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.907 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.49 31.43 0.51 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 0.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -85.09 84.66 7.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.842 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.21 82.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.813 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.64 -32.31 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.465 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.55 -30.31 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.68 -35.17 76.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.574 HD11 ' HZ2' ' A' ' 66' ' ' TRP . 35.8 tp -61.01 -44.02 98.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.683 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.23 -35.25 79.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.28 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' HE2' ' SD ' ' A' ' 99' ' ' MET . 1.2 m-85 -64.65 -47.18 79.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.59 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -87.97 -59.73 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 111.398 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.77 42.32 1.99 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.28 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.74 78.21 1.05 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.238 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.3 ttt 69.25 10.65 7.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.292 0.637 . . . . 0.0 110.56 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.07 82.4 3.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.843 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.5 t -101.51 -12.5 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.728 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -108.88 102.81 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.88 149.33 12.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t -177.35 -68.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.154 0.502 . . . . 0.0 109.739 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.44 HG12 ' HD2' ' A' ' 30' ' ' PRO . 60.0 t -68.3 140.19 92.73 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.44 ' HD2' HG12 ' A' ' 29' ' ' VAL . 30.6 Cg_exo -25.73 105.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 124.506 3.47 . . . . 0.0 113.572 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -96.79 167.94 10.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.268 -170.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 p -97.35 -79.86 0.45 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 111.651 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.512 ' HE3' ' HA ' ' A' ' 33' ' ' MET . 2.9 tpt -51.75 -62.28 1.73 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.747 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . 4.0 p-10 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.619 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.4 tt0 -102.62 -73.99 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.601 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.6 p -61.25 -39.18 89.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.508 HG21 ' HE2' ' A' ' 99' ' ' MET . 57.6 m -70.15 -41.11 74.27 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.445 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.12 -36.68 84.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.502 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.18 -43.28 87.44 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.73 96.61 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.906 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 37' ' ' THR . 90.7 mt -59.03 -50.52 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.519 . . . . 0.0 110.455 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.67 -48.88 78.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.532 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -72.11 -29.85 64.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.568 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -63.77 -48.84 75.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.651 0.262 . . . . 0.0 111.168 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.86 -32.09 72.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.689 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -66.34 -37.13 84.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.22 -36.66 84.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.35 -46.82 84.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.831 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.71 -55.49 0.36 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.369 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.23 113.48 60.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.097 0.475 . . . . 0.0 112.172 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.82 155.22 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.813 2.342 . . . . 0.0 111.772 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.93 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 m -83.44 149.15 57.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.42 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.19 -28.99 64.28 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.088 2.525 . . . . 0.0 112.195 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -46.17 -51.67 13.7 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.718 0.636 . . . . 0.0 110.569 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -63.27 -47.78 90.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.462 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' A' ' 74' ' ' VAL . 57.8 t -58.04 -53.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.438 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.6 -41.51 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.33 76.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.201 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -68.36 -45.39 72.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.735 0.302 . . . . 0.0 110.285 176.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.71 85.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.834 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.55 -46.01 64.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.218 0.532 . . . . 0.0 110.279 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -69.68 -50.47 43.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.493 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -85.44 -48.09 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.574 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.61 -59.67 0.69 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.574 ' HZ2' HD11 ' A' ' 17' ' ' LEU . 34.7 m0 51.96 -104.57 0.19 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 111.911 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 18.8 t-20 -171.61 131.64 0.77 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.68 -56.87 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.695 2.263 . . . . 0.0 113.275 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.63 -37.99 83.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.703 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 61.1 t80 -64.68 -42.99 94.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.215 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.7 m -63.66 -40.99 98.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.435 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -70.19 -37.49 75.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.25 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -52.58 -60.18 3.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' HB ' HG11 ' A' ' 57' ' ' VAL . 24.2 t -61.45 -39.37 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.261 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.98 85.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.95 -39.62 94.99 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.202 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.449 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 m0 -62.56 -48.34 79.89 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.19 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.992 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.19 -53.04 61.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.091 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.18 -51.52 69.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -39.16 84.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.33 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.48 -33.49 71.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.957 0.408 . . . . 0.0 110.869 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -74.12 -19.39 60.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.387 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.46 32.53 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.127 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 85' ' ' ASN . 0.7 OUTLIER -96.89 164.96 12.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.03 148.04 26.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.158 0.504 . . . . 0.0 110.727 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.53 145.06 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -72.61 129.3 37.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.702 0.763 . . . . 0.0 112.051 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.7 tt -135.26 1.73 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.591 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt 66.05 -70.25 0.1 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.893 -173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -161.5 136.87 5.66 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.961 -178.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 22.6 Cg_exo -63.84 78.51 0.15 Allowed 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 122.945 2.43 . . . . 0.0 112.715 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -81.82 -38.76 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.486 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -99.8 13.8 32.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.214 -170.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.7 96.03 5.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.46 0.648 . . . . 0.0 109.538 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.9 p -100.72 166.69 10.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.311 1.053 . . . . 0.0 112.197 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -45.89 -40.44 10.05 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.639 -2.073 . . . . 0.0 112.331 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -59.91 -47.36 86.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.939 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.508 ' HE2' HG21 ' A' ' 37' ' ' THR . 14.4 mmt -64.39 -45.25 88.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.205 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -60.34 -58.25 9.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.279 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.05 -31.9 70.42 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.197 0.311 . . . . 0.0 111.788 -175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -59.8 -58.24 9.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.541 0.686 . . . . 0.0 109.932 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.89 -37.46 87.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.454 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.59 -60.17 3.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.591 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.61 -27.02 66.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.466 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.95 -47.41 80.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.88 0.372 . . . . 0.0 110.596 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -77.75 -24.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.289 0.566 . . . . 0.0 110.54 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.3 tp -67.93 -17.16 64.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.54 -81.57 0.2 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.09 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.663 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 111.428 0.158 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -167.48 166.92 14.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -99.27 25.41 6.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.174 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -120.66 143.1 48.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.059 0.457 . . . . 0.0 111.358 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.39 139.22 46.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.512 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HZ2' ' HB3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -105.63 93.39 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.557 0.694 . . . . 0.0 111.209 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -77.59 102.73 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.56 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 26.2 ttt -139.76 -56.72 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -172.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 25.0 Cg_exo -64.0 -79.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.36 2.04 . . . . 0.0 112.518 -170.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 10' ' ' PRO . 49.8 p 62.5 -47.83 0.18 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 172.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 -55.66 5.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mm -60.19 -46.57 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.381 . . . . 0.0 111.544 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.4 ' OE1' ' HB2' ' A' ' 10' ' ' PRO . 8.3 pt-20 -62.9 -35.44 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.277 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -79.27 -30.97 43.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.73 0.3 . . . . 0.0 110.435 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.33 94.0 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.64 HD12 ' HG2' ' A' ' 60' ' ' ARG . 88.2 mt -68.61 -27.46 66.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.97 -42.02 77.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.886 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' HZ ' ' OE1' ' A' ' 102' ' ' GLN . 36.9 m-85 -59.62 -53.14 61.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.337 174.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -64.17 -44.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.836 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.33 47.24 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.606 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.57 51.1 4.18 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.942 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 26.8 ptt? -87.29 -3.58 59.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.689 0.396 . . . . 0.0 110.595 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t30 66.39 -74.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.252 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -179.09 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 t -73.39 -27.4 61.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.873 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.942 ' HB2' ' HB2' ' A' ' 23' ' ' MET . . . -76.67 112.43 13.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.67 0.748 . . . . 0.0 111.869 -173.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.4 m -162.24 -60.94 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 61.5 t -103.18 -58.41 0.09 OUTLIER Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.49 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 59.1 Cg_endo -74.86 129.8 12.82 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.56 1.507 . . . . 0.0 111.042 169.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 12.0 m170 -125.21 76.07 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -54.21 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.688 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -24.59 34.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 31' ' ' HIS . 13.9 t70 -53.91 -60.32 3.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.701 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.09 -43.27 91.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -68.06 -50.52 54.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.969 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.421 ' O ' HG13 ' A' ' 41' ' ' ILE . 53.7 m -73.29 -42.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.715 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.41 -48.91 75.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.91 -34.23 77.48 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.727 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.58 92.68 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.575 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 37' ' ' THR . 76.0 mt -59.02 -46.18 91.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.914 0.387 . . . . 0.0 110.488 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 94.3 mt -58.16 -47.93 81.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.527 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -68.25 -35.84 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.024 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' CE2' HD13 ' A' ' 48' ' ' LEU . 66.1 t80 -65.5 -48.83 71.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.407 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 84.5 mt -61.84 -38.38 87.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.978 0.418 . . . . 0.0 110.715 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -50.97 -51.45 52.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.45 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.0 -7.96 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 HD13 ' CE2' ' A' ' 44' ' ' TYR . 74.5 mt -77.14 -36.24 55.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.56 4.08 13.72 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.347 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 43.9 t -129.42 93.17 36.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 110.773 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.27 162.79 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.198 2.599 . . . . 0.0 111.773 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.81 137.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.743 0.306 . . . . 0.0 110.794 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' VAL . 10.3 m -73.36 127.63 88.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 23.4 Cg_endo -63.1 -29.08 74.32 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.577 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -53.06 -53.36 51.35 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 53' ' ' SER . 29.7 m -69.59 -26.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -176.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.3 -41.01 80.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 54' ' ' PRO . 63.6 t -59.63 -54.19 37.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.187 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.38 86.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.328 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.64 ' HG2' HD12 ' A' ' 17' ' ' LEU . 3.4 tpp180 -63.72 -44.13 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.554 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.448 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -59.28 -47.61 89.97 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.199 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.4 -23.51 61.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.807 0.337 . . . . 0.0 110.807 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -80.04 -45.25 18.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.959 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' HG2' ' HD3' ' A' ' 60' ' ' ARG . 38.0 mm-40 -75.42 -17.07 60.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 0.0 110.61 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.8 48.38 4.71 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.128 176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 49.5 m0 -70.72 -81.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.606 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 63.2 t30 166.18 130.79 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.606 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 40.7 Cg_exo -35.91 -48.05 1.06 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.932 3.088 . . . . 0.0 114.403 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 22.4 mm-40 -69.85 -38.44 76.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -69.42 -52.29 28.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.735 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 m -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.19 -54.66 44.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.75 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 49.7 mttm -63.81 -47.62 80.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -173.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.12 -39.56 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.81 92.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -38.32 95.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.186 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.6 m0 -65.17 -49.9 68.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.08 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.276 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.531 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 9.2 tp10 -56.83 -51.7 67.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 88.1 mttt -70.21 -29.49 66.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.471 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 77' ' ' TRP . 78.5 t -71.98 -43.13 68.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.651 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -43.86 75.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.045 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -70.13 -31.06 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 111.001 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.74 26.54 19.57 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.998 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -95.33 0.93 54.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.861 0.839 . . . . 0.0 110.333 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.8 mtm-85 64.47 156.6 0.08 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.387 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 80' ' ' LYS . 20.8 pt -119.02 17.63 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.212 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt 46.64 -151.35 0.08 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.975 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 tt -170.99 132.57 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 168.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -95.08 -18.87 20.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.738 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -123.37 102.35 36.59 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.04 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.93 -26.61 58.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.355 2.037 . . . . 0.0 112.856 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.35 118.06 21.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -79.54 -77.7 0.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.24 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -173.23 168.73 4.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.611 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.519 ' HB3' ' HE2' ' A' ' 99' ' ' MET . 40.0 t -54.86 139.99 38.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.378 1.085 . . . . 0.0 111.667 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.8 m -57.92 -21.88 45.91 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.698 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -60.15 -49.52 77.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.519 ' HE2' ' HB3' ' A' ' 96' ' ' SER . 5.4 mpp? -64.96 -28.73 69.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.714 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.09 -51.72 55.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -37.35 74.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.404 ' OE1' ' HZ ' ' A' ' 19' ' ' PHE . 29.6 tt0 -63.39 -53.24 55.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.734 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.47 -42.98 99.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.168 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -52.08 -55.88 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.928 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.71 -32.25 69.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.047 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.01 -46.51 88.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.12 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.9 -41.57 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.619 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.74 -41.2 90.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.217 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.85 5.48 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 112.042 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 110.038 172.876 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -75.93 116.77 16.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.657 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -107.93 75.47 1.0 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -133.26 127.37 33.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.904 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.25 72.53 10.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.606 -170.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -167.78 156.15 9.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.798 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.9 t 71.03 14.5 6.79 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 111.258 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.403 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 82.2 mmm -130.49 112.06 16.54 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.003 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 3.5 Cg_exo -77.61 128.74 9.64 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.298 2.665 . . . . 0.0 111.67 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' A' ' 14' ' ' GLU . 1.8 p -80.14 91.55 5.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.221 0.534 . . . . 0.0 111.418 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.24 -43.86 80.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.517 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.65 -36.86 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.637 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 38.7 tt0 -70.89 -43.91 67.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.839 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -70.86 -31.42 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.296 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.58 80.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.172 0.51 . . . . 0.0 110.212 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.33 -34.18 75.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -62.26 -41.04 98.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.053 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -73.55 -58.82 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.557 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.0 mt -72.09 -49.18 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.759 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.66 10.63 8.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.263 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 70.89 2.92 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.428 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.467 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 22.2 ptp -61.5 -28.82 69.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.306 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t30 64.29 -83.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.771 0.67 . . . . 0.0 111.278 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -99.4 10.5 41.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 42.3 t 66.21 55.94 0.85 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.856 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.27 133.27 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.057 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.414 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 43.8 m -126.39 -78.99 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.692 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.586 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 90.8 t -71.66 -60.53 2.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.099 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 88.6 Cg_endo -80.25 132.84 9.45 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.607 1.538 . . . . 0.0 111.362 172.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' HE1' ' HD1' ' A' ' 70' ' ' PHE . 5.4 m170 -126.78 139.61 52.99 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -95.67 -80.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 110.979 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 37' ' ' THR . 7.1 ptm -102.66 -14.91 16.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.959 0.885 . . . . 0.0 109.007 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -80.35 10.5 4.51 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.827 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.7 tm-20 -103.06 -73.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.479 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -76.37 -52.51 9.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.287 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 33' ' ' MET . 38.6 m -56.14 -46.21 79.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 0.0 111.005 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.95 99.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -64.04 -38.45 91.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.431 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -37.66 91.5 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.386 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.607 HG22 HD13 ' A' ' 103' ' ' LEU . 63.8 mt -59.12 -46.47 91.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.677 0.275 . . . . 0.0 110.646 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.43 -42.83 92.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -70.41 -36.5 74.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 65.9 t80 -67.97 -37.38 81.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 HD23 HD22 ' A' ' 103' ' ' LEU . 89.0 mt -65.81 -35.05 79.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.792 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -62.0 -36.43 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 18.9 t70 -61.82 -37.96 86.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.484 HD11 HD21 ' A' ' 45' ' ' LEU . 93.2 mt -72.91 -20.27 61.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.99 -32.88 4.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.65 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.9 108.2 33.3 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 0.0 111.867 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 94.4 Cg_endo -88.63 137.01 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -89.22 103.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.856 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -62.05 139.07 95.94 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.338 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' O ' HG21 ' A' ' 58' ' ' VAL . 14.9 Cg_endo -58.43 -27.69 82.59 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -42.41 98.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.232 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.445 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -65.48 -36.29 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.88 -47.96 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.189 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 54' ' ' PRO . 74.3 t -62.63 -44.12 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.357 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.95 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.113 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 3.7 mmp_? -67.1 -43.85 81.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -61.77 -32.49 81.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.51 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.74 -27.07 44.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.477 0.18 . . . . 0.0 111.46 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -81.71 -50.48 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.182 0.515 . . . . 0.0 110.602 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -83.68 -23.84 31.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.484 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.33 56.73 2.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.728 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.489 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 44.9 m0 -71.92 175.84 5.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 110.635 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -82.8 154.57 68.01 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.316 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.79 -60.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.184 2.59 . . . . 0.0 112.579 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 59.6 mm-40 -60.46 -33.93 73.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.075 0.464 . . . . 0.0 110.96 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.557 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 10.5 t80 -65.55 -57.31 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.475 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 m -61.95 -39.54 92.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 110.819 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -61.34 -57.18 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.554 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.46 -47.44 67.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.073 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.416 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 93.7 t -61.8 -39.66 84.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.609 0.242 . . . . 0.0 110.94 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.09 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.0 110.417 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.53 93.56 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.141 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.464 ' O ' HG21 ' A' ' 81' ' ' VAL . 17.4 m0 -68.93 -44.47 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.47 87.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.43 -53.09 56.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.639 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.63 -37.81 88.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.394 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 77' ' ' TRP . 93.1 t -70.1 -46.04 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.463 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.37 -44.33 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.545 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -67.06 -32.3 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.0 45.79 2.17 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.624 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.18 167.26 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -91.45 132.25 36.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.429 0.633 . . . . 0.0 111.073 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.18 90.49 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.499 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 110.89 5.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.493 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 tt -79.41 98.97 3.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.729 0.776 . . . . 0.0 109.715 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.708 ' HD3' ' H ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -67.1 -13.94 62.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.042 -175.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.95 90.48 5.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.41 0.624 . . . . 0.0 111.663 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.92 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.421 2.08 . . . . 0.0 110.766 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 56.37 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 170.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -86.2 24.49 1.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -98.15 103.9 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.516 ' HB3' ' HG3' ' A' ' 99' ' ' MET . 31.4 t -78.38 157.74 28.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.927 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 98' ' ' TYR . 14.3 t -65.97 -44.7 84.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.206 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.419 ' N ' HG23 ' A' ' 97' ' ' THR . 49.4 t80 -62.76 -27.12 69.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.889 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.516 ' HG3' ' HB3' ' A' ' 96' ' ' SER . 61.2 mtt -64.32 -47.72 78.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -62.91 -50.01 72.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.938 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 105' ' ' GLU . 48.0 mt-10 -59.22 -41.96 89.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.366 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.773 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -54.67 -55.95 24.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.502 . . . . 0.0 110.709 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.607 HD13 HG22 ' A' ' 41' ' ' ILE . 71.6 mt -60.62 -45.06 95.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.22 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -64.39 -47.63 78.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 38.8 mm-40 -64.85 -34.1 77.56 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.51 -47.66 83.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.29 -38.73 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.41 -48.15 76.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.39 -29.43 69.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.899 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.8 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.044 172.012 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.157 0.504 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -101.25 73.91 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.83 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 60.7 -164.17 0.24 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.633 0.73 . . . . 0.0 112.609 173.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -93.06 111.51 23.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.102 -0.953 . . . . 0.0 108.775 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 7' ' ' LYS . 12.3 t70 60.04 -150.68 0.42 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 57.4 mtmt -89.82 15.88 9.02 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.115 -0.365 . . . . 0.0 110.468 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.4 p 52.2 -160.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.79 0.836 . . . . 0.0 111.53 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.424 ' HG2' HG23 ' A' ' 11' ' ' THR . 50.2 ttp -139.08 88.22 13.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.269 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -92.48 80.7 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.485 2.79 . . . . 0.0 112.452 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.424 HG23 ' HG2' ' A' ' 9' ' ' MET . 5.5 t -132.4 98.9 4.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.806 0.812 . . . . 0.0 110.705 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 106' ' ' LEU . . . -71.72 -35.97 70.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.146 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -64.72 -45.04 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.685 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.752 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -75.18 -33.66 61.48 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.651 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.45 99.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 109.791 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.617 HD13 ' HG2' ' A' ' 60' ' ' ARG . 25.0 tp -64.56 -38.93 92.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.859 175.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.04 -29.82 70.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.026 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.3 -52.0 60.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.691 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.13 -48.29 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.13 31.5 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.936 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.07 28.87 4.89 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.615 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -65.8 -35.98 82.22 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.6 m120 68.57 -44.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.619 0.768 . . . . 0.0 111.771 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.653 HG21 ' H ' ' A' ' 26' ' ' SER . 1.6 m -99.07 -152.45 0.41 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.653 ' H ' HG21 ' A' ' 25' ' ' THR . 15.4 m -103.44 97.62 7.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.89 0.376 . . . . 0.0 110.041 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HA ' ' NE2' ' A' ' 31' ' ' HIS . . . -76.92 139.78 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.849 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -160.81 -56.52 0.05 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.0 m -69.03 162.5 64.63 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.736 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.37 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.526 2.151 . . . . 0.0 110.947 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.565 ' NE2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -85.42 -172.89 4.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 -171.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.5 m -103.58 -80.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.504 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 2.2 tpt -57.48 -52.03 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.044 -175.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -83.91 1.22 44.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.453 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.4 -77.44 0.57 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.387 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -63.3 -48.06 79.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 m -71.17 -30.67 66.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 110.552 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.06 83.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -56.35 -44.64 80.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.384 174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.43 -44.18 97.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.257 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 67.3 mt -66.2 -44.85 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 110.864 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.55 -37.7 84.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.701 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -66.33 -49.41 67.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.988 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' HD11 ' A' ' 48' ' ' LEU . 71.7 t80 -57.6 -44.75 85.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.575 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 94.4 mt -60.31 -47.98 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.618 0.247 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.529 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m80 -62.17 -36.77 82.86 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.751 177.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.92 -32.83 73.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.114 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 44' ' ' TYR . 81.1 mt -67.68 -16.72 64.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.268 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.37 1.45 35.33 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.109 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.46 98.04 15.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.529 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 97.8 Cg_endo -84.0 104.88 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.232 1.954 . . . . 0.0 112.855 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 101.03 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.72 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -66.05 140.54 97.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.336 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 52.3 Cg_exo -55.75 -34.86 92.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.262 2.641 . . . . 0.0 112.506 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.93 -48.72 72.76 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.828 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.77 -38.43 81.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.275 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.88 -45.48 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.823 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.499 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 96.8 t -62.41 -49.08 85.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.944 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.76 94.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.12 0.486 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.617 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.3 tpp180 -66.96 -40.42 87.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.89 -40.7 99.21 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.375 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 36.8 mt-10 -68.14 -31.11 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.581 0.229 . . . . 0.0 111.206 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -76.16 -53.38 8.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 111.267 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.731 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.89 48.71 2.42 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.751 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.644 ' HB3' ' HD2' ' A' ' 70' ' ' PHE . 48.7 m0 -81.13 0.31 36.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 93.1 m-20 72.94 145.05 0.11 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.835 0.454 . . . . 0.0 111.02 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.29 -41.29 79.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.703 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 44.9 mt-10 -63.26 -56.05 19.79 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.657 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.644 ' HD2' ' HB3' ' A' ' 66' ' ' TRP . 89.7 t80 -60.67 -47.01 88.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.826 0.346 . . . . 0.0 110.631 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 31.1 m -58.78 -41.24 86.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.978 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.98 -43.49 95.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.779 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 67.9 mttm -62.52 -53.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.538 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 46.5 t -59.7 -41.48 85.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.846 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -61.42 -40.82 95.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.388 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -61.48 -42.41 99.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.393 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.538 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 15.2 m0 -62.13 -44.77 95.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.254 0.549 . . . . 0.0 109.572 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.58 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 48.9 mt-10 -59.21 -48.14 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.354 0.409 . . . . 0.0 110.97 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.7 mtpp -60.97 -52.31 65.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 77' ' ' TRP . 62.1 t -61.38 -35.68 68.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.39 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.14 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.1 t -61.76 -48.26 81.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.453 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.77 -10.8 3.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -87.75 107.39 18.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -58.07 156.67 9.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.653 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.54 141.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.75 111.75 24.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 110.763 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 91' ' ' ASN . 14.6 tt -91.78 140.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -94.28 -8.66 38.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.562 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.5 p30 -149.16 76.61 9.35 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.425 0.631 . . . . 0.0 111.297 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.05 -6.24 17.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.512 2.142 . . . . 0.0 112.477 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.55 -10.92 59.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 91' ' ' ASN . 67.1 m-85 -89.72 -18.23 26.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -89.1 91.64 8.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -86.7 173.35 9.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.653 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -66.09 -26.89 67.69 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -45.82 -49.48 15.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.808 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.34 -43.07 87.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -46.45 89.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 97' ' ' THR . 38.2 mm-40 -55.16 -52.08 64.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.504 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 48.2 mt-30 -58.82 -54.04 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.993 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 107' ' ' VAL . 92.5 mt -59.28 -49.62 77.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.263 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.91 -46.29 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.041 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 6.2 tp10 -65.43 -31.51 72.65 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.54 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 83.3 mt -72.53 -29.71 63.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 103' ' ' LEU . 82.1 t -78.11 -35.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.511 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.64 -42.42 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 2.3 mm-40 -81.99 12.67 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.662 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.826 0.822 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -158.17 -46.05 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.974 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 t80 59.7 -83.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.986 0.804 . . . . 0.0 111.612 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt 63.17 106.16 0.03 OUTLIER 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.59 0.756 . . . . 0.0 111.868 -177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.2 138.75 56.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.899 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -137.18 -64.1 0.58 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.074 0.464 . . . . 0.0 110.347 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 t 176.42 -156.46 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -65.21 142.73 98.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HB2' HD12 ' A' ' 106' ' ' LEU . 12.3 Cg_endo -55.9 112.57 1.1 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.594 2.196 . . . . 0.0 112.126 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.73 97.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.374 0.607 . . . . 0.0 111.774 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.14 69.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.466 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.25 -56.72 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.989 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.21 -38.34 76.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.393 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -74.24 -34.18 63.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.715 0.293 . . . . 0.0 110.75 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 0.0 110.224 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.9 mm? -64.58 -33.18 75.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.553 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.89 -39.68 87.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.83 -46.92 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.33 -50.05 58.03 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.299 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.67 -8.2 6.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.574 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' MET . 26.8 ttt 63.53 23.62 13.7 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.663 0.744 . . . . 0.0 110.312 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -133.03 163.15 29.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.648 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.601 HG23 ' H ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -125.08 -158.57 0.84 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 25' ' ' THR . 38.3 m 71.54 8.29 6.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.26 0.624 . . . . 0.0 112.185 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.63 89.23 3.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.066 0.46 . . . . 0.0 109.867 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.42 ' HB3' ' CD ' ' A' ' 69' ' ' GLU . 12.6 m -122.5 -51.92 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.599 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 21.8 t -114.6 -53.47 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.198 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 12.0 Cg_endo -91.97 86.55 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.259 1.972 . . . . 0.0 110.291 171.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.522 ' HD1' ' CG ' ' A' ' 34' ' ' ASP . 6.4 p80 -132.93 96.52 3.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.378 0.609 . . . . 0.0 111.143 -172.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 m -86.38 -14.99 41.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.786 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.658 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 4.3 tpt -60.99 -64.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 11.4 p-10 -79.53 -26.95 41.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.136 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.01 -77.39 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 13.2 m -71.27 -49.82 39.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.9 0.381 . . . . 0.0 111.505 -172.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 33' ' ' MET . 17.5 m -73.18 -55.18 6.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.864 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -68.11 -37.45 81.17 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HZ1' ' HB2' ' A' ' 39' ' ' LYS . 4.4 ttmp? -67.33 -34.97 78.45 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.742 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.23 99.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.473 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.6 mt -65.89 -47.76 84.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.44 -44.57 92.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.912 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -69.96 -30.97 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.516 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 56.4 t80 -67.07 -46.15 75.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.151 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.89 -41.99 98.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.454 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.481 ' HB2' HG12 ' A' ' 81' ' ' VAL . 41.0 t-80 -50.21 -51.68 42.16 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.81 -2.6 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.472 -175.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 64.3 mt -84.93 -21.83 29.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.218 0.532 . . . . 0.0 109.577 168.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.41 0.95 14.02 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.704 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.24 98.12 47.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.923 0.362 . . . . 0.0 111.106 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.84 157.87 15.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.918 2.412 . . . . 0.0 111.788 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.36 137.98 49.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.62 0.248 . . . . 0.0 110.622 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 24.5 m -85.0 144.43 41.53 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 23.8 Cg_exo -63.41 -32.9 71.24 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.103 2.535 . . . . 0.0 112.771 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -42.35 66.68 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.93 -47.84 91.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.72 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.5 t -64.03 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.497 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.27 -58.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.488 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -30.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.551 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -67.86 -46.84 70.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.77 -34.69 90.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.98 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.05 -29.87 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.749 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -86.1 -49.78 7.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.555 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.07 -28.25 66.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.867 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.5 55.22 1.7 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.028 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 70' ' ' PHE . 44.5 m0 -81.37 -78.34 0.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.451 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 36.1 p30 175.45 160.79 0.41 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.548 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 86.5 Cg_endo -79.89 8.69 3.9 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.046 1.831 . . . . 0.0 112.933 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 28' ' ' SER . 46.1 mt-10 -107.33 -69.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.647 -174.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -59.62 -38.23 80.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.423 0.63 . . . . 0.0 110.198 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.882 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -63.36 -56.81 13.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.329 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.541 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.2 t -59.66 -35.84 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.69 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.62 86.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.93 -37.71 92.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.362 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.541 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 21.9 m0 -66.0 -44.88 83.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.83 75.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.23 -50.29 74.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.423 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -63.55 -39.31 94.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.337 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 46' ' ' HIS . 47.7 t -61.4 -51.14 76.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.313 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.92 93.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.76 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.39 -39.97 92.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.92 6.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.701 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -100.94 -166.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 110.468 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -94.6 154.77 17.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.92 0.391 . . . . 0.0 110.644 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.02 140.89 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -91.4 119.03 31.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.989 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.418 HG13 ' HD2' ' A' ' 39' ' ' LYS . 8.7 tt -112.36 151.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -96.47 -30.03 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.763 0.316 . . . . 0.0 111.081 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.539 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 15.0 m-80 -142.0 92.34 7.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -22.52 18.59 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.464 2.11 . . . . 0.0 113.029 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.49 -5.32 59.3 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' HB3' ' A' ' 91' ' ' ASN . 8.6 m-85 -71.74 -20.06 61.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.0 110.542 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -79.81 88.74 5.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 t -75.92 163.02 27.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.578 -171.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -31.17 69.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.74 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.08 -55.28 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.065 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.472 ' HE3' HG21 ' A' ' 37' ' ' THR . 69.1 mtm -62.63 -36.53 83.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.906 0.384 . . . . 0.0 110.782 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.32 -50.9 71.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.213 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 46.1 mt-10 -73.27 -24.46 60.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.384 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.849 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -65.63 -51.09 62.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 107' ' ' VAL . 98.7 mt -62.52 -42.31 99.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.14 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 83.6 tttt -55.78 -47.36 77.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.213 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.58 -38.62 90.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 0.0 110.878 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 10' ' ' PRO . 28.5 tp -71.59 -44.09 65.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.828 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 103' ' ' LEU . 80.6 t -70.41 -27.38 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.92 -43.67 69.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.528 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -91.77 3.4 55.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 178.539 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.399 0.619 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.33 -39.63 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.698 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.94 97.07 8.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.464 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -122.61 23.73 9.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -40.27 110.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.249 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -107.3 20.89 18.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.957 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.85 -167.72 1.93 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.546 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.6 ttp 68.56 98.4 0.04 OUTLIER Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.681 0.793 . . . . 0.0 111.184 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.7 84.07 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.883 2.388 . . . . 0.0 112.06 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -56.94 -22.39 37.48 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.641 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.44 91.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.46 . . . . 0.0 110.311 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.93 -39.66 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.849 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.67 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.502 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 56.7 mmtt -76.29 -35.44 58.87 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.312 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.34 83.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.588 0.709 . . . . 0.0 109.113 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.74 HD13 ' HZ2' ' A' ' 66' ' ' TRP . 23.4 tp -63.3 -37.12 86.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.252 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.31 -33.76 75.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.332 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.17 -40.51 78.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.471 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -88.15 -76.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.772 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 -4.94 81.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.748 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.13 7.48 77.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.432 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.597 ' HE2' ' HE3' ' A' ' 33' ' ' MET . 26.4 mmt -94.81 111.86 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.12 -156.99 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.06 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -86.96 41.67 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.262 -0.274 . . . . 0.0 110.875 175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 58.18 111.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.648 1.179 . . . . 0.0 112.106 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 70' ' ' PHE . . . -75.51 174.45 9.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.187 178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 p -155.19 -43.07 0.08 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.0 109.935 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.559 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 28.3 m -66.16 170.64 5.03 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.745 170.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 39.6 Cg_exo -29.75 110.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.916 3.077 . . . . 0.0 112.662 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.726 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 19.6 m80 -83.73 162.8 20.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.755 -169.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 t -103.38 -80.52 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.084 0.468 . . . . 0.0 110.506 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.597 ' HE3' ' HE2' ' A' ' 23' ' ' MET . 1.3 ttp -97.81 -29.75 13.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.51 0.671 . . . . 0.0 109.305 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 9.2 p-10 -67.81 -8.31 34.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.145 -172.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 39.8 tt0 -102.51 -48.95 3.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 110.658 173.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.8 t -65.41 -48.48 72.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.697 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 m -64.82 -40.24 94.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.359 . . . . 0.0 110.267 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.7 63.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -61.5 -28.88 69.62 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.195 0.521 . . . . 0.0 110.8 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.73 -49.9 52.0 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.382 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 103' ' ' LEU . 63.7 mt -61.84 -43.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.618 0.247 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -54.97 -47.54 74.41 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.658 ' HE3' HD11 ' A' ' 87' ' ' ILE . 9.9 mtmp? -77.9 -25.84 48.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.312 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 53.0 t80 -65.15 -47.81 75.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.13 -40.54 97.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.223 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -50.94 -54.97 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.341 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.12 -18.83 60.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 57.6 mt -68.53 -27.29 65.97 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.6 6.17 10.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.583 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.39 93.19 43.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.758 0.313 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.37 120.75 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.993 2.462 . . . . 0.0 111.838 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.31 138.66 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.299 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.93 147.46 38.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -53.19 -36.0 75.63 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.397 2.731 . . . . 0.0 112.398 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -50.05 -47.3 53.45 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.316 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.0 -40.99 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.607 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG13 ' HB ' ' A' ' 74' ' ' VAL . 61.4 t -63.87 -45.92 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.456 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 67.4 t -59.99 -48.28 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.141 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.8 89.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.439 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.736 HH11 HD22 ' A' ' 17' ' ' LEU . 14.6 tpp85 -67.79 -40.42 83.92 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.508 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.83 -37.14 93.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.479 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -62.66 -37.62 87.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.197 0.523 . . . . 0.0 110.574 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -73.03 -44.82 60.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.471 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.86 -30.03 32.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.81 57.28 1.84 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.067 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.74 ' HZ2' HD13 ' A' ' 17' ' ' LEU . 49.4 m0 -84.05 168.43 15.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 6.7 m-20 -61.83 123.58 77.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 167.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.91 -34.23 55.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.502 2.801 . . . . 0.0 113.82 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 26.5 mt-10 -64.73 -40.64 95.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.536 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 73.6 t80 -64.42 -50.97 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.142 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.519 ' HG1' ' HE3' ' A' ' 66' ' ' TRP . 21.4 m -57.27 -41.23 79.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.936 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.44 -40.71 77.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.126 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.62 -50.14 68.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.077 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.587 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 52.1 t -60.22 -40.16 82.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 110.635 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 54' ' ' PRO . . . -59.59 -40.18 86.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.684 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.9 -34.79 88.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.078 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.587 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 28.7 m0 -67.23 -47.58 70.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.7 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.95 -44.61 91.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 110.4 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -64.64 -45.79 85.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.635 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 77' ' ' TRP . 75.3 t -63.67 -40.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.37 -41.04 81.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.638 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.7 p -75.03 -16.63 60.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.03 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.53 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -109.98 163.99 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -89.27 156.57 18.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.516 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.658 HD11 ' HE3' ' A' ' 43' ' ' LYS . 21.8 pt -123.94 147.66 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 tt -71.27 131.74 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 tt -139.32 162.78 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -76.07 -53.18 8.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.723 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.76 140.3 31.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.68 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.2 7.11 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.326 2.017 . . . . 0.0 113.463 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.18 -16.33 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 77.44 -70.6 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.65 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.681 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 40.8 p90 -162.82 -170.85 2.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.772 -173.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 95' ' ' PHE . 16.6 m -85.22 146.62 26.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.771 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 p -50.06 -36.9 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -38.68 57.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.596 0.236 . . . . 0.0 111.623 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.681 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 mmt -65.76 -50.01 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 110.225 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -71.14 -30.77 66.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.085 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.56 -32.74 74.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.358 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.545 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 8.6 tp-100 -70.07 -50.54 39.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 109.696 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.649 HD12 HG12 ' A' ' 41' ' ' ILE . 86.4 mt -52.85 -49.76 65.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.028 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -59.51 -42.26 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 109' ' ' GLU . 35.4 tt0 -63.13 -39.9 96.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.572 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 95.0 mt -62.54 -36.31 82.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.97 -43.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.67 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -78.62 -45.1 22.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 17.6 mm-40 -70.97 -75.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.033 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.835 0.826 . . . . 0.0 110.471 177.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -118.74 138.81 52.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.93 -11.33 19.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 pttt 40.89 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.211 0.944 . . . . 0.0 112.064 -175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.16 81.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.22 -1.354 . . . . 0.0 113.551 -167.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.21 13.51 2.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.853 169.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.0 p 54.23 107.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 111.938 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 mmt -53.57 115.95 8.89 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.779 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.53 -176.59 1.81 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.095 2.53 . . . . 0.0 111.95 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.6 p -83.54 159.46 21.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.784 0.326 . . . . 0.0 110.3 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.41 82.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.56 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 49.9 mm -65.58 -43.01 94.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.049 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.34 -33.27 75.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.659 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 36.2 mmtt -78.48 -31.07 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.202 177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.86 99.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.275 0.559 . . . . 0.0 109.496 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 13' ' ' ILE . 62.9 mt -72.52 -27.61 62.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.436 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.6 -25.53 67.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.478 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -85.66 -48.25 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.272 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.2 mt -79.12 -37.49 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.32 -11.12 32.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.74 57.33 9.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.775 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.16 91.52 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 69.07 16.85 8.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.682 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 p -99.53 -0.71 40.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.591 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t 71.15 122.47 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.37 168.92 18.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 69' ' ' GLU . 35.8 t 73.21 2.78 4.45 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.696 0.623 . . . . 0.0 110.943 176.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.582 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 53.8 t -138.62 -63.14 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.619 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 81.6 Cg_endo -77.98 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.561 1.508 . . . . 0.0 112.399 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 10.4 m170 59.16 24.25 12.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.467 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 33' ' ' MET . 4.3 m -66.83 -80.18 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.036 0.446 . . . . 0.0 110.166 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.426 ' H ' ' HB2' ' A' ' 32' ' ' SER . 1.8 ppp? -93.1 -16.09 25.33 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.614 ' HB3' ' HA ' ' A' ' 31' ' ' HIS . 7.2 t0 -51.27 -45.57 62.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.913 -1.948 . . . . 0.0 111.315 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -99.9 -40.25 7.78 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.551 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 92' ' ' PRO . 37.0 t -61.89 -62.04 2.07 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.933 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 m -68.62 -36.29 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.915 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.25 -51.81 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.738 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HD3' HG12 ' A' ' 89' ' ' ILE . 95.2 mttt -62.98 -42.98 99.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.56 92.76 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.369 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 52.2 mt -68.91 -47.46 75.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 0.159 . . . . 0.0 111.372 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.18 -40.92 87.17 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.77 -41.34 99.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.939 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.418 ' CE2' HD13 ' A' ' 48' ' ' LEU . 67.6 t80 -73.1 -39.76 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.549 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 92.8 mt -59.36 -46.18 89.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.804 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -64.22 -36.45 84.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.43 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.36 -41.47 97.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD13 ' CE2' ' A' ' 44' ' ' TYR . 88.5 mt -64.45 -37.86 89.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.803 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.03 2.63 10.14 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.005 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.78 93.39 33.47 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 0.0 109.813 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -91.26 157.13 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.941 2.427 . . . . 0.0 113.072 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.71 141.59 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.939 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.463 ' HB2' HG23 ' A' ' 56' ' ' VAL . 12.8 m -79.81 123.44 83.84 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' O ' HG21 ' A' ' 58' ' ' VAL . 43.7 Cg_exo -56.08 -38.1 95.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.076 2.517 . . . . 0.0 112.388 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -52.52 -50.66 62.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.155 0.502 . . . . 0.0 110.913 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 53' ' ' SER . 33.3 t -64.18 -35.6 74.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.342 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.33 -40.04 87.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.728 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 54' ' ' PRO . 90.8 t -62.23 -52.94 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.635 0.255 . . . . 0.0 110.458 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.91 -43.76 86.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.2 tpp180 -64.1 -43.76 94.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' HA3' HG22 ' A' ' 71' ' ' THR . . . -60.53 -48.23 87.23 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.39 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 45.6 mt-10 -59.39 -33.23 70.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.135 0.493 . . . . 0.0 110.854 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -70.25 -48.92 54.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.547 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 60.5 mt-10 -93.48 -3.79 52.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 0.0 111.388 -173.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 67' ' ' ASN . . . 99.32 -70.63 0.54 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.594 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 11.9 m0 56.31 -1.47 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 19.4 m-80 69.58 128.97 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 123.322 0.649 . . . . 0.0 110.489 -176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.45 -47.19 23.46 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.693 2.929 . . . . 0.0 114.335 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.599 ' HB2' ' OG ' ' A' ' 28' ' ' SER . 55.7 mm-40 -69.56 -36.78 76.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' HB3' ' O ' ' A' ' 66' ' ' TRP . 68.2 t80 -69.94 -49.07 55.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.437 HG22 ' HA3' ' A' ' 61' ' ' GLY . 21.1 m -53.6 -46.62 70.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.22 -46.03 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.067 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -65.06 -40.29 94.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.82 -39.35 83.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.436 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.67 82.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.902 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.21 -40.58 87.7 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.089 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.519 ' O ' HG22 ' A' ' 81' ' ' VAL . 44.9 m0 -60.91 -54.49 44.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.11 73.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.004 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -56.41 -53.95 51.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.239 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 46.0 mtpt -66.65 -35.93 81.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.262 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 77' ' ' TRP . 76.6 t -68.76 -46.17 79.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.052 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.67 69.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 111.173 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.5 t -80.0 -18.12 51.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.747 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.81 45.8 15.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.901 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -95.95 16.3 18.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.032 0.133 . . . . 0.0 111.134 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 47.93 127.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 125.267 1.604 . . . . 0.0 113.953 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.1 pt -115.51 144.13 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.15 112.36 21.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.494 HG21 ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -124.64 -43.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.413 177.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 67.31 -70.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 111.636 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.604 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.0 OUTLIER -165.36 92.2 0.9 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.563 -175.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.494 ' HD3' HG21 ' A' ' 89' ' ' ILE . 61.1 Cg_endo -80.69 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.436 2.091 . . . . 0.0 112.69 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.8 pt-20 -156.34 24.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.038 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 53.3 m-85 73.25 -21.31 0.26 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.659 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 93' ' ' GLU . 18.1 t80 61.97 83.93 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -169.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -52.63 139.98 24.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.907 -169.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m -53.58 -41.99 67.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 112.329 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 35.5 t80 -61.04 -42.24 98.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.3 mtt -62.15 -50.7 70.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.484 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -59.43 -46.63 88.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.896 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 7.7 mt-10 -72.0 -27.36 62.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 14.0 mm100 -59.01 -48.1 82.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.156 0.503 . . . . 0.0 109.74 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.408 ' O ' HG23 ' A' ' 107' ' ' VAL . 83.1 mt -68.3 -43.51 77.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.402 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 26.9 tttm -60.47 -50.04 75.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.13 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -69.55 -25.46 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.682 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 48.3 tp -70.31 -45.71 65.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 103' ' ' LEU . 59.8 t -71.83 -25.54 24.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.337 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.09 -34.73 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.567 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.65 -70.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 168.233 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -106.73 95.92 6.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.015 0.436 . . . . 0.0 110.502 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -85.53 -25.71 26.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.126 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -85.44 149.43 25.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.579 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 66.31 -168.76 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 124.067 0.854 . . . . 0.0 110.001 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 55.44 27.88 10.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.137 0.97 . . . . 0.0 109.287 -175.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 m -87.2 111.63 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.335 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -77.31 162.58 68.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.43 114.97 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.743 2.295 . . . . 0.0 112.33 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 p -84.38 85.82 7.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.481 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.77 -47.76 6.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.194 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.484 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 61.0 mt -63.12 -45.61 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.956 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -53.77 -54.83 32.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 94.9 mttt -67.62 -35.71 79.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.462 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.93 85.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 111.077 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.559 HD13 ' HD3' ' A' ' 60' ' ' ARG . 85.5 mt -64.09 -47.22 80.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -13.58 56.79 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.855 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -64.59 -43.12 94.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.32 -39.45 48.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.711 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 70' ' ' PHE . . . -54.79 -47.98 68.74 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.036 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.05 14.96 69.01 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.227 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 67.74 169.97 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.046 0.538 . . . . 0.0 111.455 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.4 108.13 11.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.212 0.529 . . . . 0.0 110.83 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 p -120.98 -171.19 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.707 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -73.38 173.05 10.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.86 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.54 -112.34 0.62 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.605 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 6.3 p -126.02 -13.85 6.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.605 ' HB ' ' O ' ' A' ' 28' ' ' SER . 23.2 t 109.1 -57.08 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 125.775 1.63 . . . . 0.0 111.321 -175.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.929 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 3.9 Cg_exo -74.0 86.97 1.21 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.326 1.351 . . . . 0.0 110.864 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -95.76 -76.85 0.49 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.7 m -103.98 -80.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.0 110.721 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.4 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 1.2 ppp? -90.35 -12.15 38.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.946 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.929 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -65.03 -15.83 62.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.179 178.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -92.72 -55.18 3.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.28 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 89' ' ' ILE . 14.3 m -71.27 -53.19 15.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.886 -174.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' HE3' ' A' ' 99' ' ' MET . 53.1 m -62.75 -34.14 76.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.38 90.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.201 0.524 . . . . 0.0 110.132 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -64.0 -27.54 69.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.398 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.08 -55.04 23.96 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.736 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.533 HG23 HD13 ' A' ' 103' ' ' LEU . 66.4 mt -57.27 -43.65 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 110.659 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 78' ' ' ALA . 26.6 tp -56.49 -47.74 78.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.458 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.647 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 9.9 mtmp? -72.83 -30.56 64.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.426 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.462 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 66.3 t80 -63.57 -37.95 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.14 -38.92 89.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.279 176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -61.26 -34.54 75.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.07 -24.96 47.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 93.6 mt -75.93 -32.25 59.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.314 0.578 . . . . 0.0 110.411 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.44 -18.11 8.84 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.319 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.83 93.42 48.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -95.37 158.32 1.61 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.065 2.51 . . . . 0.0 111.871 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.92 138.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 110.571 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.422 ' HB2' HG21 ' A' ' 56' ' ' VAL . 23.8 m -83.03 149.24 58.68 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.39 -43.3 44.86 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.322 2.681 . . . . 0.0 112.733 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.17 -43.34 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 53' ' ' SER . 29.4 t -65.0 -36.39 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.174 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.69 -49.05 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.0 -45.55 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.76 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.84 93.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.72 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HD3' HD13 ' A' ' 17' ' ' LEU . 13.2 tpt180 -65.16 -46.12 82.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.409 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.37 99.4 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.035 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -58.51 -39.88 81.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.92 0.39 . . . . 0.0 111.084 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.1 tm0? -83.02 -48.45 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.479 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.33 -25.73 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.876 0.37 . . . . 0.0 111.463 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.81 -76.99 0.34 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.8 m0 54.2 -161.29 0.14 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.832 0.453 . . . . 0.0 111.625 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -124.26 140.23 34.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 -41.73 70.21 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.893 2.395 . . . . 0.0 112.775 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -66.86 -40.66 87.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.582 0.706 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.561 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 31.2 t80 -69.5 -53.06 20.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.409 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -58.29 -43.77 88.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -72.37 -34.44 67.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.741 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -56.91 14.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.806 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.9 -35.47 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.2 86.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.34 -37.83 62.84 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.073 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -61.44 -49.32 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.513 ' HA ' HD23 ' A' ' 42' ' ' LEU . . . -59.14 -38.09 78.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.95 -49.77 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.864 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.97 -37.24 75.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.107 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.47 -38.57 80.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.702 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.09 -30.2 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.082 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . 17.2 m -87.81 -14.61 39.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 31.86 13.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.854 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 12.6 m120 -97.59 -171.65 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -108.95 135.32 50.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -109.0 119.64 58.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.806 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.67 122.61 14.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.054 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 36' ' ' SER . 16.1 tt -129.82 135.56 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.654 ' HG3' ' OD1' ' A' ' 91' ' ' ASN . 17.5 pttm -76.01 -16.72 59.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -171.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.654 ' OD1' ' HG3' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -153.95 114.28 2.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.889 0.376 . . . . 0.0 110.399 177.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.68 80.92 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.138 2.559 . . . . 0.0 113.027 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' HG2' HD21 ' A' ' 91' ' ' ASN . 11.6 pt-20 -138.96 172.45 12.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.927 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -124.23 -80.92 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.723 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.643 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER 175.56 -176.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.951 -172.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 m -84.77 174.63 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.357 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -30.24 68.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.877 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -44.95 -55.08 5.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.622 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.481 ' HE3' HG22 ' A' ' 37' ' ' THR . 52.0 mtt -68.89 -46.32 68.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.171 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.643 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 7.7 tt0 -60.57 -48.38 82.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.261 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.05 -35.18 79.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -54.12 -58.99 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.417 0.627 . . . . 0.0 110.033 175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.533 HD13 HG23 ' A' ' 41' ' ' ILE . 94.3 mt -64.73 -39.68 94.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.911 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.74 -39.38 91.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.304 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.86 -26.56 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.746 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.66 -36.95 81.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 48' ' ' LEU . 55.8 t -77.53 -20.98 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.82 -18.76 64.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.44 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.02 -8.28 47.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.978 0.418 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.49 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -83.19 113.68 20.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -81.76 -25.5 35.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.803 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -138.76 130.43 27.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.946 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.29 145.81 47.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.207 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 23.8 pttm -140.26 84.22 1.95 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.819 0.818 . . . . 0.0 110.241 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -82.97 132.3 35.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.503 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.458 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 90.1 mmm -63.48 110.76 4.0 Favored Pre-proline 0 C--N 1.331 -0.219 0 O-C-N 123.232 0.333 . . . . 0.0 110.46 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 4.7 Cg_exo -73.01 99.54 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.789 2.326 . . . . 0.0 112.562 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p -105.85 174.35 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.452 175.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.99 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.597 . . . . 0.0 109.779 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -68.82 -44.23 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.06 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.09 -37.69 86.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.566 ' HZ3' ' HB3' ' A' ' 15' ' ' LYS . 4.2 mmmp? -70.66 -26.35 63.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.838 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.15 86.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.227 0.537 . . . . 0.0 109.718 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 17' ' ' LEU . 4.3 mm? -70.17 -32.33 70.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.088 174.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 24.0 t70 -57.17 -32.66 66.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.718 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -78.7 -63.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.679 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.15 -68.96 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.067 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.95 -8.01 84.48 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.762 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.06 -16.94 80.33 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.332 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' ' 23' ' ' MET . 25.4 ptp -103.59 97.78 7.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.839 0.828 . . . . 0.0 111.118 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.19 49.85 1.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -82.06 -168.94 2.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.133 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -84.59 -174.95 5.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.236 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 72.89 150.29 0.1 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.157 0.98 . . . . 0.0 111.906 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 20.0 m -139.82 -47.54 0.45 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.322 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 22.6 m -58.43 167.7 1.62 Allowed Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.127 167.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 34.1 Cg_exo -22.33 105.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 124.87 3.713 . . . . 0.0 113.367 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -69.99 161.47 29.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.797 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -75.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.536 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.445 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 6.8 ttp -96.64 -42.39 8.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -48.19 -45.71 34.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.541 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' OE1' ' HA ' ' A' ' 30' ' ' PRO . 26.2 tp10 -50.88 -66.3 0.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.187 0.518 . . . . 0.0 111.135 -175.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HG ' HD12 ' A' ' 89' ' ' ILE . 27.8 t -70.2 -43.1 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.462 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.514 HG23 ' HE3' ' A' ' 99' ' ' MET . 38.6 m -67.41 -42.66 82.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.62 87.08 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.479 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -56.96 -32.5 66.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.916 0.388 . . . . 0.0 110.693 174.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.46 50.61 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.092 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.94 -43.33 92.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 110.736 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.53 -39.56 76.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.142 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.615 ' HB2' ' HZ3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -69.2 -42.33 75.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.009 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -63.64 -48.45 77.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.375 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 103' ' ' LEU . 72.8 mt -61.71 -48.36 81.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.458 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.65 -36.74 77.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.007 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.8 -40.59 88.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.61 HD13 HG23 ' A' ' 107' ' ' VAL . 94.1 mt -61.66 -30.1 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 120.97 -0.09 11.75 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.928 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.05 97.89 9.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 82.1 Cg_endo -83.3 127.12 4.43 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.379 2.053 . . . . 0.0 112.265 -176.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.533 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 41.4 t -75.33 101.47 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.857 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 56' ' ' VAL . 22.8 m -70.79 125.94 92.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.49 -23.04 62.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.648 2.232 . . . . 0.0 111.706 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -58.88 -54.08 51.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.14 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 53' ' ' SER . 34.1 m -70.42 -21.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.104 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.98 -49.3 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 69.4 t -62.03 -42.64 95.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.422 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.19 96.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.888 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.54 87.92 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -60.18 -45.62 95.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.911 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 8.4 pt-20 -79.74 -20.41 46.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.82 -53.39 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.899 0.381 . . . . 0.0 110.142 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -73.73 -38.65 64.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 -173.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.91 62.22 0.56 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.973 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.452 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 24.8 m0 -98.52 160.66 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.419 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 26.7 p30 -90.05 153.7 47.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 4.9 Cg_exo -39.23 -60.41 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.613 3.542 . . . . 0.0 114.433 -174.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 4.6 mm-40 -61.21 -39.0 88.59 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.95 -44.76 84.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.0 m -58.45 -48.5 80.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -77.42 -27.14 52.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 tptp -54.4 -66.26 0.43 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.83 -40.94 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.892 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.97 96.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.967 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -66.87 -40.79 93.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.47 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.454 ' O ' HG21 ' A' ' 81' ' ' VAL . 10.6 m0 -63.46 -50.79 68.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -58.91 -39.43 81.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.85 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.5 -49.85 63.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 52.0 mttm -71.98 -41.61 67.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.317 -176.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 77' ' ' TRP . 57.8 t -68.21 -39.65 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.269 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.32 69.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.122 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -65.45 -27.99 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.98 23.04 5.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.863 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.545 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -93.1 -176.27 4.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -136.24 137.88 41.25 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.243 0.544 . . . . 0.0 110.738 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.32 125.48 74.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.613 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.14 110.2 16.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.415 0.626 . . . . 0.0 110.815 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.502 HD12 ' HG ' ' A' ' 36' ' ' SER . 15.8 tt -86.59 -3.24 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.757 178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 71.07 -52.05 0.68 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.817 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -161.59 131.71 3.46 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.86 177.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 37.0 Cg_exo -57.62 -66.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.739 2.293 . . . . 0.0 111.902 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.55 -72.5 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -78.15 5.7 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -168.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.18 102.85 14.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p -94.56 169.58 10.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -32.4 71.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.694 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 0.2 OUTLIER -56.19 -44.65 79.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 110.166 -176.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.514 ' HE3' HG23 ' A' ' 37' ' ' THR . 65.0 mtt -66.54 -49.36 66.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.366 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -61.03 -50.9 71.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.781 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.4 -47.96 82.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.445 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -54.49 -56.48 18.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.383 0.611 . . . . 0.0 110.736 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.57 HD23 HD23 ' A' ' 45' ' ' LEU . 10.4 mp -67.8 -41.08 83.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.357 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -68.96 -34.01 74.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.144 -175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.74 -43.41 89.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.75 -42.9 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.61 HG23 HD13 ' A' ' 48' ' ' LEU . 84.9 t -72.66 -32.19 40.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.121 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.72 -20.56 61.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.01 -18.13 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.775 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.92 -39.41 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.233 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.16 -23.36 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.034 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 25.5 tptp -77.08 -24.25 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.43 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 60' ' ' ARG . 75.6 mt -63.08 -33.66 75.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.36 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 20.1 t70 -60.77 -40.82 93.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.657 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -67.28 -36.23 81.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.0 mt -71.56 -46.15 64.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.57 75.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.648 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 -170.38 54.77 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.647 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -104.81 -7.01 19.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.793 0.806 . . . . 0.0 108.961 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -132.04 94.87 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.628 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.7 m -80.03 -11.76 59.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.444 . . . . 0.0 111.409 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.186 0.517 . . . . 0.0 110.23 179.101 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 t -103.15 -81.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.492 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -21.48 15.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.3 2.72 14.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.602 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -57.63 3.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 109.487 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG13 ' A' ' 89' ' ' ILE . 54.0 m -81.16 -34.96 32.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.88 -174.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -66.06 -36.34 82.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.329 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.33 99.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 36' ' ' SER . 94.2 mttt -58.18 -44.73 88.17 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.999 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.77 -50.01 69.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.226 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 110.861 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 52' ' ' VAL . 15.5 tp -62.15 -43.65 98.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.15 -23.4 62.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.259 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 50.7 t80 -68.39 -40.66 81.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.14 -43.61 97.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.251 0.548 . . . . 0.0 109.816 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.459 ' HB2' HG13 ' A' ' 81' ' ' VAL . 64.5 t60 -58.0 -41.03 82.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.647 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.08 -38.18 89.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 97.8 mt -67.1 -13.73 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.096 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.96 13.28 25.72 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.351 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.54 93.6 37.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.431 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 98.9 Cg_endo -87.75 114.83 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.504 2.136 . . . . 0.0 111.486 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 42' ' ' LEU . 27.4 m -73.64 141.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.293 0.568 . . . . 0.0 111.614 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' VAL . 12.8 m -85.36 138.0 36.55 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.688 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.12 -27.9 67.56 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.0 112.272 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -60.55 -44.62 95.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 53' ' ' SER . 10.3 m -68.18 -24.95 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.808 0.337 . . . . 0.0 110.579 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.89 -51.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.055 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.9 t -61.98 -46.7 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.21 -51.8 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.672 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 1.004 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.1 tpp180 -70.15 -28.83 65.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -63.3 -41.14 99.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.977 176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 39.4 mt-10 -67.43 -36.16 80.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 110.644 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.54 -50.76 49.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.612 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.607 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 35.8 mm-40 -84.55 -13.48 51.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.877 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.65 56.51 2.93 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.869 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.443 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 41.7 m0 -87.0 176.51 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 36.3 m-80 -92.51 126.22 53.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 80.3 Cg_exo -46.28 -44.5 20.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.937 3.091 . . . . 0.0 114.075 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.69 -37.73 85.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.106 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 48.5 t80 -70.09 -47.72 60.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 58' ' ' VAL . 25.0 m -58.79 -40.32 83.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.284 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -67.67 -38.09 83.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.849 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.34 -48.15 79.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.633 0.254 . . . . 0.0 110.539 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 70' ' ' PHE . 45.7 t -61.14 -38.31 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.85 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.66 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 79' ' ' GLU . . . -69.51 -32.08 71.27 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.059 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.433 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 24.8 m0 -71.61 -48.97 44.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.67 75.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.493 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 76' ' ' GLY . 10.2 tt0 -48.57 -59.54 3.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.824 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -68.08 -37.91 81.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.053 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 46' ' ' HIS . 41.7 t -58.18 -49.09 82.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.111 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -70.34 -32.23 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.262 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -74.12 -16.1 61.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.591 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 18.1 40.32 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.13 -174.78 3.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -134.0 152.93 52.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.981 0.42 . . . . 0.0 110.509 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.8 pt -126.93 158.83 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.4 tp -91.3 135.97 33.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.21 0.529 . . . . 0.0 110.934 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 36' ' ' SER . 19.2 tt -100.49 131.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.323 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -25.1 34.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 111.25 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -148.0 93.2 4.51 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.225 0.536 . . . . 0.0 110.373 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HA ' HD13 ' A' ' 89' ' ' ILE . 7.2 Cg_exo -74.03 -16.67 22.72 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.454 2.769 . . . . 0.0 113.348 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.44 -21.92 60.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -80.26 -7.43 59.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -81.23 82.73 7.03 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 m -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.288 1.042 . . . . 0.0 112.074 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -66.33 -36.04 81.9 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.954 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.44 -45.71 87.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.375 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.9 mtm -61.47 -40.07 93.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.065 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.99 -54.98 19.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 10.9 mm-40 -65.28 -24.12 67.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -63.89 -56.15 17.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.01 -43.68 98.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.259 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 79.7 tttt -57.03 -41.06 77.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.445 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.97 -39.01 79.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 12' ' ' ALA . 9.9 mp -67.73 -36.27 80.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.808 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.8 t -72.65 -34.96 49.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 110.2 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.1 tp -62.44 -49.9 73.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.569 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -77.43 -7.99 57.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 67.1 t60 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.787 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 106' ' ' LEU . . . . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.836 0.351 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.16 -56.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.672 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.66 -40.44 96.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.569 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -67.12 -31.85 72.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.677 0.275 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 20' ' ' ILE . . . -64.23 -42.5 96.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.217 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 4.4 mm? -65.56 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.619 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.03 -44.61 96.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 14.2 m-85 -60.11 -37.53 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 16' ' ' ALA . 75.2 mt -72.78 -65.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.249 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.47 -47.02 53.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.864 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.45 8.69 27.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.271 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt 57.12 31.17 19.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -67.39 111.32 3.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.377 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -76.98 0.89 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.182 -174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.776 -177.144 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.9 p80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.824 0.345 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.7 m -103.5 -80.47 0.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.464 0.65 . . . . 0.0 110.962 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.471 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.4 ttp -83.34 -27.21 29.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.394 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.83 -2.81 22.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.814 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 10.4 tt0 -102.3 -63.86 1.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.0 110.064 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m -63.53 -46.2 87.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.842 HG23 ' HB3' ' A' ' 95' ' ' PHE . 84.2 m -72.5 -29.77 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.01 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.41 79.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.82 -42.16 97.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.251 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 94' ' ' TYR . . . -65.14 -44.07 94.6 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.245 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 36.5 mt -68.14 -40.71 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.95 0.375 . . . . 0.0 111.146 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 52' ' ' VAL . 91.7 mt -60.58 -39.37 87.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.171 0.51 . . . . 0.0 110.002 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.839 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.644 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 82.4 t80 -58.3 -55.55 33.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.11 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 48' ' ' LEU . 7.6 mp -63.99 -36.4 83.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.394 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -54.47 -56.3 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.346 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.83 -23.62 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.081 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.7 mt -62.22 -35.33 78.59 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 109.963 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.4 3.61 3.78 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.571 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.4 99.37 45.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.762 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.542 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 64.2 Cg_endo -77.08 117.64 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.125 1.883 . . . . 0.0 111.618 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 42' ' ' LEU . 27.4 m -68.03 148.58 11.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.776 -175.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.5 m -94.71 131.71 30.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.298 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 33.5 Cg_exo -58.91 -32.22 96.96 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.267 2.645 . . . . 0.0 113.216 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -55.8 -41.83 74.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 t -61.11 -37.84 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.76 -47.16 86.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.361 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.24 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.675 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.736 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.569 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 12.2 tpt180 -68.05 -36.25 79.57 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.07 -45.19 82.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.601 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.96 -46.78 56.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 111.362 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -68.06 -42.73 80.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.502 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 3.8 tp10 -84.78 -32.79 23.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.742 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.9 62.58 0.75 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.368 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.503 ' CH2' HD12 ' A' ' 17' ' ' LEU . 39.0 m0 -102.26 152.68 20.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.572 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.68 142.04 94.69 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.7 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -45.81 37.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.934 2.423 . . . . 0.0 111.982 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -58.07 -40.64 81.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.083 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 75.6 t80 -66.06 -59.63 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.7 m -56.02 -41.94 75.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.57 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.8 -50.59 71.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.67 -43.25 63.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.667 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.563 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.6 t -61.69 -38.07 79.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -60.3 -44.19 95.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.604 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 79' ' ' GLU . . . -57.29 -41.01 92.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.401 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 m0 -65.35 -43.9 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.2 83.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.163 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 53.7 mt-10 -57.06 -48.72 77.88 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.221 0.534 . . . . 0.0 110.519 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.63 -35.59 79.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.6 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' TRP . 66.9 t -62.04 -48.84 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.625 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -62.29 -38.68 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -72.73 -16.63 61.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.741 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.99 29.9 40.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.429 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.47 154.05 17.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -77.82 142.06 38.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.245 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.5 pt -117.25 159.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.809 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tt -87.99 109.23 19.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.294 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -101.53 150.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 25.1 mtpt -84.68 -58.83 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.514 0.673 . . . . 0.0 109.73 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -111.05 124.3 33.19 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.802 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HG2' ' OE1' ' A' ' 93' ' ' GLU . 9.9 Cg_endo -53.32 -30.92 54.36 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.074 2.516 . . . . 0.0 113.02 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' ' HG2' ' A' ' 92' ' ' PRO . 1.8 mp0 -63.99 98.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.446 ' HD2' ' HA2' ' A' ' 40' ' ' GLY . 36.6 m-85 -59.72 -59.29 5.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.364 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.842 ' HB3' HG23 ' A' ' 37' ' ' THR . 26.9 p90 -162.05 172.71 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.692 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -82.68 164.34 20.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 111.705 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -32.86 74.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.484 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -53.78 -44.86 70.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.821 0.82 . . . . 0.0 110.067 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 95' ' ' PHE . 33.1 mtp -75.21 -34.16 61.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.122 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -50.63 70.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.829 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.57 -43.64 84.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -56.02 -56.73 17.18 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 111.081 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.2 mt -61.23 -44.36 97.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.644 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -59.71 -43.01 94.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.742 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.48 -48.06 80.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 12' ' ' ALA . 10.0 mp -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.829 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 103' ' ' LEU . 25.8 t -95.45 -6.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.31 -42.08 38.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -43.48 54.75 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.498 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.478 0.947 0 C-N-CA 124.154 0.982 . . . . 0.0 112.565 177.477 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HA ' HD21 ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.241 0.543 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.35 -41.08 83.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.586 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -65.28 -47.19 77.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.66 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -64.72 -42.85 94.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.0 82.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.243 0.544 . . . . 0.0 110.652 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -71.77 -24.06 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.431 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.34 -33.96 37.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.84 -44.46 89.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.3 mt -84.44 -68.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.611 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.69 45.23 3.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.056 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.52 -6.08 66.37 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.546 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ttt 69.39 105.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.529 0.732 . . . . 0.0 111.937 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -71.8 162.59 29.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.411 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.5 m -52.9 -36.63 59.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.363 0.265 . . . . 0.0 111.582 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.844 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.87 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 59.0 m170 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 m -82.96 -79.94 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.461 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.6 ttp -99.41 -24.02 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.759 0.79 . . . . 0.0 108.979 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -78.31 9.54 3.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.048 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 5.9 tt0 -103.05 -72.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.736 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -58.85 -54.33 48.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.542 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.4 m -61.58 -39.93 92.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 111.185 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.04 91.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -58.13 -48.2 80.96 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.477 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.71 82.02 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.571 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 103' ' ' LEU . 77.9 mt -62.9 -45.38 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.518 . . . . 0.0 110.715 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.85 -39.29 93.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.2 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.32 -39.03 78.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 48' ' ' LEU . 83.0 t80 -60.23 -44.55 95.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.25 -47.57 85.45 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.34 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 60.7 m80 -65.48 -36.06 82.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.46 -33.17 74.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 44' ' ' TYR . 76.6 mt -66.53 -45.27 79.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.588 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 138.51 4.69 1.62 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.676 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.43 93.29 4.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 90.0 Cg_endo -90.72 88.81 0.3 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.477 2.118 . . . . 0.0 112.924 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.18 123.52 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.7 m -89.09 154.32 49.43 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' GLU . 5.3 Cg_endo -49.86 -37.93 46.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.382 2.721 . . . . 0.0 112.396 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -48.68 -51.57 27.85 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.535 0.522 . . . . 0.0 110.883 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -64.68 -42.1 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.456 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.6 -48.03 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 54' ' ' PRO . 89.6 t -60.99 -52.29 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.34 90.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.359 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.53 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 13.0 tpp180 -67.84 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.457 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.71 -38.53 96.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.934 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.17 -38.93 84.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.591 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -75.16 -50.5 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.344 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 27.8 mm-40 -65.63 -42.66 91.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.014 0.435 . . . . 0.0 110.258 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.24 50.43 0.5 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.1 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 30.2 m0 -88.06 163.47 16.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.86 143.52 78.26 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.102 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.23 -55.81 3.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.394 2.729 . . . . 0.0 112.867 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.3 mm-40 -59.01 -37.2 76.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.472 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.445 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 80.2 t80 -64.78 -51.82 60.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -64.86 -45.89 84.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.155 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.04 -41.1 97.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.992 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.564 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 13.9 mptt -60.11 -57.53 12.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.497 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 48.4 t -58.76 -39.91 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.87 -37.63 85.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.52 86.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.262 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.564 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 8.9 m0 -67.19 -36.98 82.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.76 -44.76 89.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.306 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 2.2 tm-20 -58.17 -46.49 85.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.71 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -52.57 -58.94 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.185 178.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.5 t -67.51 -34.4 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.396 -175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.03 69.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.736 0.303 . . . . 0.0 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -81.94 -14.23 56.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.201 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.46 34.56 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -107.69 169.43 8.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.78 146.46 28.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.772 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.2 pt -128.95 159.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.999 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.074 0.464 . . . . 0.0 110.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -82.8 -12.6 12.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 75.46 -48.12 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.575 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.25 92.12 6.24 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.479 0.657 . . . . 0.0 110.911 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 -10.78 24.66 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.023 2.482 . . . . 0.0 112.424 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -72.59 -15.15 61.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.12 -1.75 58.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.961 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -82.23 84.03 7.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.0 p -71.52 147.43 47.73 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.304 1.049 . . . . 0.0 112.327 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.6 m -49.9 -42.67 48.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.67 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 62.5 t80 -57.39 -42.32 81.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.655 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.454 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 52.8 mtm -73.23 -47.29 44.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.268 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -58.14 9.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -32.34 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.923 -175.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 47.6 tt0 -62.6 -51.17 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.092 0.472 . . . . 0.0 109.811 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 41' ' ' ILE . 76.9 mt -57.75 -44.36 86.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.081 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 2.4 ttmp? -53.96 -61.78 2.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.878 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 19.8 mm-40 -57.39 -44.49 84.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.617 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 12' ' ' ALA . 32.5 tp -65.98 -44.14 85.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.697 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.54 -32.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 11.7 tp -61.05 -30.01 70.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.052 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 40.9 mt-10 -60.86 -30.13 69.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.802 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -176.127 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' HD23 ' A' ' 17' ' ' LEU . 67.8 mt -62.9 -53.23 49.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.814 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -57.44 -39.3 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HD2' HD23 ' A' ' 103' ' ' LEU . 33.6 ttmt -60.99 -53.86 52.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.751 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.12 80.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 3.6 mm? -66.85 -29.12 68.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.665 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.52 -33.77 67.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.927 0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.22 -42.7 83.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.786 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.92 -69.77 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.014 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.24 53.32 4.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.047 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.49 -146.97 18.63 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.308 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -91.45 36.16 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 110.975 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -82.28 66.8 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.095 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m 67.3 112.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.376 0.608 . . . . 0.0 111.62 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.289 176.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.9 t -96.37 -80.16 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.2 0.524 . . . . 0.0 112.182 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.401 ' O ' ' HB ' ' A' ' 37' ' ' THR . 28.8 ttp -85.05 -22.43 28.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.307 -172.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 70' ' ' PHE . 2.8 m-20 -54.0 -42.72 69.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.248 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HA ' ' CH2' ' A' ' 77' ' ' TRP . 2.4 tm-20 -50.4 -76.02 0.03 OUTLIER 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.758 0.789 . . . . 0.0 111.54 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -75.74 -37.68 59.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.701 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 33' ' ' MET . 75.0 m -68.99 -47.48 65.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.62 -38.47 89.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' A' ' 87' ' ' ILE . 3.9 ttmp? -60.9 -42.16 97.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.199 0.523 . . . . 0.0 110.527 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.12 -45.06 74.02 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.46 -42.85 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.483 0.141 . . . . 0.0 111.003 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 90.0 mt -57.36 -48.02 80.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.697 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 87' ' ' ILE . 23.2 mtpp -66.97 -37.34 84.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.297 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 67.7 t80 -65.69 -44.18 86.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.42 -42.24 88.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.828 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.16 -34.02 76.73 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.92 -43.18 79.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.605 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.3 mt -61.81 -42.23 98.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.24 6.68 2.39 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.615 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.97 99.98 51.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.782 0.325 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -88.08 121.8 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.696 2.264 . . . . 0.0 112.709 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.35 108.29 19.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -73.99 138.3 76.1 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.959 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 18.0 Cg_endo -60.05 -25.24 79.2 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.981 2.454 . . . . 0.0 111.96 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.3 -44.67 88.66 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.88 -37.78 69.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.4 t -58.4 -45.24 89.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.017 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 54' ' ' PRO . 71.8 t -63.82 -50.29 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.999 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.83 95.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.676 ' HG2' ' CD1' ' A' ' 17' ' ' LEU . 8.7 tpt180 -66.07 -41.64 90.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.236 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -60.68 -48.75 84.68 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.838 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -68.18 -27.29 66.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -69.85 -56.6 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' CD ' ' HE ' ' A' ' 60' ' ' ARG . 46.8 mt-10 -73.02 -24.6 60.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.994 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.94 49.68 2.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.006 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.419 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 36.4 m0 -74.69 147.24 41.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -63.3 142.58 97.83 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.248 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.83 -60.91 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.779 2.986 . . . . 0.0 114.432 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 4.9 mm-40 -60.16 -26.32 66.22 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 34' ' ' ASP . 30.4 t80 -66.97 -61.18 2.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 m -57.95 -38.67 76.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.261 0.553 . . . . 0.0 110.782 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -60.28 -49.52 77.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.528 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 53.6 mttm -66.79 -46.08 76.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.924 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.2 t -61.62 -40.74 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.824 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.39 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.725 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.53 99.58 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.304 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 10.2 m0 -66.82 -50.17 63.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.45 -39.03 72.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.9 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 32.8 tt0 -54.17 -54.44 39.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.824 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -68.99 -39.64 79.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.211 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' TRP . 92.5 t -69.24 -44.33 80.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.595 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.08 95.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.467 0.175 . . . . 0.0 110.833 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -65.95 -35.2 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.609 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.37 37.1 4.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.002 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.72 147.46 23.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.904 0.383 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -67.46 137.76 56.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 ' HD2' ' A' ' 43' ' ' LYS . 30.7 pt -138.44 135.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 88' ' ' LEU . 2.6 pp -69.97 131.13 43.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.849 0.833 . . . . 0.0 112.131 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.49 69.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.998 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.64 13.62 9.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.623 ' H ' ' CD ' ' A' ' 92' ' ' PRO . 5.9 m-80 -131.54 -51.25 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.071 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.623 ' CD ' ' H ' ' A' ' 91' ' ' ASN . 50.7 Cg_exo -59.25 -30.45 92.97 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.811 2.341 . . . . 0.0 113.353 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 65.97 17.98 10.94 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.205 0.526 . . . . 0.0 110.65 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 60.24 -95.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.731 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 100' ' ' GLN . 38.1 p90 179.34 177.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.637 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.167 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -58.1 -39.61 79.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -43.93 -54.12 5.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.046 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.5 mtm -75.18 -29.51 60.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.244 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 8.3 tt0 -67.17 -44.55 79.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.217 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.02 -40.43 97.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.43 -51.72 68.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.523 0.678 . . . . 0.0 109.75 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 107' ' ' VAL . 68.1 mt -56.66 -63.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.905 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -57.93 -49.32 77.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.491 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.81 -48.41 80.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.949 0.404 . . . . 0.0 109.977 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.95 2.01 16.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 103' ' ' LEU . 42.7 t -100.14 -33.89 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.41 -31.7 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.365 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -63.6 -63.31 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.7 p-80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.467 0.707 . . . . 0.0 110.883 -171.603 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 120.354 0.121 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.12 -50.95 59.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.46 -41.7 75.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -73.86 -34.89 64.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.49 -33.33 69.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 0.0 109.921 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.718 HD11 ' HG2' ' A' ' 60' ' ' ARG . 7.8 tt -62.75 -36.4 82.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.359 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.9 -46.4 89.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.187 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.49 -53.95 47.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.98 -46.24 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.664 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.29 60.89 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.294 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 -119.72 11.42 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.903 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.443 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 2.9 tpt -145.4 81.33 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 67.84 -3.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.538 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -160.15 156.36 26.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.839 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.3 m170 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.866 0.365 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.453 ' HB2' ' H ' ' A' ' 33' ' ' MET . 3.2 m -103.48 -80.65 0.52 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.482 0.658 . . . . 0.0 110.238 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.453 ' H ' ' HB2' ' A' ' 32' ' ' SER . 3.8 ptm -90.5 -9.74 46.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.877 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.56 -22.47 66.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.845 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -102.56 -65.37 1.0 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.739 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.6 m -56.11 -52.3 64.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.986 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 41' ' ' ILE . 23.5 m -66.81 -41.62 87.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.697 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -61.99 -51.37 68.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.171 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.91 -39.86 90.96 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -44.65 97.81 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.15 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' HD23 ' A' ' 45' ' ' LEU . 80.0 mt -64.38 -47.43 89.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.653 0.264 . . . . 0.0 111.008 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 52' ' ' VAL . 86.0 mt -62.42 -42.75 99.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.024 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -67.45 -40.54 85.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.777 0.322 . . . . 0.0 110.273 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.562 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 77.7 t80 -59.15 -47.91 83.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.317 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 41' ' ' ILE . 3.3 mm? -60.03 -45.18 93.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.848 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -59.91 -42.45 93.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.618 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.52 -37.8 85.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 90.3 mt -56.79 -38.48 72.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.665 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.9 -52.4 0.43 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.801 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -87.23 126.1 63.75 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 121.152 0.501 . . . . 0.0 111.611 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.1 145.75 15.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 42' ' ' LEU . 30.8 m -81.07 140.25 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.176 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB2' HG22 ' A' ' 56' ' ' VAL . 3.6 m -90.55 119.21 69.1 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.1 -38.0 39.12 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.786 2.324 . . . . 0.0 113.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -69.98 -39.41 75.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 53' ' ' SER . 27.9 m -67.37 -26.77 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 53' ' ' SER . 86.9 t -68.67 -44.4 82.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 61.3 t -62.29 -42.04 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.09 -39.56 78.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 17' ' ' LEU . 7.8 tpt180 -73.16 -34.34 66.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.296 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -58.42 -48.53 83.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 7.9 pt-20 -72.17 -26.4 62.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -82.12 -54.27 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.17 -25.83 47.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.879 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.28 60.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.391 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.429 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 34.2 m0 -103.01 165.58 10.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.7 m-20 -71.91 137.78 82.41 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.695 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 45.7 Cg_exo -56.68 -44.62 43.65 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.177 2.585 . . . . 0.0 112.567 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 52.4 mp0 -63.83 -45.8 87.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' VAL . 86.9 t80 -61.86 -54.58 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.369 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 23.4 m -58.05 -39.82 79.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.707 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.31 -46.41 73.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.928 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 61.7 mttm -66.94 -43.26 83.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.046 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.87 -36.19 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.822 0.344 . . . . 0.0 110.431 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.83 86.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.353 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.95 96.73 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.091 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . 28.1 m0 -64.2 -49.19 72.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.02 79.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.376 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -59.04 -43.14 91.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.91 0.386 . . . . 0.0 110.138 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' HG22 ' A' ' 87' ' ' ILE . 66.8 mttm -65.23 -45.46 84.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.07 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' TRP . 85.6 t -58.99 -43.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.63 65.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 p -89.74 -19.88 24.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.01 25.01 9.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.418 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -90.97 162.54 14.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 110.761 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -87.84 145.21 26.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 80' ' ' LYS . 33.7 pt -127.07 136.52 60.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.934 0.397 . . . . 0.0 110.407 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -86.84 138.54 31.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.888 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 90' ' ' LYS . 6.3 tt -126.45 161.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 89' ' ' ILE . 42.9 mmtm -74.42 44.43 0.2 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 171.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 5.0 m-20 76.23 152.2 0.14 Allowed Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.016 0.926 . . . . 0.0 111.429 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 34.38 0.42 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.695 2.263 . . . . 0.0 112.065 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 91' ' ' ASN . 10.6 tp10 -103.52 161.47 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 74.31 -30.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.264 0.626 . . . . 0.0 111.457 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.66 86.02 3.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 166.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -83.77 172.03 12.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.783 -167.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -25.99 68.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.695 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.2 -53.66 32.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.132 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -68.73 -35.48 77.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 110.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.16 -53.59 42.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.23 -38.17 76.31 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.986 0.179 . . . . 0.0 111.314 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -51.84 -60.69 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.63 0.729 . . . . 0.0 110.506 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.6 -38.17 83.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.111 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.31 -56.62 18.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.381 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.7 tt0 -64.79 -38.34 90.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.462 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -51.26 -43.24 61.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.522 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -83.06 -39.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.594 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.335 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 41.6 mt-10 -62.86 -22.55 66.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.623 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.511 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.901 0.382 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.58 -44.62 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.381 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.55 -33.31 75.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.459 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 10.9 mmpt? -75.45 -26.66 58.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.811 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.38 0.61 . . . . 0.0 109.458 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.5 mm? -74.2 -14.83 61.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 11.9 t70 -69.01 -44.95 71.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.29 -64.29 0.92 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.708 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.0 -43.14 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.15 -9.54 80.62 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.985 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.03 -14.81 71.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.787 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.599 ' SD ' ' HA ' ' A' ' 34' ' ' ASP . 65.3 mtm -88.48 75.26 8.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.698 0.761 . . . . 0.0 110.368 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -100.02 10.31 41.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.926 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.96 54.49 1.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.518 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.101 174.568 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -59.25 -67.45 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.254 0.549 . . . . 0.0 111.774 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -61.82 2.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.618 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.599 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -51.96 -68.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.979 -175.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 36.5 tt0 -62.09 -62.21 1.93 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -169.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -58.99 -47.37 85.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.368 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -75.22 -31.27 60.83 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.424 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.5 94.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.038 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.13 -43.4 82.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.078 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.597 ' CA ' ' HA ' ' A' ' 94' ' ' TYR . . . -63.9 -46.53 91.36 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.714 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.66 -47.53 90.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.522 0.201 . . . . 0.0 111.008 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.9 -38.6 86.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 111.208 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -66.59 -42.32 87.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.088 0.471 . . . . 0.0 110.269 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 54.2 t80 -66.16 -45.34 81.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.448 HD23 HD12 ' A' ' 48' ' ' LEU . 94.7 mt -60.85 -41.59 96.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -50.49 -51.94 42.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.233 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -13.79 59.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.919 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 61.6 mt -73.43 -26.15 60.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 0.0 110.292 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.88 -14.8 10.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.376 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.69 93.17 48.76 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 110.629 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -90.97 146.21 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.091 2.527 . . . . 0.0 112.078 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.71 110.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.872 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 m -66.14 139.54 96.56 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.702 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.54 -28.08 53.47 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.034 2.489 . . . . 0.0 112.743 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.03 -44.41 87.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.211 0.529 . . . . 0.0 110.317 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.32 -38.03 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.307 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.33 -47.76 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.874 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.11 -49.68 83.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.983 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.66 92.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 1.4 tpt85 -69.39 -34.44 74.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.524 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.67 -50.21 68.5 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.275 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.25 -32.07 64.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.407 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -72.09 -45.83 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.439 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 7.3 tp10 -82.75 -48.73 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.25 65.13 0.21 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.19 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.496 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 31.5 m0 -104.56 162.71 13.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.07 148.7 81.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.66 -35.09 66.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.156 2.571 . . . . 0.0 112.411 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 24.4 mm-40 -69.9 -46.74 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.08 -46.6 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.3 m -61.31 -44.78 96.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.191 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.99 -43.22 88.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.239 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 64.0 mttm -62.07 -53.57 53.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.1 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 53.0 t -59.38 -40.19 80.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.821 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.49 -32.92 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.07 -35.81 64.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.439 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 14.3 m0 -68.68 -49.35 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.18 -42.52 77.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.0 -58.42 6.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.324 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -66.22 -46.97 75.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.811 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.32 -43.66 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.565 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.49 61.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.579 0.228 . . . . 0.0 111.22 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t -67.25 -35.59 79.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.391 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.14 -3.44 8.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.63 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.28 103.9 16.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 109.759 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -53.41 141.45 24.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.984 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 20.6 pt -124.36 113.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.531 0.681 . . . . 0.0 109.86 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.86 123.86 29.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.021 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 91' ' ' ASN . 56.2 mt -66.42 -31.03 51.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.101 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? 62.29 21.55 12.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.271 1.034 . . . . 0.0 109.456 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 1.0 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 52.4 m-80 -148.43 -160.28 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 1.0 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 31.6 Cg_exo -43.37 86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.907 2.405 . . . . 0.0 114.14 168.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 89' ' ' ILE . 19.0 mm-40 -63.99 130.14 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.883 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.597 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 96.8 m-85 64.63 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.94 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER 169.85 -157.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.161 -172.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 11.3 t -108.14 -175.78 2.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -41.12 88.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -167.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 96' ' ' SER . 0.1 OUTLIER -53.46 -47.56 69.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtt -65.1 -45.3 85.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.402 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -58.68 -45.35 89.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.645 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -60.24 -44.58 95.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.431 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -64.61 -57.41 9.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.07 -46.76 87.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.704 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -65.42 -35.17 80.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.747 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.83 -38.73 91.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 110.821 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -63.55 -34.11 77.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.304 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.93 -50.67 18.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.1 -62.43 1.88 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.394 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -71.42 -59.94 2.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.286 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 . . . . . 0 N--CA 1.471 0.586 0 O-C-N 124.015 0.822 . . . . 0.0 111.569 175.776 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.39 -37.6 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 14.0 mm-40 -76.72 -25.91 54.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.103 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -81.28 -30.61 33.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 19' ' ' PHE . . . -65.58 -36.17 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 171.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 57.1 tp -58.7 -41.02 85.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.323 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.29 -46.15 86.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.774 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 16' ' ' ALA . 57.5 m-85 -62.38 -50.74 70.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.868 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.35 -55.86 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.363 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.95 29.3 5.84 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.26 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.05 -70.63 1.1 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.564 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.9 -50.64 10.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 60.49 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.649 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t -89.64 167.35 13.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.313 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 0.0 110.569 -178.133 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.516 0.198 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -95.9 -80.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 0.0 111.911 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.2 ttp -94.32 -17.01 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.544 0.688 . . . . 0.0 109.96 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.14 -21.29 66.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.218 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -93.45 -68.79 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.679 0.275 . . . . 0.0 110.825 -176.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -46.68 88.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -67.21 -36.61 82.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 0.0 111.033 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.94 89.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.525 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 31.7 mmtp -54.74 -48.0 73.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.564 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.12 -44.56 94.71 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.348 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.475 HG23 HD11 ' A' ' 103' ' ' LEU . 73.9 mt -61.05 -49.97 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.061 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.51 -44.62 93.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.429 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.42 -27.35 65.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.387 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.14 -36.52 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.449 . . . . 0.0 110.182 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 97.2 mt -64.15 -40.37 95.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.403 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -72.74 -25.0 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.65 -38.45 89.38 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.24 0.543 . . . . 0.0 109.897 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.44 -40.2 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.767 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.29 -26.81 3.67 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.97 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.91 104.7 54.24 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -92.32 -178.49 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.028 2.486 . . . . 0.0 112.081 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -109.83 121.35 62.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 56' ' ' VAL . 6.4 m -61.65 127.55 88.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 53.1 Cg_exo -53.02 -32.33 57.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.878 2.386 . . . . 0.0 112.544 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -55.99 -52.52 63.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.664 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 53' ' ' SER . 31.5 m -71.02 -24.19 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 111.015 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.46 -45.49 88.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.126 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 65.1 t -61.11 -48.99 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.646 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.57 98.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.949 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.81 -42.49 99.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.207 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.53 -47.63 89.47 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.48 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.9 -12.78 60.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.78 0.324 . . . . 0.0 110.814 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -85.8 -52.4 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -73.88 -27.34 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.959 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.37 48.21 1.45 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.532 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.489 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 40.9 m0 -83.26 153.74 24.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 67.2 t30 -63.17 127.9 91.6 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 4.9 Cg_endo -47.3 -43.82 25.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.867 . . . . 0.0 113.332 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.3 -37.1 79.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.766 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' VAL . 74.6 t80 -70.45 -53.36 16.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -58.16 -40.03 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.322 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.79 -46.91 88.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.535 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -67.41 -46.19 73.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.545 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 70' ' ' PHE . 69.6 t -60.33 -37.82 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.56 89.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.638 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.27 -35.12 69.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.899 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.544 ' O ' HG23 ' A' ' 81' ' ' VAL . 50.6 m0 -63.1 -54.13 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.36 68.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.056 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.26 -50.29 74.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.162 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -81.27 -21.51 39.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.489 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.7 t -67.78 -38.27 79.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 109.836 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.41 -44.33 36.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.239 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.3 p -75.55 -34.83 60.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.91 44.36 4.5 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.772 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -111.7 108.52 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 62.13 -141.22 0.44 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.563 0.539 . . . . 0.0 110.671 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 89' ' ' ILE . 37.0 pt 52.76 53.06 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.34 1.056 . . . . 0.0 112.22 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 3.4 pp -79.22 19.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.499 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 87' ' ' ILE . 1.1 tt 79.28 141.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.18 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -71.32 -40.94 70.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.566 0.698 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -172.19 148.67 2.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.816 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 -37.81 93.74 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.453 2.102 . . . . 0.0 111.618 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.33 -97.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.43 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -142.49 24.22 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 111.116 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.25 107.39 4.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.0 m -99.34 159.93 14.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.277 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.3 t -66.79 -28.59 68.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.0 -39.88 63.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.777 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.4 mtt -66.3 -42.23 88.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.086 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.7 -51.65 68.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.586 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' THR . 73.8 mt-10 -59.64 -42.02 91.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.13 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.5 mt-30 -56.22 -54.86 40.19 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.698 0.285 . . . . 0.0 111.155 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.0 mt -60.76 -44.67 96.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -63.83 -41.9 97.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.865 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.296 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 96.5 mt -66.54 -21.67 66.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' LEU . 98.6 t -71.8 -40.99 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 109.91 173.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -72.3 -44.3 62.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.77 -23.53 65.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 85.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.687 0.28 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.5 mp -64.13 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.128 0.489 . . . . 0.0 109.889 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.4 -50.64 72.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.15 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 28.1 mmtp -78.85 -18.51 53.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.69 77.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.641 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.1 mt -70.95 -22.41 62.22 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.183 174.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 18.4 t70 -67.48 -36.91 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -65.07 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.488 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.92 -74.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.519 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 66' ' ' TRP . . . -95.36 46.96 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.373 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.08 -58.28 1.41 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.63 95.85 9.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 66' ' ' TRP . 76.6 m-20 -116.21 144.71 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.464 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.4 t -164.54 -178.55 5.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.29 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.503 . . . . 0.0 110.579 -178.21 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.1 m170 . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 121.66 0.743 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -92.56 -49.24 6.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.809 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.606 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.59 -27.71 28.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.332 -170.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.45 -54.17 3.18 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 124.097 0.873 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.597 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 33.5 mm-40 -59.09 -63.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.427 ' CB ' ' H ' ' A' ' 94' ' ' TYR . 19.9 m -62.14 -55.81 25.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.42 HG23 ' SD ' ' A' ' 99' ' ' MET . 90.9 m -69.14 -52.5 27.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -170.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' HZ3' ' A' ' 77' ' ' TRP . . . -75.48 -44.11 45.71 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 4.2 ttmp? -67.54 -33.59 75.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.799 0.333 . . . . 0.0 110.246 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.7 -50.42 66.3 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.314 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.15 -45.22 96.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.625 0.25 . . . . 0.0 111.102 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.52 -44.83 89.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.941 0.401 . . . . 0.0 111.249 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 9.8 mtpm? -69.92 -34.1 73.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.394 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -64.73 -42.2 95.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 110.117 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.43 -42.56 92.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.495 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -61.61 -35.83 78.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.606 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.56 -43.57 89.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.388 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.472 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.65 16.29 1.67 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.21 94.11 47.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.934 0.397 . . . . 0.0 110.671 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -93.02 152.19 2.63 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.886 2.391 . . . . 0.0 112.253 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 148.26 24.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.2 m -83.11 133.37 48.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.601 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 45.2 Cg_exo -56.87 -31.42 88.96 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.267 2.645 . . . . 0.0 112.519 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.59 -42.82 64.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.304 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.92 -38.65 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.414 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.43 -46.91 85.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.471 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 85.7 t -60.09 -44.26 94.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.498 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.77 88.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.641 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.0 tpt180 -65.38 -39.75 92.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.16 97.86 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.265 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 51.5 mt-10 -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.602 -0.352 . . . . 0.0 111.188 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -76.84 -46.09 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.4 -9.16 55.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.552 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.3 -65.3 1.58 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.819 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.619 ' HA ' ' CG ' ' A' ' 24' ' ' ASN . 35.7 m0 55.35 -167.27 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.07 0.548 . . . . 0.0 111.957 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.888 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 54.4 m-80 -93.48 123.4 60.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.45 -38.2 82.78 Favored 'Trans proline' 0 CA--C 1.526 0.106 0 C-N-CA 122.996 2.464 . . . . 0.0 112.628 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -80.45 -33.39 36.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.561 . . . . 0.0 110.015 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.888 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 77.5 t80 -73.27 -43.99 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.535 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.9 m -59.51 -35.62 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -69.59 -40.36 76.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.712 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 63.2 mttt -54.76 -57.6 10.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.0 t -60.61 -37.46 75.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.06 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.49 73.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.1 51.42 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.15 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.712 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.6 m0 -64.62 -49.25 71.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.979 0.419 . . . . 0.0 110.107 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -34.41 74.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.743 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.6 -45.28 92.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.025 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.56 -49.03 79.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.427 0.632 . . . . 0.0 110.327 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 77' ' ' TRP . 61.9 t -60.77 -44.87 98.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.502 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.1 61.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.64 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -77.45 -9.31 58.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 110.798 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.88 29.01 13.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.098 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.12 171.01 8.08 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 86' ' ' ARG . 13.0 ptt180 -119.44 132.83 55.88 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.8 pt -112.73 138.55 41.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.174 0.512 . . . . 0.0 110.901 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.16 116.65 17.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 89' ' ' ILE . 16.8 tt -77.48 89.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 122.502 1.144 . . . . 0.0 110.092 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 90' ' ' LYS . 17.3 pttp -67.62 -2.74 7.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.779 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -160.12 88.35 1.88 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -177.347 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -96.35 29.15 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.523 2.816 . . . . 0.0 112.511 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.2 -55.52 33.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.606 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 20.3 m-85 -99.45 35.67 1.91 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -171.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -116.1 82.87 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -74.09 160.53 31.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.838 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -30.86 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.734 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.549 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.7 t80 -49.34 -51.64 33.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.546 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 37' ' ' THR . 68.0 mtm -69.45 -39.14 77.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -61.88 -46.58 88.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.23 -35.21 79.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.167 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 57.5 mt-30 -59.11 -50.92 72.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 110.37 175.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.48 -45.23 84.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.475 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.44 -42.39 82.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.23 -49.57 55.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.578 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -62.94 -44.51 95.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.942 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.0 -32.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 110.415 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.5 tp -67.51 -59.22 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -32.72 69.99 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.713 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.401 171.13 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 54.6 mt -70.52 -40.4 77.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.215 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.07 -39.77 93.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.91 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 48.4 tptt -68.71 -36.04 77.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.309 . . . . 0.0 110.61 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -41.48 99.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 110.27 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.528 HD13 ' HG2' ' A' ' 60' ' ' ARG . 92.0 mt -66.76 -32.7 74.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.687 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 7.4 t70 -57.49 -44.55 85.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.018 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.49 -41.85 98.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -54.25 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.648 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -54.16 30.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.81 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -111.28 4.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.904 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.6 mtt -109.21 -42.67 4.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 51.1 71.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.902 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -105.28 -78.44 0.57 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.293 0.568 . . . . 0.0 109.796 178.703 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 5.0 m170 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -104.19 -58.18 1.92 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 110.485 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -87.4 -58.52 2.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.074 -171.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.36 -5.47 32.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.014 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.679 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 21.0 tt0 -103.19 -62.74 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.09 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.8 m -58.28 -55.78 30.54 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 33' ' ' MET . 41.3 m -70.91 -30.17 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.83 0.348 . . . . 0.0 110.868 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.74 99.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' HE3' ' CG ' ' A' ' 35' ' ' GLU . 92.3 mttt -58.88 -43.69 90.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.072 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 -44.38 97.87 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.594 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.418 HG12 ' HE1' ' A' ' 95' ' ' PHE . 55.5 mt -61.32 -47.43 93.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.042 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 HG11 ' A' ' 52' ' ' VAL . 82.5 mt -64.36 -40.29 95.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 110.916 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.08 -34.23 76.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.461 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 76.3 t80 -65.62 -39.13 91.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.62 -44.18 96.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 110.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -62.62 -32.52 73.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.575 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.49 -34.46 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.305 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.3 mt -67.65 -41.68 83.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.353 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.25 -50.22 0.47 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.734 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 m -87.47 121.24 71.25 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.224 0.535 . . . . 0.0 112.226 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.8 165.8 8.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HD22 ' A' ' 42' ' ' LEU . 8.9 p -107.03 147.79 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.45 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 13.8 m -102.16 137.05 19.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 27.0 Cg_exo -62.56 -24.79 75.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.241 2.627 . . . . 0.0 112.545 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -53.36 -45.92 69.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.825 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.84 -36.52 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.62 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 74' ' ' VAL . 66.8 t -64.0 -49.73 80.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.73 -46.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.06 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.528 ' HG2' HD13 ' A' ' 17' ' ' LEU . 20.8 tpt180 -66.4 -43.35 86.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -47.08 91.3 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.429 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.13 -33.6 76.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.639 0.257 . . . . 0.0 111.418 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.97 -57.19 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.52 -31.58 68.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.161 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.66 45.03 1.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.964 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -85.65 131.43 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.449 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t30 -65.65 123.45 84.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 26.3 Cg_exo -30.11 -44.67 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.748 4.299 . . . . 0.0 115.918 -176.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.05 -35.19 72.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.096 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 74' ' ' VAL . 57.4 t80 -74.92 -47.54 29.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 m -60.44 -39.8 88.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.879 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -62.41 -43.94 97.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.927 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -56.53 -58.75 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 31.8 t -59.65 -41.59 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.564 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.07 88.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.438 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.08 -37.98 94.82 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.44 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.679 ' CZ2' ' HG3' ' A' ' 35' ' ' GLU . 11.1 m0 -66.43 -53.78 31.7 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.13 -40.29 64.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.986 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -55.24 -54.57 41.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.796 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 58.5 mttt -73.05 -39.3 66.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -42.21 92.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.541 0.21 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.83 93.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.185 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -78.92 -9.22 59.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.57 39.39 41.54 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.217 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 55.4 m-20 -98.61 152.16 19.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.38 149.72 48.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.152 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 pt -136.39 166.03 27.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.89 102.43 14.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 89' ' ' ILE . 4.0 tt -103.28 -6.94 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.068 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 90' ' ' LYS . 3.8 tptp 66.11 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.0 -169.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -153.26 126.86 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.21 -59.06 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.279 1.986 . . . . 0.0 111.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.68 ' HG2' ' HB3' ' A' ' 91' ' ' ASN . 27.7 mm-40 57.21 -81.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 172.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -85.08 53.44 2.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 41' ' ' ILE . 21.8 t80 -111.27 71.15 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -61.01 144.8 52.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.66 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 m -53.55 -38.18 63.6 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.523 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.23 -37.93 78.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.672 0.273 . . . . 0.0 111.231 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.2 mtm -75.56 -41.09 55.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.35 -47.72 82.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.768 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 13.5 tp10 -69.39 -28.0 65.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.675 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -66.24 -49.08 68.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.337 0.589 . . . . 0.0 109.819 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.44 -43.6 98.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.238 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 34.6 tttm -58.86 -37.08 75.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.144 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.5 tt0 -58.31 -54.67 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 12' ' ' ALA . 6.1 tt -56.13 -45.3 79.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.364 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.73 -42.46 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.3 tp -66.58 -44.91 80.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.992 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 52.7 mt-10 -49.15 -45.46 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.353 -172.98 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -63.28 -47.62 91.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.104 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.72 -36.76 84.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.495 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -66.85 -46.97 73.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.26 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.476 . . . . 0.0 110.314 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' A' ' 60' ' ' ARG . 21.6 tp -66.79 -34.53 78.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.419 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.93 -42.31 97.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.119 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.13 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.42 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.38 -65.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.92 -51.74 55.05 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.903 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.71 -117.17 4.97 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 ptm -165.28 117.87 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.168 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -95.68 93.61 7.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.025 0.441 . . . . 0.0 110.662 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -78.8 83.15 4.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.617 0.722 . . . . 0.0 109.68 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.176 -177.83 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 26.4 m-70 . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 m -103.3 -80.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.312 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 10.4 ttp -109.34 -17.66 13.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.737 0.779 . . . . 0.0 108.907 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -79.96 -0.25 34.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.307 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 31' ' ' HIS . 3.5 tm-20 -102.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.782 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -73.36 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.9 m -62.17 -32.31 72.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.273 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.02 89.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.836 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 87' ' ' ILE . 58.4 mttp -57.0 -44.35 82.67 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.79 -49.08 82.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.01 -42.47 88.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.817 0.342 . . . . 0.0 111.061 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.53 -44.51 85.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.46 0.648 . . . . 0.0 110.237 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.608 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 57.9 tttp -71.29 -39.38 71.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.511 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 51.2 t80 -63.24 -38.95 93.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.29 -41.81 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.71 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 51.1 m80 -61.84 -36.05 80.06 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.077 0.465 . . . . 0.0 109.945 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 13.5 t70 -62.63 -51.13 68.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 89.4 mt -54.63 -44.06 72.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.429 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.594 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 144.6 -7.29 1.73 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.159 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.15 98.05 6.02 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 121.311 0.577 . . . . 0.0 110.951 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 72.6 Cg_endo -87.74 89.13 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.548 2.166 . . . . 0.0 112.447 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.4 129.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.997 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -92.7 157.82 39.15 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 Cg_endo -52.04 -34.02 55.51 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.31 -50.52 50.48 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.208 0.528 . . . . 0.0 110.878 174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.64 -37.51 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.466 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.46 -47.65 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PRO . 85.9 t -62.01 -54.27 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HG2' HD11 ' A' ' 17' ' ' LEU . 13.9 tpp180 -65.4 -45.48 83.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.026 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.07 99.52 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.555 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.9 mt-10 -68.57 -26.18 65.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.56 0.219 . . . . 0.0 111.208 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -84.33 -46.46 11.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 111.14 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -78.35 -26.2 46.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.76 46.29 3.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.004 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -74.93 164.17 26.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.489 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.475 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 57.8 t30 -69.91 127.85 92.18 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 82.4 Cg_exo -45.25 -47.67 12.35 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.15 2.566 . . . . 0.0 113.018 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.62 -34.18 67.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.857 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' HG23 ' A' ' 74' ' ' VAL . 76.8 t80 -71.34 -59.57 2.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.05 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 24.7 m -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.584 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.54 -49.9 73.48 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -72.73 -40.74 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.613 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' CZ3' ' A' ' 77' ' ' TRP . 96.0 t -64.19 -36.07 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.699 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.99 93.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.159 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.266 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CZ3' HG22 ' A' ' 74' ' ' VAL . 27.7 m0 -65.98 -48.28 71.76 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.33 82.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.094 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -57.32 -48.53 78.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 0.0 110.763 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.68 -40.5 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.457 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' TRP . 70.5 t -68.47 -35.15 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.589 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.55 80.58 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -69.81 -21.05 63.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.308 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.66 35.53 9.23 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.14 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.3 -178.15 4.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.958 0.409 . . . . 0.0 110.348 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -111.26 138.45 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.532 HD12 ' HD3' ' A' ' 39' ' ' LYS . 39.2 pt -120.43 150.65 23.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 -172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.26 101.71 9.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.249 0.547 . . . . 0.0 109.723 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 1.4 tt -89.57 -71.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.076 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 89' ' ' ILE . 43.1 mmtm 175.66 -59.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -172.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -169.52 139.59 1.73 Allowed Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.06 -178.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.79 24.18 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.114 2.543 . . . . 0.0 114.071 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' ASN . 36.2 tt0 -75.0 -26.19 59.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.608 ' HE1' ' HD3' ' A' ' 43' ' ' LYS . 98.4 m-85 67.43 -77.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.939 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.733 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 26.0 p90 -170.21 -173.76 1.57 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.651 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 m -75.89 155.06 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.926 0.393 . . . . 0.0 111.465 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -25.82 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.382 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -43.34 -56.43 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.276 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.733 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 2.1 mpt? -64.23 -44.77 90.82 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.063 -174.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG3' ' CE1' ' A' ' 95' ' ' PHE . 97.7 mt-30 -57.62 -49.66 75.71 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 -35.21 75.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.648 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 5.8 tp-100 -61.38 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.601 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' VAL . 10.0 mp -57.26 -39.55 75.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.725 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -57.77 -52.74 64.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.998 0.428 . . . . 0.0 111.482 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.33 65.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 86.5 mt -73.51 -31.65 63.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' LEU . 29.0 t -90.03 -13.66 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 110.482 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.28 -31.78 72.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.395 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.73 -37.14 86.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.353 175.834 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.95 0.405 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.4 -30.53 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.588 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HG2' HH22 ' A' ' 60' ' ' ARG . 3.6 tm-20 -65.87 -42.63 90.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.626 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 70.5 mmtt -75.08 -20.17 59.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.26 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.08 -39.34 86.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.748 HD12 ' HG2' ' A' ' 60' ' ' ARG . 4.0 mm? -65.61 -33.0 74.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.612 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.14 -36.63 80.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.252 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.2 -43.17 95.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.665 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.87 -56.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.708 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.46 -49.58 30.75 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.602 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 -71.71 2.75 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.998 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.528 ' HG3' ' H ' ' A' ' 24' ' ' ASN . 10.2 tpt -134.53 175.5 9.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -172.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' H ' ' HG3' ' A' ' 23' ' ' MET . 4.7 p-10 -69.24 168.51 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.069 0.462 . . . . 0.0 111.432 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 3.0 t -58.97 120.48 9.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.607 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.135 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.6 m80 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.9 m -83.69 -52.41 6.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.903 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.559 ' C ' ' HE3' ' A' ' 33' ' ' MET . 0.7 OUTLIER -51.48 -35.47 40.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.949 -175.039 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.26 -66.14 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 111.58 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 mm-40 -54.12 -64.69 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.472 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 p -67.48 -42.8 82.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.415 ' CB ' ' SD ' ' A' ' 33' ' ' MET . 33.4 m -79.3 -53.33 7.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.5 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.842 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HD3' HG12 ' A' ' 89' ' ' ILE . 87.2 mttt -64.57 -37.91 89.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.066 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.53 -50.28 69.38 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.342 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 47.9 mt -66.66 -45.41 88.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.994 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 74' ' ' VAL . 79.4 mt -59.83 -45.85 91.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.627 0.251 . . . . 0.0 111.357 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.12 -44.26 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.893 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 58.4 t80 -61.28 -43.78 98.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.249 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 86.8 mt -62.14 -43.02 99.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.403 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.603 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 56.7 m80 -62.6 -37.71 87.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.488 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.95 -38.36 90.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.119 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.2 mt -66.4 -25.16 66.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.11 1.91 14.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.176 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.6 95.75 9.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 77.2 Cg_endo -86.96 94.3 0.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.281 1.987 . . . . 0.0 112.76 -177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 117.13 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.499 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -99.41 162.06 22.55 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.471 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.2 Cg_exo -53.06 -37.1 78.75 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.186 2.591 . . . . 0.0 112.955 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -56.74 -42.33 79.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.9 -49.81 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.91 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 54' ' ' PRO . 57.7 t -63.06 -47.7 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.76 93.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.782 HH22 ' HG2' ' A' ' 14' ' ' GLU . 5.4 tpp180 -66.16 -42.11 89.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.976 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.78 -36.88 81.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.176 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -71.79 -38.22 70.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.786 0.326 . . . . 0.0 110.672 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -63.32 -50.76 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 111.233 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 60' ' ' ARG . 63.0 mt-10 -87.21 -21.69 25.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 25' ' ' THR . . . 82.51 47.12 6.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.159 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -70.35 158.67 35.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.72 135.03 95.43 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.7 -24.69 23.97 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.14 -53.05 62.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.917 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.671 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 51.8 t80 -71.52 -43.52 66.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.124 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 m -58.26 -41.62 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -69.57 -42.26 74.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.671 ' CE ' ' HA ' ' A' ' 70' ' ' PHE . 53.4 mtmt -56.24 -58.71 6.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 42' ' ' LEU . 54.2 t -62.92 -40.05 87.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.543 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.63 88.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 110.516 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -65.19 -40.9 97.06 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.804 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.47 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 43.8 m0 -62.27 -44.59 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.121 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.41 96.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -45.71 88.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HD3' HG22 ' A' ' 87' ' ' ILE . 28.8 mtpp -61.62 -51.73 67.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 77' ' ' TRP . 19.5 t -67.96 -35.53 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.31 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.7 -33.76 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -79.18 -14.18 59.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.373 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.17 26.97 11.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.848 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -111.01 135.11 52.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -62.13 145.92 52.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.627 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' HD3' ' A' ' 80' ' ' LYS . 15.9 pt -103.61 129.99 54.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.5 pt? -68.12 115.37 7.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.484 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.75 HG12 ' HD3' ' A' ' 39' ' ' LYS . 25.1 mt -121.7 137.38 55.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -59.24 -41.26 88.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 89' ' ' ILE . 1.7 m-20 153.92 126.39 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 125.401 1.688 . . . . 0.0 109.19 166.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.16 -63.05 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.3 2.0 . . . . 0.0 110.943 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 68.23 -60.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.218 0.949 . . . . 0.0 112.545 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.97 6.89 23.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.812 0.339 . . . . 0.0 110.986 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -73.25 93.47 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m -111.69 -170.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 0.0 112.875 -166.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.5 -54.85 19.11 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.827 -169.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -56.36 -40.37 74.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.341 0.4 . . . . 0.0 111.786 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.3 mtt -66.28 -51.24 59.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.864 0.364 . . . . 0.0 110.743 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.0 -44.42 84.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -65.6 -45.57 82.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.856 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.416 ' O ' HD13 ' A' ' 106' ' ' LEU . 18.3 tp60 -56.46 -53.71 54.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.127 0.489 . . . . 0.0 110.617 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.0 -44.85 94.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.068 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.14 -34.75 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.68 -48.67 73.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.011 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 102' ' ' GLN . 10.1 mp -59.69 -37.22 78.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.2 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.2 t -74.76 -37.87 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 110.69 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.1 tp -58.53 -49.22 78.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.649 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.85 -12.99 61.87 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.917 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.044 0 CA-C-O 121.119 0.485 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.64 -32.31 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.465 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.55 -30.31 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.68 -35.17 76.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' HZ2' ' A' ' 66' ' ' TRP . 35.8 tp -61.01 -44.02 98.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.683 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.23 -35.25 79.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.28 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HE2' ' SD ' ' A' ' 99' ' ' MET . 1.2 m-85 -64.65 -47.18 79.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.59 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -87.97 -59.73 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 111.398 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.77 42.32 1.99 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.28 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.74 78.21 1.05 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.238 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.3 ttt 69.25 10.65 7.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.292 0.637 . . . . 0.0 110.56 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.07 82.4 3.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.843 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.5 t -101.51 -12.5 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.728 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.513 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 p -97.35 -79.86 0.45 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 111.651 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' THR . 2.9 tpt -51.75 -62.28 1.73 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.747 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . 4.0 p-10 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.619 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.4 tt0 -102.62 -73.99 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.601 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.6 p -61.25 -39.18 89.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 33' ' ' MET . 57.6 m -70.15 -41.11 74.27 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.445 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.12 -36.68 84.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.502 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.18 -43.28 87.44 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.73 96.61 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.906 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 37' ' ' THR . 90.7 mt -59.03 -50.52 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.519 . . . . 0.0 110.455 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.67 -48.88 78.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.532 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -72.11 -29.85 64.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.568 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.436 ' HD2' HD12 ' A' ' 45' ' ' LEU . 72.9 t80 -63.77 -48.84 75.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.651 0.262 . . . . 0.0 111.168 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.436 HD12 ' HD2' ' A' ' 44' ' ' TYR . 8.2 mp -67.86 -32.09 72.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.689 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -66.34 -37.13 84.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.22 -36.66 84.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.35 -46.82 84.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.831 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.71 -55.49 0.36 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.369 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.23 113.48 60.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.097 0.475 . . . . 0.0 112.172 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.82 155.22 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.813 2.342 . . . . 0.0 111.772 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.93 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 m -83.44 149.15 57.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.42 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.19 -28.99 64.28 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.088 2.525 . . . . 0.0 112.195 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -46.17 -51.67 13.7 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.718 0.636 . . . . 0.0 110.569 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.529 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -63.27 -47.78 90.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.462 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 74' ' ' VAL . 57.8 t -58.04 -53.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.438 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.6 -41.51 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.33 76.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.201 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -68.36 -45.39 72.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.735 0.302 . . . . 0.0 110.285 176.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.71 85.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.834 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.55 -46.01 64.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.218 0.532 . . . . 0.0 110.279 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -69.68 -50.47 43.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.493 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -85.44 -48.09 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.574 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.61 -59.67 0.69 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HZ2' HD12 ' A' ' 17' ' ' LEU . 34.7 m0 51.96 -104.57 0.19 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 111.911 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 18.8 t-20 -171.61 131.64 0.77 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.68 -56.87 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.695 2.263 . . . . 0.0 113.275 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.63 -37.99 83.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.731 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 61.1 t80 -64.68 -42.99 94.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.215 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.7 m -63.66 -40.99 98.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.435 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -70.19 -37.49 75.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.25 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -52.58 -60.18 3.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 57' ' ' VAL . 24.2 t -61.45 -39.37 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.261 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.98 85.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.95 -39.62 94.99 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.202 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.457 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 m0 -62.56 -48.34 79.89 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.19 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.992 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.19 -53.04 61.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.091 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.18 -51.52 69.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -39.16 84.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.33 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.48 -33.49 71.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.957 0.408 . . . . 0.0 110.869 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -74.12 -19.39 60.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.387 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.46 32.53 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.127 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.89 164.96 12.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.03 148.04 26.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.158 0.504 . . . . 0.0 110.727 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.53 145.06 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.7 pt? -72.61 129.3 37.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.702 0.763 . . . . 0.0 112.051 -173.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.7 tt -135.26 1.73 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.591 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 90' ' ' LYS . 17.1 mtmt 66.05 -70.25 0.1 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.893 -173.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 3.7 p30 -161.5 136.87 5.66 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.961 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 22.6 Cg_exo -63.84 78.51 0.15 Allowed 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 122.945 2.43 . . . . 0.0 112.715 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -81.82 -38.76 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.486 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -99.8 13.8 32.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.214 -170.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.7 96.03 5.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.46 0.648 . . . . 0.0 109.538 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.9 p -100.72 166.69 10.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.311 1.053 . . . . 0.0 112.197 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -45.89 -40.44 10.05 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.639 -2.073 . . . . 0.0 112.331 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -59.91 -47.36 86.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.939 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HE2' ' A' ' 19' ' ' PHE . 14.4 mmt -64.39 -45.25 88.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.205 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -60.34 -58.25 9.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.279 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -60.05 -31.9 70.42 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.197 0.311 . . . . 0.0 111.788 -175.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -59.8 -58.24 9.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.541 0.686 . . . . 0.0 109.932 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.89 -37.46 87.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.454 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 84.1 tttt -54.59 -60.17 3.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.591 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.61 -27.02 66.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.466 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.95 -47.41 80.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.88 0.372 . . . . 0.0 110.596 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -77.75 -24.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.289 0.566 . . . . 0.0 110.54 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.3 tp -67.93 -17.16 64.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.54 -81.57 0.2 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.09 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.663 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mm -60.19 -46.57 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.381 . . . . 0.0 111.544 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.9 -35.44 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.277 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -79.27 -30.97 43.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.73 0.3 . . . . 0.0 110.435 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.33 94.0 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.2 mt -68.61 -27.46 66.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.97 -42.02 77.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.886 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HZ ' ' OE1' ' A' ' 102' ' ' GLN . 36.9 m-85 -59.62 -53.14 61.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.337 174.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -64.17 -44.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.836 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.33 47.24 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.606 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.57 51.1 4.18 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -87.29 -3.58 59.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.689 0.396 . . . . 0.0 110.595 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t30 66.39 -74.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.252 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -179.09 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.873 -176.801 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 12.0 m170 . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -54.21 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.688 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -24.59 34.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' HIS . 13.9 t70 -53.91 -60.32 3.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.701 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.09 -43.27 91.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -68.06 -50.52 54.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.969 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 53.7 m -73.29 -42.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.715 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.41 -48.91 75.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.91 -34.23 77.48 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.727 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.58 92.68 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.575 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 37' ' ' THR . 76.0 mt -59.02 -46.18 91.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.914 0.387 . . . . 0.0 110.488 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 94.3 mt -58.16 -47.93 81.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.527 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' HIS . 89.7 mttt -68.25 -35.84 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.024 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 48' ' ' LEU . 66.1 t80 -65.5 -48.83 71.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.407 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 84.5 mt -61.84 -38.38 87.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.978 0.418 . . . . 0.0 110.715 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 41.3 t-80 -50.97 -51.45 52.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.45 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.0 -7.96 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 44' ' ' TYR . 74.5 mt -77.14 -36.24 55.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.56 4.08 13.72 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.347 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 43.9 t -129.42 93.17 36.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 110.773 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.27 162.79 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.198 2.599 . . . . 0.0 111.773 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.81 137.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.743 0.306 . . . . 0.0 110.794 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 56' ' ' VAL . 10.3 m -73.36 127.63 88.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 23.4 Cg_endo -63.1 -29.08 74.32 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.577 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -53.06 -53.36 51.35 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 53' ' ' SER . 29.7 m -69.59 -26.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -176.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.3 -41.01 80.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 54' ' ' PRO . 63.6 t -59.63 -54.19 37.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.187 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.38 86.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.328 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HG2' HD13 ' A' ' 17' ' ' LEU . 3.4 tpp180 -63.72 -44.13 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.554 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -59.28 -47.61 89.97 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.199 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.4 -23.51 61.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.807 0.337 . . . . 0.0 110.807 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -80.04 -45.25 18.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.959 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 60' ' ' ARG . 38.0 mm-40 -75.42 -17.07 60.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 0.0 110.61 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.8 48.38 4.71 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.128 176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 49.5 m0 -70.72 -81.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.608 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 63.2 t30 166.18 130.79 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.608 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 40.7 Cg_exo -35.91 -48.05 1.06 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.932 3.088 . . . . 0.0 114.403 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 22.4 mm-40 -69.85 -38.44 76.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -69.42 -52.29 28.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.735 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 m -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.19 -54.66 44.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.75 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 49.7 mttm -63.81 -47.62 80.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -173.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.12 -39.56 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.81 92.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -38.32 95.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.186 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.6 m0 -65.17 -49.9 68.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.08 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.276 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 9.2 tp10 -56.83 -51.7 67.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 88.1 mttt -70.21 -29.49 66.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.471 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 77' ' ' TRP . 78.5 t -71.98 -43.13 68.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.651 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -43.86 75.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.045 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -70.13 -31.06 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 111.001 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.74 26.54 19.57 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.998 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -95.33 0.93 54.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.861 0.839 . . . . 0.0 110.333 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.8 mtm-85 64.47 156.6 0.08 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.387 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 80' ' ' LYS . 20.8 pt -119.02 17.63 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.212 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt 46.64 -151.35 0.08 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.975 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 tt -170.99 132.57 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 168.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -95.08 -18.87 20.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.738 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -123.37 102.35 36.59 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.04 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.93 -26.61 58.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.355 2.037 . . . . 0.0 112.856 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.35 118.06 21.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -79.54 -77.7 0.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.24 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -173.23 168.73 4.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.611 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.0 t -54.86 139.99 38.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.378 1.085 . . . . 0.0 111.667 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.8 m -57.92 -21.88 45.91 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.698 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -60.15 -49.52 77.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -64.96 -28.73 69.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.714 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.09 -51.72 55.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -37.35 74.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.403 ' OE1' ' HZ ' ' A' ' 19' ' ' PHE . 29.6 tt0 -63.39 -53.24 55.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.734 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.47 -42.98 99.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.168 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -52.08 -55.88 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.928 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.71 -32.25 69.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.047 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.01 -46.51 88.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.12 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.9 -41.57 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.619 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.74 -41.2 90.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.217 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.85 5.48 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 112.042 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 110.038 172.876 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.65 -36.86 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.637 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.89 -43.91 67.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.839 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HE3' HE21 ' A' ' 102' ' ' GLN . 25.4 tptp -70.86 -31.42 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.296 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.58 80.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.172 0.51 . . . . 0.0 110.212 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.33 -34.18 75.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -62.26 -41.04 98.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.053 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -73.55 -58.82 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.556 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.0 mt -72.09 -49.18 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.759 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.66 10.63 8.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.263 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 70.89 2.92 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.428 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 22.2 ptp -61.5 -28.82 69.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.306 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t30 64.29 -83.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.771 0.67 . . . . 0.0 111.278 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -99.4 10.5 41.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 42.3 t . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.439 ' HE1' ' HD1' ' A' ' 70' ' ' PHE . 5.4 m170 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -95.67 -80.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 110.979 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 37' ' ' THR . 7.1 ptm -102.66 -14.91 16.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.959 0.885 . . . . 0.0 109.007 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -80.35 10.5 4.51 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.827 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.7 tm-20 -103.06 -73.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.479 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -76.37 -52.51 9.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.287 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 33' ' ' MET . 38.6 m -56.14 -46.21 79.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 0.0 111.005 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.95 99.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 39' ' ' LYS . 34.6 ttmt -64.04 -38.45 91.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.431 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -37.66 91.5 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.386 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 103' ' ' LEU . 63.8 mt -59.12 -46.47 91.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.677 0.275 . . . . 0.0 110.646 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.43 -42.83 92.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -70.41 -36.5 74.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 65.9 t80 -67.97 -37.38 81.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 103' ' ' LEU . 89.0 mt -65.81 -35.05 79.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.792 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -62.0 -36.43 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 18.9 t70 -61.82 -37.96 86.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 45' ' ' LEU . 93.2 mt -72.91 -20.27 61.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.99 -32.88 4.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.65 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.9 108.2 33.3 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 0.0 111.867 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 94.4 Cg_endo -88.63 137.01 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -89.22 103.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.856 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.403 ' HB2' HG23 ' A' ' 56' ' ' VAL . 50.9 m -62.05 139.07 95.94 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 14.9 Cg_endo -58.43 -27.69 82.59 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -42.41 98.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.232 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.452 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -65.48 -36.29 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.88 -47.96 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.189 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 74.3 t -62.63 -44.12 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.357 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.95 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.113 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 3.7 mmp_? -67.1 -43.85 81.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -61.77 -32.49 81.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.51 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.74 -27.07 44.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.477 0.18 . . . . 0.0 111.46 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -81.71 -50.48 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.182 0.515 . . . . 0.0 110.602 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 27.6 mm-40 -83.68 -23.84 31.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.484 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.33 56.73 2.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.728 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.507 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 44.9 m0 -71.92 175.84 5.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 110.635 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -82.8 154.57 68.01 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.316 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 10.9 Cg_endo -54.79 -60.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.184 2.59 . . . . 0.0 112.579 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -60.46 -33.93 73.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.075 0.464 . . . . 0.0 110.96 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.556 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 10.5 t80 -65.55 -57.31 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.475 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 m -61.95 -39.54 92.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 110.819 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 68' ' ' PRO . 22.2 tttp -61.34 -57.18 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.554 -176.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.46 -47.44 67.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.073 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 93.7 t -61.8 -39.66 84.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.609 0.242 . . . . 0.0 110.94 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.09 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.0 110.417 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.53 93.56 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.141 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 81' ' ' VAL . 17.4 m0 -68.93 -44.47 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.47 87.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.43 -53.09 56.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.639 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.63 -37.81 88.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.394 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 77' ' ' TRP . 93.1 t -70.1 -46.04 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.463 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.37 -44.33 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.545 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -67.06 -32.3 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.0 45.79 2.17 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.624 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.18 167.26 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -91.45 132.25 36.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.429 0.633 . . . . 0.0 111.073 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.18 90.49 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.499 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 110.89 5.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.493 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 tt -79.41 98.97 3.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.729 0.776 . . . . 0.0 109.715 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -67.1 -13.94 62.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.042 -175.064 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.95 90.48 5.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.41 0.624 . . . . 0.0 111.663 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.92 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.421 2.08 . . . . 0.0 110.766 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 56.37 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 170.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -86.2 24.49 1.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -98.15 103.9 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' A' ' 99' ' ' MET . 31.4 t -78.38 157.74 28.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.927 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 98' ' ' TYR . 14.3 t -65.97 -44.7 84.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.206 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.436 ' N ' HG23 ' A' ' 97' ' ' THR . 49.4 t80 -62.76 -27.12 69.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.889 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 96' ' ' SER . 61.2 mtt -64.32 -47.72 78.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -62.91 -50.01 72.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.938 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 105' ' ' GLU . 48.0 mt-10 -59.22 -41.96 89.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.366 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.444 HE21 ' HE3' ' A' ' 15' ' ' LYS . 7.9 tp60 -54.67 -55.95 24.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.502 . . . . 0.0 110.709 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 41' ' ' ILE . 71.6 mt -60.62 -45.06 95.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.22 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -64.39 -47.63 78.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 38.8 mm-40 -64.85 -34.1 77.56 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.51 -47.66 83.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.29 -38.73 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.41 -48.15 76.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.39 -29.43 69.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.899 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.8 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.044 172.012 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.3 mp -64.72 -45.04 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.685 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.752 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -75.18 -33.66 61.48 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.651 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.45 99.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 109.791 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 60' ' ' ARG . 25.0 tp -64.56 -38.93 92.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.859 175.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.04 -29.82 70.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.026 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.3 -52.0 60.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.691 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.13 -48.29 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.13 31.5 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.936 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.07 28.87 4.89 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.615 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -65.8 -35.98 82.22 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 68.57 -44.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.619 0.768 . . . . 0.0 111.771 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 26' ' ' SER . 1.6 m -99.07 -152.45 0.41 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.673 ' H ' HG22 ' A' ' 25' ' ' THR . 15.4 m . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 120.89 0.376 . . . . 0.0 110.041 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.506 0.194 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.5 m -103.58 -80.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.2 tpt -57.48 -52.03 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.044 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -83.91 1.22 44.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.453 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.4 -77.44 0.57 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.387 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -63.3 -48.06 79.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 m -71.17 -30.67 66.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 110.552 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.06 83.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -56.35 -44.64 80.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.384 174.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.43 -44.18 97.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.257 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 67.3 mt -66.2 -44.85 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 110.864 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.55 -37.7 84.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.701 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -66.33 -49.41 67.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.988 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' HD11 ' A' ' 48' ' ' LEU . 71.7 t80 -57.6 -44.75 85.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.575 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 94.4 mt -60.31 -47.98 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.618 0.247 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m80 -62.17 -36.77 82.86 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.751 177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.92 -32.83 73.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.114 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 44' ' ' TYR . 81.1 mt -67.68 -16.72 64.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.268 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 107.37 1.45 35.33 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.109 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.46 98.04 15.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 97.8 Cg_endo -84.0 104.88 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.232 1.954 . . . . 0.0 112.855 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 101.03 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.72 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.6 m -66.05 140.54 97.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.336 -177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.491 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 52.3 Cg_exo -55.75 -34.86 92.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.262 2.641 . . . . 0.0 112.506 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.93 -48.72 72.76 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.828 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.77 -38.43 81.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.275 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.88 -45.48 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.823 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 96.8 t -62.41 -49.08 85.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.944 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.76 94.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.12 0.486 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HG2' HD11 ' A' ' 17' ' ' LEU . 10.3 tpp180 -66.96 -40.42 87.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.89 -40.7 99.21 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.375 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 36.8 mt-10 -68.14 -31.11 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.581 0.229 . . . . 0.0 111.206 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -76.16 -53.38 8.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 111.267 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.731 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.89 48.71 2.42 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.751 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.654 ' HB3' ' HD2' ' A' ' 70' ' ' PHE . 48.7 m0 -81.13 0.31 36.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 93.1 m-20 72.94 145.05 0.11 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.835 0.454 . . . . 0.0 111.02 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.29 -41.29 79.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.703 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 44.9 mt-10 -63.26 -56.05 19.79 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.657 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.654 ' HD2' ' HB3' ' A' ' 66' ' ' TRP . 89.7 t80 -60.67 -47.01 88.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.826 0.346 . . . . 0.0 110.631 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 31.1 m -58.78 -41.24 86.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.978 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.98 -43.49 95.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.779 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 67.9 mttm -62.52 -53.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.546 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 46.5 t -59.7 -41.48 85.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.846 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -61.42 -40.82 95.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.388 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -61.48 -42.41 99.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.393 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.546 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 15.2 m0 -62.13 -44.77 95.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.254 0.549 . . . . 0.0 109.572 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.58 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 48.9 mt-10 -59.21 -48.14 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.354 0.409 . . . . 0.0 110.97 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.7 mtpp -60.97 -52.31 65.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' TRP . 62.1 t -61.38 -35.68 68.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.39 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.14 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.1 t -61.76 -48.26 81.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.453 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.77 -10.8 3.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -87.75 107.39 18.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -58.07 156.67 9.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.653 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.54 141.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.75 111.75 24.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 110.763 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 91' ' ' ASN . 14.6 tt -91.78 140.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -94.28 -8.66 38.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.562 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.589 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.5 p30 -149.16 76.61 9.35 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.425 0.631 . . . . 0.0 111.297 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.05 -6.24 17.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.512 2.142 . . . . 0.0 112.477 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.55 -10.92 59.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 91' ' ' ASN . 67.1 m-85 -89.72 -18.23 26.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -89.1 91.64 8.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -86.7 173.35 9.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -66.09 -26.89 67.69 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -45.82 -49.48 15.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.808 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.34 -43.07 87.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -46.45 89.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 97' ' ' THR . 38.2 mm-40 -55.16 -52.08 64.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 48.2 mt-30 -58.82 -54.04 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.993 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 107' ' ' VAL . 92.5 mt -59.28 -49.62 77.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.263 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.91 -46.29 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.041 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 6.2 tp10 -65.43 -31.51 72.65 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.54 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 83.3 mt -72.53 -29.71 63.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 103' ' ' LEU . 82.1 t -78.11 -35.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.511 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.64 -42.42 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 2.3 mm-40 -81.99 12.67 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.662 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.25 -56.72 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.989 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.21 -38.34 76.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.393 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 49.4 tptt -74.24 -34.18 63.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.715 0.293 . . . . 0.0 110.75 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 0.0 110.224 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.9 mm? -64.58 -33.18 75.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.553 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.89 -39.68 87.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.83 -46.92 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.33 -50.05 58.03 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.299 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.67 -8.2 6.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.574 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' MET . 26.8 ttt 63.53 23.62 13.7 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.663 0.744 . . . . 0.0 110.312 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -133.03 163.15 29.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.648 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -125.08 -158.57 0.84 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.597 ' H ' HG22 ' A' ' 25' ' ' THR . 38.3 m . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 123.26 0.624 . . . . 0.0 112.185 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.537 ' HD1' ' CG ' ' A' ' 34' ' ' ASP . 6.4 p80 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 121.378 0.609 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 m -86.38 -14.99 41.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.786 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.485 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.3 tpt -60.99 -64.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.537 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 11.4 p-10 -79.53 -26.95 41.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.136 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.01 -77.39 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 13.2 m -71.27 -49.82 39.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.9 0.381 . . . . 0.0 111.505 -172.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 33' ' ' MET . 17.5 m -73.18 -55.18 6.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.864 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -68.11 -37.45 81.17 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 89' ' ' ILE . 4.4 ttmp? -67.33 -34.97 78.45 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.742 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.23 99.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.473 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 103' ' ' LEU . 69.6 mt -65.89 -47.76 84.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.44 -44.57 92.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.912 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -69.96 -30.97 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 56.4 t80 -67.07 -46.15 75.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.151 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.89 -41.99 98.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.454 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.484 ' HB2' HG13 ' A' ' 81' ' ' VAL . 41.0 t-80 -50.21 -51.68 42.16 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.81 -2.6 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.472 -175.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 64.3 mt -84.93 -21.83 29.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.218 0.532 . . . . 0.0 109.577 168.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.41 0.95 14.02 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.704 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.24 98.12 47.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.923 0.362 . . . . 0.0 111.106 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.84 157.87 15.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.918 2.412 . . . . 0.0 111.788 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.36 137.98 49.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.62 0.248 . . . . 0.0 110.622 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 24.5 m -85.0 144.43 41.53 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 23.8 Cg_exo -63.41 -32.9 71.24 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.103 2.535 . . . . 0.0 112.771 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -42.35 66.68 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.93 -47.84 91.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.72 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.5 t -64.03 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.497 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.27 -58.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.488 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -30.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.551 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -67.86 -46.84 70.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.77 -34.69 90.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.98 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.05 -29.87 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.749 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -86.1 -49.78 7.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.555 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.07 -28.25 66.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.867 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.5 55.22 1.7 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.028 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 70' ' ' PHE . 44.5 m0 -81.37 -78.34 0.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 36.1 p30 175.45 160.79 0.41 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.548 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 86.5 Cg_endo -79.89 8.69 3.9 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.046 1.831 . . . . 0.0 112.933 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 46.1 mt-10 -107.33 -69.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.647 -174.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -59.62 -38.23 80.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.423 0.63 . . . . 0.0 110.198 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.882 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 74.0 mmtt -63.36 -56.81 13.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.329 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.551 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.2 t -59.66 -35.84 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.69 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.62 86.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.93 -37.71 92.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.362 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 21.9 m0 -66.0 -44.88 83.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.83 75.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.23 -50.29 74.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.423 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -63.55 -39.31 94.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.337 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 46' ' ' HIS . 47.7 t -61.4 -51.14 76.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.313 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.92 93.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.76 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.39 -39.97 92.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.92 6.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.701 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -100.94 -166.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 110.468 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -94.6 154.77 17.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.92 0.391 . . . . 0.0 110.644 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.02 140.89 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -91.4 119.03 31.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.989 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.411 HG13 ' HD2' ' A' ' 39' ' ' LYS . 8.7 tt -112.36 151.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -96.47 -30.03 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.763 0.316 . . . . 0.0 111.081 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 15.0 m-80 -142.0 92.34 7.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -22.52 18.59 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.464 2.11 . . . . 0.0 113.029 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.49 -5.32 59.3 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' ' 91' ' ' ASN . 8.6 m-85 -71.74 -20.06 61.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.0 110.542 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -79.81 88.74 5.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 t -75.92 163.02 27.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.578 -171.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -31.17 69.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.74 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.08 -55.28 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.065 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.1 mtm -62.63 -36.53 83.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.906 0.384 . . . . 0.0 110.782 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -50.9 71.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.213 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 46.1 mt-10 -73.27 -24.46 60.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.384 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -65.63 -51.09 62.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 107' ' ' VAL . 98.7 mt -62.52 -42.31 99.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.14 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 83.6 tttt -55.78 -47.36 77.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.213 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.58 -38.62 90.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 0.0 110.878 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 tp -71.59 -44.09 65.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.828 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 103' ' ' LEU . 80.6 t -70.41 -27.38 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.92 -43.67 69.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.528 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -91.77 3.4 55.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 178.539 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 121.067 0.46 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.93 -39.66 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.849 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.67 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.502 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 56.7 mmtt -76.29 -35.44 58.87 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.312 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.34 83.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.588 0.709 . . . . 0.0 109.113 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.758 HD22 HH11 ' A' ' 60' ' ' ARG . 23.4 tp -63.3 -37.12 86.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.252 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.31 -33.76 75.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.332 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.17 -40.51 78.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.471 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -88.15 -76.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.772 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 -4.94 81.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.748 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.13 7.48 77.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.432 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -94.81 111.86 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.12 -156.99 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.06 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -86.96 41.67 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.262 -0.274 . . . . 0.0 110.875 175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 124.648 1.179 . . . . 0.0 112.106 -178.626 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 19.6 m80 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 t -103.38 -80.52 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.084 0.468 . . . . 0.0 110.506 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.3 ttp -97.81 -29.75 13.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.51 0.671 . . . . 0.0 109.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 9.2 p-10 -67.81 -8.31 34.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.145 -172.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 39.8 tt0 -102.51 -48.95 3.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 110.658 173.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.8 t -65.41 -48.48 72.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.697 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 m -64.82 -40.24 94.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.359 . . . . 0.0 110.267 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.7 63.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -61.5 -28.88 69.62 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.195 0.521 . . . . 0.0 110.8 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.73 -49.9 52.0 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.382 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 103' ' ' LEU . 63.7 mt -61.84 -43.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.618 0.247 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -54.97 -47.54 74.41 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.68 ' HE3' HD11 ' A' ' 87' ' ' ILE . 9.9 mtmp? -77.9 -25.84 48.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.312 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.533 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 53.0 t80 -65.15 -47.81 75.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.13 -40.54 97.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.223 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -50.94 -54.97 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.341 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.12 -18.83 60.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 57.6 mt -68.53 -27.29 65.97 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.6 6.17 10.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.583 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.39 93.19 43.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.758 0.313 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.37 120.75 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.993 2.462 . . . . 0.0 111.838 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.31 138.66 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.299 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.93 147.46 38.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -53.19 -36.0 75.63 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.397 2.731 . . . . 0.0 112.398 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -50.05 -47.3 53.45 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.316 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.0 -40.99 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.607 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.4 t -63.87 -45.92 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.456 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 67.4 t -59.99 -48.28 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.141 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.8 89.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.439 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.758 HH11 HD22 ' A' ' 17' ' ' LEU . 14.6 tpp85 -67.79 -40.42 83.92 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.508 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.83 -37.14 93.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.479 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -62.66 -37.62 87.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.197 0.523 . . . . 0.0 110.574 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -73.03 -44.82 60.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.471 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.86 -30.03 32.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.81 57.28 1.84 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.067 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.753 ' HZ2' HD11 ' A' ' 17' ' ' LEU . 49.4 m0 -84.05 168.43 15.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -61.83 123.58 77.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 167.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.91 -34.23 55.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.502 2.801 . . . . 0.0 113.82 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -64.73 -40.64 95.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 74' ' ' VAL . 73.6 t80 -64.42 -50.97 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.142 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 21.4 m -57.27 -41.23 79.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.936 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.44 -40.71 77.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.126 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.62 -50.14 68.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.077 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.599 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 52.1 t -60.22 -40.16 82.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 110.635 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 54' ' ' PRO . . . -59.59 -40.18 86.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.684 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.9 -34.79 88.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.078 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.599 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 28.7 m0 -67.23 -47.58 70.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.7 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.95 -44.61 91.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 110.4 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -64.64 -45.79 85.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.635 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.3 t -63.67 -40.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.37 -41.04 81.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.638 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.7 p -75.03 -16.63 60.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.03 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.53 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -109.98 163.99 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -89.27 156.57 18.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.516 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.68 HD11 ' HE3' ' A' ' 43' ' ' LYS . 21.8 pt -123.94 147.66 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 89' ' ' ILE . 6.6 tt -71.27 131.74 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 88' ' ' LEU . 13.5 tt -139.32 162.78 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -76.07 -53.18 8.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.723 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.76 140.3 31.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.68 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.2 7.11 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.326 2.017 . . . . 0.0 113.463 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.18 -16.33 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 77.44 -70.6 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.65 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.684 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 40.8 p90 -162.82 -170.85 2.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.772 -173.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 95' ' ' PHE . 16.6 m -85.22 146.62 26.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.771 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 p -50.06 -36.9 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -38.68 57.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.596 0.236 . . . . 0.0 111.623 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.684 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 mmt -65.76 -50.01 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 110.225 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.14 -30.77 66.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.085 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.56 -32.74 74.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.358 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.556 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.0 tp60 -70.07 -50.54 39.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 109.696 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 41' ' ' ILE . 86.4 mt -52.85 -49.76 65.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.028 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -59.51 -42.26 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 109' ' ' GLU . 35.4 tt0 -63.13 -39.9 96.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.572 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 95.0 mt -62.54 -36.31 82.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.97 -43.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.67 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -78.62 -45.1 22.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 17.6 mm-40 -70.97 -75.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.033 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.835 0.826 . . . . 0.0 110.471 177.575 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.943 0.402 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 49.9 mm -65.58 -43.01 94.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.049 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.34 -33.27 75.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.659 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 36.2 mmtt -78.48 -31.07 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.202 177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.86 99.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.275 0.559 . . . . 0.0 109.496 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 13' ' ' ILE . 62.9 mt -72.52 -27.61 62.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.436 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.6 -25.53 67.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.478 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -85.66 -48.25 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.272 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.2 mt -79.12 -37.49 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.32 -11.12 32.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.74 57.33 9.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.775 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.16 91.52 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 69.07 16.85 8.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.682 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 p -99.53 -0.71 40.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.591 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.954 -179.118 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 10.4 m170 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.55 0.214 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -66.83 -80.18 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.036 0.446 . . . . 0.0 110.166 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -93.1 -16.09 25.33 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.605 ' HB3' ' HA ' ' A' ' 31' ' ' HIS . 7.2 t0 -51.27 -45.57 62.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.913 -1.948 . . . . 0.0 111.315 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -99.9 -40.25 7.78 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.551 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 92' ' ' PRO . 37.0 t -61.89 -62.04 2.07 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.933 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 m -68.62 -36.29 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.915 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.25 -51.81 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.738 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HD3' HG12 ' A' ' 89' ' ' ILE . 95.2 mttt -62.98 -42.98 99.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.56 92.76 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.369 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 52.2 mt -68.91 -47.46 75.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 0.159 . . . . 0.0 111.372 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.18 -40.92 87.17 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.77 -41.34 99.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.939 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.431 ' CE2' HD11 ' A' ' 48' ' ' LEU . 67.6 t80 -73.1 -39.76 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.549 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 92.8 mt -59.36 -46.18 89.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.804 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.22 -36.45 84.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.43 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.36 -41.47 97.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD11 ' CE2' ' A' ' 44' ' ' TYR . 88.5 mt -64.45 -37.86 89.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.803 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.03 2.63 10.14 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.005 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.78 93.39 33.47 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 0.0 109.813 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -91.26 157.13 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.941 2.427 . . . . 0.0 113.072 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.71 141.59 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.939 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.483 ' HB2' HG23 ' A' ' 56' ' ' VAL . 12.8 m -79.81 123.44 83.84 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 58' ' ' VAL . 43.7 Cg_exo -56.08 -38.1 95.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.076 2.517 . . . . 0.0 112.388 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -52.52 -50.66 62.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.155 0.502 . . . . 0.0 110.913 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 53' ' ' SER . 33.3 t -64.18 -35.6 74.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.342 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.33 -40.04 87.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.728 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 54' ' ' PRO . 90.8 t -62.23 -52.94 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.635 0.255 . . . . 0.0 110.458 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.91 -43.76 86.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.2 tpp180 -64.1 -43.76 94.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 71' ' ' THR . . . -60.53 -48.23 87.23 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.39 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 45.6 mt-10 -59.39 -33.23 70.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.135 0.493 . . . . 0.0 110.854 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -70.25 -48.92 54.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.547 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 60.5 mt-10 -93.48 -3.79 52.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 0.0 111.388 -173.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.32 -70.63 0.54 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 11.9 m0 56.31 -1.47 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 69.58 128.97 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 123.322 0.649 . . . . 0.0 110.489 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.45 -47.19 23.46 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.693 2.929 . . . . 0.0 114.335 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -69.56 -36.78 76.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 66' ' ' TRP . 68.2 t80 -69.94 -49.07 55.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 61' ' ' GLY . 21.1 m -53.6 -46.62 70.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.22 -46.03 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.067 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -65.06 -40.29 94.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.82 -39.35 83.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.436 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.67 82.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.902 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.21 -40.58 87.7 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.089 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.9 m0 -60.91 -54.49 44.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.11 73.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.004 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -56.41 -53.95 51.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.239 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 46.0 mtpt -66.65 -35.93 81.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.262 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 77' ' ' TRP . 76.6 t -68.76 -46.17 79.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.052 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.67 69.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 111.173 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.5 t -80.0 -18.12 51.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.747 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.81 45.8 15.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.901 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.95 16.3 18.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.032 0.133 . . . . 0.0 111.134 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 47.93 127.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 125.267 1.604 . . . . 0.0 113.953 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.1 pt -115.51 144.13 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.15 112.36 21.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -124.64 -43.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.413 177.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 67.31 -70.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 111.636 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -165.36 92.2 0.9 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.563 -175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.5 ' HD3' HG23 ' A' ' 89' ' ' ILE . 61.1 Cg_endo -80.69 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.436 2.091 . . . . 0.0 112.69 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.8 pt-20 -156.34 24.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.038 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 53.3 m-85 73.25 -21.31 0.26 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.659 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 93' ' ' GLU . 18.1 t80 61.97 83.93 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -169.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -52.63 139.98 24.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.907 -169.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m -53.58 -41.99 67.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 112.329 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 35.5 t80 -61.04 -42.24 98.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.3 mtt -62.15 -50.7 70.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.484 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -59.43 -46.63 88.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.896 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 7.7 mt-10 -72.0 -27.36 62.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 14.0 mm100 -59.01 -48.1 82.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.156 0.503 . . . . 0.0 109.74 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 107' ' ' VAL . 83.1 mt -68.3 -43.51 77.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.402 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 26.9 tttm -60.47 -50.04 75.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.13 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -69.55 -25.46 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.682 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 48.3 tp -70.31 -45.71 65.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 103' ' ' LEU . 59.8 t -71.83 -25.54 24.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.337 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.09 -34.73 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.567 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.65 -70.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 168.233 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.787 0.327 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 61.0 mt -63.12 -45.61 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.956 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -53.77 -54.83 32.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 94.9 mttt -67.62 -35.71 79.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.462 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.93 85.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 111.077 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 85.5 mt -64.09 -47.22 80.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -13.58 56.79 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.855 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -64.59 -43.12 94.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.139 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.32 -39.45 48.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.711 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 70' ' ' PHE . . . -54.79 -47.98 68.74 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.036 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.05 14.96 69.01 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.227 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 67.74 169.97 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.046 0.538 . . . . 0.0 111.455 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.4 108.13 11.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.212 0.529 . . . . 0.0 110.83 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 p -120.98 -171.19 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.707 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.86 -179.09 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.643 0.258 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.7 m -103.98 -80.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.0 110.721 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -90.35 -12.15 38.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.946 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -15.83 62.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.179 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -92.72 -55.18 3.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.28 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.471 ' HB3' HD11 ' A' ' 89' ' ' ILE . 14.3 m -71.27 -53.19 15.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.886 -174.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -62.75 -34.14 76.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.38 90.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.201 0.524 . . . . 0.0 110.132 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -64.0 -27.54 69.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.398 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.08 -55.04 23.96 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.736 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 HD11 ' A' ' 103' ' ' LEU . 66.4 mt -57.27 -43.65 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 110.659 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 78' ' ' ALA . 26.6 tp -56.49 -47.74 78.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.458 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 43' ' ' LYS . 9.9 mtmp? -72.83 -30.56 64.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.426 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 66.3 t80 -63.57 -37.95 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 48' ' ' LEU . 94.2 mt -66.14 -38.92 89.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.279 176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -61.26 -34.54 75.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.07 -24.96 47.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 93.6 mt -75.93 -32.25 59.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.314 0.578 . . . . 0.0 110.411 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.44 -18.11 8.84 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.319 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.83 93.42 48.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -95.37 158.32 1.61 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.065 2.51 . . . . 0.0 111.871 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.92 138.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 110.571 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 56' ' ' VAL . 23.8 m -83.03 149.24 58.68 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.39 -43.3 44.86 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.322 2.681 . . . . 0.0 112.733 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.17 -43.34 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 53' ' ' SER . 29.4 t -65.0 -36.39 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.174 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.69 -49.05 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.0 -45.55 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.76 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.84 93.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.72 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 13.2 tpt180 -65.16 -46.12 82.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.409 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.37 99.4 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.035 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -58.51 -39.88 81.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.92 0.39 . . . . 0.0 111.084 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.1 tm0? -83.02 -48.45 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.479 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.33 -25.73 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.876 0.37 . . . . 0.0 111.463 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.81 -76.99 0.34 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.8 m0 54.2 -161.29 0.14 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.832 0.453 . . . . 0.0 111.625 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -124.26 140.23 34.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 -41.73 70.21 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.893 2.395 . . . . 0.0 112.775 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -66.86 -40.66 87.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.582 0.706 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 31.2 t80 -69.5 -53.06 20.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.409 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -58.29 -43.77 88.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -72.37 -34.44 67.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.741 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -56.91 14.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.806 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.9 -35.47 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.2 86.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.34 -37.83 62.84 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.073 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -61.44 -49.32 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -59.14 -38.09 78.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.95 -49.77 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.864 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.97 -37.24 75.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.107 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.47 -38.57 80.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.702 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.09 -30.2 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.082 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . 17.2 m -87.81 -14.61 39.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 31.86 13.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.854 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 12.6 m120 -97.59 -171.65 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -108.95 135.32 50.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -109.0 119.64 58.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.806 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.67 122.61 14.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.054 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 36' ' ' SER . 16.1 tt -129.82 135.56 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HG3' ' OD1' ' A' ' 91' ' ' ASN . 17.5 pttm -76.01 -16.72 59.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -171.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.672 ' OD1' ' HG3' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -153.95 114.28 2.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.889 0.376 . . . . 0.0 110.399 177.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.68 80.92 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.138 2.559 . . . . 0.0 113.027 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.551 ' HG2' HD22 ' A' ' 91' ' ' ASN . 11.6 pt-20 -138.96 172.45 12.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.927 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -124.23 -80.92 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.723 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER 175.56 -176.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.951 -172.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 m -84.77 174.63 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.357 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -30.24 68.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.877 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -44.95 -55.08 5.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.622 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.89 -46.32 68.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.171 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.656 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 7.7 tt0 -60.57 -48.38 82.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.261 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.05 -35.18 79.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -54.12 -58.99 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.417 0.627 . . . . 0.0 110.033 175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 41' ' ' ILE . 94.3 mt -64.73 -39.68 94.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.911 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.74 -39.38 91.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.304 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.86 -26.56 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.746 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.66 -36.95 81.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 48' ' ' LEU . 55.8 t -77.53 -20.98 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.82 -18.76 64.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.44 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.02 -8.28 47.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.978 0.418 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.49 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 121.355 0.597 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -68.82 -44.23 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.06 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.09 -37.69 86.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 4.2 mmmp? -70.66 -26.35 63.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.838 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.15 86.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.227 0.537 . . . . 0.0 109.718 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.17 -32.33 70.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.088 174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 24.0 t70 -57.17 -32.66 66.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.718 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -78.7 -63.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.679 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.15 -68.96 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.067 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.95 -8.01 84.48 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.762 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.06 -16.94 80.33 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.332 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 25.4 ptp -103.59 97.78 7.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.839 0.828 . . . . 0.0 111.118 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.19 49.85 1.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -82.06 -168.94 2.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.133 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.236 -178.979 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.17 0.51 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -75.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.536 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.463 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 6.8 ttp -96.64 -42.39 8.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -48.19 -45.71 34.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.541 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -50.88 -66.3 0.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.187 0.518 . . . . 0.0 111.135 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 t -70.2 -43.1 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.462 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 33' ' ' MET . 38.6 m -67.41 -42.66 82.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.62 87.08 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.479 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -56.96 -32.5 66.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.916 0.388 . . . . 0.0 110.693 174.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.46 50.61 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.092 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.94 -43.33 92.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 110.736 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.53 -39.56 76.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.142 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -69.2 -42.33 75.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.009 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -63.64 -48.45 77.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.375 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.569 HD21 HD23 ' A' ' 103' ' ' LEU . 72.8 mt -61.71 -48.36 81.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.458 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.65 -36.74 77.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.007 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.8 -40.59 88.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 107' ' ' VAL . 94.1 mt -61.66 -30.1 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 120.97 -0.09 11.75 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.928 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.05 97.89 9.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 82.1 Cg_endo -83.3 127.12 4.43 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.379 2.053 . . . . 0.0 112.265 -176.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.538 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 41.4 t -75.33 101.47 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.857 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 56' ' ' VAL . 22.8 m -70.79 125.94 92.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.49 -23.04 62.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.648 2.232 . . . . 0.0 111.706 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -58.88 -54.08 51.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.14 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 53' ' ' SER . 34.1 m -70.42 -21.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.104 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.98 -49.3 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 69.4 t -62.03 -42.64 95.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.422 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.19 96.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.888 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.63 -37.54 87.92 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 177.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -60.18 -45.62 95.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.911 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 8.4 pt-20 -79.74 -20.41 46.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.82 -53.39 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.899 0.381 . . . . 0.0 110.142 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 4.6 tp10 -73.73 -38.65 64.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 -173.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.91 62.22 0.56 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.973 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.469 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 24.8 m0 -98.52 160.66 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.426 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 26.7 p30 -90.05 153.7 47.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 4.9 Cg_exo -39.23 -60.41 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.613 3.542 . . . . 0.0 114.433 -174.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 4.6 mm-40 -61.21 -39.0 88.59 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.95 -44.76 84.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.0 m -58.45 -48.5 80.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -77.42 -27.14 52.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 tptp -54.4 -66.26 0.43 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.83 -40.94 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.892 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.97 96.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.967 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -66.87 -40.79 93.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.47 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.443 ' O ' HG23 ' A' ' 81' ' ' VAL . 10.6 m0 -63.46 -50.79 68.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -58.91 -39.43 81.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.85 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.5 -49.85 63.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 52.0 mttm -71.98 -41.61 67.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.317 -176.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 77' ' ' TRP . 57.8 t -68.21 -39.65 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.269 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.32 69.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.122 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -65.45 -27.99 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.98 23.04 5.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.863 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.1 -176.27 4.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -136.24 137.88 41.25 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.243 0.544 . . . . 0.0 110.738 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.32 125.48 74.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.613 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.14 110.2 16.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.415 0.626 . . . . 0.0 110.815 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.8 tt -86.59 -3.24 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.757 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 71.07 -52.05 0.68 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.817 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -161.59 131.71 3.46 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.86 177.575 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 37.0 Cg_exo -57.62 -66.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.739 2.293 . . . . 0.0 111.902 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.55 -72.5 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -78.15 5.7 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -168.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.18 102.85 14.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p -94.56 169.58 10.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -32.4 71.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.694 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 0.2 OUTLIER -56.19 -44.65 79.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 110.166 -176.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.54 -49.36 66.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.366 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -61.03 -50.9 71.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.781 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.4 -47.96 82.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.445 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -54.49 -56.48 18.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.383 0.611 . . . . 0.0 110.736 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.569 HD23 HD21 ' A' ' 45' ' ' LEU . 10.4 mp -67.8 -41.08 83.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.357 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -68.96 -34.01 74.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.144 -175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.74 -43.41 89.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.75 -42.9 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 48' ' ' LEU . 84.9 t -72.66 -32.19 40.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.121 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.72 -20.56 61.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.01 -18.13 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.775 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -87.85 -23.2 24.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.103 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 t80 75.3 -43.6 0.51 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.0 116.04 4.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.33 111.07 4.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.372 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.65 -66.58 0.29 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.42 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.1 m 65.02 -168.29 0.21 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.92 0.488 . . . . 0.0 110.431 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.3 ttm -156.17 119.07 2.3 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.403 -0.186 . . . . 0.0 110.829 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.45 113.96 2.31 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.575 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 14' ' ' GLU . 35.7 p -75.45 75.22 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.462 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . . . -64.16 -53.0 56.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.21 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.92 -39.41 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.233 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 2.7 mt-10 -77.16 -23.36 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.034 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 25.5 tptp -77.08 -24.25 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.43 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 60' ' ' ARG . 75.6 mt -63.08 -33.66 75.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.36 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 20.1 t70 -60.77 -40.82 93.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.657 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -67.28 -36.23 81.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.0 mt -71.56 -46.15 64.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.57 75.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.648 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 -170.38 54.77 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.647 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -104.81 -7.01 19.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.793 0.806 . . . . 0.0 108.961 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -132.04 94.87 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.628 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.7 m -80.03 -11.76 59.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.444 . . . . 0.0 111.409 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -79.38 83.62 5.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.186 0.517 . . . . 0.0 110.23 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.59 151.44 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.042 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -152.36 -72.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.738 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.578 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 33.8 t -80.05 -56.89 0.7 Allowed Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.743 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 7.9 Cg_endo -88.73 94.66 0.37 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.434 2.089 . . . . 0.0 112.157 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -104.61 149.44 25.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 t -103.15 -81.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.492 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -21.48 15.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.3 2.72 14.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.602 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -57.63 3.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 109.487 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG13 ' A' ' 89' ' ' ILE . 54.0 m -81.16 -34.96 32.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.88 -174.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -66.06 -36.34 82.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.329 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.33 99.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 36' ' ' SER . 94.2 mttt -58.18 -44.73 88.17 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.999 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.77 -50.01 69.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.226 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 110.861 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 52' ' ' VAL . 15.5 tp -62.15 -43.65 98.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.15 -23.4 62.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.259 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 50.7 t80 -68.39 -40.66 81.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.14 -43.61 97.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.251 0.548 . . . . 0.0 109.816 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.459 ' HB2' HG13 ' A' ' 81' ' ' VAL . 64.5 t60 -58.0 -41.03 82.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.647 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.08 -38.18 89.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 97.8 mt -67.1 -13.73 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.096 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.96 13.28 25.72 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.351 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.54 93.6 37.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.431 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 98.9 Cg_endo -87.75 114.83 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.504 2.136 . . . . 0.0 111.486 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 42' ' ' LEU . 27.4 m -73.64 141.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.293 0.568 . . . . 0.0 111.614 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' VAL . 12.8 m -85.36 138.0 36.55 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.688 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.12 -27.9 67.56 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.0 112.272 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -60.55 -44.62 95.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 53' ' ' SER . 10.3 m -68.18 -24.95 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.808 0.337 . . . . 0.0 110.579 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.89 -51.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.055 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.9 t -61.98 -46.7 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.21 -51.8 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.672 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 1.004 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.1 tpp180 -70.15 -28.83 65.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -63.3 -41.14 99.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.977 176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 39.4 mt-10 -67.43 -36.16 80.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 110.644 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -68.54 -50.76 49.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.612 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.607 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 35.8 mm-40 -84.55 -13.48 51.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.877 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.65 56.51 2.93 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.869 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.443 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 41.7 m0 -87.0 176.51 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 36.3 m-80 -92.51 126.22 53.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 80.3 Cg_exo -46.28 -44.5 20.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.937 3.091 . . . . 0.0 114.075 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.69 -37.73 85.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.106 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 48.5 t80 -70.09 -47.72 60.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 58' ' ' VAL . 25.0 m -58.79 -40.32 83.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.284 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -67.67 -38.09 83.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.849 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.34 -48.15 79.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.633 0.254 . . . . 0.0 110.539 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 70' ' ' PHE . 45.7 t -61.14 -38.31 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.85 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.66 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 79' ' ' GLU . . . -69.51 -32.08 71.27 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.059 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.433 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 24.8 m0 -71.61 -48.97 44.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.67 75.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.493 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 76' ' ' GLY . 10.2 tt0 -48.57 -59.54 3.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.824 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -68.08 -37.91 81.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.053 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 46' ' ' HIS . 41.7 t -58.18 -49.09 82.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.111 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -70.34 -32.23 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.262 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -74.12 -16.1 61.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.591 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 18.1 40.32 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.13 -174.78 3.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -134.0 152.93 52.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.981 0.42 . . . . 0.0 110.509 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.8 pt -126.93 158.83 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.4 tp -91.3 135.97 33.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.21 0.529 . . . . 0.0 110.934 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 36' ' ' SER . 19.2 tt -100.49 131.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.323 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -25.1 34.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 111.25 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -148.0 93.2 4.51 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.225 0.536 . . . . 0.0 110.373 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HA ' HD13 ' A' ' 89' ' ' ILE . 7.2 Cg_exo -74.03 -16.67 22.72 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.454 2.769 . . . . 0.0 113.348 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.44 -21.92 60.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -80.26 -7.43 59.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -81.23 82.73 7.03 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 m -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.288 1.042 . . . . 0.0 112.074 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -66.33 -36.04 81.9 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.954 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.44 -45.71 87.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.375 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.9 mtm -61.47 -40.07 93.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.065 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -65.99 -54.98 19.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 10.9 mm-40 -65.28 -24.12 67.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -63.89 -56.15 17.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.01 -43.68 98.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.259 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 79.7 tttt -57.03 -41.06 77.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.445 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.97 -39.01 79.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 12' ' ' ALA . 9.9 mp -67.73 -36.27 80.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.808 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.8 t -72.65 -34.96 49.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 110.2 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.1 tp -62.44 -49.9 73.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.569 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -77.43 -7.99 57.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 67.1 t60 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.787 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.748 0.785 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -131.13 24.09 4.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.244 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -109.39 110.81 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.381 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 25.3 mtpp -137.92 90.32 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.561 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 6.0 t70 160.03 -158.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.778 1.299 . . . . 0.0 108.877 176.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 96.5 mttt -74.95 167.07 22.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -64.57 147.02 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.023 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 70.6 mtm -62.02 147.58 89.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.218 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 32.2 Cg_exo -58.83 96.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.005 2.47 . . . . 0.0 112.89 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -117.09 40.33 3.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.049 0.928 . . . . 0.0 109.325 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 106' ' ' LEU . . . -57.47 -37.51 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.346 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.16 -56.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.672 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.66 -40.44 96.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.569 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -67.12 -31.85 72.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.677 0.275 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 20' ' ' ILE . . . -64.23 -42.5 96.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.217 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 4.4 mm? -65.56 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.619 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.03 -44.61 96.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 14.2 m-85 -60.11 -37.53 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 16' ' ' ALA . 75.2 mt -72.78 -65.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.249 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.47 -47.02 53.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.864 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.45 8.69 27.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.271 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt 57.12 31.17 19.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -67.39 111.32 3.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.377 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -76.98 0.89 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.182 -174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -134.71 18.59 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.776 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.28 90.28 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.477 0.656 . . . . 0.0 110.96 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.8 m -154.89 -45.97 0.08 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.389 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.611 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 67.3 t -120.78 -57.96 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.283 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 74.0 Cg_endo -78.95 95.18 1.06 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.148 1.232 . . . . 0.0 111.604 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -128.43 117.14 20.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.7 m -103.5 -80.47 0.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.464 0.65 . . . . 0.0 110.962 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.471 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.4 ttp -83.34 -27.21 29.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.394 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.83 -2.81 22.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.814 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 10.4 tt0 -102.3 -63.86 1.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.0 110.064 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m -63.53 -46.2 87.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.842 HG23 ' HB3' ' A' ' 95' ' ' PHE . 84.2 m -72.5 -29.77 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.01 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.41 79.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.82 -42.16 97.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.251 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 94' ' ' TYR . . . -65.14 -44.07 94.6 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.245 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 36.5 mt -68.14 -40.71 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.95 0.375 . . . . 0.0 111.146 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 52' ' ' VAL . 91.7 mt -60.58 -39.37 87.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.171 0.51 . . . . 0.0 110.002 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.839 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.644 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 82.4 t80 -58.3 -55.55 33.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.11 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 48' ' ' LEU . 7.6 mp -63.99 -36.4 83.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.394 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -54.47 -56.3 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.346 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.83 -23.62 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.081 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.7 mt -62.22 -35.33 78.59 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 109.963 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.4 3.61 3.78 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.571 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.4 99.37 45.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.762 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.542 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 64.2 Cg_endo -77.08 117.64 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.125 1.883 . . . . 0.0 111.618 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 42' ' ' LEU . 27.4 m -68.03 148.58 11.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.776 -175.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.5 m -94.71 131.71 30.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.298 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 33.5 Cg_exo -58.91 -32.22 96.96 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.267 2.645 . . . . 0.0 113.216 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -55.8 -41.83 74.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 t -61.11 -37.84 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.76 -47.16 86.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.361 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.24 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.675 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.736 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.569 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 12.2 tpt180 -68.05 -36.25 79.57 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.07 -45.19 82.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.601 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.96 -46.78 56.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 111.362 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -68.06 -42.73 80.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.502 -175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 3.8 tp10 -84.78 -32.79 23.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.742 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.9 62.58 0.75 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.368 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.503 ' CH2' HD12 ' A' ' 17' ' ' LEU . 39.0 m0 -102.26 152.68 20.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.572 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.68 142.04 94.69 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.7 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -45.81 37.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.934 2.423 . . . . 0.0 111.982 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -58.07 -40.64 81.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.083 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 75.6 t80 -66.06 -59.63 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.7 m -56.02 -41.94 75.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.57 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.8 -50.59 71.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.67 -43.25 63.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.667 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.563 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.6 t -61.69 -38.07 79.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -60.3 -44.19 95.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.604 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 79' ' ' GLU . . . -57.29 -41.01 92.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.401 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 m0 -65.35 -43.9 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.2 83.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.163 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 53.7 mt-10 -57.06 -48.72 77.88 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.221 0.534 . . . . 0.0 110.519 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.63 -35.59 79.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.6 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' TRP . 66.9 t -62.04 -48.84 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.625 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -62.29 -38.68 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -72.73 -16.63 61.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.741 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.99 29.9 40.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.429 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -97.47 154.05 17.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -77.82 142.06 38.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.245 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.5 pt -117.25 159.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.809 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tt -87.99 109.23 19.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.294 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -101.53 150.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 25.1 mtpt -84.68 -58.83 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.514 0.673 . . . . 0.0 109.73 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -111.05 124.3 33.19 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.802 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HG2' ' OE1' ' A' ' 93' ' ' GLU . 9.9 Cg_endo -53.32 -30.92 54.36 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.074 2.516 . . . . 0.0 113.02 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' ' HG2' ' A' ' 92' ' ' PRO . 1.8 mp0 -63.99 98.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.446 ' HD2' ' HA2' ' A' ' 40' ' ' GLY . 36.6 m-85 -59.72 -59.29 5.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.364 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.842 ' HB3' HG23 ' A' ' 37' ' ' THR . 26.9 p90 -162.05 172.71 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.692 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -82.68 164.34 20.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 111.705 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -32.86 74.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.484 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -53.78 -44.86 70.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.821 0.82 . . . . 0.0 110.067 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 95' ' ' PHE . 33.1 mtp -75.21 -34.16 61.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.122 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -50.63 70.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.829 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.57 -43.64 84.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -56.02 -56.73 17.18 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 111.081 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.2 mt -61.23 -44.36 97.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.644 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -59.71 -43.01 94.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.742 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.48 -48.06 80.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 12' ' ' ALA . 10.0 mp -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.829 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 103' ' ' LEU . 25.8 t -95.45 -6.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.31 -42.08 38.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -43.48 54.75 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.498 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.478 0.947 0 C-N-CA 124.154 0.982 . . . . 0.0 112.565 177.477 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.234 0.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -143.25 -63.09 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -101.72 -43.99 5.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.852 -171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.34 -175.87 4.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.985 0.421 . . . . 0.0 111.66 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.06 162.0 29.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.542 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -118.11 -7.43 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.909 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.0 p -73.6 154.16 39.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.462 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.478 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 25.3 mmt -100.22 115.49 65.42 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 2.6 Cg_exo -75.11 84.54 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.789 2.326 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.2 p -99.62 -82.06 0.45 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.772 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HA ' HD21 ' A' ' 106' ' ' LEU . . . -67.36 -36.73 81.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.72 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.35 -41.08 83.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.586 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 10' ' ' PRO . 21.5 tt0 -65.28 -47.19 77.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.66 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -64.72 -42.85 94.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.0 82.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.243 0.544 . . . . 0.0 110.652 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -71.77 -24.06 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.431 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.34 -33.96 37.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.84 -44.46 89.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.3 mt -84.44 -68.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.611 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.69 45.23 3.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.056 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.52 -6.08 66.37 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.546 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ttt 69.39 105.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.529 0.732 . . . . 0.0 111.937 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 21.5 t-20 -71.8 162.59 29.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.411 172.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.5 m -52.9 -36.63 59.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.363 0.265 . . . . 0.0 111.582 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 p -114.46 -54.29 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 24' ' ' ASN . . . 59.03 17.98 5.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 172.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -132.2 -40.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.913 0.864 . . . . 0.0 109.234 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.1 m -70.63 -179.04 0.6 Allowed Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.973 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 99.1 Cg_exo -46.26 107.76 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.47 1.447 . . . . 0.0 110.513 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.87 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 59.0 m170 -56.63 143.68 35.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.983 -170.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 m -82.96 -79.94 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.461 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.6 ttp -99.41 -24.02 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.759 0.79 . . . . 0.0 108.979 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -78.31 9.54 3.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.048 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 5.9 tt0 -103.05 -72.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.736 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -58.85 -54.33 48.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.542 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.4 m -61.58 -39.93 92.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 111.185 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.04 91.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -58.13 -48.2 80.96 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.477 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.71 82.02 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.571 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 103' ' ' LEU . 77.9 mt -62.9 -45.38 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.518 . . . . 0.0 110.715 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.85 -39.29 93.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.2 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.32 -39.03 78.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 48' ' ' LEU . 83.0 t80 -60.23 -44.55 95.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.25 -47.57 85.45 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.34 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 60.7 m80 -65.48 -36.06 82.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.46 -33.17 74.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 44' ' ' TYR . 76.6 mt -66.53 -45.27 79.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.588 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 138.51 4.69 1.62 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.676 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.43 93.29 4.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 90.0 Cg_endo -90.72 88.81 0.3 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.477 2.118 . . . . 0.0 112.924 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.18 123.52 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.7 m -89.09 154.32 49.43 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' GLU . 5.3 Cg_endo -49.86 -37.93 46.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.382 2.721 . . . . 0.0 112.396 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -48.68 -51.57 27.85 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.535 0.522 . . . . 0.0 110.883 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -64.68 -42.1 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.456 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.6 -48.03 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 54' ' ' PRO . 89.6 t -60.99 -52.29 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.34 90.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.359 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.53 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 13.0 tpp180 -67.84 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.457 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.71 -38.53 96.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.934 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.17 -38.93 84.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.591 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -75.16 -50.5 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.344 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 27.8 mm-40 -65.63 -42.66 91.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.014 0.435 . . . . 0.0 110.258 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.24 50.43 0.5 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.1 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 30.2 m0 -88.06 163.47 16.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.86 143.52 78.26 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.102 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.23 -55.81 3.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.394 2.729 . . . . 0.0 112.867 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.3 mm-40 -59.01 -37.2 76.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.472 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 80.2 t80 -64.78 -51.82 60.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -64.86 -45.89 84.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.155 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.04 -41.1 97.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.992 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.564 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 13.9 mptt -60.11 -57.53 12.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.497 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 48.4 t -58.76 -39.91 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.87 -37.63 85.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.52 86.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.262 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.564 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 8.9 m0 -67.19 -36.98 82.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.76 -44.76 89.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.306 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 2.2 tm-20 -58.17 -46.49 85.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.71 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -52.57 -58.94 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.185 178.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.5 t -67.51 -34.4 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.396 -175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.03 69.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.736 0.303 . . . . 0.0 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -81.94 -14.23 56.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.201 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.46 34.56 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -107.69 169.43 8.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.78 146.46 28.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.772 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.2 pt -128.95 159.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.999 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.074 0.464 . . . . 0.0 110.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -82.8 -12.6 12.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 75.46 -48.12 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.575 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.25 92.12 6.24 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.479 0.657 . . . . 0.0 110.911 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 -10.78 24.66 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.023 2.482 . . . . 0.0 112.424 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -72.59 -15.15 61.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.12 -1.75 58.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.961 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -82.23 84.03 7.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.0 p -71.52 147.43 47.73 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.304 1.049 . . . . 0.0 112.327 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.6 m -49.9 -42.67 48.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.67 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 62.5 t80 -57.39 -42.32 81.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.655 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.454 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 52.8 mtm -73.23 -47.29 44.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.268 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -58.14 9.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -32.34 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.923 -175.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 47.6 tt0 -62.6 -51.17 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.092 0.472 . . . . 0.0 109.811 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 41' ' ' ILE . 76.9 mt -57.75 -44.36 86.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.081 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 2.4 ttmp? -53.96 -61.78 2.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.878 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 19.8 mm-40 -57.39 -44.49 84.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.617 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 12' ' ' ALA . 32.5 tp -65.98 -44.14 85.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.697 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.54 -32.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 11.7 tp -61.05 -30.01 70.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.052 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 40.9 mt-10 -60.86 -30.13 69.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.802 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -176.127 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.237 0.395 0 CA-C-O 122.165 0.983 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 4' ' ' PHE . 5.5 p-10 -162.1 35.95 0.12 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.134 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 87.3 m-85 72.42 -88.53 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.662 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 4' ' ' PHE . 42.0 tttp 174.79 131.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 123.284 0.365 . . . . 0.0 110.414 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 28.2 t70 174.62 118.29 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.854 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 6' ' ' ASP . 6.6 mmtm -167.05 100.67 0.53 Allowed 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.701 0.625 . . . . 0.0 110.461 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -115.28 148.77 38.77 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ttt 54.63 81.04 0.27 Allowed Pre-proline 0 C--O 1.234 0.273 0 O-C-N 123.832 0.708 . . . . 0.0 110.354 -172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 110' ' ' HIS . 30.2 Cg_endo -62.94 108.66 0.78 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.868 2.379 . . . . 0.0 113.152 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -82.28 74.22 9.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.838 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -40.06 66.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.412 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' HD23 ' A' ' 17' ' ' LEU . 67.8 mt -62.9 -53.23 49.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.814 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 21.0 tp10 -57.44 -39.3 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HD2' HD23 ' A' ' 103' ' ' LEU . 33.6 ttmt -60.99 -53.86 52.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.751 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.12 80.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 3.6 mm? -66.85 -29.12 68.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.665 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.52 -33.77 67.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.927 0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.22 -42.7 83.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.786 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.92 -69.77 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.014 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.24 53.32 4.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.047 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.49 -146.97 18.63 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.308 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -91.45 36.16 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 110.975 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -82.28 66.8 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.095 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m 67.3 112.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.376 0.608 . . . . 0.0 111.62 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -67.46 89.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.289 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.94 -167.53 2.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.165 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -136.39 -67.39 0.51 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.565 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 43.5 t -79.81 -52.97 1.02 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 3.5 Cg_endo -85.72 73.86 3.69 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.23 1.953 . . . . 0.0 111.893 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.54 157.62 18.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.9 t -96.37 -80.16 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.2 0.524 . . . . 0.0 112.182 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.401 ' O ' ' HB ' ' A' ' 37' ' ' THR . 28.8 ttp -85.05 -22.43 28.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.307 -172.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 70' ' ' PHE . 2.8 m-20 -54.0 -42.72 69.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.248 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HA ' ' CH2' ' A' ' 77' ' ' TRP . 2.4 tm-20 -50.4 -76.02 0.03 OUTLIER 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.758 0.789 . . . . 0.0 111.54 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -75.74 -37.68 59.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.701 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 33' ' ' MET . 75.0 m -68.99 -47.48 65.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.62 -38.47 89.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' A' ' 87' ' ' ILE . 3.9 ttmp? -60.9 -42.16 97.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.199 0.523 . . . . 0.0 110.527 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.12 -45.06 74.02 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.46 -42.85 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.483 0.141 . . . . 0.0 111.003 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 90.0 mt -57.36 -48.02 80.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.697 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 87' ' ' ILE . 23.2 mtpp -66.97 -37.34 84.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.297 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 67.7 t80 -65.69 -44.18 86.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.42 -42.24 88.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.828 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.16 -34.02 76.73 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.92 -43.18 79.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.605 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.3 mt -61.81 -42.23 98.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.24 6.68 2.39 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.615 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.97 99.98 51.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.782 0.325 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -88.08 121.8 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.696 2.264 . . . . 0.0 112.709 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.35 108.29 19.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -73.99 138.3 76.1 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.959 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 18.0 Cg_endo -60.05 -25.24 79.2 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.981 2.454 . . . . 0.0 111.96 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.3 -44.67 88.66 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.88 -37.78 69.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.4 t -58.4 -45.24 89.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.017 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 54' ' ' PRO . 71.8 t -63.82 -50.29 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.999 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.83 95.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.676 ' HG2' ' CD1' ' A' ' 17' ' ' LEU . 8.7 tpt180 -66.07 -41.64 90.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.236 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -60.68 -48.75 84.68 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.838 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -68.18 -27.29 66.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -69.85 -56.6 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' CD ' ' HE ' ' A' ' 60' ' ' ARG . 46.8 mt-10 -73.02 -24.6 60.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.994 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.94 49.68 2.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.006 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.419 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 36.4 m0 -74.69 147.24 41.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -63.3 142.58 97.83 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.248 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.83 -60.91 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.779 2.986 . . . . 0.0 114.432 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 4.9 mm-40 -60.16 -26.32 66.22 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 34' ' ' ASP . 30.4 t80 -66.97 -61.18 2.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 m -57.95 -38.67 76.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.261 0.553 . . . . 0.0 110.782 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -60.28 -49.52 77.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.528 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 53.6 mttm -66.79 -46.08 76.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.924 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.2 t -61.62 -40.74 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.824 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.39 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.725 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.53 99.58 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.304 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 10.2 m0 -66.82 -50.17 63.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.45 -39.03 72.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.9 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 32.8 tt0 -54.17 -54.44 39.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.824 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -68.99 -39.64 79.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.211 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' TRP . 92.5 t -69.24 -44.33 80.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.595 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.08 95.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.467 0.175 . . . . 0.0 110.833 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -65.95 -35.2 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.609 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.37 37.1 4.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.002 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -96.72 147.46 23.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.904 0.383 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -67.46 137.76 56.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 ' HD2' ' A' ' 43' ' ' LYS . 30.7 pt -138.44 135.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 88' ' ' LEU . 2.6 pp -69.97 131.13 43.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.849 0.833 . . . . 0.0 112.131 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.49 69.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.998 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.64 13.62 9.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.623 ' H ' ' CD ' ' A' ' 92' ' ' PRO . 5.9 m-80 -131.54 -51.25 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.071 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.623 ' CD ' ' H ' ' A' ' 91' ' ' ASN . 50.7 Cg_exo -59.25 -30.45 92.97 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.811 2.341 . . . . 0.0 113.353 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 65.97 17.98 10.94 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.205 0.526 . . . . 0.0 110.65 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 60.24 -95.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.731 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 100' ' ' GLN . 38.1 p90 179.34 177.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.637 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.167 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -58.1 -39.61 79.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -43.93 -54.12 5.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.046 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.5 mtm -75.18 -29.51 60.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.244 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 8.3 tt0 -67.17 -44.55 79.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.217 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.02 -40.43 97.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.43 -51.72 68.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.523 0.678 . . . . 0.0 109.75 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 107' ' ' VAL . 68.1 mt -56.66 -63.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.905 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -57.93 -49.32 77.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.491 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.81 -48.41 80.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.949 0.404 . . . . 0.0 109.977 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.95 2.01 16.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 103' ' ' LEU . 42.7 t -100.14 -33.89 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.41 -31.7 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.365 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -63.6 -63.31 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 24.7 p-80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.467 0.707 . . . . 0.0 110.883 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -116.69 -150.44 0.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -71.29 -8.26 52.46 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 69.99 100.21 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.58 0.752 . . . . 0.0 112.638 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -167.55 143.3 4.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.96 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -65.47 -45.2 84.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.335 0.588 . . . . 0.0 110.126 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' A' ' 110' ' ' HIS . 4.2 p -152.08 99.68 2.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.162 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.8 ttm -128.03 115.23 20.38 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.958 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.7 94.61 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.568 2.179 . . . . 0.0 112.096 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 p -76.17 5.5 6.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.564 0.697 . . . . 0.0 110.442 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.58 -25.64 68.33 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.263 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.12 -50.95 59.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.46 -41.7 75.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -73.86 -34.89 64.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.49 -33.33 69.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 0.0 109.921 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.718 HD11 ' HG2' ' A' ' 60' ' ' ARG . 7.8 tt -62.75 -36.4 82.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.359 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.9 -46.4 89.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.187 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.49 -53.95 47.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.98 -46.24 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.664 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.29 60.89 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.294 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 -119.72 11.42 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.903 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.443 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 2.9 tpt -145.4 81.33 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 67.84 -3.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.538 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -160.15 156.36 26.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -134.03 -163.68 1.4 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.48 166.56 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -132.21 -72.3 0.53 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.581 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 61.0 t -76.86 -57.25 1.21 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.817 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 73.0 Cg_endo -75.89 77.34 3.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.853 1.702 . . . . 0.0 112.164 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -88.43 112.71 23.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.453 ' HB2' ' H ' ' A' ' 33' ' ' MET . 3.2 m -103.48 -80.65 0.52 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.482 0.658 . . . . 0.0 110.238 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.453 ' H ' ' HB2' ' A' ' 32' ' ' SER . 3.8 ptm -90.5 -9.74 46.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.877 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.56 -22.47 66.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.845 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -102.56 -65.37 1.0 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.739 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.6 m -56.11 -52.3 64.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.986 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 41' ' ' ILE . 23.5 m -66.81 -41.62 87.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.697 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -61.99 -51.37 68.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.171 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.91 -39.86 90.96 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -44.65 97.81 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.15 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' HD23 ' A' ' 45' ' ' LEU . 80.0 mt -64.38 -47.43 89.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.653 0.264 . . . . 0.0 111.008 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 52' ' ' VAL . 86.0 mt -62.42 -42.75 99.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.024 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -67.45 -40.54 85.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.777 0.322 . . . . 0.0 110.273 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.562 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 77.7 t80 -59.15 -47.91 83.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.317 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 41' ' ' ILE . 3.3 mm? -60.03 -45.18 93.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.848 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -59.91 -42.45 93.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.618 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.52 -37.8 85.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 90.3 mt -56.79 -38.48 72.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.665 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.9 -52.4 0.43 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.801 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -87.23 126.1 63.75 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 121.152 0.501 . . . . 0.0 111.611 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.1 145.75 15.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 42' ' ' LEU . 30.8 m -81.07 140.25 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.176 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB2' HG22 ' A' ' 56' ' ' VAL . 3.6 m -90.55 119.21 69.1 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.1 -38.0 39.12 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.786 2.324 . . . . 0.0 113.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -69.98 -39.41 75.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 53' ' ' SER . 27.9 m -67.37 -26.77 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 53' ' ' SER . 86.9 t -68.67 -44.4 82.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 61.3 t -62.29 -42.04 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.09 -39.56 78.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 17' ' ' LEU . 7.8 tpt180 -73.16 -34.34 66.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.296 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -58.42 -48.53 83.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 7.9 pt-20 -72.17 -26.4 62.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -82.12 -54.27 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.17 -25.83 47.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.879 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.28 60.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.391 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.429 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 34.2 m0 -103.01 165.58 10.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.7 m-20 -71.91 137.78 82.41 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.695 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 45.7 Cg_exo -56.68 -44.62 43.65 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.177 2.585 . . . . 0.0 112.567 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 52.4 mp0 -63.83 -45.8 87.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' VAL . 86.9 t80 -61.86 -54.58 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.369 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 23.4 m -58.05 -39.82 79.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.707 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.31 -46.41 73.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.928 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 61.7 mttm -66.94 -43.26 83.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.046 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.87 -36.19 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.822 0.344 . . . . 0.0 110.431 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.83 86.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.353 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.95 96.73 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.091 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . 28.1 m0 -64.2 -49.19 72.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.02 79.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.376 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -59.04 -43.14 91.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.91 0.386 . . . . 0.0 110.138 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' HG22 ' A' ' 87' ' ' ILE . 66.8 mttm -65.23 -45.46 84.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.07 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' TRP . 85.6 t -58.99 -43.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.63 65.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 p -89.74 -19.88 24.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.01 25.01 9.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.418 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -90.97 162.54 14.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 110.761 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -87.84 145.21 26.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 80' ' ' LYS . 33.7 pt -127.07 136.52 60.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.934 0.397 . . . . 0.0 110.407 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -86.84 138.54 31.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.888 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 90' ' ' LYS . 6.3 tt -126.45 161.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 89' ' ' ILE . 42.9 mmtm -74.42 44.43 0.2 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 171.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 5.0 m-20 76.23 152.2 0.14 Allowed Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.016 0.926 . . . . 0.0 111.429 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 34.38 0.42 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.695 2.263 . . . . 0.0 112.065 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 91' ' ' ASN . 10.6 tp10 -103.52 161.47 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 74.31 -30.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.264 0.626 . . . . 0.0 111.457 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.66 86.02 3.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 166.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -83.77 172.03 12.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.783 -167.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -25.99 68.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.695 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.2 -53.66 32.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.132 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -68.73 -35.48 77.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 110.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.16 -53.59 42.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.23 -38.17 76.31 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.986 0.179 . . . . 0.0 111.314 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -51.84 -60.69 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.63 0.729 . . . . 0.0 110.506 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.6 -38.17 83.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.111 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.31 -56.62 18.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.381 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.7 tt0 -64.79 -38.34 90.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.462 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -51.26 -43.24 61.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.522 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -83.06 -39.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.594 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.335 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 41.6 mt-10 -62.86 -22.55 66.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.623 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 71.2 m-70 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.118 0.485 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.7 106.56 18.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.245 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 89.2 t80 -90.87 96.38 10.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 44.2 tttm 70.19 139.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.898 0.749 . . . . 0.0 109.942 -169.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.68 163.26 22.61 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.901 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -134.74 152.87 52.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 -171.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 p -62.09 111.09 1.8 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.33 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mtp -120.81 125.19 27.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.333 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.53 115.44 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.26 . . . . 0.0 112.293 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -77.23 2.12 16.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.83 92.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.663 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.58 -44.62 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.381 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.55 -33.31 75.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.459 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 10.9 mmpt? -75.45 -26.66 58.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.811 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.38 0.61 . . . . 0.0 109.458 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.5 mm? -74.2 -14.83 61.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 11.9 t70 -69.01 -44.95 71.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.29 -64.29 0.92 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.708 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.0 -43.14 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.15 -9.54 80.62 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.985 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.03 -14.81 71.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.787 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.599 ' SD ' ' HA ' ' A' ' 34' ' ' ASP . 65.3 mtm -88.48 75.26 8.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.698 0.761 . . . . 0.0 110.368 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -100.02 10.31 41.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.926 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.96 54.49 1.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.518 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.7 m 57.62 31.22 20.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.101 174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . . . -64.83 112.92 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.141 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 m -165.06 -51.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' O ' ' HD2' ' A' ' 31' ' ' HIS . 56.4 t -72.98 139.69 80.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -30.23 96.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.853 3.036 . . . . 0.0 113.351 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -173.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -59.25 -67.45 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.254 0.549 . . . . 0.0 111.774 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -61.82 2.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.618 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.599 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -51.96 -68.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.979 -175.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 36.5 tt0 -62.09 -62.21 1.93 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -169.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -58.99 -47.37 85.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.368 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -75.22 -31.27 60.83 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.424 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.5 94.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.038 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.13 -43.4 82.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.078 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.597 ' CA ' ' HA ' ' A' ' 94' ' ' TYR . . . -63.9 -46.53 91.36 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.714 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.66 -47.53 90.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.522 0.201 . . . . 0.0 111.008 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.9 -38.6 86.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 111.208 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -66.59 -42.32 87.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.088 0.471 . . . . 0.0 110.269 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 54.2 t80 -66.16 -45.34 81.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.448 HD23 HD12 ' A' ' 48' ' ' LEU . 94.7 mt -60.85 -41.59 96.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -50.49 -51.94 42.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.233 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -13.79 59.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.919 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 61.6 mt -73.43 -26.15 60.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 0.0 110.292 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.88 -14.8 10.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.376 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.69 93.17 48.76 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 110.629 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -90.97 146.21 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.091 2.527 . . . . 0.0 112.078 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.71 110.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.872 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 m -66.14 139.54 96.56 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.702 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.54 -28.08 53.47 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.034 2.489 . . . . 0.0 112.743 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.03 -44.41 87.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.211 0.529 . . . . 0.0 110.317 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.32 -38.03 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.307 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.33 -47.76 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.874 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.11 -49.68 83.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.983 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.66 92.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 1.4 tpt85 -69.39 -34.44 74.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.524 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.67 -50.21 68.5 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.275 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.25 -32.07 64.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.407 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -72.09 -45.83 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.439 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 7.3 tp10 -82.75 -48.73 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.25 65.13 0.21 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.19 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.496 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 31.5 m0 -104.56 162.71 13.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.07 148.7 81.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.66 -35.09 66.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.156 2.571 . . . . 0.0 112.411 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 24.4 mm-40 -69.9 -46.74 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.08 -46.6 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.3 m -61.31 -44.78 96.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.191 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.99 -43.22 88.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.239 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 64.0 mttm -62.07 -53.57 53.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.1 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 53.0 t -59.38 -40.19 80.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.821 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.49 -32.92 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.07 -35.81 64.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.439 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 14.3 m0 -68.68 -49.35 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.18 -42.52 77.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.0 -58.42 6.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.324 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -66.22 -46.97 75.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.811 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.32 -43.66 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.565 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.49 61.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.579 0.228 . . . . 0.0 111.22 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t -67.25 -35.59 79.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.391 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.14 -3.44 8.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.63 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.28 103.9 16.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 109.759 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -53.41 141.45 24.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.984 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 20.6 pt -124.36 113.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.531 0.681 . . . . 0.0 109.86 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.86 123.86 29.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.021 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 91' ' ' ASN . 56.2 mt -66.42 -31.03 51.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.101 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? 62.29 21.55 12.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.271 1.034 . . . . 0.0 109.456 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 1.0 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 52.4 m-80 -148.43 -160.28 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 1.0 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 31.6 Cg_exo -43.37 86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.907 2.405 . . . . 0.0 114.14 168.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 89' ' ' ILE . 19.0 mm-40 -63.99 130.14 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.883 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.597 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 96.8 m-85 64.63 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.94 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER 169.85 -157.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.161 -172.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 11.3 t -108.14 -175.78 2.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -41.12 88.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -167.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 96' ' ' SER . 0.1 OUTLIER -53.46 -47.56 69.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtt -65.1 -45.3 85.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.402 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -58.68 -45.35 89.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.645 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -60.24 -44.58 95.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.431 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -64.61 -57.41 9.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.07 -46.76 87.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.704 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -65.42 -35.17 80.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.747 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.83 -38.73 91.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 110.821 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -63.55 -34.11 77.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.304 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.93 -50.67 18.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.1 -62.43 1.88 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.394 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -71.42 -59.94 2.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.286 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 . . . . . 0 N--CA 1.471 0.586 0 O-C-N 124.015 0.822 . . . . 0.0 111.569 175.776 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' PHE . 11.1 p . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -97.38 11.11 37.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' H ' HG22 ' A' ' 2' ' ' VAL . 42.9 t80 -166.9 138.6 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.447 0.165 . . . . 0.0 110.625 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.588 ' HE3' ' HA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -70.39 122.26 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 175.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.71 170.88 13.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.937 0.398 . . . . 0.0 110.604 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -93.27 19.96 7.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.957 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -125.64 157.13 38.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.057 0.456 . . . . 0.0 110.419 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 ptp -140.96 157.87 66.27 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.0 118.13 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.896 2.397 . . . . 0.0 111.965 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 14' ' ' GLU . 8.9 t -131.35 148.84 52.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.138 0.494 . . . . 0.0 111.204 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.21 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.39 -37.6 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 14.0 mm-40 -76.72 -25.91 54.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.103 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -81.28 -30.61 33.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 19' ' ' PHE . . . -65.58 -36.17 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 171.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 57.1 tp -58.7 -41.02 85.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.323 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.29 -46.15 86.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.774 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 16' ' ' ALA . 57.5 m-85 -62.38 -50.74 70.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.868 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.35 -55.86 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.363 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.95 29.3 5.84 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.26 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.05 -70.63 1.1 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.564 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.9 -50.64 10.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 60.49 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.649 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t -89.64 167.35 13.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.313 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -71.96 88.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 0.0 110.569 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . . . -94.01 121.66 35.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.692 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.4 m -130.1 -47.37 1.11 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.542 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 m -74.34 173.62 6.32 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.248 167.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 51.5 Cg_exo -55.34 -19.89 23.6 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.262 1.974 . . . . 0.0 111.553 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.622 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 70.48 -167.17 0.16 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.348 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -95.9 -80.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 0.0 111.911 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.2 ttp -94.32 -17.01 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.544 0.688 . . . . 0.0 109.96 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.14 -21.29 66.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.218 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -93.45 -68.79 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.679 0.275 . . . . 0.0 110.825 -176.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -46.68 88.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -67.21 -36.61 82.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 0.0 111.033 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.94 89.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.525 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 31.7 mmtp -54.74 -48.0 73.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.564 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.12 -44.56 94.71 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.348 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.475 HG23 HD11 ' A' ' 103' ' ' LEU . 73.9 mt -61.05 -49.97 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.061 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.51 -44.62 93.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.429 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.42 -27.35 65.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.387 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.14 -36.52 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.449 . . . . 0.0 110.182 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 97.2 mt -64.15 -40.37 95.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.403 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -72.74 -25.0 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.65 -38.45 89.38 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.24 0.543 . . . . 0.0 109.897 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.44 -40.2 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.767 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.29 -26.81 3.67 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.97 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.91 104.7 54.24 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -92.32 -178.49 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.028 2.486 . . . . 0.0 112.081 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -109.83 121.35 62.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 56' ' ' VAL . 6.4 m -61.65 127.55 88.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 53.1 Cg_exo -53.02 -32.33 57.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.878 2.386 . . . . 0.0 112.544 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -55.99 -52.52 63.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.664 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 53' ' ' SER . 31.5 m -71.02 -24.19 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 111.015 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.46 -45.49 88.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.126 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 65.1 t -61.11 -48.99 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.646 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.57 98.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.949 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.81 -42.49 99.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.207 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.53 -47.63 89.47 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.48 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.9 -12.78 60.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.78 0.324 . . . . 0.0 110.814 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -85.8 -52.4 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -73.88 -27.34 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.959 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.37 48.21 1.45 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.532 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.489 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 40.9 m0 -83.26 153.74 24.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 67.2 t30 -63.17 127.9 91.6 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 4.9 Cg_endo -47.3 -43.82 25.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.867 . . . . 0.0 113.332 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.3 -37.1 79.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.766 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' VAL . 74.6 t80 -70.45 -53.36 16.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -58.16 -40.03 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.322 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.79 -46.91 88.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.535 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -67.41 -46.19 73.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.545 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 70' ' ' PHE . 69.6 t -60.33 -37.82 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.56 89.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.638 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.27 -35.12 69.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.899 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.544 ' O ' HG23 ' A' ' 81' ' ' VAL . 50.6 m0 -63.1 -54.13 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.36 68.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.056 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.26 -50.29 74.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.162 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -81.27 -21.51 39.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.489 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.7 t -67.78 -38.27 79.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 109.836 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.41 -44.33 36.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.239 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.3 p -75.55 -34.83 60.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.91 44.36 4.5 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.772 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -111.7 108.52 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 62.13 -141.22 0.44 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.563 0.539 . . . . 0.0 110.671 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 89' ' ' ILE . 37.0 pt 52.76 53.06 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.34 1.056 . . . . 0.0 112.22 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 3.4 pp -79.22 19.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.499 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 87' ' ' ILE . 1.1 tt 79.28 141.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.18 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -71.32 -40.94 70.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.566 0.698 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -172.19 148.67 2.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.816 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 -37.81 93.74 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.453 2.102 . . . . 0.0 111.618 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.33 -97.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.43 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -142.49 24.22 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 111.116 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.25 107.39 4.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.0 m -99.34 159.93 14.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.277 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.3 t -66.79 -28.59 68.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.0 -39.88 63.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.777 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.4 mtt -66.3 -42.23 88.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.086 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.7 -51.65 68.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.586 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' THR . 73.8 mt-10 -59.64 -42.02 91.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.13 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 92.5 mt-30 -56.22 -54.86 40.19 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.698 0.285 . . . . 0.0 111.155 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.0 mt -60.76 -44.67 96.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -63.83 -41.9 97.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.865 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.296 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 96.5 mt -66.54 -21.67 66.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' LEU . 98.6 t -71.8 -40.99 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 109.91 173.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -72.3 -44.3 62.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.77 -23.53 65.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 85.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.02 -2.99 56.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 t80 71.29 -105.52 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.676 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 86.5 tttt 177.73 168.2 0.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 14.5 m-20 -56.58 109.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 169.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -75.55 -76.29 0.15 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -126.07 109.6 12.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.6 ttm -84.42 114.67 56.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.646 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.07 137.14 64.89 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.797 2.331 . . . . 0.0 112.114 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -77.52 85.35 3.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.563 0.697 . . . . 0.0 110.681 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.4 88.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.583 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.5 mp -64.13 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.128 0.489 . . . . 0.0 109.889 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.4 -50.64 72.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.15 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 28.1 mmtp -78.85 -18.51 53.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.69 77.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.641 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.1 mt -70.95 -22.41 62.22 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.183 174.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 18.4 t70 -67.48 -36.91 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -65.07 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.488 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.92 -74.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.519 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 66' ' ' TRP . . . -95.36 46.96 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.373 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.08 -58.28 1.41 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.63 95.85 9.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 66' ' ' TRP . 76.6 m-20 -116.21 144.71 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.464 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.509 HG21 ' CG2' ' A' ' 29' ' ' VAL . 12.4 t -164.54 -178.55 5.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.29 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -85.98 45.93 1.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.503 . . . . 0.0 110.579 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' ASN . . . -170.86 -151.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.385 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 28.4 t -137.5 56.8 1.76 Allowed 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 25' ' ' THR . 31.3 t -46.09 -44.59 37.24 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.056 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 81.6 Cg_exo -50.16 -37.95 49.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.462 1.441 . . . . 0.0 111.343 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 68.18 -69.86 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.558 1.143 . . . . 0.0 111.968 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -92.56 -49.24 6.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.809 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.606 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.59 -27.71 28.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.332 -170.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -41.45 -54.17 3.18 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 124.097 0.873 . . . . 0.0 110.632 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.597 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 33.5 mm-40 -59.09 -63.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.427 ' CB ' ' H ' ' A' ' 94' ' ' TYR . 19.9 m -62.14 -55.81 25.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.42 HG23 ' SD ' ' A' ' 99' ' ' MET . 90.9 m -69.14 -52.5 27.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -170.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' HZ3' ' A' ' 77' ' ' TRP . . . -75.48 -44.11 45.71 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 4.2 ttmp? -67.54 -33.59 75.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.799 0.333 . . . . 0.0 110.246 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.7 -50.42 66.3 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.314 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.15 -45.22 96.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.625 0.25 . . . . 0.0 111.102 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.52 -44.83 89.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.941 0.401 . . . . 0.0 111.249 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 9.8 mtpm? -69.92 -34.1 73.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.394 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -64.73 -42.2 95.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 110.117 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.43 -42.56 92.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.495 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -61.61 -35.83 78.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.606 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.56 -43.57 89.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.388 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.472 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.65 16.29 1.67 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.21 94.11 47.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.934 0.397 . . . . 0.0 110.671 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -93.02 152.19 2.63 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.886 2.391 . . . . 0.0 112.253 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 148.26 24.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.2 m -83.11 133.37 48.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.601 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 45.2 Cg_exo -56.87 -31.42 88.96 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.267 2.645 . . . . 0.0 112.519 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.59 -42.82 64.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.304 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.92 -38.65 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.414 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.43 -46.91 85.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.471 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 85.7 t -60.09 -44.26 94.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.498 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.77 88.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.641 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.0 tpt180 -65.38 -39.75 92.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.16 97.86 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.265 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 51.5 mt-10 -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.602 -0.352 . . . . 0.0 111.188 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -76.84 -46.09 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.4 -9.16 55.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.552 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.3 -65.3 1.58 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.819 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.619 ' HA ' ' CG ' ' A' ' 24' ' ' ASN . 35.7 m0 55.35 -167.27 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.07 0.548 . . . . 0.0 111.957 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.888 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 54.4 m-80 -93.48 123.4 60.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.45 -38.2 82.78 Favored 'Trans proline' 0 CA--C 1.526 0.106 0 C-N-CA 122.996 2.464 . . . . 0.0 112.628 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 2.6 tm-20 -80.45 -33.39 36.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.561 . . . . 0.0 110.015 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.888 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 77.5 t80 -73.27 -43.99 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.535 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.9 m -59.51 -35.62 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -69.59 -40.36 76.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.712 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 63.2 mttt -54.76 -57.6 10.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.0 t -60.61 -37.46 75.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.06 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.49 73.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.1 51.42 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.15 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.712 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.6 m0 -64.62 -49.25 71.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.979 0.419 . . . . 0.0 110.107 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -34.41 74.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.743 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.6 -45.28 92.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.025 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.56 -49.03 79.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.427 0.632 . . . . 0.0 110.327 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 77' ' ' TRP . 61.9 t -60.77 -44.87 98.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.502 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.1 61.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.64 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -77.45 -9.31 58.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 110.798 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.88 29.01 13.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.098 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -100.12 171.01 8.08 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 86' ' ' ARG . 13.0 ptt180 -119.44 132.83 55.88 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.8 pt -112.73 138.55 41.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.174 0.512 . . . . 0.0 110.901 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.16 116.65 17.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 89' ' ' ILE . 16.8 tt -77.48 89.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 122.502 1.144 . . . . 0.0 110.092 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 90' ' ' LYS . 17.3 pttp -67.62 -2.74 7.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.779 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -160.12 88.35 1.88 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -177.347 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -96.35 29.15 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.523 2.816 . . . . 0.0 112.511 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.2 -55.52 33.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.606 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 20.3 m-85 -99.45 35.67 1.91 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -171.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -116.1 82.87 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -74.09 160.53 31.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.838 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -30.86 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.734 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.549 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.7 t80 -49.34 -51.64 33.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.546 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 37' ' ' THR . 68.0 mtm -69.45 -39.14 77.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -61.88 -46.58 88.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.23 -35.21 79.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.167 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 57.5 mt-30 -59.11 -50.92 72.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 110.37 175.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.48 -45.23 84.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.475 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.44 -42.39 82.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.23 -49.57 55.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.578 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -62.94 -44.51 95.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.942 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.0 -32.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 110.415 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.5 tp -67.51 -59.22 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -32.72 69.99 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.713 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.401 171.13 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -140.48 112.52 7.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.303 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.25 105.61 17.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.522 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -76.89 104.18 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.01 -166.04 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.337 -173.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -116.76 99.83 7.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.094 -179.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.2 m -128.39 178.51 6.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.249 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -87.52 109.18 24.22 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 121.099 0.476 . . . . 0.0 110.025 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.76 -60.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.154 2.569 . . . . 0.0 114.401 -170.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.2 p -78.06 -6.57 55.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -171.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 106' ' ' LEU . . . -64.35 -46.62 82.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.2 0.524 . . . . 0.0 110.401 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 54.6 mt -70.52 -40.4 77.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.215 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.07 -39.77 93.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.91 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 48.4 tptt -68.71 -36.04 77.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.309 . . . . 0.0 110.61 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -41.48 99.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 110.27 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.528 HD13 ' HG2' ' A' ' 60' ' ' ARG . 92.0 mt -66.76 -32.7 74.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.687 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 7.4 t70 -57.49 -44.55 85.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.018 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.49 -41.85 98.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -54.25 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.648 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -54.16 30.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.81 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -111.28 4.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.904 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.6 mtt -109.21 -42.67 4.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 51.1 71.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.902 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -105.28 -78.44 0.57 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 t -102.04 4.25 39.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.293 0.568 . . . . 0.0 109.796 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.24 111.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.734 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 60.8 m -154.41 -52.57 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.18 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 51.3 t -109.15 -47.86 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.305 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 18.9 Cg_exo -67.68 110.54 2.13 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.415 1.41 . . . . 0.0 109.785 165.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 5.0 m170 -131.21 103.3 6.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.614 -172.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -104.19 -58.18 1.92 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 110.485 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -87.4 -58.52 2.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.074 -171.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.36 -5.47 32.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.014 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.679 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 21.0 tt0 -103.19 -62.74 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.09 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.8 m -58.28 -55.78 30.54 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 33' ' ' MET . 41.3 m -70.91 -30.17 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.83 0.348 . . . . 0.0 110.868 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.74 99.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' HE3' ' CG ' ' A' ' 35' ' ' GLU . 92.3 mttt -58.88 -43.69 90.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.072 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 -44.38 97.87 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.594 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.418 HG12 ' HE1' ' A' ' 95' ' ' PHE . 55.5 mt -61.32 -47.43 93.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.042 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 HG11 ' A' ' 52' ' ' VAL . 82.5 mt -64.36 -40.29 95.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 110.916 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.08 -34.23 76.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.461 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 76.3 t80 -65.62 -39.13 91.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.62 -44.18 96.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 110.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -62.62 -32.52 73.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.575 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.49 -34.46 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.305 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.3 mt -67.65 -41.68 83.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.353 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.25 -50.22 0.47 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.734 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 m -87.47 121.24 71.25 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.224 0.535 . . . . 0.0 112.226 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.8 165.8 8.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HD22 ' A' ' 42' ' ' LEU . 8.9 p -107.03 147.79 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.45 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 13.8 m -102.16 137.05 19.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 27.0 Cg_exo -62.56 -24.79 75.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.241 2.627 . . . . 0.0 112.545 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -53.36 -45.92 69.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.825 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.84 -36.52 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.62 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 74' ' ' VAL . 66.8 t -64.0 -49.73 80.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.73 -46.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.06 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.528 ' HG2' HD13 ' A' ' 17' ' ' LEU . 20.8 tpt180 -66.4 -43.35 86.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -47.08 91.3 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.429 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.13 -33.6 76.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.639 0.257 . . . . 0.0 111.418 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.97 -57.19 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.52 -31.58 68.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.161 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.66 45.03 1.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.964 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -85.65 131.43 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.449 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t30 -65.65 123.45 84.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 26.3 Cg_exo -30.11 -44.67 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.748 4.299 . . . . 0.0 115.918 -176.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 1.4 mp0 -59.05 -35.19 72.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.096 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 74' ' ' VAL . 57.4 t80 -74.92 -47.54 29.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 m -60.44 -39.8 88.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.879 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -62.41 -43.94 97.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.927 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -56.53 -58.75 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 31.8 t -59.65 -41.59 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.564 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.07 88.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.438 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.08 -37.98 94.82 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.44 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.679 ' CZ2' ' HG3' ' A' ' 35' ' ' GLU . 11.1 m0 -66.43 -53.78 31.7 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.13 -40.29 64.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.986 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -55.24 -54.57 41.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.796 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 58.5 mttt -73.05 -39.3 66.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -42.21 92.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.541 0.21 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.83 93.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.185 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -78.92 -9.22 59.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.57 39.39 41.54 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.217 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 55.4 m-20 -98.61 152.16 19.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.38 149.72 48.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.152 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 pt -136.39 166.03 27.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.89 102.43 14.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 89' ' ' ILE . 4.0 tt -103.28 -6.94 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.068 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 90' ' ' LYS . 3.8 tptp 66.11 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.0 -169.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -153.26 126.86 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.21 -59.06 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.279 1.986 . . . . 0.0 111.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.68 ' HG2' ' HB3' ' A' ' 91' ' ' ASN . 27.7 mm-40 57.21 -81.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 172.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -85.08 53.44 2.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 41' ' ' ILE . 21.8 t80 -111.27 71.15 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -61.01 144.8 52.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.66 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 m -53.55 -38.18 63.6 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.523 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.23 -37.93 78.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.672 0.273 . . . . 0.0 111.231 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.2 mtm -75.56 -41.09 55.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.35 -47.72 82.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.768 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 13.5 tp10 -69.39 -28.0 65.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.675 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -66.24 -49.08 68.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.337 0.589 . . . . 0.0 109.819 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.44 -43.6 98.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.238 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 34.6 tttm -58.86 -37.08 75.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.144 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.5 tt0 -58.31 -54.67 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 12' ' ' ALA . 6.1 tt -56.13 -45.3 79.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.364 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.73 -42.46 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.3 tp -66.58 -44.91 80.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.992 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 52.7 mt-10 -49.15 -45.46 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.353 -172.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.515 0.198 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.05 -59.25 0.57 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.516 0.727 . . . . 0.0 111.811 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -114.75 109.98 19.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.259 0.552 . . . . 0.0 110.877 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -152.16 165.47 34.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.51 106.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.144 0.497 . . . . 0.0 110.595 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -88.53 141.67 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.203 -172.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 m 65.73 102.5 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.969 0.793 . . . . 0.0 111.436 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' THR . 72.3 mtm -138.1 126.27 14.11 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.695 -177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 10.5 Cg_exo -71.44 29.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.201 2.601 . . . . 0.0 112.832 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' MET . 9.0 t -78.44 -1.17 32.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.589 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.27 -38.17 82.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -63.28 -47.62 91.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.104 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.72 -36.76 84.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.495 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -66.85 -46.97 73.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.26 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.476 . . . . 0.0 110.314 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' A' ' 60' ' ' ARG . 21.6 tp -66.79 -34.53 78.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.419 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.93 -42.31 97.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.119 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.13 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.42 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.38 -65.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.92 -51.74 55.05 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.903 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.71 -117.17 4.97 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 ptm -165.28 117.87 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.168 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -95.68 93.61 7.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.025 0.441 . . . . 0.0 110.662 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -78.8 83.15 4.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.617 0.722 . . . . 0.0 109.68 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t 70.41 -6.12 1.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.176 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.81 114.39 5.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.254 0.55 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 3.3 p -141.11 -57.18 0.5 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.436 -175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 60.6 t -83.07 -54.83 0.53 Allowed Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 90.6 Cg_endo -81.41 131.83 7.71 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.578 1.518 . . . . 0.0 111.462 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 26.4 m-70 -131.38 152.64 50.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 m -103.3 -80.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.312 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 10.4 ttp -109.34 -17.66 13.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.737 0.779 . . . . 0.0 108.907 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -79.96 -0.25 34.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.307 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 31' ' ' HIS . 3.5 tm-20 -102.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.782 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -73.36 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.9 m -62.17 -32.31 72.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.273 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.02 89.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.836 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 87' ' ' ILE . 58.4 mttp -57.0 -44.35 82.67 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.79 -49.08 82.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.01 -42.47 88.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.817 0.342 . . . . 0.0 111.061 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.53 -44.51 85.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.46 0.648 . . . . 0.0 110.237 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.608 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 57.9 tttp -71.29 -39.38 71.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.511 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 51.2 t80 -63.24 -38.95 93.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.29 -41.81 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.71 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 51.1 m80 -61.84 -36.05 80.06 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.077 0.465 . . . . 0.0 109.945 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 13.5 t70 -62.63 -51.13 68.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 89.4 mt -54.63 -44.06 72.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.429 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.594 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 144.6 -7.29 1.73 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.159 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.15 98.05 6.02 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 121.311 0.577 . . . . 0.0 110.951 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 72.6 Cg_endo -87.74 89.13 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.548 2.166 . . . . 0.0 112.447 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.4 129.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.997 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -92.7 157.82 39.15 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 Cg_endo -52.04 -34.02 55.51 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.31 -50.52 50.48 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.208 0.528 . . . . 0.0 110.878 174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.64 -37.51 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.466 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.46 -47.65 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PRO . 85.9 t -62.01 -54.27 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HG2' HD11 ' A' ' 17' ' ' LEU . 13.9 tpp180 -65.4 -45.48 83.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.026 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.07 99.52 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.555 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.9 mt-10 -68.57 -26.18 65.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.56 0.219 . . . . 0.0 111.208 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -84.33 -46.46 11.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 111.14 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -78.35 -26.2 46.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.76 46.29 3.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.004 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -74.93 164.17 26.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.489 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.475 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 57.8 t30 -69.91 127.85 92.18 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 82.4 Cg_exo -45.25 -47.67 12.35 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.15 2.566 . . . . 0.0 113.018 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 3.7 mm-40 -56.62 -34.18 67.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.857 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' HG23 ' A' ' 74' ' ' VAL . 76.8 t80 -71.34 -59.57 2.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.05 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 24.7 m -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.584 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.54 -49.9 73.48 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -72.73 -40.74 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.613 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' CZ3' ' A' ' 77' ' ' TRP . 96.0 t -64.19 -36.07 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.699 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.99 93.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.159 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.266 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CZ3' HG22 ' A' ' 74' ' ' VAL . 27.7 m0 -65.98 -48.28 71.76 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.33 82.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.094 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -57.32 -48.53 78.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 0.0 110.763 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.68 -40.5 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.457 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' TRP . 70.5 t -68.47 -35.15 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.589 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.55 80.58 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -69.81 -21.05 63.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.308 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.66 35.53 9.23 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.14 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.3 -178.15 4.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.958 0.409 . . . . 0.0 110.348 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -111.26 138.45 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.532 HD12 ' HD3' ' A' ' 39' ' ' LYS . 39.2 pt -120.43 150.65 23.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 -172.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.26 101.71 9.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.249 0.547 . . . . 0.0 109.723 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 1.4 tt -89.57 -71.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.076 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 89' ' ' ILE . 43.1 mmtm 175.66 -59.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -172.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -169.52 139.59 1.73 Allowed Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.06 -178.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.79 24.18 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.114 2.543 . . . . 0.0 114.071 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' ASN . 36.2 tt0 -75.0 -26.19 59.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.608 ' HE1' ' HD3' ' A' ' 43' ' ' LYS . 98.4 m-85 67.43 -77.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.939 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.733 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 26.0 p90 -170.21 -173.76 1.57 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.651 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 m -75.89 155.06 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.926 0.393 . . . . 0.0 111.465 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -25.82 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.382 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -43.34 -56.43 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.276 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.733 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 2.1 mpt? -64.23 -44.77 90.82 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.063 -174.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG3' ' CE1' ' A' ' 95' ' ' PHE . 97.7 mt-30 -57.62 -49.66 75.71 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 -35.21 75.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.648 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 5.8 tp-100 -61.38 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.601 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' VAL . 10.0 mp -57.26 -39.55 75.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.725 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -57.77 -52.74 64.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.998 0.428 . . . . 0.0 111.482 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.33 65.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 86.5 mt -73.51 -31.65 63.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' LEU . 29.0 t -90.03 -13.66 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 110.482 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.28 -31.78 72.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.395 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.73 -37.14 86.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.353 175.834 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.8 t . . . . . 0 C--O 1.233 0.222 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -64.99 137.97 58.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 112.64 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -98.37 104.48 16.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.811 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -87.05 -160.61 0.6 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -67.37 -174.64 0.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.36 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -76.57 75.95 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 110.652 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -101.66 106.67 17.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.264 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.3 mtp -141.21 71.39 27.52 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -96.2 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.263 2.642 . . . . 0.0 112.7 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 14' ' ' GLU . 21.7 p 49.95 76.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.608 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.73 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.514 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.4 -30.53 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.588 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HG2' HH22 ' A' ' 60' ' ' ARG . 3.6 tm-20 -65.87 -42.63 90.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.626 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 70.5 mmtt -75.08 -20.17 59.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.26 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.08 -39.34 86.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.748 HD12 ' HG2' ' A' ' 60' ' ' ARG . 4.0 mm? -65.61 -33.0 74.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.612 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.14 -36.63 80.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.252 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.2 -43.17 95.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.665 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.87 -56.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.708 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.46 -49.58 30.75 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.602 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 -71.71 2.75 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.998 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.528 ' HG3' ' H ' ' A' ' 24' ' ' ASN . 10.2 tpt -134.53 175.5 9.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -172.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' H ' ' HG3' ' A' ' 23' ' ' MET . 4.7 p-10 -69.24 168.51 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.069 0.462 . . . . 0.0 111.432 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 3.0 t -58.97 120.48 9.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.607 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -157.16 -50.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.54 -161.91 1.04 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.123 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.687 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 15.5 t -96.98 25.51 5.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.734 HG13 ' HD2' ' A' ' 30' ' ' PRO . 45.7 t 85.03 157.92 0.11 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 113.467 -1.697 . . . . 0.0 106.522 -165.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.734 ' HD2' HG13 ' A' ' 29' ' ' VAL . 34.4 Cg_exo -30.53 -14.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.075 3.85 . . . . 0.0 116.847 173.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 29' ' ' VAL . 42.6 m80 86.78 -47.78 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.278 1.031 . . . . 0.0 110.871 168.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.9 m -83.69 -52.41 6.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.903 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.559 ' C ' ' HE3' ' A' ' 33' ' ' MET . 0.7 OUTLIER -51.48 -35.47 40.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.949 -175.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.26 -66.14 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 111.58 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 mm-40 -54.12 -64.69 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.472 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 p -67.48 -42.8 82.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.415 ' CB ' ' SD ' ' A' ' 33' ' ' MET . 33.4 m -79.3 -53.33 7.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.5 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.842 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HD3' HG12 ' A' ' 89' ' ' ILE . 87.2 mttt -64.57 -37.91 89.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.066 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.53 -50.28 69.38 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.342 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 47.9 mt -66.66 -45.41 88.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.994 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 74' ' ' VAL . 79.4 mt -59.83 -45.85 91.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.627 0.251 . . . . 0.0 111.357 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.12 -44.26 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.893 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 58.4 t80 -61.28 -43.78 98.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.249 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 86.8 mt -62.14 -43.02 99.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.403 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.603 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 56.7 m80 -62.6 -37.71 87.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.488 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.95 -38.36 90.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.119 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.2 mt -66.4 -25.16 66.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.11 1.91 14.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.176 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.6 95.75 9.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 77.2 Cg_endo -86.96 94.3 0.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.281 1.987 . . . . 0.0 112.76 -177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 117.13 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.499 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -99.41 162.06 22.55 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.471 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.2 Cg_exo -53.06 -37.1 78.75 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.186 2.591 . . . . 0.0 112.955 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -56.74 -42.33 79.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.9 -49.81 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.91 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 54' ' ' PRO . 57.7 t -63.06 -47.7 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.76 93.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.782 HH22 ' HG2' ' A' ' 14' ' ' GLU . 5.4 tpp180 -66.16 -42.11 89.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.976 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.78 -36.88 81.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.176 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -71.79 -38.22 70.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.786 0.326 . . . . 0.0 110.672 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -63.32 -50.76 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 111.233 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 60' ' ' ARG . 63.0 mt-10 -87.21 -21.69 25.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 25' ' ' THR . . . 82.51 47.12 6.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.159 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -70.35 158.67 35.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.72 135.03 95.43 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.7 -24.69 23.97 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.14 -53.05 62.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.917 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.671 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 51.8 t80 -71.52 -43.52 66.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.124 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 m -58.26 -41.62 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -69.57 -42.26 74.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.671 ' CE ' ' HA ' ' A' ' 70' ' ' PHE . 53.4 mtmt -56.24 -58.71 6.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 42' ' ' LEU . 54.2 t -62.92 -40.05 87.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.543 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.63 88.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 110.516 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -65.19 -40.9 97.06 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.804 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.47 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 43.8 m0 -62.27 -44.59 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.121 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.41 96.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -45.71 88.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HD3' HG22 ' A' ' 87' ' ' ILE . 28.8 mtpp -61.62 -51.73 67.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 77' ' ' TRP . 19.5 t -67.96 -35.53 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.31 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.7 -33.76 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -79.18 -14.18 59.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.373 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.17 26.97 11.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.848 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -111.01 135.11 52.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -62.13 145.92 52.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.627 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' HD3' ' A' ' 80' ' ' LYS . 15.9 pt -103.61 129.99 54.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.5 pt? -68.12 115.37 7.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.484 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.75 HG12 ' HD3' ' A' ' 39' ' ' LYS . 25.1 mt -121.7 137.38 55.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -59.24 -41.26 88.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 89' ' ' ILE . 1.7 m-20 153.92 126.39 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 125.401 1.688 . . . . 0.0 109.19 166.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.16 -63.05 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.3 2.0 . . . . 0.0 110.943 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 68.23 -60.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.218 0.949 . . . . 0.0 112.545 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.97 6.89 23.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.812 0.339 . . . . 0.0 110.986 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -73.25 93.47 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m -111.69 -170.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 0.0 112.875 -166.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.5 -54.85 19.11 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.827 -169.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -56.36 -40.37 74.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.341 0.4 . . . . 0.0 111.786 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.3 mtt -66.28 -51.24 59.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.864 0.364 . . . . 0.0 110.743 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.0 -44.42 84.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -65.6 -45.57 82.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.856 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.416 ' O ' HD13 ' A' ' 106' ' ' LEU . 18.3 tp60 -56.46 -53.71 54.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.127 0.489 . . . . 0.0 110.617 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.0 -44.85 94.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.068 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.14 -34.75 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.68 -48.67 73.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.011 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 102' ' ' GLN . 10.1 mp -59.69 -37.22 78.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.2 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.2 t -74.76 -37.87 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 110.69 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.1 tp -58.53 -49.22 78.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.649 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.85 -12.99 61.87 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.917 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.713 0.292 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -70.93 138.23 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -150.61 -41.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.28 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 71.53 165.64 0.29 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.054 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.85 26.48 13.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.573 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.75 106.34 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.754 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -140.4 111.09 6.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.476 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.3 mmt -95.95 131.67 28.57 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.907 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.49 31.43 0.51 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 0.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -85.09 84.66 7.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.842 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.21 82.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.813 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.64 -32.31 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.465 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.55 -30.31 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.68 -35.17 76.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' HZ2' ' A' ' 66' ' ' TRP . 35.8 tp -61.01 -44.02 98.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.683 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.23 -35.25 79.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.28 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HE2' ' SD ' ' A' ' 99' ' ' MET . 1.2 m-85 -64.65 -47.18 79.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.59 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -87.97 -59.73 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 111.398 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.77 42.32 1.99 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.28 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.74 78.21 1.05 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.238 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.3 ttt 69.25 10.65 7.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.292 0.637 . . . . 0.0 110.56 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.07 82.4 3.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.843 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.5 t -101.51 -12.5 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.728 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -108.88 102.81 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' NE2' ' A' ' 31' ' ' HIS . . . -162.88 149.33 12.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t -177.35 -68.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.154 0.502 . . . . 0.0 109.739 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' A' ' 30' ' ' PRO . 60.0 t -68.3 140.19 92.73 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 30.6 Cg_exo -25.73 105.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 124.506 3.47 . . . . 0.0 113.572 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -96.79 167.94 10.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.268 -170.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 p -97.35 -79.86 0.45 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 111.651 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' THR . 2.9 tpt -51.75 -62.28 1.73 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.747 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . 4.0 p-10 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.619 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.4 tt0 -102.62 -73.99 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.601 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.6 p -61.25 -39.18 89.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 33' ' ' MET . 57.6 m -70.15 -41.11 74.27 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.445 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.12 -36.68 84.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.502 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.18 -43.28 87.44 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.73 96.61 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.906 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 37' ' ' THR . 90.7 mt -59.03 -50.52 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.519 . . . . 0.0 110.455 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.67 -48.88 78.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.532 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -72.11 -29.85 64.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.568 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.436 ' HD2' HD12 ' A' ' 45' ' ' LEU . 72.9 t80 -63.77 -48.84 75.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.651 0.262 . . . . 0.0 111.168 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.436 HD12 ' HD2' ' A' ' 44' ' ' TYR . 8.2 mp -67.86 -32.09 72.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.689 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -66.34 -37.13 84.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.22 -36.66 84.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.35 -46.82 84.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.831 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.71 -55.49 0.36 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.369 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.23 113.48 60.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.097 0.475 . . . . 0.0 112.172 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.82 155.22 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.813 2.342 . . . . 0.0 111.772 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.93 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 m -83.44 149.15 57.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.42 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.19 -28.99 64.28 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.088 2.525 . . . . 0.0 112.195 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -46.17 -51.67 13.7 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.718 0.636 . . . . 0.0 110.569 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.529 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -63.27 -47.78 90.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.462 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 74' ' ' VAL . 57.8 t -58.04 -53.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.438 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.6 -41.51 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.33 76.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.201 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -68.36 -45.39 72.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.735 0.302 . . . . 0.0 110.285 176.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.71 85.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.834 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.55 -46.01 64.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.218 0.532 . . . . 0.0 110.279 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -69.68 -50.47 43.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.493 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -85.44 -48.09 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.574 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.61 -59.67 0.69 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HZ2' HD12 ' A' ' 17' ' ' LEU . 34.7 m0 51.96 -104.57 0.19 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 111.911 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 18.8 t-20 -171.61 131.64 0.77 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.68 -56.87 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.695 2.263 . . . . 0.0 113.275 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.63 -37.99 83.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.731 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 61.1 t80 -64.68 -42.99 94.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.215 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.7 m -63.66 -40.99 98.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.435 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -70.19 -37.49 75.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.25 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -52.58 -60.18 3.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 57' ' ' VAL . 24.2 t -61.45 -39.37 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.261 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.98 85.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.95 -39.62 94.99 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.202 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.457 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 m0 -62.56 -48.34 79.89 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.19 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.992 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.19 -53.04 61.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.091 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.18 -51.52 69.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -39.16 84.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.33 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.48 -33.49 71.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.957 0.408 . . . . 0.0 110.869 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -74.12 -19.39 60.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.387 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.46 32.53 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.127 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -96.89 164.96 12.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.03 148.04 26.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.158 0.504 . . . . 0.0 110.727 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.53 145.06 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.7 pt? -72.61 129.3 37.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.702 0.763 . . . . 0.0 112.051 -173.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.7 tt -135.26 1.73 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.591 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 90' ' ' LYS . 17.1 mtmt 66.05 -70.25 0.1 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.893 -173.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 3.7 p30 -161.5 136.87 5.66 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.961 -178.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 22.6 Cg_exo -63.84 78.51 0.15 Allowed 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 122.945 2.43 . . . . 0.0 112.715 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -81.82 -38.76 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.486 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -99.8 13.8 32.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.214 -170.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.7 96.03 5.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.46 0.648 . . . . 0.0 109.538 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.9 p -100.72 166.69 10.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.311 1.053 . . . . 0.0 112.197 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -45.89 -40.44 10.05 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.639 -2.073 . . . . 0.0 112.331 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -59.91 -47.36 86.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.939 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HE2' ' A' ' 19' ' ' PHE . 14.4 mmt -64.39 -45.25 88.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.205 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -60.34 -58.25 9.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.279 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -60.05 -31.9 70.42 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.197 0.311 . . . . 0.0 111.788 -175.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -59.8 -58.24 9.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.541 0.686 . . . . 0.0 109.932 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.89 -37.46 87.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.454 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 84.1 tttt -54.59 -60.17 3.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.591 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.61 -27.02 66.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.466 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.95 -47.41 80.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.88 0.372 . . . . 0.0 110.596 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -77.75 -24.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.289 0.566 . . . . 0.0 110.54 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.3 tp -67.93 -17.16 64.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.54 -81.57 0.2 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.09 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.663 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 111.428 0.158 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -167.48 166.92 14.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -99.27 25.41 6.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.174 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -120.66 143.1 48.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.059 0.457 . . . . 0.0 111.358 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.39 139.22 46.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.512 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.63 93.39 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.557 0.694 . . . . 0.0 111.209 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -77.59 102.73 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.558 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 26.2 ttt -139.76 -56.72 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -172.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 25.0 Cg_exo -64.0 -79.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.36 2.04 . . . . 0.0 112.518 -170.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.8 p 62.5 -47.83 0.18 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 172.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 -55.66 5.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mm -60.19 -46.57 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.381 . . . . 0.0 111.544 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' A' ' 10' ' ' PRO . 8.3 pt-20 -62.9 -35.44 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.277 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -79.27 -30.97 43.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.73 0.3 . . . . 0.0 110.435 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.33 94.0 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.2 mt -68.61 -27.46 66.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.97 -42.02 77.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.886 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HZ ' ' OE1' ' A' ' 102' ' ' GLN . 36.9 m-85 -59.62 -53.14 61.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.337 174.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -64.17 -44.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.836 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.33 47.24 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.606 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.57 51.1 4.18 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.945 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 26.8 ptt? -87.29 -3.58 59.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.689 0.396 . . . . 0.0 110.595 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t30 66.39 -74.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.252 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -179.09 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 t -73.39 -27.4 61.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.873 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.945 ' HB3' ' HB2' ' A' ' 23' ' ' MET . . . -76.67 112.43 13.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.67 0.748 . . . . 0.0 111.869 -173.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.409 ' CB ' HD22 ' A' ' 67' ' ' ASN . 68.4 m -162.24 -60.94 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.597 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 61.5 t -103.18 -58.41 0.09 OUTLIER Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.49 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 59.1 Cg_endo -74.86 129.8 12.82 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.56 1.507 . . . . 0.0 111.042 169.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 12.0 m170 -125.21 76.07 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -54.21 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.688 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -24.59 34.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' HIS . 13.9 t70 -53.91 -60.32 3.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.701 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.09 -43.27 91.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -68.06 -50.52 54.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.969 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 53.7 m -73.29 -42.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.715 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.41 -48.91 75.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.91 -34.23 77.48 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.727 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.58 92.68 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.575 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 37' ' ' THR . 76.0 mt -59.02 -46.18 91.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.914 0.387 . . . . 0.0 110.488 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 94.3 mt -58.16 -47.93 81.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.527 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' HIS . 89.7 mttt -68.25 -35.84 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.024 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 48' ' ' LEU . 66.1 t80 -65.5 -48.83 71.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.407 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 84.5 mt -61.84 -38.38 87.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.978 0.418 . . . . 0.0 110.715 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 41.3 t-80 -50.97 -51.45 52.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.45 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.0 -7.96 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 44' ' ' TYR . 74.5 mt -77.14 -36.24 55.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.56 4.08 13.72 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.347 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 43.9 t -129.42 93.17 36.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 110.773 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.27 162.79 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.198 2.599 . . . . 0.0 111.773 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.81 137.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.743 0.306 . . . . 0.0 110.794 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 56' ' ' VAL . 10.3 m -73.36 127.63 88.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 23.4 Cg_endo -63.1 -29.08 74.32 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.577 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -53.06 -53.36 51.35 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 53' ' ' SER . 29.7 m -69.59 -26.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -176.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.3 -41.01 80.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 54' ' ' PRO . 63.6 t -59.63 -54.19 37.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.187 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.38 86.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.328 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HG2' HD13 ' A' ' 17' ' ' LEU . 3.4 tpp180 -63.72 -44.13 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.554 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -59.28 -47.61 89.97 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.199 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.4 -23.51 61.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.807 0.337 . . . . 0.0 110.807 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -80.04 -45.25 18.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.959 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 60' ' ' ARG . 38.0 mm-40 -75.42 -17.07 60.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 0.0 110.61 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.8 48.38 4.71 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.128 176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 49.5 m0 -70.72 -81.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.608 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 63.2 t30 166.18 130.79 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.608 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 40.7 Cg_exo -35.91 -48.05 1.06 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.932 3.088 . . . . 0.0 114.403 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 22.4 mm-40 -69.85 -38.44 76.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -69.42 -52.29 28.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.735 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 m -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.19 -54.66 44.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.75 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 49.7 mttm -63.81 -47.62 80.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -173.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.12 -39.56 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.81 92.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -38.32 95.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.186 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.6 m0 -65.17 -49.9 68.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.08 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.276 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 9.2 tp10 -56.83 -51.7 67.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 88.1 mttt -70.21 -29.49 66.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.471 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 77' ' ' TRP . 78.5 t -71.98 -43.13 68.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.651 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -43.86 75.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.045 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -70.13 -31.06 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 111.001 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.74 26.54 19.57 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.998 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -95.33 0.93 54.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.861 0.839 . . . . 0.0 110.333 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.8 mtm-85 64.47 156.6 0.08 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.387 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 80' ' ' LYS . 20.8 pt -119.02 17.63 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.212 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt 46.64 -151.35 0.08 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.975 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 tt -170.99 132.57 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 168.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -95.08 -18.87 20.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.738 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -123.37 102.35 36.59 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.04 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.93 -26.61 58.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.355 2.037 . . . . 0.0 112.856 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.35 118.06 21.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -79.54 -77.7 0.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.24 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -173.23 168.73 4.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.611 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.0 t -54.86 139.99 38.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.378 1.085 . . . . 0.0 111.667 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.8 m -57.92 -21.88 45.91 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.698 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -60.15 -49.52 77.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -64.96 -28.73 69.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.714 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.09 -51.72 55.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -37.35 74.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.403 ' OE1' ' HZ ' ' A' ' 19' ' ' PHE . 29.6 tt0 -63.39 -53.24 55.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.734 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.47 -42.98 99.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.168 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -52.08 -55.88 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.928 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.71 -32.25 69.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.047 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.01 -46.51 88.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.12 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.9 -41.57 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.619 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.74 -41.2 90.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.217 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.85 5.48 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 112.042 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 110.038 172.876 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -75.93 116.77 16.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.657 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -107.93 75.47 1.0 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -133.26 127.37 33.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.904 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.25 72.53 10.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.606 -170.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -167.78 156.15 9.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.798 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.9 t 71.03 14.5 6.79 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 111.258 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.417 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 82.2 mmm -130.49 112.06 16.54 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.003 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 3.5 Cg_exo -77.61 128.74 9.64 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.298 2.665 . . . . 0.0 111.67 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 14' ' ' GLU . 1.8 p -80.14 91.55 5.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.221 0.534 . . . . 0.0 111.418 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.24 -43.86 80.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.517 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.65 -36.86 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.637 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 38.7 tt0 -70.89 -43.91 67.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.839 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HE3' HE21 ' A' ' 102' ' ' GLN . 25.4 tptp -70.86 -31.42 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.296 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.58 80.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.172 0.51 . . . . 0.0 110.212 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.33 -34.18 75.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -62.26 -41.04 98.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.053 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -73.55 -58.82 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.556 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.0 mt -72.09 -49.18 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.759 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.66 10.63 8.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.263 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 70.89 2.92 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.428 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 22.2 ptp -61.5 -28.82 69.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.306 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t30 64.29 -83.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.771 0.67 . . . . 0.0 111.278 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -99.4 10.5 41.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 42.3 t 66.21 55.94 0.85 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.856 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.27 133.27 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.057 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 43.8 m -126.39 -78.99 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.692 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.638 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 90.8 t -71.66 -60.53 2.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.099 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 88.6 Cg_endo -80.25 132.84 9.45 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.607 1.538 . . . . 0.0 111.362 172.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.439 ' HE1' ' HD1' ' A' ' 70' ' ' PHE . 5.4 m170 -126.78 139.61 52.99 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -95.67 -80.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 110.979 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 37' ' ' THR . 7.1 ptm -102.66 -14.91 16.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.959 0.885 . . . . 0.0 109.007 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -80.35 10.5 4.51 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.827 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.7 tm-20 -103.06 -73.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.479 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -76.37 -52.51 9.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.287 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 33' ' ' MET . 38.6 m -56.14 -46.21 79.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 0.0 111.005 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.95 99.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 39' ' ' LYS . 34.6 ttmt -64.04 -38.45 91.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.431 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -37.66 91.5 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.386 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 103' ' ' LEU . 63.8 mt -59.12 -46.47 91.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.677 0.275 . . . . 0.0 110.646 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.43 -42.83 92.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -70.41 -36.5 74.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 65.9 t80 -67.97 -37.38 81.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 103' ' ' LEU . 89.0 mt -65.81 -35.05 79.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.792 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -62.0 -36.43 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 18.9 t70 -61.82 -37.96 86.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 45' ' ' LEU . 93.2 mt -72.91 -20.27 61.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.99 -32.88 4.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.65 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.9 108.2 33.3 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 0.0 111.867 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 94.4 Cg_endo -88.63 137.01 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -89.22 103.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.856 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.403 ' HB2' HG23 ' A' ' 56' ' ' VAL . 50.9 m -62.05 139.07 95.94 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 14.9 Cg_endo -58.43 -27.69 82.59 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -42.41 98.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.232 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.452 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -65.48 -36.29 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.88 -47.96 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.189 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 74.3 t -62.63 -44.12 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.357 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.95 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.113 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 3.7 mmp_? -67.1 -43.85 81.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -61.77 -32.49 81.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.51 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.74 -27.07 44.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.477 0.18 . . . . 0.0 111.46 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -81.71 -50.48 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.182 0.515 . . . . 0.0 110.602 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 27.6 mm-40 -83.68 -23.84 31.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.484 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.33 56.73 2.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.728 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.507 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 44.9 m0 -71.92 175.84 5.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 110.635 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -82.8 154.57 68.01 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.316 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 10.9 Cg_endo -54.79 -60.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.184 2.59 . . . . 0.0 112.579 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 59.6 mm-40 -60.46 -33.93 73.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.075 0.464 . . . . 0.0 110.96 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.556 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 10.5 t80 -65.55 -57.31 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.475 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 m -61.95 -39.54 92.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 110.819 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 68' ' ' PRO . 22.2 tttp -61.34 -57.18 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.554 -176.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.46 -47.44 67.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.073 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 93.7 t -61.8 -39.66 84.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.609 0.242 . . . . 0.0 110.94 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.09 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.0 110.417 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.53 93.56 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.141 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 81' ' ' VAL . 17.4 m0 -68.93 -44.47 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.47 87.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.43 -53.09 56.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.639 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.63 -37.81 88.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.394 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 77' ' ' TRP . 93.1 t -70.1 -46.04 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.463 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.37 -44.33 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.545 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -67.06 -32.3 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.0 45.79 2.17 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.624 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.18 167.26 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -91.45 132.25 36.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.429 0.633 . . . . 0.0 111.073 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.18 90.49 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.499 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 110.89 5.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.493 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 tt -79.41 98.97 3.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.729 0.776 . . . . 0.0 109.715 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -67.1 -13.94 62.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.042 -175.064 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.95 90.48 5.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.41 0.624 . . . . 0.0 111.663 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.92 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.421 2.08 . . . . 0.0 110.766 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 56.37 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 170.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -86.2 24.49 1.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -98.15 103.9 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' A' ' 99' ' ' MET . 31.4 t -78.38 157.74 28.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.927 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 98' ' ' TYR . 14.3 t -65.97 -44.7 84.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.206 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.436 ' N ' HG23 ' A' ' 97' ' ' THR . 49.4 t80 -62.76 -27.12 69.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.889 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 96' ' ' SER . 61.2 mtt -64.32 -47.72 78.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -62.91 -50.01 72.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.938 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 105' ' ' GLU . 48.0 mt-10 -59.22 -41.96 89.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.366 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.444 HE21 ' HE3' ' A' ' 15' ' ' LYS . 7.9 tp60 -54.67 -55.95 24.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.502 . . . . 0.0 110.709 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 41' ' ' ILE . 71.6 mt -60.62 -45.06 95.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.22 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -64.39 -47.63 78.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 38.8 mm-40 -64.85 -34.1 77.56 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.51 -47.66 83.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.29 -38.73 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.41 -48.15 76.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.39 -29.43 69.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.899 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.8 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.044 172.012 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.157 0.504 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -101.25 73.91 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.83 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 60.7 -164.17 0.24 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.633 0.73 . . . . 0.0 112.609 173.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -93.06 111.51 23.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.102 -0.953 . . . . 0.0 108.775 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 7' ' ' LYS . 12.3 t70 60.04 -150.68 0.42 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 57.4 mtmt -89.82 15.88 9.02 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.115 -0.365 . . . . 0.0 110.468 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.4 p 52.2 -160.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.79 0.836 . . . . 0.0 111.53 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.453 ' HG2' HG22 ' A' ' 11' ' ' THR . 50.2 ttp -139.08 88.22 13.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.269 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -92.48 80.7 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.485 2.79 . . . . 0.0 112.452 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.453 HG22 ' HG2' ' A' ' 9' ' ' MET . 5.5 t -132.4 98.9 4.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.806 0.812 . . . . 0.0 110.705 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.97 70.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.3 mp -64.72 -45.04 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.685 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.752 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -75.18 -33.66 61.48 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.651 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.45 99.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 109.791 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 60' ' ' ARG . 25.0 tp -64.56 -38.93 92.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.859 175.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.04 -29.82 70.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.026 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.3 -52.0 60.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.691 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.13 -48.29 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.13 31.5 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.936 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.07 28.87 4.89 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.615 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -65.8 -35.98 82.22 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 68.57 -44.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.619 0.768 . . . . 0.0 111.771 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 26' ' ' SER . 1.6 m -99.07 -152.45 0.41 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.673 ' H ' HG22 ' A' ' 25' ' ' THR . 15.4 m -103.44 97.62 7.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.89 0.376 . . . . 0.0 110.041 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HA ' ' NE2' ' A' ' 31' ' ' HIS . . . -76.92 139.78 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.849 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -160.81 -56.52 0.05 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.0 m -69.03 162.5 64.63 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.736 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.37 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.526 2.151 . . . . 0.0 110.947 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.558 ' NE2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -85.42 -172.89 4.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 -171.17 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.5 m -103.58 -80.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.2 tpt -57.48 -52.03 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.044 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -83.91 1.22 44.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.453 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.4 -77.44 0.57 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.387 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -63.3 -48.06 79.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 m -71.17 -30.67 66.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 110.552 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.06 83.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -56.35 -44.64 80.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.384 174.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.43 -44.18 97.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.257 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 67.3 mt -66.2 -44.85 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 110.864 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.55 -37.7 84.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.701 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -66.33 -49.41 67.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.988 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' HD11 ' A' ' 48' ' ' LEU . 71.7 t80 -57.6 -44.75 85.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.575 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 94.4 mt -60.31 -47.98 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.618 0.247 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m80 -62.17 -36.77 82.86 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.751 177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.92 -32.83 73.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.114 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 44' ' ' TYR . 81.1 mt -67.68 -16.72 64.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.268 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 107.37 1.45 35.33 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.109 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.46 98.04 15.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 97.8 Cg_endo -84.0 104.88 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.232 1.954 . . . . 0.0 112.855 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 101.03 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.72 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.6 m -66.05 140.54 97.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.336 -177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 52.3 Cg_exo -55.75 -34.86 92.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.262 2.641 . . . . 0.0 112.506 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.93 -48.72 72.76 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.828 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.77 -38.43 81.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.275 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.88 -45.48 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.823 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 96.8 t -62.41 -49.08 85.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.944 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.76 94.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.12 0.486 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HG2' HD11 ' A' ' 17' ' ' LEU . 10.3 tpp180 -66.96 -40.42 87.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.89 -40.7 99.21 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.375 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 36.8 mt-10 -68.14 -31.11 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.581 0.229 . . . . 0.0 111.206 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -76.16 -53.38 8.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 111.267 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.731 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.89 48.71 2.42 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.751 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.654 ' HB3' ' HD2' ' A' ' 70' ' ' PHE . 48.7 m0 -81.13 0.31 36.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 93.1 m-20 72.94 145.05 0.11 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.835 0.454 . . . . 0.0 111.02 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.29 -41.29 79.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.703 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 44.9 mt-10 -63.26 -56.05 19.79 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.657 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.654 ' HD2' ' HB3' ' A' ' 66' ' ' TRP . 89.7 t80 -60.67 -47.01 88.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.826 0.346 . . . . 0.0 110.631 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 31.1 m -58.78 -41.24 86.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.978 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.98 -43.49 95.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.779 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 67.9 mttm -62.52 -53.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.546 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 46.5 t -59.7 -41.48 85.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.846 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -61.42 -40.82 95.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.388 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -61.48 -42.41 99.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.393 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.546 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 15.2 m0 -62.13 -44.77 95.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.254 0.549 . . . . 0.0 109.572 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.58 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 48.9 mt-10 -59.21 -48.14 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.354 0.409 . . . . 0.0 110.97 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.7 mtpp -60.97 -52.31 65.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' TRP . 62.1 t -61.38 -35.68 68.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.39 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.14 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.1 t -61.76 -48.26 81.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.453 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.77 -10.8 3.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -87.75 107.39 18.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -58.07 156.67 9.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.653 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.54 141.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.75 111.75 24.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 110.763 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 91' ' ' ASN . 14.6 tt -91.78 140.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -94.28 -8.66 38.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.562 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.589 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.5 p30 -149.16 76.61 9.35 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.425 0.631 . . . . 0.0 111.297 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.05 -6.24 17.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.512 2.142 . . . . 0.0 112.477 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.55 -10.92 59.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 91' ' ' ASN . 67.1 m-85 -89.72 -18.23 26.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -89.1 91.64 8.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -86.7 173.35 9.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -66.09 -26.89 67.69 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -45.82 -49.48 15.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.808 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.34 -43.07 87.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -46.45 89.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 97' ' ' THR . 38.2 mm-40 -55.16 -52.08 64.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 48.2 mt-30 -58.82 -54.04 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.993 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 107' ' ' VAL . 92.5 mt -59.28 -49.62 77.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.263 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.91 -46.29 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.041 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 6.2 tp10 -65.43 -31.51 72.65 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.54 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 83.3 mt -72.53 -29.71 63.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 103' ' ' LEU . 82.1 t -78.11 -35.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.511 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.64 -42.42 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 2.3 mm-40 -81.99 12.67 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.662 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.826 0.822 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -158.17 -46.05 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.974 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 t80 59.7 -83.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.986 0.804 . . . . 0.0 111.612 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 43.8 mtpt 63.17 106.16 0.03 OUTLIER 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.59 0.756 . . . . 0.0 111.868 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.2 138.75 56.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.899 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 5' ' ' LYS . 61.6 mttp -137.18 -64.1 0.58 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.074 0.464 . . . . 0.0 110.347 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 t 176.42 -156.46 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -65.21 142.73 98.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.3 Cg_endo -55.9 112.57 1.1 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.594 2.196 . . . . 0.0 112.126 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.73 97.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.374 0.607 . . . . 0.0 111.774 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.14 69.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.466 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.25 -56.72 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.989 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.21 -38.34 76.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.393 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 49.4 tptt -74.24 -34.18 63.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.715 0.293 . . . . 0.0 110.75 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 0.0 110.224 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.9 mm? -64.58 -33.18 75.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.553 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.89 -39.68 87.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.83 -46.92 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.33 -50.05 58.03 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.299 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.67 -8.2 6.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.574 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' MET . 26.8 ttt 63.53 23.62 13.7 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.663 0.744 . . . . 0.0 110.312 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -133.03 163.15 29.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.648 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -125.08 -158.57 0.84 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.597 ' H ' HG22 ' A' ' 25' ' ' THR . 38.3 m 71.54 8.29 6.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.26 0.624 . . . . 0.0 112.185 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.63 89.23 3.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.066 0.46 . . . . 0.0 109.867 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' CD ' ' A' ' 69' ' ' GLU . 12.6 m -122.5 -51.92 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.635 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 21.8 t -114.6 -53.47 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.198 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 12.0 Cg_endo -91.97 86.55 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.259 1.972 . . . . 0.0 110.291 171.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.537 ' HD1' ' CG ' ' A' ' 34' ' ' ASP . 6.4 p80 -132.93 96.52 3.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.378 0.609 . . . . 0.0 111.143 -172.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 m -86.38 -14.99 41.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.786 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.485 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.3 tpt -60.99 -64.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.537 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 11.4 p-10 -79.53 -26.95 41.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.136 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.01 -77.39 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 13.2 m -71.27 -49.82 39.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.9 0.381 . . . . 0.0 111.505 -172.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 33' ' ' MET . 17.5 m -73.18 -55.18 6.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.864 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -68.11 -37.45 81.17 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 89' ' ' ILE . 4.4 ttmp? -67.33 -34.97 78.45 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.742 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.23 99.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.473 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 103' ' ' LEU . 69.6 mt -65.89 -47.76 84.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.44 -44.57 92.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.912 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -69.96 -30.97 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 56.4 t80 -67.07 -46.15 75.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.151 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.89 -41.99 98.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.454 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.484 ' HB2' HG13 ' A' ' 81' ' ' VAL . 41.0 t-80 -50.21 -51.68 42.16 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.81 -2.6 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.472 -175.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 64.3 mt -84.93 -21.83 29.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.218 0.532 . . . . 0.0 109.577 168.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.41 0.95 14.02 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.704 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.24 98.12 47.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.923 0.362 . . . . 0.0 111.106 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.84 157.87 15.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.918 2.412 . . . . 0.0 111.788 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.36 137.98 49.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.62 0.248 . . . . 0.0 110.622 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 24.5 m -85.0 144.43 41.53 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 23.8 Cg_exo -63.41 -32.9 71.24 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.103 2.535 . . . . 0.0 112.771 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -42.35 66.68 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.93 -47.84 91.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.72 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.5 t -64.03 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.497 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.27 -58.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.488 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -30.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.551 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -67.86 -46.84 70.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.77 -34.69 90.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.98 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.05 -29.87 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.749 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -86.1 -49.78 7.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.555 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.07 -28.25 66.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.867 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.5 55.22 1.7 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.028 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 70' ' ' PHE . 44.5 m0 -81.37 -78.34 0.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 36.1 p30 175.45 160.79 0.41 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.548 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 86.5 Cg_endo -79.89 8.69 3.9 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.046 1.831 . . . . 0.0 112.933 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 28' ' ' SER . 46.1 mt-10 -107.33 -69.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.647 -174.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -59.62 -38.23 80.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.423 0.63 . . . . 0.0 110.198 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.882 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 74.0 mmtt -63.36 -56.81 13.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.329 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.551 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.2 t -59.66 -35.84 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.69 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.62 86.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.93 -37.71 92.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.362 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 21.9 m0 -66.0 -44.88 83.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.83 75.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.23 -50.29 74.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.423 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -63.55 -39.31 94.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.337 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 46' ' ' HIS . 47.7 t -61.4 -51.14 76.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.313 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.92 93.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.76 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.39 -39.97 92.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.92 6.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.701 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -100.94 -166.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 110.468 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -94.6 154.77 17.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.92 0.391 . . . . 0.0 110.644 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.02 140.89 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -91.4 119.03 31.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.989 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.411 HG13 ' HD2' ' A' ' 39' ' ' LYS . 8.7 tt -112.36 151.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -96.47 -30.03 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.763 0.316 . . . . 0.0 111.081 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 15.0 m-80 -142.0 92.34 7.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -22.52 18.59 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.464 2.11 . . . . 0.0 113.029 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.49 -5.32 59.3 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' ' 91' ' ' ASN . 8.6 m-85 -71.74 -20.06 61.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.0 110.542 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -79.81 88.74 5.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 t -75.92 163.02 27.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.578 -171.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -31.17 69.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.74 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.08 -55.28 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.065 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.1 mtm -62.63 -36.53 83.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.906 0.384 . . . . 0.0 110.782 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -50.9 71.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.213 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 46.1 mt-10 -73.27 -24.46 60.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.384 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -65.63 -51.09 62.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 107' ' ' VAL . 98.7 mt -62.52 -42.31 99.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.14 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 83.6 tttt -55.78 -47.36 77.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.213 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.58 -38.62 90.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 0.0 110.878 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 10' ' ' PRO . 28.5 tp -71.59 -44.09 65.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.828 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 103' ' ' LEU . 80.6 t -70.41 -27.38 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.92 -43.67 69.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.528 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -91.77 3.4 55.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 178.539 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.399 0.619 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.33 -39.63 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.698 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.94 97.07 8.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.464 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -122.61 23.73 9.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -40.27 110.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.249 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -107.3 20.89 18.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.957 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.85 -167.72 1.93 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.546 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.6 ttp 68.56 98.4 0.04 OUTLIER Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.681 0.793 . . . . 0.0 111.184 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.7 84.07 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.883 2.388 . . . . 0.0 112.06 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -56.94 -22.39 37.48 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.641 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.44 91.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.46 . . . . 0.0 110.311 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.93 -39.66 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.849 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.67 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.502 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 56.7 mmtt -76.29 -35.44 58.87 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.312 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.34 83.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.588 0.709 . . . . 0.0 109.113 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.758 HD22 HH11 ' A' ' 60' ' ' ARG . 23.4 tp -63.3 -37.12 86.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.252 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.31 -33.76 75.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.332 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.17 -40.51 78.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.471 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -88.15 -76.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.772 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 -4.94 81.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.748 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.13 7.48 77.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.432 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -94.81 111.86 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.12 -156.99 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.06 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -86.96 41.67 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.262 -0.274 . . . . 0.0 110.875 175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 58.18 111.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.648 1.179 . . . . 0.0 112.106 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 70' ' ' PHE . . . -75.51 174.45 9.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.187 178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 p -155.19 -43.07 0.08 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.0 109.935 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.556 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 28.3 m -66.16 170.64 5.03 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.745 170.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 39.6 Cg_exo -29.75 110.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.916 3.077 . . . . 0.0 112.662 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 19.6 m80 -83.73 162.8 20.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.755 -169.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 t -103.38 -80.52 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.084 0.468 . . . . 0.0 110.506 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.3 ttp -97.81 -29.75 13.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.51 0.671 . . . . 0.0 109.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 9.2 p-10 -67.81 -8.31 34.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.145 -172.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 39.8 tt0 -102.51 -48.95 3.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 110.658 173.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.8 t -65.41 -48.48 72.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.697 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 m -64.82 -40.24 94.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.359 . . . . 0.0 110.267 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.7 63.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -61.5 -28.88 69.62 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.195 0.521 . . . . 0.0 110.8 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.73 -49.9 52.0 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.382 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 103' ' ' LEU . 63.7 mt -61.84 -43.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.618 0.247 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -54.97 -47.54 74.41 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.68 ' HE3' HD11 ' A' ' 87' ' ' ILE . 9.9 mtmp? -77.9 -25.84 48.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.312 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.533 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 53.0 t80 -65.15 -47.81 75.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.13 -40.54 97.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.223 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -50.94 -54.97 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.341 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.12 -18.83 60.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 57.6 mt -68.53 -27.29 65.97 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.6 6.17 10.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.583 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.39 93.19 43.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.758 0.313 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.37 120.75 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.993 2.462 . . . . 0.0 111.838 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.31 138.66 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.299 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.93 147.46 38.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -53.19 -36.0 75.63 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.397 2.731 . . . . 0.0 112.398 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -50.05 -47.3 53.45 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.316 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.0 -40.99 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.607 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.4 t -63.87 -45.92 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.456 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 67.4 t -59.99 -48.28 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.141 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.8 89.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.439 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.758 HH11 HD22 ' A' ' 17' ' ' LEU . 14.6 tpp85 -67.79 -40.42 83.92 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.508 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.83 -37.14 93.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.479 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -62.66 -37.62 87.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.197 0.523 . . . . 0.0 110.574 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -73.03 -44.82 60.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.471 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.86 -30.03 32.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.81 57.28 1.84 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.067 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.753 ' HZ2' HD11 ' A' ' 17' ' ' LEU . 49.4 m0 -84.05 168.43 15.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 6.7 m-20 -61.83 123.58 77.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 167.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.91 -34.23 55.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.502 2.801 . . . . 0.0 113.82 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 26.5 mt-10 -64.73 -40.64 95.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 73.6 t80 -64.42 -50.97 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.142 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 21.4 m -57.27 -41.23 79.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.936 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.44 -40.71 77.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.126 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.62 -50.14 68.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.077 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.599 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 52.1 t -60.22 -40.16 82.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 110.635 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 54' ' ' PRO . . . -59.59 -40.18 86.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.684 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.9 -34.79 88.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.078 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.599 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 28.7 m0 -67.23 -47.58 70.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.7 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.95 -44.61 91.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 110.4 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -64.64 -45.79 85.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.635 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.3 t -63.67 -40.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.37 -41.04 81.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.638 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.7 p -75.03 -16.63 60.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.03 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.53 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -109.98 163.99 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -89.27 156.57 18.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.516 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.68 HD11 ' HE3' ' A' ' 43' ' ' LYS . 21.8 pt -123.94 147.66 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 89' ' ' ILE . 6.6 tt -71.27 131.74 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 88' ' ' LEU . 13.5 tt -139.32 162.78 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -76.07 -53.18 8.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.723 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.76 140.3 31.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.68 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.2 7.11 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.326 2.017 . . . . 0.0 113.463 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.18 -16.33 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 77.44 -70.6 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.65 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.684 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 40.8 p90 -162.82 -170.85 2.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.772 -173.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 95' ' ' PHE . 16.6 m -85.22 146.62 26.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.771 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 p -50.06 -36.9 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -38.68 57.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.596 0.236 . . . . 0.0 111.623 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.684 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 mmt -65.76 -50.01 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 110.225 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.14 -30.77 66.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.085 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.56 -32.74 74.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.358 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.556 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 54.0 tp60 -70.07 -50.54 39.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 109.696 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 41' ' ' ILE . 86.4 mt -52.85 -49.76 65.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.028 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -59.51 -42.26 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 109' ' ' GLU . 35.4 tt0 -63.13 -39.9 96.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.572 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 95.0 mt -62.54 -36.31 82.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.97 -43.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.67 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -78.62 -45.1 22.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 17.6 mm-40 -70.97 -75.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.033 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.835 0.826 . . . . 0.0 110.471 177.575 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -118.74 138.81 52.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.93 -11.33 19.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 pttt 40.89 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.211 0.944 . . . . 0.0 112.064 -175.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.16 81.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.22 -1.354 . . . . 0.0 113.551 -167.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.21 13.51 2.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.853 169.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.0 p 54.23 107.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 111.938 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 mmt -53.57 115.95 8.89 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.779 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.53 -176.59 1.81 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.095 2.53 . . . . 0.0 111.95 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.6 p -83.54 159.46 21.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.784 0.326 . . . . 0.0 110.3 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.41 82.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 49.9 mm -65.58 -43.01 94.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.049 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.34 -33.27 75.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.659 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 36.2 mmtt -78.48 -31.07 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.202 177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.86 99.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.275 0.559 . . . . 0.0 109.496 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 13' ' ' ILE . 62.9 mt -72.52 -27.61 62.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.436 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.6 -25.53 67.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.478 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -85.66 -48.25 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.272 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.2 mt -79.12 -37.49 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.32 -11.12 32.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.74 57.33 9.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.775 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.16 91.52 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 69.07 16.85 8.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.682 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 p -99.53 -0.71 40.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.591 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t 71.15 122.47 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.37 168.92 18.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.606 ' OG ' ' HB2' ' A' ' 69' ' ' GLU . 35.8 t 73.21 2.78 4.45 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.696 0.623 . . . . 0.0 110.943 176.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.635 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 53.8 t -138.62 -63.14 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.619 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 81.6 Cg_endo -77.98 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.561 1.508 . . . . 0.0 112.399 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 10.4 m170 59.16 24.25 12.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.467 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -66.83 -80.18 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.036 0.446 . . . . 0.0 110.166 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -93.1 -16.09 25.33 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.605 ' HB3' ' HA ' ' A' ' 31' ' ' HIS . 7.2 t0 -51.27 -45.57 62.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.913 -1.948 . . . . 0.0 111.315 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -99.9 -40.25 7.78 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.551 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 92' ' ' PRO . 37.0 t -61.89 -62.04 2.07 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.933 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 m -68.62 -36.29 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.915 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.25 -51.81 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.738 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HD3' HG12 ' A' ' 89' ' ' ILE . 95.2 mttt -62.98 -42.98 99.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.56 92.76 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.369 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 52.2 mt -68.91 -47.46 75.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 0.159 . . . . 0.0 111.372 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.18 -40.92 87.17 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.77 -41.34 99.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.939 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.431 ' CE2' HD11 ' A' ' 48' ' ' LEU . 67.6 t80 -73.1 -39.76 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.549 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 92.8 mt -59.36 -46.18 89.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.804 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -64.22 -36.45 84.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.43 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.36 -41.47 97.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD11 ' CE2' ' A' ' 44' ' ' TYR . 88.5 mt -64.45 -37.86 89.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.803 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.03 2.63 10.14 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.005 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.78 93.39 33.47 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 0.0 109.813 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -91.26 157.13 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.941 2.427 . . . . 0.0 113.072 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.71 141.59 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.939 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.483 ' HB2' HG23 ' A' ' 56' ' ' VAL . 12.8 m -79.81 123.44 83.84 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 58' ' ' VAL . 43.7 Cg_exo -56.08 -38.1 95.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.076 2.517 . . . . 0.0 112.388 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -52.52 -50.66 62.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.155 0.502 . . . . 0.0 110.913 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 53' ' ' SER . 33.3 t -64.18 -35.6 74.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.342 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.33 -40.04 87.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.728 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 54' ' ' PRO . 90.8 t -62.23 -52.94 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.635 0.255 . . . . 0.0 110.458 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.91 -43.76 86.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.2 tpp180 -64.1 -43.76 94.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 71' ' ' THR . . . -60.53 -48.23 87.23 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.39 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 45.6 mt-10 -59.39 -33.23 70.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.135 0.493 . . . . 0.0 110.854 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -70.25 -48.92 54.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.547 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 60.5 mt-10 -93.48 -3.79 52.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 0.0 111.388 -173.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.32 -70.63 0.54 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 11.9 m0 56.31 -1.47 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 12.5 m120 69.58 128.97 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 123.322 0.649 . . . . 0.0 110.489 -176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.45 -47.19 23.46 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.693 2.929 . . . . 0.0 114.335 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.606 ' HB2' ' OG ' ' A' ' 28' ' ' SER . 55.7 mm-40 -69.56 -36.78 76.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 66' ' ' TRP . 68.2 t80 -69.94 -49.07 55.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 61' ' ' GLY . 21.1 m -53.6 -46.62 70.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.22 -46.03 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.067 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -65.06 -40.29 94.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.82 -39.35 83.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.436 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.67 82.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.902 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.21 -40.58 87.7 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.089 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.9 m0 -60.91 -54.49 44.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.11 73.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.004 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -56.41 -53.95 51.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.239 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 46.0 mtpt -66.65 -35.93 81.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.262 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 77' ' ' TRP . 76.6 t -68.76 -46.17 79.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.052 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.67 69.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 111.173 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.5 t -80.0 -18.12 51.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.747 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.81 45.8 15.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.901 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -95.95 16.3 18.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.032 0.133 . . . . 0.0 111.134 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 47.93 127.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 125.267 1.604 . . . . 0.0 113.953 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.1 pt -115.51 144.13 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.15 112.36 21.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -124.64 -43.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.413 177.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 67.31 -70.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 111.636 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -165.36 92.2 0.9 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.563 -175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.5 ' HD3' HG23 ' A' ' 89' ' ' ILE . 61.1 Cg_endo -80.69 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.436 2.091 . . . . 0.0 112.69 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.8 pt-20 -156.34 24.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.038 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 53.3 m-85 73.25 -21.31 0.26 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.659 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 93' ' ' GLU . 18.1 t80 61.97 83.93 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -169.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -52.63 139.98 24.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.907 -169.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m -53.58 -41.99 67.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 112.329 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 35.5 t80 -61.04 -42.24 98.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.3 mtt -62.15 -50.7 70.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.484 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -59.43 -46.63 88.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.896 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 7.7 mt-10 -72.0 -27.36 62.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 14.0 mm100 -59.01 -48.1 82.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.156 0.503 . . . . 0.0 109.74 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 107' ' ' VAL . 83.1 mt -68.3 -43.51 77.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.402 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 26.9 tttm -60.47 -50.04 75.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.13 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -69.55 -25.46 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.682 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 48.3 tp -70.31 -45.71 65.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 103' ' ' LEU . 59.8 t -71.83 -25.54 24.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.337 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.09 -34.73 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.567 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.65 -70.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 168.233 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -106.73 95.92 6.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.015 0.436 . . . . 0.0 110.502 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -85.53 -25.71 26.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.126 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -85.44 149.43 25.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.579 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 66.31 -168.76 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 124.067 0.854 . . . . 0.0 110.001 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 55.44 27.88 10.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.137 0.97 . . . . 0.0 109.287 -175.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 m -87.2 111.63 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.335 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -77.31 162.58 68.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.43 114.97 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.743 2.295 . . . . 0.0 112.33 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 p -84.38 85.82 7.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.481 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.77 -47.76 6.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.194 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 61.0 mt -63.12 -45.61 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.956 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -53.77 -54.83 32.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 94.9 mttt -67.62 -35.71 79.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.462 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.93 85.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 111.077 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 85.5 mt -64.09 -47.22 80.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -13.58 56.79 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.855 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -64.59 -43.12 94.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.139 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.32 -39.45 48.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.711 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 70' ' ' PHE . . . -54.79 -47.98 68.74 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.036 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.05 14.96 69.01 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.227 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 67.74 169.97 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.046 0.538 . . . . 0.0 111.455 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.4 108.13 11.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.212 0.529 . . . . 0.0 110.83 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 p -120.98 -171.19 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.707 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -73.38 173.05 10.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.86 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.54 -112.34 0.62 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 6.3 p -126.02 -13.85 6.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 28' ' ' SER . 23.2 t 109.1 -57.08 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 125.775 1.63 . . . . 0.0 111.321 -175.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.972 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 3.9 Cg_exo -74.0 86.97 1.21 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.326 1.351 . . . . 0.0 110.864 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -95.76 -76.85 0.49 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.7 m -103.98 -80.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.0 110.721 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -90.35 -12.15 38.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.946 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.972 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -65.03 -15.83 62.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.179 178.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -92.72 -55.18 3.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.28 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.471 ' HB3' HD11 ' A' ' 89' ' ' ILE . 14.3 m -71.27 -53.19 15.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.886 -174.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -62.75 -34.14 76.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.38 90.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.201 0.524 . . . . 0.0 110.132 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -64.0 -27.54 69.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.398 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.08 -55.04 23.96 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.736 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 HD11 ' A' ' 103' ' ' LEU . 66.4 mt -57.27 -43.65 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 110.659 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 78' ' ' ALA . 26.6 tp -56.49 -47.74 78.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.458 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 43' ' ' LYS . 9.9 mtmp? -72.83 -30.56 64.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.426 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 66.3 t80 -63.57 -37.95 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 48' ' ' LEU . 94.2 mt -66.14 -38.92 89.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.279 176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -61.26 -34.54 75.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.07 -24.96 47.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 93.6 mt -75.93 -32.25 59.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.314 0.578 . . . . 0.0 110.411 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.44 -18.11 8.84 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.319 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.83 93.42 48.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -95.37 158.32 1.61 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.065 2.51 . . . . 0.0 111.871 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.92 138.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 110.571 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 56' ' ' VAL . 23.8 m -83.03 149.24 58.68 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.39 -43.3 44.86 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.322 2.681 . . . . 0.0 112.733 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.17 -43.34 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 53' ' ' SER . 29.4 t -65.0 -36.39 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.174 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.69 -49.05 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.0 -45.55 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.76 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.84 93.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.72 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 13.2 tpt180 -65.16 -46.12 82.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.409 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.37 99.4 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.035 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -58.51 -39.88 81.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.92 0.39 . . . . 0.0 111.084 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.1 tm0? -83.02 -48.45 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.479 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.33 -25.73 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.876 0.37 . . . . 0.0 111.463 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.81 -76.99 0.34 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.8 m0 54.2 -161.29 0.14 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.832 0.453 . . . . 0.0 111.625 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -124.26 140.23 34.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 -41.73 70.21 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.893 2.395 . . . . 0.0 112.775 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -66.86 -40.66 87.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.582 0.706 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 31.2 t80 -69.5 -53.06 20.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.409 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -58.29 -43.77 88.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -72.37 -34.44 67.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.741 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -56.91 14.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.806 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.9 -35.47 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.2 86.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.34 -37.83 62.84 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.073 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -61.44 -49.32 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -59.14 -38.09 78.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.95 -49.77 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.864 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.97 -37.24 75.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.107 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.47 -38.57 80.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.702 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.09 -30.2 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.082 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . 17.2 m -87.81 -14.61 39.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 31.86 13.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.854 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 12.6 m120 -97.59 -171.65 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -108.95 135.32 50.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -109.0 119.64 58.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.806 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.67 122.61 14.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.054 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 36' ' ' SER . 16.1 tt -129.82 135.56 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HG3' ' OD1' ' A' ' 91' ' ' ASN . 17.5 pttm -76.01 -16.72 59.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -171.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.672 ' OD1' ' HG3' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -153.95 114.28 2.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.889 0.376 . . . . 0.0 110.399 177.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.68 80.92 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.138 2.559 . . . . 0.0 113.027 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.551 ' HG2' HD22 ' A' ' 91' ' ' ASN . 11.6 pt-20 -138.96 172.45 12.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.927 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -124.23 -80.92 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.723 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER 175.56 -176.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.951 -172.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 m -84.77 174.63 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.357 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -30.24 68.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.877 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -44.95 -55.08 5.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.622 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.89 -46.32 68.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.171 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.656 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 7.7 tt0 -60.57 -48.38 82.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.261 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.05 -35.18 79.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -54.12 -58.99 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.417 0.627 . . . . 0.0 110.033 175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 41' ' ' ILE . 94.3 mt -64.73 -39.68 94.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.911 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.74 -39.38 91.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.304 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.86 -26.56 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.746 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.66 -36.95 81.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 48' ' ' LEU . 55.8 t -77.53 -20.98 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.82 -18.76 64.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.44 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.02 -8.28 47.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.978 0.418 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.49 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -83.19 113.68 20.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -81.76 -25.5 35.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.803 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -138.76 130.43 27.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.946 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.29 145.81 47.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.207 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 23.8 pttm -140.26 84.22 1.95 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.819 0.818 . . . . 0.0 110.241 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -82.97 132.3 35.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.503 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 90.1 mmm -63.48 110.76 4.0 Favored Pre-proline 0 C--N 1.331 -0.219 0 O-C-N 123.232 0.333 . . . . 0.0 110.46 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 4.7 Cg_exo -73.01 99.54 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.789 2.326 . . . . 0.0 112.562 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p -105.85 174.35 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.452 175.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.99 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.597 . . . . 0.0 109.779 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -68.82 -44.23 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.06 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.09 -37.69 86.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 4.2 mmmp? -70.66 -26.35 63.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.838 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.15 86.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.227 0.537 . . . . 0.0 109.718 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.17 -32.33 70.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.088 174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 24.0 t70 -57.17 -32.66 66.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.718 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -78.7 -63.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.679 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.15 -68.96 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.067 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.95 -8.01 84.48 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.762 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.06 -16.94 80.33 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.332 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 25.4 ptp -103.59 97.78 7.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.839 0.828 . . . . 0.0 111.118 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.19 49.85 1.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -82.06 -168.94 2.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.133 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -84.59 -174.95 5.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.236 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 72.89 150.29 0.1 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.157 0.98 . . . . 0.0 111.906 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 20.0 m -139.82 -47.54 0.45 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.322 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.577 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 22.6 m -58.43 167.7 1.62 Allowed Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.127 167.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 34.1 Cg_exo -22.33 105.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 124.87 3.713 . . . . 0.0 113.367 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -69.99 161.47 29.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.797 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -75.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.536 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.463 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 6.8 ttp -96.64 -42.39 8.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -48.19 -45.71 34.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.541 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 30' ' ' PRO . 26.2 tp10 -50.88 -66.3 0.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.187 0.518 . . . . 0.0 111.135 -175.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 t -70.2 -43.1 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.462 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 33' ' ' MET . 38.6 m -67.41 -42.66 82.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.62 87.08 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.479 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -56.96 -32.5 66.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.916 0.388 . . . . 0.0 110.693 174.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.46 50.61 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.092 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.94 -43.33 92.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 110.736 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.53 -39.56 76.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.142 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -69.2 -42.33 75.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.009 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -63.64 -48.45 77.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.375 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.569 HD21 HD23 ' A' ' 103' ' ' LEU . 72.8 mt -61.71 -48.36 81.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.458 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.65 -36.74 77.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.007 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.8 -40.59 88.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 107' ' ' VAL . 94.1 mt -61.66 -30.1 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 120.97 -0.09 11.75 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.928 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.05 97.89 9.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 82.1 Cg_endo -83.3 127.12 4.43 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.379 2.053 . . . . 0.0 112.265 -176.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.538 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 41.4 t -75.33 101.47 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.857 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 56' ' ' VAL . 22.8 m -70.79 125.94 92.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.49 -23.04 62.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.648 2.232 . . . . 0.0 111.706 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -58.88 -54.08 51.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.14 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 53' ' ' SER . 34.1 m -70.42 -21.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.104 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.98 -49.3 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 69.4 t -62.03 -42.64 95.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.422 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.19 96.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.888 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.63 -37.54 87.92 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 177.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -60.18 -45.62 95.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.911 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 8.4 pt-20 -79.74 -20.41 46.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.82 -53.39 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.899 0.381 . . . . 0.0 110.142 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 4.6 tp10 -73.73 -38.65 64.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 -173.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.91 62.22 0.56 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.973 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.469 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 24.8 m0 -98.52 160.66 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.426 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 26.7 p30 -90.05 153.7 47.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 4.9 Cg_exo -39.23 -60.41 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.613 3.542 . . . . 0.0 114.433 -174.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 4.6 mm-40 -61.21 -39.0 88.59 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.95 -44.76 84.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.0 m -58.45 -48.5 80.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -77.42 -27.14 52.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 tptp -54.4 -66.26 0.43 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.83 -40.94 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.892 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.97 96.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.967 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -66.87 -40.79 93.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.47 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.443 ' O ' HG23 ' A' ' 81' ' ' VAL . 10.6 m0 -63.46 -50.79 68.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -58.91 -39.43 81.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.85 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.5 -49.85 63.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 52.0 mttm -71.98 -41.61 67.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.317 -176.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 77' ' ' TRP . 57.8 t -68.21 -39.65 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.269 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.32 69.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.122 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -65.45 -27.99 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.98 23.04 5.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.863 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.1 -176.27 4.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -136.24 137.88 41.25 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.243 0.544 . . . . 0.0 110.738 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.32 125.48 74.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.613 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.14 110.2 16.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.415 0.626 . . . . 0.0 110.815 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.8 tt -86.59 -3.24 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.757 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 71.07 -52.05 0.68 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.817 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -161.59 131.71 3.46 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.86 177.575 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 37.0 Cg_exo -57.62 -66.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.739 2.293 . . . . 0.0 111.902 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.55 -72.5 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -78.15 5.7 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -168.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.18 102.85 14.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p -94.56 169.58 10.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -32.4 71.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.694 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 0.2 OUTLIER -56.19 -44.65 79.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 110.166 -176.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.54 -49.36 66.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.366 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -61.03 -50.9 71.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.781 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.4 -47.96 82.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.445 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -54.49 -56.48 18.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.383 0.611 . . . . 0.0 110.736 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.569 HD23 HD21 ' A' ' 45' ' ' LEU . 10.4 mp -67.8 -41.08 83.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.357 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -68.96 -34.01 74.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.144 -175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.74 -43.41 89.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.75 -42.9 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 48' ' ' LEU . 84.9 t -72.66 -32.19 40.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.121 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.72 -20.56 61.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.01 -18.13 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.775 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.963 0.411 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.92 -39.41 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.233 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -77.16 -23.36 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.034 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 25.5 tptp -77.08 -24.25 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.43 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 60' ' ' ARG . 75.6 mt -63.08 -33.66 75.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.36 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 20.1 t70 -60.77 -40.82 93.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.657 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -67.28 -36.23 81.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.0 mt -71.56 -46.15 64.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.57 75.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.648 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 -170.38 54.77 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.647 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -104.81 -7.01 19.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.793 0.806 . . . . 0.0 108.961 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -132.04 94.87 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.628 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.7 m -80.03 -11.76 59.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.444 . . . . 0.0 111.409 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 121.186 0.517 . . . . 0.0 110.23 179.101 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 t -103.15 -81.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.492 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -21.48 15.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.3 2.72 14.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.602 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -57.63 3.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 109.487 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG13 ' A' ' 89' ' ' ILE . 54.0 m -81.16 -34.96 32.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.88 -174.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -66.06 -36.34 82.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.329 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.33 99.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 36' ' ' SER . 94.2 mttt -58.18 -44.73 88.17 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.999 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.77 -50.01 69.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.226 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 110.861 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 52' ' ' VAL . 15.5 tp -62.15 -43.65 98.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.15 -23.4 62.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.259 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 50.7 t80 -68.39 -40.66 81.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.14 -43.61 97.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.251 0.548 . . . . 0.0 109.816 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.459 ' HB2' HG13 ' A' ' 81' ' ' VAL . 17.9 t-80 -58.0 -41.03 82.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.647 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.08 -38.18 89.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 97.8 mt -67.1 -13.73 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.096 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.96 13.28 25.72 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.351 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.54 93.6 37.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.431 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 98.9 Cg_endo -87.75 114.83 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.504 2.136 . . . . 0.0 111.486 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 42' ' ' LEU . 27.4 m -73.64 141.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.293 0.568 . . . . 0.0 111.614 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' VAL . 12.8 m -85.36 138.0 36.55 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.688 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.12 -27.9 67.56 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.0 112.272 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -60.55 -44.62 95.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 53' ' ' SER . 10.3 m -68.18 -24.95 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.808 0.337 . . . . 0.0 110.579 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.89 -51.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.055 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.9 t -61.98 -46.7 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.21 -51.8 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.672 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 1.004 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.1 tpp180 -70.15 -28.83 65.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -63.3 -41.14 99.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.977 176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 39.4 mt-10 -67.43 -36.16 80.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 110.644 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -68.54 -50.76 49.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.612 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.607 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 35.8 mm-40 -84.55 -13.48 51.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.877 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.65 56.51 2.93 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.869 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.443 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 41.7 m0 -87.0 176.51 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 36.3 m-80 -92.51 126.22 53.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 80.3 Cg_exo -46.28 -44.5 20.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.937 3.091 . . . . 0.0 114.075 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.69 -37.73 85.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.106 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 48.5 t80 -70.09 -47.72 60.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 58' ' ' VAL . 25.0 m -58.79 -40.32 83.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.284 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -67.67 -38.09 83.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.849 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.34 -48.15 79.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.633 0.254 . . . . 0.0 110.539 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 70' ' ' PHE . 45.7 t -61.14 -38.31 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.85 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.66 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 79' ' ' GLU . . . -69.51 -32.08 71.27 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.059 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.433 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 24.8 m0 -71.61 -48.97 44.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.67 75.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.493 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 76' ' ' GLY . 10.2 tt0 -48.57 -59.54 3.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.824 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -68.08 -37.91 81.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.053 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 46' ' ' HIS . 41.7 t -58.18 -49.09 82.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.111 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -70.34 -32.23 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.262 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -74.12 -16.1 61.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.591 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 18.1 40.32 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.13 -174.78 3.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -134.0 152.93 52.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.981 0.42 . . . . 0.0 110.509 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.8 pt -126.93 158.83 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.4 tp -91.3 135.97 33.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.21 0.529 . . . . 0.0 110.934 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 36' ' ' SER . 19.2 tt -100.49 131.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.323 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -25.1 34.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 111.25 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -148.0 93.2 4.51 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.225 0.536 . . . . 0.0 110.373 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HA ' HD13 ' A' ' 89' ' ' ILE . 7.2 Cg_exo -74.03 -16.67 22.72 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.454 2.769 . . . . 0.0 113.348 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.44 -21.92 60.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -80.26 -7.43 59.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -81.23 82.73 7.03 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 m -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.288 1.042 . . . . 0.0 112.074 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -66.33 -36.04 81.9 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.954 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.44 -45.71 87.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.375 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.9 mtm -61.47 -40.07 93.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.065 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.99 -54.98 19.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 10.9 mm-40 -65.28 -24.12 67.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -56.15 17.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.01 -43.68 98.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.259 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 79.7 tttt -57.03 -41.06 77.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.445 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.97 -39.01 79.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 12' ' ' ALA . 9.9 mp -67.73 -36.27 80.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.808 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.8 t -72.65 -34.96 49.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 110.2 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.1 tp -62.44 -49.9 73.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.569 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -77.43 -7.99 57.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 67.1 t60 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.787 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 106' ' ' LEU . . . . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 120.836 0.351 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.16 -56.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.672 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.66 -40.44 96.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.569 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -67.12 -31.85 72.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.677 0.275 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 20' ' ' ILE . . . -64.23 -42.5 96.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.217 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 4.4 mm? -65.56 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.619 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.03 -44.61 96.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 14.2 m-85 -60.11 -37.53 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 16' ' ' ALA . 75.2 mt -72.78 -65.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.249 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.47 -47.02 53.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.864 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.45 8.69 27.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.271 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt 57.12 31.17 19.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -67.39 111.32 3.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.377 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -76.98 0.89 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.182 -174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.776 -177.144 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.9 p80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.824 0.345 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.7 m -103.5 -80.47 0.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.464 0.65 . . . . 0.0 110.962 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.471 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.4 ttp -83.34 -27.21 29.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.394 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.83 -2.81 22.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.814 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 10.4 tt0 -102.3 -63.86 1.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.0 110.064 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m -63.53 -46.2 87.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.842 HG23 ' HB3' ' A' ' 95' ' ' PHE . 84.2 m -72.5 -29.77 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.01 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.41 79.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.82 -42.16 97.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.251 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 94' ' ' TYR . . . -65.14 -44.07 94.6 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.245 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 36.5 mt -68.14 -40.71 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.95 0.375 . . . . 0.0 111.146 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 52' ' ' VAL . 91.7 mt -60.58 -39.37 87.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.171 0.51 . . . . 0.0 110.002 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.839 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.644 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 82.4 t80 -58.3 -55.55 33.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.11 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 48' ' ' LEU . 7.6 mp -63.99 -36.4 83.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.394 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -54.47 -56.3 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.346 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.83 -23.62 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.081 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.7 mt -62.22 -35.33 78.59 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 109.963 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.4 3.61 3.78 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.571 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.4 99.37 45.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.762 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.542 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 64.2 Cg_endo -77.08 117.64 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.125 1.883 . . . . 0.0 111.618 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 42' ' ' LEU . 27.4 m -68.03 148.58 11.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.776 -175.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.5 m -94.71 131.71 30.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.298 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 33.5 Cg_exo -58.91 -32.22 96.96 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.267 2.645 . . . . 0.0 113.216 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -55.8 -41.83 74.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 t -61.11 -37.84 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.76 -47.16 86.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.361 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.24 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.675 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.736 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.569 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 12.2 tpt180 -68.05 -36.25 79.57 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.07 -45.19 82.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.601 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.96 -46.78 56.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 111.362 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.41 ' HB3' HE21 ' A' ' 63' ' ' GLN . 1.0 OUTLIER -68.06 -42.73 80.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.502 -175.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 3.8 tp10 -84.78 -32.79 23.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.742 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.9 62.58 0.75 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.368 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.503 ' CH2' HD12 ' A' ' 17' ' ' LEU . 39.0 m0 -102.26 152.68 20.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.572 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.68 142.04 94.69 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.7 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -45.81 37.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.934 2.423 . . . . 0.0 111.982 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -58.07 -40.64 81.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.083 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 75.6 t80 -66.06 -59.63 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.7 m -56.02 -41.94 75.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.57 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.8 -50.59 71.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.67 -43.25 63.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.667 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.563 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.6 t -61.69 -38.07 79.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -60.3 -44.19 95.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.604 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 79' ' ' GLU . . . -57.29 -41.01 92.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.401 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 m0 -65.35 -43.9 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.2 83.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.163 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 53.7 mt-10 -57.06 -48.72 77.88 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.221 0.534 . . . . 0.0 110.519 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.63 -35.59 79.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.6 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' TRP . 66.9 t -62.04 -48.84 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.625 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -62.29 -38.68 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -72.73 -16.63 61.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.741 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.99 29.9 40.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.429 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -97.47 154.05 17.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -77.82 142.06 38.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.245 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.5 pt -117.25 159.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.809 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tt -87.99 109.23 19.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.294 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -101.53 150.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 25.1 mtpt -84.68 -58.83 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.514 0.673 . . . . 0.0 109.73 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -111.05 124.3 33.19 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.802 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HG2' ' OE1' ' A' ' 93' ' ' GLU . 9.9 Cg_endo -53.32 -30.92 54.36 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.074 2.516 . . . . 0.0 113.02 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' ' HG2' ' A' ' 92' ' ' PRO . 1.8 mp0 -63.99 98.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.446 ' HD2' ' HA2' ' A' ' 40' ' ' GLY . 36.6 m-85 -59.72 -59.29 5.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.364 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.842 ' HB3' HG23 ' A' ' 37' ' ' THR . 26.9 p90 -162.05 172.71 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.692 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -82.68 164.34 20.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 111.705 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -32.86 74.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.484 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -53.78 -44.86 70.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.821 0.82 . . . . 0.0 110.067 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 95' ' ' PHE . 33.1 mtp -75.21 -34.16 61.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.122 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -50.63 70.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.829 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.57 -43.64 84.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -56.02 -56.73 17.18 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 111.081 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.2 mt -61.23 -44.36 97.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.644 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -59.71 -43.01 94.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.742 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.48 -48.06 80.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 12' ' ' ALA . 10.0 mp -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.829 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 103' ' ' LEU . 25.8 t -95.45 -6.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.31 -42.08 38.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -43.48 54.75 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.498 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.478 0.947 0 C-N-CA 124.154 0.982 . . . . 0.0 112.565 177.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HA ' HD21 ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.241 0.543 . . . . 0.0 109.72 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.35 -41.08 83.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.586 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -65.28 -47.19 77.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.66 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -64.72 -42.85 94.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.0 82.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.243 0.544 . . . . 0.0 110.652 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -71.77 -24.06 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.431 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.34 -33.96 37.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.84 -44.46 89.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.3 mt -84.44 -68.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.611 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.69 45.23 3.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.056 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.52 -6.08 66.37 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.546 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ttt 69.39 105.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.529 0.732 . . . . 0.0 111.937 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -71.8 162.59 29.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.411 172.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.5 m -52.9 -36.63 59.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.363 0.265 . . . . 0.0 111.582 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 p . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.844 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.87 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 59.0 m170 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.958 0.409 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 m -82.96 -79.94 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.461 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.6 ttp -99.41 -24.02 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.759 0.79 . . . . 0.0 108.979 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -78.31 9.54 3.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.048 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 5.9 tt0 -103.05 -72.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.736 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -58.85 -54.33 48.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.542 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.4 m -61.58 -39.93 92.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 111.185 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.04 91.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -58.13 -48.2 80.96 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.477 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.71 82.02 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.571 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 103' ' ' LEU . 77.9 mt -62.9 -45.38 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.518 . . . . 0.0 110.715 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.85 -39.29 93.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.2 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.32 -39.03 78.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 48' ' ' LEU . 83.0 t80 -60.23 -44.55 95.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.25 -47.57 85.45 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.34 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 60.7 m80 -65.48 -36.06 82.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.46 -33.17 74.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 44' ' ' TYR . 76.6 mt -66.53 -45.27 79.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.588 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 138.51 4.69 1.62 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.676 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.43 93.29 4.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 90.0 Cg_endo -90.72 88.81 0.3 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.477 2.118 . . . . 0.0 112.924 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.18 123.52 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.7 m -89.09 154.32 49.43 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' GLU . 5.3 Cg_endo -49.86 -37.93 46.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.382 2.721 . . . . 0.0 112.396 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -48.68 -51.57 27.85 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.535 0.522 . . . . 0.0 110.883 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -64.68 -42.1 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.456 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.6 -48.03 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 54' ' ' PRO . 89.6 t -60.99 -52.29 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.34 90.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.359 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.53 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 13.0 tpp180 -67.84 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.457 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.71 -38.53 96.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.934 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.17 -38.93 84.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.591 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.16 -50.5 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.344 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 27.8 mm-40 -65.63 -42.66 91.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.014 0.435 . . . . 0.0 110.258 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.24 50.43 0.5 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.1 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 30.2 m0 -88.06 163.47 16.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.86 143.52 78.26 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.102 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.23 -55.81 3.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.394 2.729 . . . . 0.0 112.867 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.3 mm-40 -59.01 -37.2 76.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.472 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.445 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 80.2 t80 -64.78 -51.82 60.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -64.86 -45.89 84.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.155 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.04 -41.1 97.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.992 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.564 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 13.9 mptt -60.11 -57.53 12.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.497 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 48.4 t -58.76 -39.91 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.87 -37.63 85.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.52 86.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.262 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.564 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 8.9 m0 -67.19 -36.98 82.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.76 -44.76 89.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.306 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 2.2 tm-20 -58.17 -46.49 85.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.71 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -52.57 -58.94 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.185 178.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.5 t -67.51 -34.4 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.396 -175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.03 69.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.736 0.303 . . . . 0.0 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -81.94 -14.23 56.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.201 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.46 34.56 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -107.69 169.43 8.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.78 146.46 28.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.772 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.2 pt -128.95 159.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.999 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.074 0.464 . . . . 0.0 110.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -82.8 -12.6 12.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 75.46 -48.12 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.575 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.25 92.12 6.24 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.479 0.657 . . . . 0.0 110.911 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 -10.78 24.66 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.023 2.482 . . . . 0.0 112.424 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -72.59 -15.15 61.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.12 -1.75 58.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.961 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -82.23 84.03 7.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.0 p -71.52 147.43 47.73 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.304 1.049 . . . . 0.0 112.327 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.6 m -49.9 -42.67 48.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.67 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 62.5 t80 -57.39 -42.32 81.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.655 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.454 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 52.8 mtm -73.23 -47.29 44.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.268 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -58.14 9.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -32.34 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.923 -175.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 8.4 tt0 -62.6 -51.17 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.092 0.472 . . . . 0.0 109.811 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 41' ' ' ILE . 76.9 mt -57.75 -44.36 86.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.081 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 2.4 ttmp? -53.96 -61.78 2.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.878 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 19.8 mm-40 -57.39 -44.49 84.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.617 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 12' ' ' ALA . 32.5 tp -65.98 -44.14 85.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.697 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.54 -32.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 11.7 tp -61.05 -30.01 70.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.052 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 40.9 mt-10 -60.86 -30.13 69.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.802 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -176.127 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.891 0.377 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' HD23 ' A' ' 17' ' ' LEU . 67.8 mt -62.9 -53.23 49.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.814 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -57.44 -39.3 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HD2' HD23 ' A' ' 103' ' ' LEU . 33.6 ttmt -60.99 -53.86 52.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.751 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.12 80.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 3.6 mm? -66.85 -29.12 68.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.665 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.52 -33.77 67.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.927 0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.22 -42.7 83.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.786 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.92 -69.77 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.014 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.24 53.32 4.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.047 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.49 -146.97 18.63 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.308 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -91.45 36.16 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 110.975 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -82.28 66.8 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.095 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m 67.3 112.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.376 0.608 . . . . 0.0 111.62 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.289 176.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.9 t -96.37 -80.16 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.2 0.524 . . . . 0.0 112.182 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.401 ' O ' ' HB ' ' A' ' 37' ' ' THR . 28.8 ttp -85.05 -22.43 28.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.307 -172.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 70' ' ' PHE . 2.8 m-20 -54.0 -42.72 69.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.248 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HA ' ' CH2' ' A' ' 77' ' ' TRP . 2.4 tm-20 -50.4 -76.02 0.03 OUTLIER 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.758 0.789 . . . . 0.0 111.54 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -75.74 -37.68 59.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.701 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 33' ' ' MET . 75.0 m -68.99 -47.48 65.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.62 -38.47 89.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' A' ' 87' ' ' ILE . 3.9 ttmp? -60.9 -42.16 97.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.199 0.523 . . . . 0.0 110.527 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.12 -45.06 74.02 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.46 -42.85 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.483 0.141 . . . . 0.0 111.003 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 90.0 mt -57.36 -48.02 80.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.697 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 87' ' ' ILE . 23.2 mtpp -66.97 -37.34 84.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.297 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 67.7 t80 -65.69 -44.18 86.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.42 -42.24 88.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.828 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.16 -34.02 76.73 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.92 -43.18 79.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.605 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.3 mt -61.81 -42.23 98.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.24 6.68 2.39 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.615 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.97 99.98 51.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.782 0.325 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -88.08 121.8 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.696 2.264 . . . . 0.0 112.709 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.35 108.29 19.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -73.99 138.3 76.1 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.959 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 18.0 Cg_endo -60.05 -25.24 79.2 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.981 2.454 . . . . 0.0 111.96 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.3 -44.67 88.66 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.88 -37.78 69.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.4 t -58.4 -45.24 89.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.017 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 54' ' ' PRO . 71.8 t -63.82 -50.29 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.999 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.83 95.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.676 ' HG2' ' CD1' ' A' ' 17' ' ' LEU . 8.7 tpt180 -66.07 -41.64 90.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.236 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -60.68 -48.75 84.68 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.838 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -68.18 -27.29 66.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -69.85 -56.6 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' CD ' ' HE ' ' A' ' 60' ' ' ARG . 46.8 mt-10 -73.02 -24.6 60.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.994 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.94 49.68 2.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.006 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.419 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 36.4 m0 -74.69 147.24 41.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -63.3 142.58 97.83 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.248 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.83 -60.91 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.779 2.986 . . . . 0.0 114.432 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 4.9 mm-40 -60.16 -26.32 66.22 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 34' ' ' ASP . 30.4 t80 -66.97 -61.18 2.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 m -57.95 -38.67 76.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.261 0.553 . . . . 0.0 110.782 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -60.28 -49.52 77.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.528 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 53.6 mttm -66.79 -46.08 76.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.924 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.2 t -61.62 -40.74 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.824 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.39 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.725 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.53 99.58 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.304 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 10.2 m0 -66.82 -50.17 63.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.45 -39.03 72.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.9 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 32.8 tt0 -54.17 -54.44 39.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.824 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -68.99 -39.64 79.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.211 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' TRP . 92.5 t -69.24 -44.33 80.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.595 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.08 95.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.467 0.175 . . . . 0.0 110.833 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -65.95 -35.2 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.609 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.37 37.1 4.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.002 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -96.72 147.46 23.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.904 0.383 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -67.46 137.76 56.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 ' HD2' ' A' ' 43' ' ' LYS . 30.7 pt -138.44 135.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 88' ' ' LEU . 2.6 pp -69.97 131.13 43.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.849 0.833 . . . . 0.0 112.131 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.49 69.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.998 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.64 13.62 9.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.623 ' H ' ' CD ' ' A' ' 92' ' ' PRO . 5.9 m-80 -131.54 -51.25 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.071 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.623 ' CD ' ' H ' ' A' ' 91' ' ' ASN . 50.7 Cg_exo -59.25 -30.45 92.97 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.811 2.341 . . . . 0.0 113.353 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 65.97 17.98 10.94 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.205 0.526 . . . . 0.0 110.65 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 60.24 -95.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.731 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 100' ' ' GLN . 38.1 p90 179.34 177.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.637 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.167 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -58.1 -39.61 79.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -43.93 -54.12 5.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.046 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.5 mtm -75.18 -29.51 60.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.244 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 8.3 tt0 -67.17 -44.55 79.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.217 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.02 -40.43 97.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.43 -51.72 68.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.523 0.678 . . . . 0.0 109.75 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 107' ' ' VAL . 68.1 mt -56.66 -63.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.905 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -57.93 -49.32 77.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.491 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.81 -48.41 80.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.949 0.404 . . . . 0.0 109.977 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.95 2.01 16.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 103' ' ' LEU . 42.7 t -100.14 -33.89 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.41 -31.7 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.365 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -63.6 -63.31 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.412 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 11.4 p80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.467 0.707 . . . . 0.0 110.883 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 120.354 0.121 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.12 -50.95 59.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.46 -41.7 75.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -73.86 -34.89 64.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.49 -33.33 69.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 0.0 109.921 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.718 HD11 ' HG2' ' A' ' 60' ' ' ARG . 7.8 tt -62.75 -36.4 82.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.359 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.9 -46.4 89.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.187 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.49 -53.95 47.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.98 -46.24 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.664 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.29 60.89 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.294 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 -119.72 11.42 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.903 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.443 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 2.9 tpt -145.4 81.33 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 67.84 -3.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.538 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -160.15 156.36 26.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.839 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.3 m170 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.866 0.365 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.453 ' HB2' ' H ' ' A' ' 33' ' ' MET . 3.2 m -103.48 -80.65 0.52 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.482 0.658 . . . . 0.0 110.238 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.453 ' H ' ' HB2' ' A' ' 32' ' ' SER . 3.8 ptm -90.5 -9.74 46.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.877 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.56 -22.47 66.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.845 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -102.56 -65.37 1.0 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.739 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.6 m -56.11 -52.3 64.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.986 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 41' ' ' ILE . 23.5 m -66.81 -41.62 87.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.697 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -61.99 -51.37 68.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.171 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.91 -39.86 90.96 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -44.65 97.81 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.15 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' HD23 ' A' ' 45' ' ' LEU . 80.0 mt -64.38 -47.43 89.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.653 0.264 . . . . 0.0 111.008 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 52' ' ' VAL . 86.0 mt -62.42 -42.75 99.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.024 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -67.45 -40.54 85.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.777 0.322 . . . . 0.0 110.273 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.562 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 77.7 t80 -59.15 -47.91 83.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.317 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 41' ' ' ILE . 3.3 mm? -60.03 -45.18 93.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.848 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.91 -42.45 93.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.618 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.52 -37.8 85.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 90.3 mt -56.79 -38.48 72.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.665 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.9 -52.4 0.43 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.801 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -87.23 126.1 63.75 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 121.152 0.501 . . . . 0.0 111.611 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.1 145.75 15.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 42' ' ' LEU . 30.8 m -81.07 140.25 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.176 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB2' HG22 ' A' ' 56' ' ' VAL . 3.6 m -90.55 119.21 69.1 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.1 -38.0 39.12 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.786 2.324 . . . . 0.0 113.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -69.98 -39.41 75.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 53' ' ' SER . 27.9 m -67.37 -26.77 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 53' ' ' SER . 86.9 t -68.67 -44.4 82.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 61.3 t -62.29 -42.04 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.09 -39.56 78.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 17' ' ' LEU . 7.8 tpt180 -73.16 -34.34 66.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.296 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -58.42 -48.53 83.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 7.9 pt-20 -72.17 -26.4 62.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -82.12 -54.27 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.17 -25.83 47.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.879 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.28 60.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.391 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.429 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 34.2 m0 -103.01 165.58 10.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.7 m-20 -71.91 137.78 82.41 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.695 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 45.7 Cg_exo -56.68 -44.62 43.65 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.177 2.585 . . . . 0.0 112.567 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 52.4 mp0 -63.83 -45.8 87.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' VAL . 86.9 t80 -61.86 -54.58 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.369 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 23.4 m -58.05 -39.82 79.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.707 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.31 -46.41 73.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.928 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 61.7 mttm -66.94 -43.26 83.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.046 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.87 -36.19 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.822 0.344 . . . . 0.0 110.431 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.83 86.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.353 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.95 96.73 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.091 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . 28.1 m0 -64.2 -49.19 72.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.02 79.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.376 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -59.04 -43.14 91.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.91 0.386 . . . . 0.0 110.138 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' HG22 ' A' ' 87' ' ' ILE . 66.8 mttm -65.23 -45.46 84.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.07 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' TRP . 85.6 t -58.99 -43.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.63 65.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 p -89.74 -19.88 24.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.01 25.01 9.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.418 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -90.97 162.54 14.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 110.761 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -87.84 145.21 26.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 80' ' ' LYS . 33.7 pt -127.07 136.52 60.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.934 0.397 . . . . 0.0 110.407 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -86.84 138.54 31.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.888 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 90' ' ' LYS . 6.3 tt -126.45 161.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 89' ' ' ILE . 42.9 mmtm -74.42 44.43 0.2 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 171.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER 76.23 152.2 0.14 Allowed Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.016 0.926 . . . . 0.0 111.429 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 34.38 0.42 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.695 2.263 . . . . 0.0 112.065 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 91' ' ' ASN . 10.6 tp10 -103.52 161.47 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 74.31 -30.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.264 0.626 . . . . 0.0 111.457 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.66 86.02 3.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 166.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -83.77 172.03 12.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.783 -167.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -25.99 68.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.695 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.2 -53.66 32.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.132 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -68.73 -35.48 77.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 110.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.16 -53.59 42.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.23 -38.17 76.31 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.986 0.179 . . . . 0.0 111.314 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -51.84 -60.69 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.63 0.729 . . . . 0.0 110.506 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.6 -38.17 83.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.111 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.31 -56.62 18.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.381 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.7 tt0 -64.79 -38.34 90.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.462 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -51.26 -43.24 61.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.522 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -83.06 -39.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.594 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.335 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 41.6 mt-10 -62.86 -22.55 66.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.623 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.511 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.901 0.382 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.58 -44.62 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.381 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.55 -33.31 75.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.459 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 10.9 mmpt? -75.45 -26.66 58.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.811 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.38 0.61 . . . . 0.0 109.458 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.5 mm? -74.2 -14.83 61.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 11.9 t70 -69.01 -44.95 71.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.29 -64.29 0.92 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.708 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.0 -43.14 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.15 -9.54 80.62 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.985 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.03 -14.81 71.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.787 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.599 ' SD ' ' HA ' ' A' ' 34' ' ' ASP . 65.3 mtm -88.48 75.26 8.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.698 0.761 . . . . 0.0 110.368 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -100.02 10.31 41.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.926 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.96 54.49 1.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.518 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.101 174.568 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -59.25 -67.45 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.254 0.549 . . . . 0.0 111.774 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -61.82 2.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.618 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.599 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -51.96 -68.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.979 -175.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 36.5 tt0 -62.09 -62.21 1.93 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -169.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -58.99 -47.37 85.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.368 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -75.22 -31.27 60.83 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.424 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.5 94.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.038 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.13 -43.4 82.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.078 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.597 ' CA ' ' HA ' ' A' ' 94' ' ' TYR . . . -63.9 -46.53 91.36 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.714 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.66 -47.53 90.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.522 0.201 . . . . 0.0 111.008 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.9 -38.6 86.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 111.208 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -66.59 -42.32 87.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.088 0.471 . . . . 0.0 110.269 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 54.2 t80 -66.16 -45.34 81.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.448 HD23 HD12 ' A' ' 48' ' ' LEU . 94.7 mt -60.85 -41.59 96.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -50.49 -51.94 42.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.233 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -13.79 59.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.919 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 61.6 mt -73.43 -26.15 60.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 0.0 110.292 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.88 -14.8 10.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.376 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.69 93.17 48.76 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 110.629 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -90.97 146.21 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.091 2.527 . . . . 0.0 112.078 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.71 110.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.872 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 m -66.14 139.54 96.56 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.702 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.54 -28.08 53.47 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.034 2.489 . . . . 0.0 112.743 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.03 -44.41 87.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.211 0.529 . . . . 0.0 110.317 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.32 -38.03 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.307 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.33 -47.76 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.874 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.11 -49.68 83.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.983 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.66 92.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 1.4 tpt85 -69.39 -34.44 74.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.524 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.67 -50.21 68.5 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.275 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.25 -32.07 64.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.407 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -72.09 -45.83 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.439 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 7.3 tp10 -82.75 -48.73 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.25 65.13 0.21 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.19 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.496 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 31.5 m0 -104.56 162.71 13.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.07 148.7 81.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.66 -35.09 66.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.156 2.571 . . . . 0.0 112.411 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 24.4 mm-40 -69.9 -46.74 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.08 -46.6 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.3 m -61.31 -44.78 96.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.191 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.99 -43.22 88.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.239 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 64.0 mttm -62.07 -53.57 53.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.1 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 53.0 t -59.38 -40.19 80.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.821 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.49 -32.92 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.07 -35.81 64.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.439 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 14.3 m0 -68.68 -49.35 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.18 -42.52 77.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.0 -58.42 6.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.324 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -66.22 -46.97 75.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.811 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.32 -43.66 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.565 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.49 61.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.579 0.228 . . . . 0.0 111.22 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t -67.25 -35.59 79.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.391 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.14 -3.44 8.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.63 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.28 103.9 16.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 109.759 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -53.41 141.45 24.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.984 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 20.6 pt -124.36 113.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.531 0.681 . . . . 0.0 109.86 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.86 123.86 29.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.021 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 91' ' ' ASN . 56.2 mt -66.42 -31.03 51.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.101 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? 62.29 21.55 12.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.271 1.034 . . . . 0.0 109.456 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 1.0 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 52.4 m-80 -148.43 -160.28 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 1.0 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 31.6 Cg_exo -43.37 86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.907 2.405 . . . . 0.0 114.14 168.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 89' ' ' ILE . 19.0 mm-40 -63.99 130.14 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.883 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.597 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 96.8 m-85 64.63 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.94 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER 169.85 -157.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.161 -172.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 11.3 t -108.14 -175.78 2.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -41.12 88.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -167.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 96' ' ' SER . 0.1 OUTLIER -53.46 -47.56 69.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtt -65.1 -45.3 85.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.402 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -58.68 -45.35 89.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.645 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -60.24 -44.58 95.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.431 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -64.61 -57.41 9.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.07 -46.76 87.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.704 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -65.42 -35.17 80.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.747 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.83 -38.73 91.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 110.821 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -63.55 -34.11 77.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.304 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.93 -50.67 18.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.1 -62.43 1.88 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.394 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -71.42 -59.94 2.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.286 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 . . . . . 0 N--CA 1.471 0.586 0 O-C-N 124.015 0.822 . . . . 0.0 111.569 175.776 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.854 0.359 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.39 -37.6 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 14.0 mm-40 -76.72 -25.91 54.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.103 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -81.28 -30.61 33.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 19' ' ' PHE . . . -65.58 -36.17 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 171.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 57.1 tp -58.7 -41.02 85.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.323 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.29 -46.15 86.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.774 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 16' ' ' ALA . 57.5 m-85 -62.38 -50.74 70.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.868 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.35 -55.86 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.363 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.95 29.3 5.84 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.26 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.05 -70.63 1.1 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.564 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.9 -50.64 10.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 60.49 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.649 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t -89.64 167.35 13.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.313 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 0.0 110.569 -178.133 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.516 0.198 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -95.9 -80.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 0.0 111.911 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.2 ttp -94.32 -17.01 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.544 0.688 . . . . 0.0 109.96 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.14 -21.29 66.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.218 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -93.45 -68.79 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.679 0.275 . . . . 0.0 110.825 -176.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -46.68 88.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -67.21 -36.61 82.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 0.0 111.033 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.94 89.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.525 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 31.7 mmtp -54.74 -48.0 73.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.564 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.12 -44.56 94.71 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.348 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.475 HG23 HD11 ' A' ' 103' ' ' LEU . 73.9 mt -61.05 -49.97 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.061 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.51 -44.62 93.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.429 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.42 -27.35 65.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.387 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.14 -36.52 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.449 . . . . 0.0 110.182 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 97.2 mt -64.15 -40.37 95.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.403 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -72.74 -25.0 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.65 -38.45 89.38 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.24 0.543 . . . . 0.0 109.897 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.44 -40.2 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.767 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.29 -26.81 3.67 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.97 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.91 104.7 54.24 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -92.32 -178.49 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.028 2.486 . . . . 0.0 112.081 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -109.83 121.35 62.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 56' ' ' VAL . 6.4 m -61.65 127.55 88.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 53.1 Cg_exo -53.02 -32.33 57.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.878 2.386 . . . . 0.0 112.544 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -55.99 -52.52 63.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.664 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 53' ' ' SER . 31.5 m -71.02 -24.19 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 111.015 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.46 -45.49 88.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.126 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 65.1 t -61.11 -48.99 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.646 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.57 98.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.949 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.81 -42.49 99.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.207 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.53 -47.63 89.47 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.48 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.9 -12.78 60.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.78 0.324 . . . . 0.0 110.814 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -85.8 -52.4 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -73.88 -27.34 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.959 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.37 48.21 1.45 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.532 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.489 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 40.9 m0 -83.26 153.74 24.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 67.2 t30 -63.17 127.9 91.6 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 4.9 Cg_endo -47.3 -43.82 25.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.867 . . . . 0.0 113.332 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.3 -37.1 79.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.766 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' VAL . 74.6 t80 -70.45 -53.36 16.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -58.16 -40.03 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.322 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.79 -46.91 88.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.535 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -67.41 -46.19 73.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.545 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 70' ' ' PHE . 69.6 t -60.33 -37.82 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.56 89.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.638 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.27 -35.12 69.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.899 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.544 ' O ' HG23 ' A' ' 81' ' ' VAL . 50.6 m0 -63.1 -54.13 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.36 68.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.056 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.26 -50.29 74.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.162 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -81.27 -21.51 39.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.489 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.7 t -67.78 -38.27 79.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 109.836 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.41 -44.33 36.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.239 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.3 p -75.55 -34.83 60.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.91 44.36 4.5 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.772 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -111.7 108.52 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 62.13 -141.22 0.44 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.563 0.539 . . . . 0.0 110.671 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 89' ' ' ILE . 37.0 pt 52.76 53.06 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.34 1.056 . . . . 0.0 112.22 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 3.4 pp -79.22 19.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.499 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 87' ' ' ILE . 1.1 tt 79.28 141.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.18 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -71.32 -40.94 70.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.566 0.698 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -172.19 148.67 2.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.816 175.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 -37.81 93.74 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.453 2.102 . . . . 0.0 111.618 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.33 -97.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.43 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -142.49 24.22 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 111.116 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.25 107.39 4.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.0 m -99.34 159.93 14.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.277 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.3 t -66.79 -28.59 68.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.0 -39.88 63.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.777 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.4 mtt -66.3 -42.23 88.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.086 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.7 -51.65 68.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.586 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' THR . 73.8 mt-10 -59.64 -42.02 91.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.13 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 22.1 mt-30 -56.22 -54.86 40.19 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.698 0.285 . . . . 0.0 111.155 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.0 mt -60.76 -44.67 96.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -63.83 -41.9 97.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.865 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.296 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 96.5 mt -66.54 -21.67 66.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' LEU . 98.6 t -71.8 -40.99 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 109.91 173.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -72.3 -44.3 62.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.77 -23.53 65.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 85.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.687 0.28 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.5 mp -64.13 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.128 0.489 . . . . 0.0 109.889 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.4 -50.64 72.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.15 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 28.1 mmtp -78.85 -18.51 53.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.69 77.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.641 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.1 mt -70.95 -22.41 62.22 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.183 174.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 18.4 t70 -67.48 -36.91 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -65.07 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.488 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.92 -74.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.519 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 66' ' ' TRP . . . -95.36 46.96 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.373 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.08 -58.28 1.41 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.63 95.85 9.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 66' ' ' TRP . 76.6 m-20 -116.21 144.71 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.464 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.4 t -164.54 -178.55 5.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.29 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.503 . . . . 0.0 110.579 -178.21 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.1 m170 . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 121.66 0.743 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -92.56 -49.24 6.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.809 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.606 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.59 -27.71 28.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.332 -170.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.45 -54.17 3.18 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 124.097 0.873 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.597 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 33.5 mm-40 -59.09 -63.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.427 ' CB ' ' H ' ' A' ' 94' ' ' TYR . 19.9 m -62.14 -55.81 25.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.42 HG23 ' SD ' ' A' ' 99' ' ' MET . 90.9 m -69.14 -52.5 27.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -170.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' HZ3' ' A' ' 77' ' ' TRP . . . -75.48 -44.11 45.71 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 4.2 ttmp? -67.54 -33.59 75.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.799 0.333 . . . . 0.0 110.246 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.7 -50.42 66.3 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.314 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.15 -45.22 96.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.625 0.25 . . . . 0.0 111.102 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.52 -44.83 89.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.941 0.401 . . . . 0.0 111.249 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 9.8 mtpm? -69.92 -34.1 73.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.394 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -64.73 -42.2 95.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 110.117 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.43 -42.56 92.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.495 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.61 -35.83 78.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.606 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.56 -43.57 89.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.388 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.472 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.65 16.29 1.67 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.21 94.11 47.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.934 0.397 . . . . 0.0 110.671 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -93.02 152.19 2.63 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.886 2.391 . . . . 0.0 112.253 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 148.26 24.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.2 m -83.11 133.37 48.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.601 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 45.2 Cg_exo -56.87 -31.42 88.96 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.267 2.645 . . . . 0.0 112.519 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.59 -42.82 64.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.304 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.92 -38.65 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.414 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.43 -46.91 85.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.471 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 85.7 t -60.09 -44.26 94.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.498 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.77 88.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.641 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.0 tpt180 -65.38 -39.75 92.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.16 97.86 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.265 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 51.5 mt-10 -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.602 -0.352 . . . . 0.0 111.188 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.84 -46.09 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.4 -9.16 55.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.552 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.3 -65.3 1.58 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.819 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.619 ' HA ' ' CG ' ' A' ' 24' ' ' ASN . 35.7 m0 55.35 -167.27 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.07 0.548 . . . . 0.0 111.957 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.888 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 54.4 m-80 -93.48 123.4 60.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.45 -38.2 82.78 Favored 'Trans proline' 0 CA--C 1.526 0.106 0 C-N-CA 122.996 2.464 . . . . 0.0 112.628 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -80.45 -33.39 36.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.561 . . . . 0.0 110.015 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.888 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 77.5 t80 -73.27 -43.99 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.535 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.9 m -59.51 -35.62 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -69.59 -40.36 76.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.712 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 63.2 mttt -54.76 -57.6 10.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.0 t -60.61 -37.46 75.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.06 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.49 73.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.1 51.42 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.15 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.712 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.6 m0 -64.62 -49.25 71.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.979 0.419 . . . . 0.0 110.107 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -34.41 74.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.743 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.6 -45.28 92.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.025 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.56 -49.03 79.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.427 0.632 . . . . 0.0 110.327 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 77' ' ' TRP . 61.9 t -60.77 -44.87 98.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.502 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.1 61.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.64 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -77.45 -9.31 58.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 110.798 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.88 29.01 13.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.098 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.616 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -100.12 171.01 8.08 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 86' ' ' ARG . 13.0 ptt180 -119.44 132.83 55.88 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.8 pt -112.73 138.55 41.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.174 0.512 . . . . 0.0 110.901 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.16 116.65 17.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 89' ' ' ILE . 16.8 tt -77.48 89.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 122.502 1.144 . . . . 0.0 110.092 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 90' ' ' LYS . 17.3 pttp -67.62 -2.74 7.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.779 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -160.12 88.35 1.88 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -177.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -96.35 29.15 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.523 2.816 . . . . 0.0 112.511 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.2 -55.52 33.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.606 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 20.3 m-85 -99.45 35.67 1.91 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -171.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HE2' HE21 ' A' ' 100' ' ' GLN . 10.7 t80 -116.1 82.87 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -74.09 160.53 31.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.838 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -30.86 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.734 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.549 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.7 t80 -49.34 -51.64 33.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.546 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 37' ' ' THR . 68.0 mtm -69.45 -39.14 77.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.502 HE21 ' HE2' ' A' ' 95' ' ' PHE . 73.4 mt-30 -61.88 -46.58 88.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.23 -35.21 79.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.167 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 57.5 mt-30 -59.11 -50.92 72.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 110.37 175.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.48 -45.23 84.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.475 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.44 -42.39 82.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.23 -49.57 55.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.578 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -62.94 -44.51 95.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.942 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.0 -32.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 110.415 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.5 tp -67.51 -59.22 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -32.72 69.99 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.713 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.401 171.13 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 54.6 mt -70.52 -40.4 77.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.215 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.07 -39.77 93.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.91 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 48.4 tptt -68.71 -36.04 77.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.309 . . . . 0.0 110.61 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -41.48 99.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 110.27 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.528 HD13 ' HG2' ' A' ' 60' ' ' ARG . 92.0 mt -66.76 -32.7 74.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.687 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 7.4 t70 -57.49 -44.55 85.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.018 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.49 -41.85 98.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -54.25 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.648 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -54.16 30.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.81 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -111.28 4.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.904 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.6 mtt -109.21 -42.67 4.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 51.1 71.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.902 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -105.28 -78.44 0.57 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.293 0.568 . . . . 0.0 109.796 178.703 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 5.0 m170 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.763 0.316 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -104.19 -58.18 1.92 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 110.485 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -87.4 -58.52 2.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.074 -171.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.36 -5.47 32.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.014 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.679 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 21.0 tt0 -103.19 -62.74 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.09 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.8 m -58.28 -55.78 30.54 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 33' ' ' MET . 41.3 m -70.91 -30.17 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.83 0.348 . . . . 0.0 110.868 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.74 99.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' HE3' ' CG ' ' A' ' 35' ' ' GLU . 92.3 mttt -58.88 -43.69 90.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.072 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 -44.38 97.87 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.594 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.418 HG12 ' HE1' ' A' ' 95' ' ' PHE . 55.5 mt -61.32 -47.43 93.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.042 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 HG11 ' A' ' 52' ' ' VAL . 82.5 mt -64.36 -40.29 95.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 110.916 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.08 -34.23 76.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.461 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 76.3 t80 -65.62 -39.13 91.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.62 -44.18 96.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 110.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -62.62 -32.52 73.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.575 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.49 -34.46 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.305 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.3 mt -67.65 -41.68 83.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.353 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.25 -50.22 0.47 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.734 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 m -87.47 121.24 71.25 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.224 0.535 . . . . 0.0 112.226 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.8 165.8 8.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HD22 ' A' ' 42' ' ' LEU . 8.9 p -107.03 147.79 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.45 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 13.8 m -102.16 137.05 19.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 27.0 Cg_exo -62.56 -24.79 75.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.241 2.627 . . . . 0.0 112.545 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -53.36 -45.92 69.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.825 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.84 -36.52 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.62 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 74' ' ' VAL . 66.8 t -64.0 -49.73 80.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.73 -46.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.06 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.528 ' HG2' HD13 ' A' ' 17' ' ' LEU . 20.8 tpt180 -66.4 -43.35 86.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -47.08 91.3 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.429 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.13 -33.6 76.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.639 0.257 . . . . 0.0 111.418 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.97 -57.19 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.52 -31.58 68.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.161 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.66 45.03 1.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.964 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -85.65 131.43 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.449 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t30 -65.65 123.45 84.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 26.3 Cg_exo -30.11 -44.67 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.748 4.299 . . . . 0.0 115.918 -176.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.05 -35.19 72.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.096 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 74' ' ' VAL . 57.4 t80 -74.92 -47.54 29.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 m -60.44 -39.8 88.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.879 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -62.41 -43.94 97.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.927 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -56.53 -58.75 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 31.8 t -59.65 -41.59 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.564 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.07 88.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.438 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.08 -37.98 94.82 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.44 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.679 ' CZ2' ' HG3' ' A' ' 35' ' ' GLU . 11.1 m0 -66.43 -53.78 31.7 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.13 -40.29 64.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.986 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -55.24 -54.57 41.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.796 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 58.5 mttt -73.05 -39.3 66.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -42.21 92.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.541 0.21 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.83 93.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.185 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -78.92 -9.22 59.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.57 39.39 41.54 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.217 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 55.4 m-20 -98.61 152.16 19.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.38 149.72 48.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.152 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 pt -136.39 166.03 27.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.89 102.43 14.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 89' ' ' ILE . 4.0 tt -103.28 -6.94 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.068 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 90' ' ' LYS . 3.8 tptp 66.11 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.0 -169.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -153.26 126.86 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.21 -59.06 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.279 1.986 . . . . 0.0 111.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.68 ' HG2' ' HB3' ' A' ' 91' ' ' ASN . 27.7 mm-40 57.21 -81.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 172.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -85.08 53.44 2.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 41' ' ' ILE . 21.8 t80 -111.27 71.15 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -61.01 144.8 52.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.66 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 m -53.55 -38.18 63.6 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.523 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.23 -37.93 78.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.672 0.273 . . . . 0.0 111.231 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.2 mtm -75.56 -41.09 55.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.35 -47.72 82.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.768 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 13.5 tp10 -69.39 -28.0 65.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.675 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -66.24 -49.08 68.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.337 0.589 . . . . 0.0 109.819 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.44 -43.6 98.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.238 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 34.6 tttm -58.86 -37.08 75.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.144 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.5 tt0 -58.31 -54.67 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 12' ' ' ALA . 6.1 tt -56.13 -45.3 79.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.364 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.73 -42.46 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.3 tp -66.58 -44.91 80.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.992 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 52.7 mt-10 -49.15 -45.46 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.353 -172.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -63.28 -47.62 91.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.104 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.72 -36.76 84.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.495 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -66.85 -46.97 73.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.26 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.476 . . . . 0.0 110.314 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' A' ' 60' ' ' ARG . 21.6 tp -66.79 -34.53 78.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.419 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.93 -42.31 97.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.119 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.13 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.42 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.38 -65.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.92 -51.74 55.05 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.903 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.71 -117.17 4.97 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 ptm -165.28 117.87 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.168 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -95.68 93.61 7.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.025 0.441 . . . . 0.0 110.662 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -78.8 83.15 4.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.617 0.722 . . . . 0.0 109.68 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.176 -177.83 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 26.4 m-70 . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 m -103.3 -80.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.312 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 10.4 ttp -109.34 -17.66 13.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.737 0.779 . . . . 0.0 108.907 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -79.96 -0.25 34.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.307 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 31' ' ' HIS . 3.5 tm-20 -102.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.782 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -73.36 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.9 m -62.17 -32.31 72.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.273 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.02 89.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.836 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 87' ' ' ILE . 58.4 mttp -57.0 -44.35 82.67 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.79 -49.08 82.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.01 -42.47 88.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.817 0.342 . . . . 0.0 111.061 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.53 -44.51 85.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.46 0.648 . . . . 0.0 110.237 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.608 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 57.9 tttp -71.29 -39.38 71.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.511 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 51.2 t80 -63.24 -38.95 93.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.29 -41.81 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.71 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 51.1 m80 -61.84 -36.05 80.06 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.077 0.465 . . . . 0.0 109.945 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 13.5 t70 -62.63 -51.13 68.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 89.4 mt -54.63 -44.06 72.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.429 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.594 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 144.6 -7.29 1.73 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.159 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.15 98.05 6.02 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 121.311 0.577 . . . . 0.0 110.951 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 72.6 Cg_endo -87.74 89.13 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.548 2.166 . . . . 0.0 112.447 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.4 129.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.997 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -92.7 157.82 39.15 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 Cg_endo -52.04 -34.02 55.51 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.31 -50.52 50.48 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.208 0.528 . . . . 0.0 110.878 174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.64 -37.51 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.466 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.46 -47.65 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PRO . 85.9 t -62.01 -54.27 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HG2' HD11 ' A' ' 17' ' ' LEU . 13.9 tpp180 -65.4 -45.48 83.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.026 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.07 99.52 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.555 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.9 mt-10 -68.57 -26.18 65.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.56 0.219 . . . . 0.0 111.208 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.33 -46.46 11.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 111.14 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -78.35 -26.2 46.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.76 46.29 3.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.004 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -74.93 164.17 26.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.489 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.475 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 57.8 t30 -69.91 127.85 92.18 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 82.4 Cg_exo -45.25 -47.67 12.35 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.15 2.566 . . . . 0.0 113.018 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.62 -34.18 67.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.857 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' HG23 ' A' ' 74' ' ' VAL . 76.8 t80 -71.34 -59.57 2.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.05 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 24.7 m -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.584 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.54 -49.9 73.48 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -72.73 -40.74 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.613 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' CZ3' ' A' ' 77' ' ' TRP . 96.0 t -64.19 -36.07 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.699 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.99 93.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.159 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.266 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CZ3' HG22 ' A' ' 74' ' ' VAL . 27.7 m0 -65.98 -48.28 71.76 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.33 82.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.094 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -57.32 -48.53 78.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 0.0 110.763 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.68 -40.5 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.457 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' TRP . 70.5 t -68.47 -35.15 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.589 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.55 80.58 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -69.81 -21.05 63.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.308 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.66 35.53 9.23 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.14 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.3 -178.15 4.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.958 0.409 . . . . 0.0 110.348 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -111.26 138.45 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.532 HD12 ' HD3' ' A' ' 39' ' ' LYS . 39.2 pt -120.43 150.65 23.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 -172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.26 101.71 9.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.249 0.547 . . . . 0.0 109.723 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 1.4 tt -89.57 -71.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.076 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 89' ' ' ILE . 43.1 mmtm 175.66 -59.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -172.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -169.52 139.59 1.73 Allowed Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.06 -178.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.79 24.18 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.114 2.543 . . . . 0.0 114.071 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' ASN . 36.2 tt0 -75.0 -26.19 59.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.608 ' HE1' ' HD3' ' A' ' 43' ' ' LYS . 98.4 m-85 67.43 -77.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.939 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.733 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 26.0 p90 -170.21 -173.76 1.57 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.651 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 m -75.89 155.06 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.926 0.393 . . . . 0.0 111.465 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -25.82 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.382 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -43.34 -56.43 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.276 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.733 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 2.1 mpt? -64.23 -44.77 90.82 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.063 -174.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG3' ' CE1' ' A' ' 95' ' ' PHE . 24.4 mt-30 -57.62 -49.66 75.71 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 -35.21 75.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.648 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 5.8 tp-100 -61.38 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.601 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' VAL . 10.0 mp -57.26 -39.55 75.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.725 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -57.77 -52.74 64.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.998 0.428 . . . . 0.0 111.482 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.33 65.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 86.5 mt -73.51 -31.65 63.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' LEU . 29.0 t -90.03 -13.66 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 110.482 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.28 -31.78 72.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.395 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.73 -37.14 86.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.353 175.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.95 0.405 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.4 -30.53 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.588 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HG2' HH22 ' A' ' 60' ' ' ARG . 3.6 tm-20 -65.87 -42.63 90.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.626 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 70.5 mmtt -75.08 -20.17 59.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.26 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.08 -39.34 86.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.748 HD12 ' HG2' ' A' ' 60' ' ' ARG . 4.0 mm? -65.61 -33.0 74.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.612 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.14 -36.63 80.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.252 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.2 -43.17 95.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.665 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.87 -56.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.708 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.46 -49.58 30.75 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.602 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 -71.71 2.75 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.998 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.528 ' HG3' ' H ' ' A' ' 24' ' ' ASN . 10.2 tpt -134.53 175.5 9.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -172.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' H ' ' HG3' ' A' ' 23' ' ' MET . 4.7 p-10 -69.24 168.51 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.069 0.462 . . . . 0.0 111.432 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 3.0 t -58.97 120.48 9.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.607 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.325 -0.477 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.135 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.6 m80 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.188 0.518 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.9 m -83.69 -52.41 6.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.903 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.559 ' C ' ' HE3' ' A' ' 33' ' ' MET . 0.7 OUTLIER -51.48 -35.47 40.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.949 -175.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.26 -66.14 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 111.58 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 mm-40 -54.12 -64.69 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.472 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 p -67.48 -42.8 82.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.415 ' CB ' ' SD ' ' A' ' 33' ' ' MET . 33.4 m -79.3 -53.33 7.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.5 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.842 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HD3' HG12 ' A' ' 89' ' ' ILE . 87.2 mttt -64.57 -37.91 89.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.066 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.53 -50.28 69.38 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.342 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 47.9 mt -66.66 -45.41 88.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.994 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 74' ' ' VAL . 79.4 mt -59.83 -45.85 91.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.627 0.251 . . . . 0.0 111.357 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.12 -44.26 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.893 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 58.4 t80 -61.28 -43.78 98.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.249 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 86.8 mt -62.14 -43.02 99.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.403 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.603 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 56.7 m80 -62.6 -37.71 87.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.488 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.95 -38.36 90.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.119 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.2 mt -66.4 -25.16 66.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.11 1.91 14.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.176 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.6 95.75 9.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 77.2 Cg_endo -86.96 94.3 0.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.281 1.987 . . . . 0.0 112.76 -177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 117.13 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.499 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -99.41 162.06 22.55 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.471 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.2 Cg_exo -53.06 -37.1 78.75 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.186 2.591 . . . . 0.0 112.955 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -56.74 -42.33 79.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.9 -49.81 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.91 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 54' ' ' PRO . 57.7 t -63.06 -47.7 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.76 93.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.782 HH22 ' HG2' ' A' ' 14' ' ' GLU . 5.4 tpp180 -66.16 -42.11 89.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.976 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.78 -36.88 81.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.176 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -71.79 -38.22 70.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.786 0.326 . . . . 0.0 110.672 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -63.32 -50.76 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 111.233 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 60' ' ' ARG . 63.0 mt-10 -87.21 -21.69 25.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 25' ' ' THR . . . 82.51 47.12 6.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.159 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -70.35 158.67 35.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.72 135.03 95.43 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.7 -24.69 23.97 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.14 -53.05 62.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.917 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.671 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 51.8 t80 -71.52 -43.52 66.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.124 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 m -58.26 -41.62 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -69.57 -42.26 74.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.671 ' CE ' ' HA ' ' A' ' 70' ' ' PHE . 53.4 mtmt -56.24 -58.71 6.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 42' ' ' LEU . 54.2 t -62.92 -40.05 87.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.543 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.63 88.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 110.516 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -65.19 -40.9 97.06 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.804 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.47 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 43.8 m0 -62.27 -44.59 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.121 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.41 96.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -45.71 88.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HD3' HG22 ' A' ' 87' ' ' ILE . 28.8 mtpp -61.62 -51.73 67.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 77' ' ' TRP . 19.5 t -67.96 -35.53 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.31 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.7 -33.76 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -79.18 -14.18 59.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.373 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.17 26.97 11.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.848 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -111.01 135.11 52.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -62.13 145.92 52.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.627 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' HD3' ' A' ' 80' ' ' LYS . 15.9 pt -103.61 129.99 54.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.5 pt? -68.12 115.37 7.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.484 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.75 HG12 ' HD3' ' A' ' 39' ' ' LYS . 25.1 mt -121.7 137.38 55.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -59.24 -41.26 88.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 153.92 126.39 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 125.401 1.688 . . . . 0.0 109.19 166.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.16 -63.05 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.3 2.0 . . . . 0.0 110.943 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 68.23 -60.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.218 0.949 . . . . 0.0 112.545 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.97 6.89 23.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.812 0.339 . . . . 0.0 110.986 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -73.25 93.47 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m -111.69 -170.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 0.0 112.875 -166.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.5 -54.85 19.11 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.827 -169.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -56.36 -40.37 74.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.341 0.4 . . . . 0.0 111.786 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.3 mtt -66.28 -51.24 59.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.864 0.364 . . . . 0.0 110.743 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.0 -44.42 84.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -65.6 -45.57 82.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.856 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.416 ' O ' HD13 ' A' ' 106' ' ' LEU . 18.3 tp60 -56.46 -53.71 54.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.127 0.489 . . . . 0.0 110.617 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.0 -44.85 94.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.068 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.14 -34.75 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.68 -48.67 73.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.011 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 102' ' ' GLN . 10.1 mp -59.69 -37.22 78.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.2 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.2 t -74.76 -37.87 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 110.69 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.1 tp -58.53 -49.22 78.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.649 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.85 -12.99 61.87 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.917 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.044 0 CA-C-O 121.119 0.485 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.64 -32.31 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.465 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.55 -30.31 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.68 -35.17 76.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' HZ2' ' A' ' 66' ' ' TRP . 35.8 tp -61.01 -44.02 98.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.683 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.23 -35.25 79.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.28 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HE2' ' SD ' ' A' ' 99' ' ' MET . 1.2 m-85 -64.65 -47.18 79.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.59 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -87.97 -59.73 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 111.398 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.77 42.32 1.99 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.28 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.74 78.21 1.05 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.238 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.3 ttt 69.25 10.65 7.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.292 0.637 . . . . 0.0 110.56 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.07 82.4 3.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.843 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.5 t -101.51 -12.5 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.728 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.513 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 120.81 0.338 . . . . 0.0 111.268 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 p -97.35 -79.86 0.45 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 111.651 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' THR . 2.9 tpt -51.75 -62.28 1.73 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.747 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . 4.0 p-10 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.619 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.4 tt0 -102.62 -73.99 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.601 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.6 p -61.25 -39.18 89.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 33' ' ' MET . 57.6 m -70.15 -41.11 74.27 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.445 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.12 -36.68 84.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.502 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.18 -43.28 87.44 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.73 96.61 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.906 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 37' ' ' THR . 90.7 mt -59.03 -50.52 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.519 . . . . 0.0 110.455 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.67 -48.88 78.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.532 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -72.11 -29.85 64.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.568 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.436 ' HD2' HD12 ' A' ' 45' ' ' LEU . 72.9 t80 -63.77 -48.84 75.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.651 0.262 . . . . 0.0 111.168 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.436 HD12 ' HD2' ' A' ' 44' ' ' TYR . 8.2 mp -67.86 -32.09 72.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.689 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -66.34 -37.13 84.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.22 -36.66 84.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.35 -46.82 84.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.831 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.71 -55.49 0.36 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.369 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.23 113.48 60.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.097 0.475 . . . . 0.0 112.172 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.82 155.22 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.813 2.342 . . . . 0.0 111.772 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.93 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 m -83.44 149.15 57.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.42 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.19 -28.99 64.28 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.088 2.525 . . . . 0.0 112.195 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -46.17 -51.67 13.7 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.718 0.636 . . . . 0.0 110.569 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.529 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -63.27 -47.78 90.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.462 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 74' ' ' VAL . 57.8 t -58.04 -53.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.438 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.6 -41.51 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.33 76.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.201 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -68.36 -45.39 72.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.735 0.302 . . . . 0.0 110.285 176.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.71 85.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.834 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.55 -46.01 64.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.218 0.532 . . . . 0.0 110.279 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -69.68 -50.47 43.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.493 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -85.44 -48.09 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.574 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.61 -59.67 0.69 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HZ2' HD12 ' A' ' 17' ' ' LEU . 34.7 m0 51.96 -104.57 0.19 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 111.911 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 18.8 t-20 -171.61 131.64 0.77 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.68 -56.87 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.695 2.263 . . . . 0.0 113.275 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.63 -37.99 83.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.731 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 61.1 t80 -64.68 -42.99 94.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.215 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.7 m -63.66 -40.99 98.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.435 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -70.19 -37.49 75.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.25 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -52.58 -60.18 3.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 57' ' ' VAL . 24.2 t -61.45 -39.37 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.261 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.98 85.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.95 -39.62 94.99 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.202 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.457 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 m0 -62.56 -48.34 79.89 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.19 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.992 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.19 -53.04 61.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.091 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.18 -51.52 69.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -39.16 84.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.33 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.48 -33.49 71.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.957 0.408 . . . . 0.0 110.869 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -74.12 -19.39 60.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.387 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.46 32.53 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.127 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.575 ' N ' HD22 ' A' ' 85' ' ' ASN . 0.7 OUTLIER -96.89 164.96 12.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.03 148.04 26.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.158 0.504 . . . . 0.0 110.727 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.53 145.06 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.7 pt? -72.61 129.3 37.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.702 0.763 . . . . 0.0 112.051 -173.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.7 tt -135.26 1.73 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.591 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 90' ' ' LYS . 17.1 mtmt 66.05 -70.25 0.1 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.893 -173.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -161.5 136.87 5.66 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.961 -178.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 22.6 Cg_exo -63.84 78.51 0.15 Allowed 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 122.945 2.43 . . . . 0.0 112.715 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -81.82 -38.76 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.486 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -99.8 13.8 32.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.214 -170.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.7 96.03 5.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.46 0.648 . . . . 0.0 109.538 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.9 p -100.72 166.69 10.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.311 1.053 . . . . 0.0 112.197 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -45.89 -40.44 10.05 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.639 -2.073 . . . . 0.0 112.331 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -59.91 -47.36 86.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.939 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HE2' ' A' ' 19' ' ' PHE . 14.4 mmt -64.39 -45.25 88.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.205 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -60.34 -58.25 9.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.279 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -60.05 -31.9 70.42 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.197 0.311 . . . . 0.0 111.788 -175.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -59.8 -58.24 9.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.541 0.686 . . . . 0.0 109.932 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.89 -37.46 87.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.454 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 84.1 tttt -54.59 -60.17 3.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.591 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.61 -27.02 66.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.466 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.95 -47.41 80.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.88 0.372 . . . . 0.0 110.596 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -77.75 -24.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.289 0.566 . . . . 0.0 110.54 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.3 tp -67.93 -17.16 64.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.54 -81.57 0.2 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.09 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.663 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mm -60.19 -46.57 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.381 . . . . 0.0 111.544 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.9 -35.44 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.277 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -79.27 -30.97 43.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.73 0.3 . . . . 0.0 110.435 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.33 94.0 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.2 mt -68.61 -27.46 66.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.97 -42.02 77.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.886 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HZ ' ' OE1' ' A' ' 102' ' ' GLN . 36.9 m-85 -59.62 -53.14 61.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.337 174.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -64.17 -44.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.836 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.33 47.24 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.606 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.57 51.1 4.18 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -87.29 -3.58 59.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.689 0.396 . . . . 0.0 110.595 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t30 66.39 -74.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.252 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -179.09 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.873 -176.801 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 12.0 m170 . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -54.21 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.688 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -24.59 34.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' HIS . 13.9 t70 -53.91 -60.32 3.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.701 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.09 -43.27 91.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -68.06 -50.52 54.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.969 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 53.7 m -73.29 -42.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.715 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.41 -48.91 75.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.91 -34.23 77.48 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.727 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.58 92.68 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.575 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 37' ' ' THR . 76.0 mt -59.02 -46.18 91.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.914 0.387 . . . . 0.0 110.488 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 94.3 mt -58.16 -47.93 81.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.527 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' HIS . 89.7 mttt -68.25 -35.84 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.024 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 48' ' ' LEU . 66.1 t80 -65.5 -48.83 71.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.407 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 84.5 mt -61.84 -38.38 87.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.978 0.418 . . . . 0.0 110.715 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 41.3 t-80 -50.97 -51.45 52.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.45 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.0 -7.96 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 44' ' ' TYR . 74.5 mt -77.14 -36.24 55.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.56 4.08 13.72 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.347 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 43.9 t -129.42 93.17 36.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 110.773 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.27 162.79 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.198 2.599 . . . . 0.0 111.773 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.81 137.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.743 0.306 . . . . 0.0 110.794 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 56' ' ' VAL . 10.3 m -73.36 127.63 88.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 23.4 Cg_endo -63.1 -29.08 74.32 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.577 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -53.06 -53.36 51.35 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 53' ' ' SER . 29.7 m -69.59 -26.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -176.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.3 -41.01 80.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 54' ' ' PRO . 63.6 t -59.63 -54.19 37.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.187 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.38 86.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.328 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HG2' HD13 ' A' ' 17' ' ' LEU . 3.4 tpp180 -63.72 -44.13 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.554 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -59.28 -47.61 89.97 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.199 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.4 -23.51 61.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.807 0.337 . . . . 0.0 110.807 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -80.04 -45.25 18.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.959 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 60' ' ' ARG . 38.0 mm-40 -75.42 -17.07 60.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 0.0 110.61 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.8 48.38 4.71 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.128 176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 49.5 m0 -70.72 -81.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.608 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 63.2 t30 166.18 130.79 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.608 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 40.7 Cg_exo -35.91 -48.05 1.06 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.932 3.088 . . . . 0.0 114.403 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 22.4 mm-40 -69.85 -38.44 76.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -69.42 -52.29 28.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.735 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 m -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.19 -54.66 44.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.75 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 49.7 mttm -63.81 -47.62 80.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -173.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.12 -39.56 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.81 92.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -38.32 95.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.186 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.6 m0 -65.17 -49.9 68.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.08 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.276 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 9.2 tp10 -56.83 -51.7 67.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 88.1 mttt -70.21 -29.49 66.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.471 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 77' ' ' TRP . 78.5 t -71.98 -43.13 68.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.651 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -43.86 75.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.045 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -70.13 -31.06 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 111.001 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.74 26.54 19.57 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.998 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -95.33 0.93 54.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.861 0.839 . . . . 0.0 110.333 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.8 mtm-85 64.47 156.6 0.08 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.387 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 80' ' ' LYS . 20.8 pt -119.02 17.63 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.212 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt 46.64 -151.35 0.08 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.975 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 tt -170.99 132.57 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 168.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -95.08 -18.87 20.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.738 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -123.37 102.35 36.59 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.04 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.93 -26.61 58.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.355 2.037 . . . . 0.0 112.856 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.35 118.06 21.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -79.54 -77.7 0.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.24 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -173.23 168.73 4.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.611 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.0 t -54.86 139.99 38.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.378 1.085 . . . . 0.0 111.667 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.8 m -57.92 -21.88 45.91 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.698 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -60.15 -49.52 77.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -64.96 -28.73 69.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.714 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.09 -51.72 55.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -37.35 74.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.403 ' OE1' ' HZ ' ' A' ' 19' ' ' PHE . 29.6 tt0 -63.39 -53.24 55.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.734 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.47 -42.98 99.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.168 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -52.08 -55.88 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.928 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.71 -32.25 69.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.047 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.01 -46.51 88.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.12 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.9 -41.57 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.619 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.74 -41.2 90.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.217 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.85 5.48 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 112.042 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 110.038 172.876 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.776 0.322 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.65 -36.86 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.637 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.89 -43.91 67.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.839 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -70.86 -31.42 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.296 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.58 80.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.172 0.51 . . . . 0.0 110.212 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.33 -34.18 75.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -62.26 -41.04 98.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.053 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -73.55 -58.82 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.556 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.0 mt -72.09 -49.18 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.759 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.66 10.63 8.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.263 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 70.89 2.92 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.428 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 22.2 ptp -61.5 -28.82 69.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.306 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t30 64.29 -83.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.771 0.67 . . . . 0.0 111.278 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -99.4 10.5 41.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 42.3 t . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.856 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.439 ' HE1' ' HD1' ' A' ' 70' ' ' PHE . 5.4 m170 . . . . . 0 N--CA 1.456 -0.167 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -95.67 -80.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 110.979 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 37' ' ' THR . 7.1 ptm -102.66 -14.91 16.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.959 0.885 . . . . 0.0 109.007 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -80.35 10.5 4.51 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.827 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.7 tm-20 -103.06 -73.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.479 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -76.37 -52.51 9.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.287 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 33' ' ' MET . 38.6 m -56.14 -46.21 79.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 0.0 111.005 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.95 99.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 39' ' ' LYS . 34.6 ttmt -64.04 -38.45 91.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.431 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -37.66 91.5 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.386 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 103' ' ' LEU . 63.8 mt -59.12 -46.47 91.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.677 0.275 . . . . 0.0 110.646 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.43 -42.83 92.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -70.41 -36.5 74.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 65.9 t80 -67.97 -37.38 81.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 103' ' ' LEU . 89.0 mt -65.81 -35.05 79.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.792 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -62.0 -36.43 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 18.9 t70 -61.82 -37.96 86.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 45' ' ' LEU . 93.2 mt -72.91 -20.27 61.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.99 -32.88 4.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.65 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.9 108.2 33.3 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 0.0 111.867 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 94.4 Cg_endo -88.63 137.01 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -89.22 103.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.856 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.403 ' HB2' HG23 ' A' ' 56' ' ' VAL . 50.9 m -62.05 139.07 95.94 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 14.9 Cg_endo -58.43 -27.69 82.59 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -42.41 98.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.232 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.452 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -65.48 -36.29 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.88 -47.96 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.189 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 74.3 t -62.63 -44.12 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.357 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.95 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.113 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 3.7 mmp_? -67.1 -43.85 81.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -61.77 -32.49 81.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.51 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.74 -27.07 44.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.477 0.18 . . . . 0.0 111.46 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -81.71 -50.48 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.182 0.515 . . . . 0.0 110.602 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 27.6 mm-40 -83.68 -23.84 31.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.484 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.33 56.73 2.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.728 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.507 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 44.9 m0 -71.92 175.84 5.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 110.635 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -82.8 154.57 68.01 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.316 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 10.9 Cg_endo -54.79 -60.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.184 2.59 . . . . 0.0 112.579 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -60.46 -33.93 73.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.075 0.464 . . . . 0.0 110.96 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.556 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 10.5 t80 -65.55 -57.31 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.475 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 m -61.95 -39.54 92.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 110.819 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 68' ' ' PRO . 22.2 tttp -61.34 -57.18 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.554 -176.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.46 -47.44 67.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.073 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 93.7 t -61.8 -39.66 84.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.609 0.242 . . . . 0.0 110.94 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.09 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.0 110.417 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.53 93.56 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.141 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 81' ' ' VAL . 17.4 m0 -68.93 -44.47 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.47 87.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.43 -53.09 56.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.639 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.63 -37.81 88.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.394 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 77' ' ' TRP . 93.1 t -70.1 -46.04 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.463 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.37 -44.33 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.545 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -67.06 -32.3 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.0 45.79 2.17 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.624 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.18 167.26 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -91.45 132.25 36.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.429 0.633 . . . . 0.0 111.073 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.18 90.49 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.499 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 110.89 5.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.493 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 tt -79.41 98.97 3.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.729 0.776 . . . . 0.0 109.715 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -67.1 -13.94 62.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.042 -175.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.95 90.48 5.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.41 0.624 . . . . 0.0 111.663 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.92 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.421 2.08 . . . . 0.0 110.766 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 56.37 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 170.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -86.2 24.49 1.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -98.15 103.9 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' A' ' 99' ' ' MET . 31.4 t -78.38 157.74 28.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.927 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 98' ' ' TYR . 14.3 t -65.97 -44.7 84.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.206 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.436 ' N ' HG23 ' A' ' 97' ' ' THR . 49.4 t80 -62.76 -27.12 69.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.889 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 96' ' ' SER . 61.2 mtt -64.32 -47.72 78.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -62.91 -50.01 72.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.938 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 105' ' ' GLU . 48.0 mt-10 -59.22 -41.96 89.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.366 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.791 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -54.67 -55.95 24.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.502 . . . . 0.0 110.709 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 41' ' ' ILE . 71.6 mt -60.62 -45.06 95.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.22 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -64.39 -47.63 78.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 38.8 mm-40 -64.85 -34.1 77.56 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.51 -47.66 83.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.29 -38.73 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.41 -48.15 76.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.39 -29.43 69.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.899 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.8 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.044 172.012 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.3 mp -64.72 -45.04 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.685 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.752 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -75.18 -33.66 61.48 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.651 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.45 99.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 109.791 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 60' ' ' ARG . 25.0 tp -64.56 -38.93 92.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.859 175.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.04 -29.82 70.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.026 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.3 -52.0 60.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.691 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.13 -48.29 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.13 31.5 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.936 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.07 28.87 4.89 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.615 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -65.8 -35.98 82.22 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.6 m120 68.57 -44.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.619 0.768 . . . . 0.0 111.771 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 26' ' ' SER . 1.6 m -99.07 -152.45 0.41 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.673 ' H ' HG22 ' A' ' 25' ' ' THR . 15.4 m . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 120.89 0.376 . . . . 0.0 110.041 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.506 0.194 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.5 m -103.58 -80.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.2 tpt -57.48 -52.03 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.044 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -83.91 1.22 44.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.453 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.4 -77.44 0.57 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.387 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -63.3 -48.06 79.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 m -71.17 -30.67 66.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 110.552 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.06 83.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -56.35 -44.64 80.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.384 174.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.43 -44.18 97.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.257 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 67.3 mt -66.2 -44.85 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 110.864 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.55 -37.7 84.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.701 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -66.33 -49.41 67.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.988 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' HD11 ' A' ' 48' ' ' LEU . 71.7 t80 -57.6 -44.75 85.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.575 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 94.4 mt -60.31 -47.98 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.618 0.247 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m80 -62.17 -36.77 82.86 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.751 177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.92 -32.83 73.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.114 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 44' ' ' TYR . 81.1 mt -67.68 -16.72 64.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.268 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 107.37 1.45 35.33 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.109 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.46 98.04 15.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 97.8 Cg_endo -84.0 104.88 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.232 1.954 . . . . 0.0 112.855 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 101.03 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.72 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.6 m -66.05 140.54 97.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.336 -177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.491 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 52.3 Cg_exo -55.75 -34.86 92.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.262 2.641 . . . . 0.0 112.506 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.93 -48.72 72.76 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.828 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.77 -38.43 81.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.275 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.88 -45.48 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.823 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 96.8 t -62.41 -49.08 85.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.944 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.76 94.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.12 0.486 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HG2' HD11 ' A' ' 17' ' ' LEU . 10.3 tpp180 -66.96 -40.42 87.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.89 -40.7 99.21 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.375 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 36.8 mt-10 -68.14 -31.11 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.581 0.229 . . . . 0.0 111.206 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -76.16 -53.38 8.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 111.267 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.731 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.89 48.71 2.42 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.751 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.654 ' HB3' ' HD2' ' A' ' 70' ' ' PHE . 48.7 m0 -81.13 0.31 36.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 93.1 m-20 72.94 145.05 0.11 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.835 0.454 . . . . 0.0 111.02 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.29 -41.29 79.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.703 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 44.9 mt-10 -63.26 -56.05 19.79 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.657 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.654 ' HD2' ' HB3' ' A' ' 66' ' ' TRP . 89.7 t80 -60.67 -47.01 88.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.826 0.346 . . . . 0.0 110.631 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 31.1 m -58.78 -41.24 86.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.978 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.98 -43.49 95.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.779 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 67.9 mttm -62.52 -53.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.546 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 46.5 t -59.7 -41.48 85.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.846 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -61.42 -40.82 95.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.388 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -61.48 -42.41 99.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.393 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.546 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 15.2 m0 -62.13 -44.77 95.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.254 0.549 . . . . 0.0 109.572 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.58 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 48.9 mt-10 -59.21 -48.14 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.354 0.409 . . . . 0.0 110.97 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.7 mtpp -60.97 -52.31 65.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' TRP . 62.1 t -61.38 -35.68 68.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.39 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.14 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.1 t -61.76 -48.26 81.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.453 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.77 -10.8 3.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -87.75 107.39 18.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -58.07 156.67 9.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.653 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.54 141.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.75 111.75 24.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 110.763 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 91' ' ' ASN . 14.6 tt -91.78 140.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -94.28 -8.66 38.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.562 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.589 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.5 p30 -149.16 76.61 9.35 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.425 0.631 . . . . 0.0 111.297 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.05 -6.24 17.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.512 2.142 . . . . 0.0 112.477 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.55 -10.92 59.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 91' ' ' ASN . 67.1 m-85 -89.72 -18.23 26.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -89.1 91.64 8.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -86.7 173.35 9.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -66.09 -26.89 67.69 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -45.82 -49.48 15.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.808 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.34 -43.07 87.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -46.45 89.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 97' ' ' THR . 38.2 mm-40 -55.16 -52.08 64.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 48.2 mt-30 -58.82 -54.04 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.993 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 107' ' ' VAL . 92.5 mt -59.28 -49.62 77.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.263 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.91 -46.29 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.041 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 6.2 tp10 -65.43 -31.51 72.65 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.54 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 83.3 mt -72.53 -29.71 63.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 103' ' ' LEU . 82.1 t -78.11 -35.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.511 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.64 -42.42 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 2.3 mm-40 -81.99 12.67 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.662 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.25 -56.72 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.989 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.21 -38.34 76.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.393 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 49.4 tptt -74.24 -34.18 63.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.715 0.293 . . . . 0.0 110.75 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 0.0 110.224 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.9 mm? -64.58 -33.18 75.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.553 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.89 -39.68 87.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.83 -46.92 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.33 -50.05 58.03 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.299 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.67 -8.2 6.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.574 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' MET . 26.8 ttt 63.53 23.62 13.7 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.663 0.744 . . . . 0.0 110.312 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -133.03 163.15 29.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.648 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -125.08 -158.57 0.84 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.597 ' H ' HG22 ' A' ' 25' ' ' THR . 38.3 m . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 123.26 0.624 . . . . 0.0 112.185 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.537 ' HD1' ' CG ' ' A' ' 34' ' ' ASP . 6.4 p80 . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 121.378 0.609 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 m -86.38 -14.99 41.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.786 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.485 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.3 tpt -60.99 -64.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.537 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 11.4 p-10 -79.53 -26.95 41.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.136 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.01 -77.39 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 13.2 m -71.27 -49.82 39.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.9 0.381 . . . . 0.0 111.505 -172.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 33' ' ' MET . 17.5 m -73.18 -55.18 6.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.864 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -68.11 -37.45 81.17 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 89' ' ' ILE . 4.4 ttmp? -67.33 -34.97 78.45 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.742 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.23 99.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.473 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 103' ' ' LEU . 69.6 mt -65.89 -47.76 84.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.44 -44.57 92.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.912 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -69.96 -30.97 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 56.4 t80 -67.07 -46.15 75.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.151 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.89 -41.99 98.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.454 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.484 ' HB2' HG13 ' A' ' 81' ' ' VAL . 41.0 t-80 -50.21 -51.68 42.16 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.81 -2.6 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.472 -175.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 64.3 mt -84.93 -21.83 29.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.218 0.532 . . . . 0.0 109.577 168.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.41 0.95 14.02 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.704 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.24 98.12 47.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.923 0.362 . . . . 0.0 111.106 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.84 157.87 15.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.918 2.412 . . . . 0.0 111.788 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.36 137.98 49.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.62 0.248 . . . . 0.0 110.622 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 24.5 m -85.0 144.43 41.53 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 23.8 Cg_exo -63.41 -32.9 71.24 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.103 2.535 . . . . 0.0 112.771 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -42.35 66.68 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.93 -47.84 91.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.72 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.5 t -64.03 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.497 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.27 -58.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.488 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -30.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.551 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -67.86 -46.84 70.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.77 -34.69 90.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.98 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.05 -29.87 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.749 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -86.1 -49.78 7.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.555 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.07 -28.25 66.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.867 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.5 55.22 1.7 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.028 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 70' ' ' PHE . 44.5 m0 -81.37 -78.34 0.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 36.1 p30 175.45 160.79 0.41 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.548 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 86.5 Cg_endo -79.89 8.69 3.9 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.046 1.831 . . . . 0.0 112.933 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' LYS . 46.1 mt-10 -107.33 -69.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.647 -174.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -59.62 -38.23 80.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.423 0.63 . . . . 0.0 110.198 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.882 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 74.0 mmtt -63.36 -56.81 13.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.329 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.551 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.2 t -59.66 -35.84 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.69 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.62 86.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.93 -37.71 92.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.362 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 21.9 m0 -66.0 -44.88 83.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.83 75.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.23 -50.29 74.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.423 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -63.55 -39.31 94.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.337 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 46' ' ' HIS . 47.7 t -61.4 -51.14 76.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.313 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.92 93.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.76 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.39 -39.97 92.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.92 6.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.701 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -100.94 -166.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 110.468 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -94.6 154.77 17.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.92 0.391 . . . . 0.0 110.644 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.02 140.89 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -91.4 119.03 31.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.989 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.411 HG13 ' HD2' ' A' ' 39' ' ' LYS . 8.7 tt -112.36 151.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -96.47 -30.03 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.763 0.316 . . . . 0.0 111.081 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 15.0 m-80 -142.0 92.34 7.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -22.52 18.59 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.464 2.11 . . . . 0.0 113.029 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.49 -5.32 59.3 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' ' 91' ' ' ASN . 8.6 m-85 -71.74 -20.06 61.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.0 110.542 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -79.81 88.74 5.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 t -75.92 163.02 27.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.578 -171.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -31.17 69.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.74 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.08 -55.28 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.065 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.1 mtm -62.63 -36.53 83.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.906 0.384 . . . . 0.0 110.782 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.32 -50.9 71.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.213 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 46.1 mt-10 -73.27 -24.46 60.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.384 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.875 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -65.63 -51.09 62.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 107' ' ' VAL . 98.7 mt -62.52 -42.31 99.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.14 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 83.6 tttt -55.78 -47.36 77.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.213 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.58 -38.62 90.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 0.0 110.878 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 tp -71.59 -44.09 65.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.828 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 103' ' ' LEU . 80.6 t -70.41 -27.38 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.92 -43.67 69.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.528 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -91.77 3.4 55.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 178.539 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 121.067 0.46 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.93 -39.66 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.849 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.67 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.502 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 56.7 mmtt -76.29 -35.44 58.87 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.312 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.34 83.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.588 0.709 . . . . 0.0 109.113 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.758 HD22 HH11 ' A' ' 60' ' ' ARG . 23.4 tp -63.3 -37.12 86.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.252 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.31 -33.76 75.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.332 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.17 -40.51 78.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.471 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -88.15 -76.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.772 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 -4.94 81.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.748 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.13 7.48 77.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.432 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -94.81 111.86 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.12 -156.99 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.06 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -86.96 41.67 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.262 -0.274 . . . . 0.0 110.875 175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 124.648 1.179 . . . . 0.0 112.106 -178.626 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 19.6 m80 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.666 0.27 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 t -103.38 -80.52 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.084 0.468 . . . . 0.0 110.506 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.3 ttp -97.81 -29.75 13.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.51 0.671 . . . . 0.0 109.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 9.2 p-10 -67.81 -8.31 34.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.145 -172.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 39.8 tt0 -102.51 -48.95 3.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 110.658 173.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.8 t -65.41 -48.48 72.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.697 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 m -64.82 -40.24 94.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.359 . . . . 0.0 110.267 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.7 63.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -61.5 -28.88 69.62 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.195 0.521 . . . . 0.0 110.8 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.73 -49.9 52.0 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.382 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 103' ' ' LEU . 63.7 mt -61.84 -43.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.618 0.247 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -54.97 -47.54 74.41 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.68 ' HE3' HD11 ' A' ' 87' ' ' ILE . 9.9 mtmp? -77.9 -25.84 48.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.312 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.533 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 53.0 t80 -65.15 -47.81 75.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.13 -40.54 97.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.223 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -50.94 -54.97 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.341 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.12 -18.83 60.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 57.6 mt -68.53 -27.29 65.97 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.6 6.17 10.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.583 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.39 93.19 43.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.758 0.313 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.37 120.75 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.993 2.462 . . . . 0.0 111.838 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.31 138.66 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.299 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.93 147.46 38.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -53.19 -36.0 75.63 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.397 2.731 . . . . 0.0 112.398 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -50.05 -47.3 53.45 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.316 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.0 -40.99 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.607 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.4 t -63.87 -45.92 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.456 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 67.4 t -59.99 -48.28 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.141 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.8 89.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.439 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.758 HH11 HD22 ' A' ' 17' ' ' LEU . 14.6 tpp85 -67.79 -40.42 83.92 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.508 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.83 -37.14 93.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.479 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -62.66 -37.62 87.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.197 0.523 . . . . 0.0 110.574 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -73.03 -44.82 60.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.471 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.86 -30.03 32.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.81 57.28 1.84 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.067 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.753 ' HZ2' HD11 ' A' ' 17' ' ' LEU . 49.4 m0 -84.05 168.43 15.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -61.83 123.58 77.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 167.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.91 -34.23 55.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.502 2.801 . . . . 0.0 113.82 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -64.73 -40.64 95.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 74' ' ' VAL . 73.6 t80 -64.42 -50.97 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.142 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 21.4 m -57.27 -41.23 79.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.936 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.44 -40.71 77.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.126 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.62 -50.14 68.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.077 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.599 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 52.1 t -60.22 -40.16 82.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 110.635 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 54' ' ' PRO . . . -59.59 -40.18 86.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.684 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.9 -34.79 88.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.078 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.599 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 28.7 m0 -67.23 -47.58 70.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.7 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.95 -44.61 91.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 110.4 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -64.64 -45.79 85.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.635 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.3 t -63.67 -40.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.37 -41.04 81.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.638 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.7 p -75.03 -16.63 60.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.03 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.53 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -109.98 163.99 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -89.27 156.57 18.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.516 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.68 HD11 ' HE3' ' A' ' 43' ' ' LYS . 21.8 pt -123.94 147.66 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 89' ' ' ILE . 6.6 tt -71.27 131.74 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 88' ' ' LEU . 13.5 tt -139.32 162.78 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -76.07 -53.18 8.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.723 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.76 140.3 31.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.68 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.2 7.11 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.326 2.017 . . . . 0.0 113.463 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.18 -16.33 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 77.44 -70.6 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.65 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.684 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 40.8 p90 -162.82 -170.85 2.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.772 -173.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 95' ' ' PHE . 16.6 m -85.22 146.62 26.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.771 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 p -50.06 -36.9 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -38.68 57.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.596 0.236 . . . . 0.0 111.623 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.684 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 mmt -65.76 -50.01 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 110.225 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -71.14 -30.77 66.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.085 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.56 -32.74 74.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.358 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.556 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 8.6 tp-100 -70.07 -50.54 39.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 109.696 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 41' ' ' ILE . 86.4 mt -52.85 -49.76 65.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.028 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -59.51 -42.26 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 109' ' ' GLU . 35.4 tt0 -63.13 -39.9 96.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.572 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 95.0 mt -62.54 -36.31 82.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.97 -43.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.67 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -78.62 -45.1 22.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 17.6 mm-40 -70.97 -75.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.033 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.835 0.826 . . . . 0.0 110.471 177.575 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.943 0.402 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 49.9 mm -65.58 -43.01 94.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.049 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.34 -33.27 75.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.659 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 36.2 mmtt -78.48 -31.07 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.202 177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.86 99.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.275 0.559 . . . . 0.0 109.496 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 13' ' ' ILE . 62.9 mt -72.52 -27.61 62.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.436 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.6 -25.53 67.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.478 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -85.66 -48.25 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.272 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.2 mt -79.12 -37.49 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.32 -11.12 32.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.74 57.33 9.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.775 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.16 91.52 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 69.07 16.85 8.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.682 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 p -99.53 -0.71 40.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.591 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.954 -179.118 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 10.4 m170 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.55 0.214 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -66.83 -80.18 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.036 0.446 . . . . 0.0 110.166 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -93.1 -16.09 25.33 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.605 ' HB3' ' HA ' ' A' ' 31' ' ' HIS . 7.2 t0 -51.27 -45.57 62.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.913 -1.948 . . . . 0.0 111.315 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -99.9 -40.25 7.78 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.551 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 92' ' ' PRO . 37.0 t -61.89 -62.04 2.07 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.933 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 m -68.62 -36.29 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.915 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.25 -51.81 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.738 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HD3' HG12 ' A' ' 89' ' ' ILE . 95.2 mttt -62.98 -42.98 99.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.56 92.76 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.369 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 52.2 mt -68.91 -47.46 75.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 0.159 . . . . 0.0 111.372 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.18 -40.92 87.17 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.77 -41.34 99.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.939 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.431 ' CE2' HD11 ' A' ' 48' ' ' LEU . 67.6 t80 -73.1 -39.76 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.549 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 92.8 mt -59.36 -46.18 89.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.804 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -64.22 -36.45 84.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.43 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.36 -41.47 97.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD11 ' CE2' ' A' ' 44' ' ' TYR . 88.5 mt -64.45 -37.86 89.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.803 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.03 2.63 10.14 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.005 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.78 93.39 33.47 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 0.0 109.813 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -91.26 157.13 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.941 2.427 . . . . 0.0 113.072 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.71 141.59 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.939 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.483 ' HB2' HG23 ' A' ' 56' ' ' VAL . 12.8 m -79.81 123.44 83.84 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 58' ' ' VAL . 43.7 Cg_exo -56.08 -38.1 95.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.076 2.517 . . . . 0.0 112.388 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -52.52 -50.66 62.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.155 0.502 . . . . 0.0 110.913 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 53' ' ' SER . 33.3 t -64.18 -35.6 74.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.342 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.33 -40.04 87.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.728 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 54' ' ' PRO . 90.8 t -62.23 -52.94 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.635 0.255 . . . . 0.0 110.458 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.91 -43.76 86.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.2 tpp180 -64.1 -43.76 94.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 71' ' ' THR . . . -60.53 -48.23 87.23 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.39 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 45.6 mt-10 -59.39 -33.23 70.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.135 0.493 . . . . 0.0 110.854 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -70.25 -48.92 54.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.547 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 60.5 mt-10 -93.48 -3.79 52.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 0.0 111.388 -173.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.32 -70.63 0.54 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 11.9 m0 56.31 -1.47 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 69.58 128.97 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 123.322 0.649 . . . . 0.0 110.489 -176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.45 -47.19 23.46 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.693 2.929 . . . . 0.0 114.335 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -69.56 -36.78 76.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 66' ' ' TRP . 68.2 t80 -69.94 -49.07 55.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 61' ' ' GLY . 21.1 m -53.6 -46.62 70.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.22 -46.03 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.067 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -65.06 -40.29 94.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.82 -39.35 83.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.436 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.67 82.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.902 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.21 -40.58 87.7 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.089 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.9 m0 -60.91 -54.49 44.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.11 73.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.004 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -56.41 -53.95 51.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.239 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 46.0 mtpt -66.65 -35.93 81.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.262 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 77' ' ' TRP . 76.6 t -68.76 -46.17 79.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.052 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.67 69.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 111.173 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.5 t -80.0 -18.12 51.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.747 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.81 45.8 15.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.901 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -95.95 16.3 18.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.032 0.133 . . . . 0.0 111.134 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 47.93 127.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 125.267 1.604 . . . . 0.0 113.953 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.1 pt -115.51 144.13 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.15 112.36 21.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -124.64 -43.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.413 177.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 67.31 -70.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 111.636 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.618 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -165.36 92.2 0.9 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.563 -175.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.5 ' HD3' HG23 ' A' ' 89' ' ' ILE . 61.1 Cg_endo -80.69 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.436 2.091 . . . . 0.0 112.69 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.8 pt-20 -156.34 24.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.038 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 53.3 m-85 73.25 -21.31 0.26 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.659 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 93' ' ' GLU . 18.1 t80 61.97 83.93 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -169.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -52.63 139.98 24.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.907 -169.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m -53.58 -41.99 67.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 112.329 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 35.5 t80 -61.04 -42.24 98.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.3 mtt -62.15 -50.7 70.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.484 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -59.43 -46.63 88.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.896 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 7.7 mt-10 -72.0 -27.36 62.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 14.0 mm100 -59.01 -48.1 82.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.156 0.503 . . . . 0.0 109.74 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 107' ' ' VAL . 83.1 mt -68.3 -43.51 77.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.402 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 26.9 tttm -60.47 -50.04 75.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.13 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -69.55 -25.46 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.682 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 48.3 tp -70.31 -45.71 65.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 103' ' ' LEU . 59.8 t -71.83 -25.54 24.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.337 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.09 -34.73 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.567 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.65 -70.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 168.233 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 120.787 0.327 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 61.0 mt -63.12 -45.61 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.956 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -53.77 -54.83 32.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 94.9 mttt -67.62 -35.71 79.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.462 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.93 85.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 111.077 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 85.5 mt -64.09 -47.22 80.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -13.58 56.79 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.855 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -64.59 -43.12 94.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.32 -39.45 48.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.711 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 70' ' ' PHE . . . -54.79 -47.98 68.74 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.036 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.05 14.96 69.01 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.227 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 67.74 169.97 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.046 0.538 . . . . 0.0 111.455 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.4 108.13 11.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.212 0.529 . . . . 0.0 110.83 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 p -120.98 -171.19 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.707 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.86 -179.09 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m80 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.643 0.258 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.7 m -103.98 -80.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.0 110.721 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -90.35 -12.15 38.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.946 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -15.83 62.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.179 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -92.72 -55.18 3.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.28 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.471 ' HB3' HD11 ' A' ' 89' ' ' ILE . 14.3 m -71.27 -53.19 15.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.886 -174.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -62.75 -34.14 76.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.38 90.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.201 0.524 . . . . 0.0 110.132 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -64.0 -27.54 69.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.398 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.08 -55.04 23.96 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.736 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 HD11 ' A' ' 103' ' ' LEU . 66.4 mt -57.27 -43.65 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 110.659 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 78' ' ' ALA . 26.6 tp -56.49 -47.74 78.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.458 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 43' ' ' LYS . 9.9 mtmp? -72.83 -30.56 64.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.426 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 66.3 t80 -63.57 -37.95 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 48' ' ' LEU . 94.2 mt -66.14 -38.92 89.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.279 176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -61.26 -34.54 75.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.07 -24.96 47.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 93.6 mt -75.93 -32.25 59.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.314 0.578 . . . . 0.0 110.411 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.44 -18.11 8.84 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.319 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.83 93.42 48.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -95.37 158.32 1.61 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.065 2.51 . . . . 0.0 111.871 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.92 138.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 110.571 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 56' ' ' VAL . 23.8 m -83.03 149.24 58.68 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.39 -43.3 44.86 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.322 2.681 . . . . 0.0 112.733 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.17 -43.34 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 53' ' ' SER . 29.4 t -65.0 -36.39 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.174 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.69 -49.05 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.0 -45.55 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.76 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.84 93.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.72 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 13.2 tpt180 -65.16 -46.12 82.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.409 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.37 99.4 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.035 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -58.51 -39.88 81.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.92 0.39 . . . . 0.0 111.084 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.1 tm0? -83.02 -48.45 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.479 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.33 -25.73 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.876 0.37 . . . . 0.0 111.463 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.81 -76.99 0.34 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.8 m0 54.2 -161.29 0.14 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.832 0.453 . . . . 0.0 111.625 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -124.26 140.23 34.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 -41.73 70.21 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.893 2.395 . . . . 0.0 112.775 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -66.86 -40.66 87.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.582 0.706 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 31.2 t80 -69.5 -53.06 20.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.409 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -58.29 -43.77 88.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -72.37 -34.44 67.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.741 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -56.91 14.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.806 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.9 -35.47 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.2 86.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.34 -37.83 62.84 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.073 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -61.44 -49.32 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -59.14 -38.09 78.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.95 -49.77 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.864 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.97 -37.24 75.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.107 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.47 -38.57 80.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.702 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.09 -30.2 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.082 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . 17.2 m -87.81 -14.61 39.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 31.86 13.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.854 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 12.6 m120 -97.59 -171.65 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -108.95 135.32 50.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -109.0 119.64 58.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.806 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.67 122.61 14.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.054 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 36' ' ' SER . 16.1 tt -129.82 135.56 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HG3' ' OD1' ' A' ' 91' ' ' ASN . 17.5 pttm -76.01 -16.72 59.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -171.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.672 ' OD1' ' HG3' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -153.95 114.28 2.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.889 0.376 . . . . 0.0 110.399 177.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.68 80.92 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.138 2.559 . . . . 0.0 113.027 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.551 ' HG2' HD22 ' A' ' 91' ' ' ASN . 11.6 pt-20 -138.96 172.45 12.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.927 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -124.23 -80.92 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.723 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER 175.56 -176.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.951 -172.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 m -84.77 174.63 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.357 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -30.24 68.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.877 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -44.95 -55.08 5.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.622 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.89 -46.32 68.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.171 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.656 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 7.7 tt0 -60.57 -48.38 82.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.261 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.05 -35.18 79.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -54.12 -58.99 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.417 0.627 . . . . 0.0 110.033 175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 41' ' ' ILE . 94.3 mt -64.73 -39.68 94.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.911 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.74 -39.38 91.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.304 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.86 -26.56 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.746 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.66 -36.95 81.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 48' ' ' LEU . 55.8 t -77.53 -20.98 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.82 -18.76 64.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.44 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.02 -8.28 47.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.978 0.418 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.49 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 121.355 0.597 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -68.82 -44.23 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.06 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.09 -37.69 86.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 4.2 mmmp? -70.66 -26.35 63.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.838 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.15 86.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.227 0.537 . . . . 0.0 109.718 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.17 -32.33 70.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.088 174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 24.0 t70 -57.17 -32.66 66.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.718 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -78.7 -63.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.679 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.15 -68.96 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.067 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.95 -8.01 84.48 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.762 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.06 -16.94 80.33 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.332 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 25.4 ptp -103.59 97.78 7.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.839 0.828 . . . . 0.0 111.118 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.19 49.85 1.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -82.06 -168.94 2.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.133 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.236 -178.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.9 m170 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.17 0.51 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -75.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.536 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.463 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 6.8 ttp -96.64 -42.39 8.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -48.19 -45.71 34.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.541 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -50.88 -66.3 0.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.187 0.518 . . . . 0.0 111.135 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 t -70.2 -43.1 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.462 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 33' ' ' MET . 38.6 m -67.41 -42.66 82.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.62 87.08 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.479 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -56.96 -32.5 66.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.916 0.388 . . . . 0.0 110.693 174.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.46 50.61 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.092 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.94 -43.33 92.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 110.736 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.53 -39.56 76.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.142 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -69.2 -42.33 75.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.009 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -63.64 -48.45 77.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.375 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.569 HD21 HD23 ' A' ' 103' ' ' LEU . 72.8 mt -61.71 -48.36 81.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.458 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.65 -36.74 77.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.007 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.8 -40.59 88.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 107' ' ' VAL . 94.1 mt -61.66 -30.1 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 120.97 -0.09 11.75 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.928 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.05 97.89 9.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 82.1 Cg_endo -83.3 127.12 4.43 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.379 2.053 . . . . 0.0 112.265 -176.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.538 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 41.4 t -75.33 101.47 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.857 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 56' ' ' VAL . 22.8 m -70.79 125.94 92.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.49 -23.04 62.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.648 2.232 . . . . 0.0 111.706 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -58.88 -54.08 51.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.14 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 53' ' ' SER . 34.1 m -70.42 -21.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.104 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.98 -49.3 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 69.4 t -62.03 -42.64 95.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.422 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.19 96.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.888 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.63 -37.54 87.92 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 177.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -60.18 -45.62 95.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.911 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 8.4 pt-20 -79.74 -20.41 46.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.82 -53.39 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.899 0.381 . . . . 0.0 110.142 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 4.6 tp10 -73.73 -38.65 64.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 -173.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.91 62.22 0.56 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.973 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.469 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 24.8 m0 -98.52 160.66 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.426 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 26.7 p30 -90.05 153.7 47.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 4.9 Cg_exo -39.23 -60.41 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.613 3.542 . . . . 0.0 114.433 -174.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 4.6 mm-40 -61.21 -39.0 88.59 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.95 -44.76 84.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.0 m -58.45 -48.5 80.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -77.42 -27.14 52.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 tptp -54.4 -66.26 0.43 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.83 -40.94 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.892 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.97 96.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.967 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -66.87 -40.79 93.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.47 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.443 ' O ' HG23 ' A' ' 81' ' ' VAL . 10.6 m0 -63.46 -50.79 68.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -58.91 -39.43 81.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.85 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.5 -49.85 63.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 52.0 mttm -71.98 -41.61 67.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.317 -176.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 77' ' ' TRP . 57.8 t -68.21 -39.65 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.269 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.32 69.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.122 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -65.45 -27.99 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.98 23.04 5.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.863 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.554 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -93.1 -176.27 4.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -136.24 137.88 41.25 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.243 0.544 . . . . 0.0 110.738 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.32 125.48 74.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.613 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.14 110.2 16.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.415 0.626 . . . . 0.0 110.815 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.8 tt -86.59 -3.24 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.757 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 71.07 -52.05 0.68 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.817 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -161.59 131.71 3.46 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.86 177.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 37.0 Cg_exo -57.62 -66.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.739 2.293 . . . . 0.0 111.902 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.55 -72.5 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -78.15 5.7 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -168.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.18 102.85 14.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p -94.56 169.58 10.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -32.4 71.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.694 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 0.2 OUTLIER -56.19 -44.65 79.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 110.166 -176.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.54 -49.36 66.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.366 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -61.03 -50.9 71.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.781 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.4 -47.96 82.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.445 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -54.49 -56.48 18.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.383 0.611 . . . . 0.0 110.736 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.569 HD23 HD21 ' A' ' 45' ' ' LEU . 10.4 mp -67.8 -41.08 83.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.357 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -68.96 -34.01 74.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.144 -175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.74 -43.41 89.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.75 -42.9 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 48' ' ' LEU . 84.9 t -72.66 -32.19 40.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.121 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.72 -20.56 61.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.01 -18.13 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.775 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -87.85 -23.2 24.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.103 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.2 t80 75.3 -43.6 0.51 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.0 116.04 4.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -69.33 111.07 4.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.372 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.65 -66.58 0.29 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.42 172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.1 m 65.02 -168.29 0.21 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.92 0.488 . . . . 0.0 110.431 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.3 ttm -156.17 119.07 2.3 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.403 -0.186 . . . . 0.0 110.829 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.45 113.96 2.31 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.551 2.167 . . . . 0.0 111.575 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 14' ' ' GLU . 35.7 p -75.45 75.22 2.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.462 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' A' ' 106' ' ' LEU . . . -64.16 -53.0 56.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.21 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.92 -39.41 83.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.233 -177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 2.7 mt-10 -77.16 -23.36 51.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.034 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 25.5 tptp -77.08 -24.25 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.43 80.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 60' ' ' ARG . 75.6 mt -63.08 -33.66 75.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.36 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 20.1 t70 -60.77 -40.82 93.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.657 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -67.28 -36.23 81.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.351 . . . . 0.0 110.91 176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.0 mt -71.56 -46.15 64.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.57 75.98 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.648 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.56 -170.38 54.77 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.647 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -104.81 -7.01 19.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.793 0.806 . . . . 0.0 108.961 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -132.04 94.87 3.56 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.628 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.7 m -80.03 -11.76 59.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.033 0.444 . . . . 0.0 111.409 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -79.38 83.62 5.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.186 0.517 . . . . 0.0 110.23 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -166.59 151.44 7.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.042 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -152.36 -72.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.738 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.578 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 33.8 t -80.05 -56.89 0.7 Allowed Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.743 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 7.9 Cg_endo -88.73 94.66 0.37 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.434 2.089 . . . . 0.0 112.157 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -104.61 149.44 25.52 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 t -103.15 -81.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.492 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -21.48 15.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.3 2.72 14.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.602 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.47 -57.63 3.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.382 0.61 . . . . 0.0 109.487 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 1.008 ' HB3' HG13 ' A' ' 89' ' ' ILE . 54.0 m -81.16 -34.96 32.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.88 -174.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 m -66.06 -36.34 82.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.329 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.59 -43.33 99.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 36' ' ' SER . 94.2 mttt -58.18 -44.73 88.17 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.999 175.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -57.77 -50.01 69.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.226 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 110.861 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.794 HD11 HG21 ' A' ' 52' ' ' VAL . 15.5 tp -62.15 -43.65 98.36 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.915 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.15 -23.4 62.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.259 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.4 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 50.7 t80 -68.39 -40.66 81.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.14 -43.61 97.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.251 0.548 . . . . 0.0 109.816 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.459 ' HB2' HG13 ' A' ' 81' ' ' VAL . 17.9 t-80 -58.0 -41.03 82.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.647 176.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -65.08 -38.18 89.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 97.8 mt -67.1 -13.73 62.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.096 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 104.96 13.28 25.72 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.351 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.54 93.6 37.25 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.947 0.403 . . . . 0.0 110.431 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 98.9 Cg_endo -87.75 114.83 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.504 2.136 . . . . 0.0 111.486 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG21 HD11 ' A' ' 42' ' ' LEU . 27.4 m -73.64 141.15 16.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.293 0.568 . . . . 0.0 111.614 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.664 ' O ' HG22 ' A' ' 56' ' ' VAL . 12.8 m -85.36 138.0 36.55 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.688 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.12 -27.9 67.56 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.0 112.272 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -60.55 -44.62 95.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.823 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 53' ' ' SER . 10.3 m -68.18 -24.95 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.808 0.337 . . . . 0.0 110.579 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.89 -51.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.055 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.9 t -61.98 -46.7 95.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.21 -51.8 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.672 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 1.004 ' HG2' HD13 ' A' ' 17' ' ' LEU . 10.1 tpp180 -70.15 -28.83 65.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.832 0.348 . . . . 0.0 110.33 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -63.3 -41.14 99.6 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.977 176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 39.4 mt-10 -67.43 -36.16 80.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 110.644 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -68.54 -50.76 49.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.612 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.607 ' HG2' ' HD2' ' A' ' 60' ' ' ARG . 35.8 mm-40 -84.55 -13.48 51.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.877 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.65 56.51 2.93 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.869 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.443 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 41.7 m0 -87.0 176.51 7.6 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 36.3 m-80 -92.51 126.22 53.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 80.3 Cg_exo -46.28 -44.5 20.01 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.937 3.091 . . . . 0.0 114.075 -173.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.69 -37.73 85.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.106 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 48.5 t80 -70.09 -47.72 60.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 58' ' ' VAL . 25.0 m -58.79 -40.32 83.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.284 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -67.67 -38.09 83.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.849 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.34 -48.15 79.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.633 0.254 . . . . 0.0 110.539 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 70' ' ' PHE . 45.7 t -61.14 -38.31 79.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.42 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.85 77.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.66 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 79' ' ' GLU . . . -69.51 -32.08 71.27 Favored Glycine 0 C--O 1.236 0.237 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.059 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.433 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 24.8 m0 -71.61 -48.97 44.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.67 75.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.493 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 76' ' ' GLY . 10.2 tt0 -48.57 -59.54 3.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.824 173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -68.08 -37.91 81.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.053 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 46' ' ' HIS . 41.7 t -58.18 -49.09 82.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.111 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -70.34 -32.23 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.262 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -74.12 -16.1 61.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.591 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 18.1 40.32 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.41 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.13 -174.78 3.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -134.0 152.93 52.04 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.981 0.42 . . . . 0.0 110.509 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.8 pt -126.93 158.83 37.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.848 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.4 tp -91.3 135.97 33.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.21 0.529 . . . . 0.0 110.934 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.008 HG13 ' HB3' ' A' ' 36' ' ' SER . 19.2 tt -100.49 131.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.323 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.1 -25.1 34.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.036 0.446 . . . . 0.0 111.25 -174.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -148.0 93.2 4.51 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.225 0.536 . . . . 0.0 110.373 -179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HA ' HD13 ' A' ' 89' ' ' ILE . 7.2 Cg_exo -74.03 -16.67 22.72 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.454 2.769 . . . . 0.0 113.348 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.44 -21.92 60.34 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -80.26 -7.43 59.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -81.23 82.73 7.03 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.9 m -76.19 149.99 37.17 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.288 1.042 . . . . 0.0 112.074 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.2 m -66.33 -36.04 81.9 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.954 -173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.44 -45.71 87.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.375 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.9 mtm -61.47 -40.07 93.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.927 0.394 . . . . 0.0 111.065 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -65.99 -54.98 19.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 10.9 mm-40 -65.28 -24.12 67.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -56.15 17.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.4 mt -61.01 -43.68 98.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.259 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 79.7 tttt -57.03 -41.06 77.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.445 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.97 -39.01 79.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 12' ' ' ALA . 9.9 mp -67.73 -36.27 80.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.808 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 99.8 t -72.65 -34.96 49.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.069 0.461 . . . . 0.0 110.2 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.1 tp -62.44 -49.9 73.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.569 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -77.43 -7.99 57.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.723 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 67.1 t60 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.787 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.748 0.785 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -131.13 24.09 4.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.244 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -109.39 110.81 22.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.381 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 25.3 mtpp -137.92 90.32 2.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.561 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 6.0 t70 160.03 -158.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.778 1.299 . . . . 0.0 108.877 176.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 96.5 mttt -74.95 167.07 22.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -64.57 147.02 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.023 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 70.6 mtm -62.02 147.58 89.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.218 -177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 32.2 Cg_exo -58.83 96.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.005 2.47 . . . . 0.0 112.89 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -117.09 40.33 3.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.049 0.928 . . . . 0.0 109.325 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.707 ' HA ' HD23 ' A' ' 106' ' ' LEU . . . -57.47 -37.51 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.346 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.16 -56.4 10.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.672 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.66 -40.44 96.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.569 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -67.12 -31.85 72.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.677 0.275 . . . . 0.0 110.486 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 20' ' ' ILE . . . -64.23 -42.5 96.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.912 0.387 . . . . 0.0 110.217 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 4.4 mm? -65.56 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.619 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.03 -44.61 96.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.587 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 14.2 m-85 -60.11 -37.53 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.42 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 16' ' ' ALA . 75.2 mt -72.78 -65.62 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.249 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.47 -47.02 53.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.864 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.45 8.69 27.0 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.271 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 65.7 mtt 57.12 31.17 19.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.049 0.452 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -67.39 111.32 3.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.377 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -76.98 0.89 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.182 -174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.0 t -134.71 18.59 3.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.87 0.367 . . . . 0.0 110.776 -177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.28 90.28 4.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.477 0.656 . . . . 0.0 110.96 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.8 m -154.89 -45.97 0.08 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.389 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.611 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 67.3 t -120.78 -57.96 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.283 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 74.0 Cg_endo -78.95 95.18 1.06 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.148 1.232 . . . . 0.0 111.604 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -128.43 117.14 20.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.7 m -103.5 -80.47 0.52 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.464 0.65 . . . . 0.0 110.962 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.471 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.4 ttp -83.34 -27.21 29.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.394 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.83 -2.81 22.07 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.814 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' CD ' ' HD2' ' A' ' 90' ' ' LYS . 10.4 tt0 -102.3 -63.86 1.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.0 110.064 172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.0 m -63.53 -46.2 87.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.842 HG23 ' HB3' ' A' ' 95' ' ' PHE . 84.2 m -72.5 -29.77 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.01 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.39 -48.41 79.87 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.82 -42.16 97.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.251 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 94' ' ' TYR . . . -65.14 -44.07 94.6 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.245 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 36.5 mt -68.14 -40.71 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.95 0.375 . . . . 0.0 111.146 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.865 HD22 HG21 ' A' ' 52' ' ' VAL . 91.7 mt -60.58 -39.37 87.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.171 0.51 . . . . 0.0 110.002 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.839 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.644 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 82.4 t80 -58.3 -55.55 33.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.11 177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 48' ' ' LEU . 7.6 mp -63.99 -36.4 83.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.394 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -54.47 -56.3 20.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.346 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.83 -23.62 65.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.081 -175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.7 mt -62.22 -35.33 78.59 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 109.963 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.4 3.61 3.78 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.571 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.4 99.37 45.67 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 110.762 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.542 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 64.2 Cg_endo -77.08 117.64 4.5 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.125 1.883 . . . . 0.0 111.618 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.865 HG21 HD22 ' A' ' 42' ' ' LEU . 27.4 m -68.03 148.58 11.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.776 -175.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.5 m -94.71 131.71 30.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.298 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 33.5 Cg_exo -58.91 -32.22 96.96 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.267 2.645 . . . . 0.0 113.216 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -55.8 -41.83 74.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.706 0.289 . . . . 0.0 110.894 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 t -61.11 -37.84 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.531 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.76 -47.16 86.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.361 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.24 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.675 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.736 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.569 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 12.2 tpt180 -68.05 -36.25 79.57 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.07 -45.19 82.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.601 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -71.96 -46.78 56.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 111.362 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.41 ' HB3' HE21 ' A' ' 63' ' ' GLN . 1.0 OUTLIER -68.06 -42.73 80.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.502 -175.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 3.8 tp10 -84.78 -32.79 23.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.742 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.9 62.58 0.75 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.368 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.503 ' CH2' HD12 ' A' ' 17' ' ' LEU . 39.0 m0 -102.26 152.68 20.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.86 0.362 . . . . 0.0 110.572 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.68 142.04 94.69 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.7 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.02 -45.81 37.99 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.934 2.423 . . . . 0.0 111.982 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -58.07 -40.64 81.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.083 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 74' ' ' VAL . 75.6 t80 -66.06 -59.63 3.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.7 m -56.02 -41.94 75.7 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.57 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -56.8 -50.59 71.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.67 -43.25 63.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.667 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.563 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.6 t -61.69 -38.07 79.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 110.713 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -60.3 -44.19 95.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.604 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 79' ' ' GLU . . . -57.29 -41.01 92.77 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.401 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 16.8 m0 -65.35 -43.9 89.42 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.2 83.42 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.163 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 53.7 mt-10 -57.06 -48.72 77.88 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.221 0.534 . . . . 0.0 110.519 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -67.63 -35.59 79.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.6 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 77' ' ' TRP . 66.9 t -62.04 -48.84 86.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.625 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 51' ' ' PRO . . . -62.29 -38.68 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -72.73 -16.63 61.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.741 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.99 29.9 40.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.429 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -97.47 154.05 17.74 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -77.82 142.06 38.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.245 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.5 pt -117.25 159.88 17.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.809 -175.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.5 tt -87.99 109.23 19.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.294 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -101.53 150.17 6.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 25.1 mtpt -84.68 -58.83 2.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.514 0.673 . . . . 0.0 109.73 -177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -111.05 124.3 33.19 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.802 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.422 ' HG2' ' OE1' ' A' ' 93' ' ' GLU . 9.9 Cg_endo -53.32 -30.92 54.36 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.074 2.516 . . . . 0.0 113.02 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' OE1' ' HG2' ' A' ' 92' ' ' PRO . 1.8 mp0 -63.99 98.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.446 ' HD2' ' HA2' ' A' ' 40' ' ' GLY . 36.6 m-85 -59.72 -59.29 5.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.364 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.842 ' HB3' HG23 ' A' ' 37' ' ' THR . 26.9 p90 -162.05 172.71 15.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.692 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.6 m -82.68 164.34 20.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.875 0.369 . . . . 0.0 111.705 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -32.86 74.78 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.484 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -53.78 -44.86 70.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.821 0.82 . . . . 0.0 110.067 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 95' ' ' PHE . 33.1 mtp -75.21 -34.16 61.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.122 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -50.63 70.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.829 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.57 -43.64 84.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.244 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -56.02 -56.73 17.18 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 111.081 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.2 mt -61.23 -44.36 97.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.644 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -59.71 -43.01 94.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.742 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.48 -48.06 80.23 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 12' ' ' ALA . 10.0 mp -65.78 -28.16 68.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.829 -176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 103' ' ' LEU . 25.8 t -95.45 -6.06 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.0 110.503 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.31 -42.08 38.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -43.48 54.75 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.498 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.5 p80 . . . . . 0 N--CA 1.478 0.947 0 C-N-CA 124.154 0.982 . . . . 0.0 112.565 177.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.234 0.251 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -143.25 -63.09 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -101.72 -43.99 5.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.852 -171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.34 -175.87 4.92 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.985 0.421 . . . . 0.0 111.66 -174.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -73.06 162.0 29.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.542 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -118.11 -7.43 10.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.909 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.0 p -73.6 154.16 39.89 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.462 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.478 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 25.3 mmt -100.22 115.49 65.42 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.862 0.363 . . . . 0.0 110.912 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 2.6 Cg_exo -75.11 84.54 1.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.789 2.326 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.2 p -99.62 -82.06 0.45 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.772 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.54 ' HA ' HD21 ' A' ' 106' ' ' LEU . . . -67.36 -36.73 81.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.72 175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.35 -41.08 83.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.586 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 10' ' ' PRO . 21.5 tt0 -65.28 -47.19 77.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.66 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -64.72 -42.85 94.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.01 -36.0 82.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.243 0.544 . . . . 0.0 110.652 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -71.77 -24.06 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.431 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.34 -33.96 37.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -64.84 -44.46 89.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.924 176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.3 mt -84.44 -68.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.611 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.69 45.23 3.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.056 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.52 -6.08 66.37 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.546 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.7 ttt 69.39 105.14 0.06 Allowed 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.529 0.732 . . . . 0.0 111.937 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 21.5 t-20 -71.8 162.59 29.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.411 172.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.5 m -52.9 -36.63 59.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.363 0.265 . . . . 0.0 111.582 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 p -114.46 -54.29 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 175.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 24' ' ' ASN . . . 59.03 17.98 5.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 172.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 m -132.2 -40.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.913 0.864 . . . . 0.0 109.234 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.1 m -70.63 -179.04 0.6 Allowed Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.973 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 99.1 Cg_exo -46.26 107.76 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.47 1.447 . . . . 0.0 110.513 168.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.87 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 59.0 m170 -56.63 143.68 35.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.983 -170.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 m -82.96 -79.94 0.18 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.461 -175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.6 ttp -99.41 -24.02 14.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.759 0.79 . . . . 0.0 108.979 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -78.31 9.54 3.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.048 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 5.9 tt0 -103.05 -72.62 0.69 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.736 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 t -58.85 -54.33 48.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.542 -174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 34.4 m -61.58 -39.93 92.95 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.865 0.364 . . . . 0.0 111.185 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -42.04 91.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -58.13 -48.2 80.96 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.477 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.54 -47.71 82.02 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.571 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.636 HG12 HD11 ' A' ' 103' ' ' LEU . 77.9 mt -62.9 -45.38 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.189 0.518 . . . . 0.0 110.715 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.0 tp -63.85 -39.29 93.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.2 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.32 -39.03 78.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.643 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.538 ' CE2' HD11 ' A' ' 48' ' ' LEU . 83.0 t80 -60.23 -44.55 95.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.25 -47.57 85.45 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.34 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 60.7 m80 -65.48 -36.06 82.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.46 -33.17 74.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.017 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.538 HD11 ' CE2' ' A' ' 44' ' ' TYR . 76.6 mt -66.53 -45.27 79.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.588 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 138.51 4.69 1.62 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.676 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.43 93.29 4.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 90.0 Cg_endo -90.72 88.81 0.3 Allowed 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 122.477 2.118 . . . . 0.0 112.924 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 p -70.18 123.52 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.7 m -89.09 154.32 49.43 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' GLU . 5.3 Cg_endo -49.86 -37.93 46.71 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.382 2.721 . . . . 0.0 112.396 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -48.68 -51.57 27.85 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.535 0.522 . . . . 0.0 110.883 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -64.68 -42.1 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.456 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.6 -48.03 90.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 54' ' ' PRO . 89.6 t -60.99 -52.29 63.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.024 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.34 90.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.359 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.53 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 13.0 tpp180 -67.84 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.457 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.71 -38.53 96.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.934 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.17 -38.93 84.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.28 -0.46 . . . . 0.0 110.591 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -75.16 -50.5 16.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.344 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 60' ' ' ARG . 27.8 mm-40 -65.63 -42.66 91.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.014 0.435 . . . . 0.0 110.258 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 114.24 50.43 0.5 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.1 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 30.2 m0 -88.06 163.47 16.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.86 143.52 78.26 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.102 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.23 -55.81 3.7 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.394 2.729 . . . . 0.0 112.867 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.3 mm-40 -59.01 -37.2 76.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.472 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 80.2 t80 -64.78 -51.82 60.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.178 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 m -64.86 -45.89 84.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.155 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -62.04 -41.1 97.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.992 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.564 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 13.9 mptt -60.11 -57.53 12.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.497 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 48.4 t -58.76 -39.91 78.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 -176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.87 -37.63 85.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.52 86.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.262 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.564 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 8.9 m0 -67.19 -36.98 82.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.76 -44.76 89.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.306 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 2.2 tm-20 -58.17 -46.49 85.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.71 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -52.57 -58.94 5.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.185 178.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.5 t -67.51 -34.4 68.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.396 -175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.03 69.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.736 0.303 . . . . 0.0 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -81.94 -14.23 56.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.144 0.497 . . . . 0.0 110.201 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.46 34.56 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.339 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -107.69 169.43 8.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -103.78 146.46 28.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.772 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.2 pt -128.95 159.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.999 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.6 mp -96.84 115.79 28.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.074 0.464 . . . . 0.0 110.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.9 tt -82.8 -12.6 12.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 75.46 -48.12 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.575 173.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.25 92.12 6.24 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.479 0.657 . . . . 0.0 110.911 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.18 -10.78 24.66 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.023 2.482 . . . . 0.0 112.424 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -72.59 -15.15 61.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.476 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -87.12 -1.75 58.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.961 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -82.23 84.03 7.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.0 p -71.52 147.43 47.73 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.304 1.049 . . . . 0.0 112.327 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.6 m -49.9 -42.67 48.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 112.797 -2.001 . . . . 0.0 111.67 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.481 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 62.5 t80 -57.39 -42.32 81.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.655 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.454 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 52.8 mtm -73.23 -47.29 44.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.268 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -58.14 9.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.71 -32.34 73.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.923 -175.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 8.4 tt0 -62.6 -51.17 68.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.092 0.472 . . . . 0.0 109.811 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.636 HD11 HG12 ' A' ' 41' ' ' ILE . 76.9 mt -57.75 -44.36 86.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.081 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 2.4 ttmp? -53.96 -61.78 2.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.878 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 19.8 mm-40 -57.39 -44.49 84.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.617 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA ' ' A' ' 12' ' ' ALA . 32.5 tp -65.98 -44.14 85.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.697 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.54 -32.54 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.896 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 104' ' ' LYS . 11.7 tp -61.05 -30.01 70.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.052 -176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 40.9 mt-10 -60.86 -30.13 69.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.802 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -176.127 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.237 0.395 0 CA-C-O 122.165 0.983 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 4' ' ' PHE . 5.5 p-10 -162.1 35.95 0.12 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.134 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 87.3 m-85 72.42 -88.53 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.662 -167.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 4' ' ' PHE . 42.0 tttp 174.79 131.33 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 123.284 0.365 . . . . 0.0 110.414 174.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 28.2 t70 174.62 118.29 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.854 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 6' ' ' ASP . 6.6 mmtm -167.05 100.67 0.53 Allowed 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.701 0.625 . . . . 0.0 110.461 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -115.28 148.77 38.77 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ttt 54.63 81.04 0.27 Allowed Pre-proline 0 C--O 1.234 0.273 0 O-C-N 123.832 0.708 . . . . 0.0 110.354 -172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 110' ' ' HIS . 30.2 Cg_endo -62.94 108.66 0.78 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.868 2.379 . . . . 0.0 113.152 -174.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -82.28 74.22 9.27 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.838 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -40.06 66.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.412 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' O ' HD23 ' A' ' 17' ' ' LEU . 67.8 mt -62.9 -53.23 49.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.814 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 21.0 tp10 -57.44 -39.3 75.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.817 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HD2' HD23 ' A' ' 103' ' ' LEU . 33.6 ttmt -60.99 -53.86 52.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.751 178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.12 80.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 3.6 mm? -66.85 -29.12 68.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.665 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.52 -33.77 67.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.927 0.394 . . . . 0.0 110.453 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -67.22 -42.7 83.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.786 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.3 mt -76.92 -69.77 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.014 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.24 53.32 4.15 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.047 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.49 -146.97 18.63 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.308 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -91.45 36.16 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.838 0.351 . . . . 0.0 110.975 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -82.28 66.8 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.095 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.8 m 67.3 112.31 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.376 0.608 . . . . 0.0 111.62 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 m -67.46 89.68 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.289 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.94 -167.53 2.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.165 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -136.39 -67.39 0.51 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -174.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.565 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 43.5 t -79.81 -52.97 1.02 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.63 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 3.5 Cg_endo -85.72 73.86 3.69 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.23 1.953 . . . . 0.0 111.893 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.54 157.62 18.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.9 t -96.37 -80.16 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.2 0.524 . . . . 0.0 112.182 -169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.401 ' O ' ' HB ' ' A' ' 37' ' ' THR . 28.8 ttp -85.05 -22.43 28.99 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.307 -172.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 70' ' ' PHE . 2.8 m-20 -54.0 -42.72 69.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.248 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' HA ' ' CH2' ' A' ' 77' ' ' TRP . 2.4 tm-20 -50.4 -76.02 0.03 OUTLIER 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.758 0.789 . . . . 0.0 111.54 -173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -75.74 -37.68 59.12 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.701 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 33' ' ' MET . 75.0 m -68.99 -47.48 65.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -65.62 -38.47 89.52 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.352 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HD3' HD12 ' A' ' 87' ' ' ILE . 3.9 ttmp? -60.9 -42.16 97.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.199 0.523 . . . . 0.0 110.527 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.12 -45.06 74.02 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.327 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.46 -42.85 89.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.483 0.141 . . . . 0.0 111.003 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 90.0 mt -57.36 -48.02 80.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.697 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HD2' HD11 ' A' ' 87' ' ' ILE . 23.2 mtpp -66.97 -37.34 84.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.297 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 67.7 t80 -65.69 -44.18 86.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.723 0.297 . . . . 0.0 110.596 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.42 -42.24 88.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.828 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -63.16 -34.02 76.73 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.92 -43.18 79.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.605 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 85.3 mt -61.81 -42.23 98.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 134.24 6.68 2.39 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.615 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.97 99.98 51.5 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.782 0.325 . . . . 0.0 110.128 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -88.08 121.8 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.696 2.264 . . . . 0.0 112.709 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -91.35 108.29 19.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -73.99 138.3 76.1 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.959 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 18.0 Cg_endo -60.05 -25.24 79.2 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.981 2.454 . . . . 0.0 111.96 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.3 -44.67 88.66 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.88 -37.78 69.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.4 t -58.4 -45.24 89.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.017 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 54' ' ' PRO . 71.8 t -63.82 -50.29 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.999 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.83 95.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.233 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.676 ' HG2' ' CD1' ' A' ' 17' ' ' LEU . 8.7 tpt180 -66.07 -41.64 90.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.236 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -60.68 -48.75 84.68 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.838 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -68.18 -27.29 66.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.911 0.386 . . . . 0.0 110.729 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -69.85 -56.6 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' CD ' ' HE ' ' A' ' 60' ' ' ARG . 46.8 mt-10 -73.02 -24.6 60.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.994 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.94 49.68 2.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.006 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.419 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 36.4 m0 -74.69 147.24 41.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -63.3 142.58 97.83 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.248 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -48.83 -60.91 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.779 2.986 . . . . 0.0 114.432 -171.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.596 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 4.9 mm-40 -60.16 -26.32 66.22 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 34' ' ' ASP . 30.4 t80 -66.97 -61.18 2.07 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 m -57.95 -38.67 76.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.261 0.553 . . . . 0.0 110.782 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -60.28 -49.52 77.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.528 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 53.6 mttm -66.79 -46.08 76.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.924 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 62.2 t -61.62 -40.74 87.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.824 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.39 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.725 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.52 -41.53 99.58 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.304 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 10.2 m0 -66.82 -50.17 63.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.45 -39.03 72.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.9 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 32.8 tt0 -54.17 -54.44 39.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.824 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -68.99 -39.64 79.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.211 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' TRP . 92.5 t -69.24 -44.33 80.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.595 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.08 95.14 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.467 0.175 . . . . 0.0 110.833 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.4 t -65.95 -35.2 79.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.609 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.37 37.1 4.15 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.002 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -96.72 147.46 23.89 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.904 0.383 . . . . 0.0 110.161 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -67.46 137.76 56.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 ' HD2' ' A' ' 43' ' ' LYS . 30.7 pt -138.44 135.65 44.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 170.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 88' ' ' LEU . 2.6 pp -69.97 131.13 43.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.849 0.833 . . . . 0.0 112.131 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.49 69.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.998 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.64 13.62 9.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.623 ' H ' ' CD ' ' A' ' 92' ' ' PRO . 5.9 m-80 -131.54 -51.25 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.071 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.623 ' CD ' ' H ' ' A' ' 91' ' ' ASN . 50.7 Cg_exo -59.25 -30.45 92.97 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.811 2.341 . . . . 0.0 113.353 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 65.97 17.98 10.94 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.205 0.526 . . . . 0.0 110.65 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 60.24 -95.9 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.731 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 100' ' ' GLN . 38.1 p90 179.34 177.23 0.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.637 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 38.4 t -77.74 152.45 33.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.167 -174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -58.1 -39.61 79.07 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -43.93 -54.12 5.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.046 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 68.5 mtm -75.18 -29.51 60.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.244 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 8.3 tt0 -67.17 -44.55 79.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.217 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.02 -40.43 97.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -57.43 -51.72 68.29 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.523 0.678 . . . . 0.0 109.75 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 107' ' ' VAL . 68.1 mt -56.66 -63.91 1.04 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.905 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -57.93 -49.32 77.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.491 -170.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.81 -48.41 80.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.949 0.404 . . . . 0.0 109.977 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.95 2.01 16.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.43 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 103' ' ' LEU . 42.7 t -100.14 -33.89 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.41 -31.7 67.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.365 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -63.6 -63.31 1.21 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.4 p80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 123.467 0.707 . . . . 0.0 110.883 -171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.86 0.362 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -116.69 -150.44 0.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -71.29 -8.26 52.46 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 69.99 100.21 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.58 0.752 . . . . 0.0 112.638 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -167.55 143.3 4.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.96 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -65.47 -45.2 84.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.335 0.588 . . . . 0.0 110.126 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' A' ' 110' ' ' HIS . 4.2 p -152.08 99.68 2.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.162 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.8 ttm -128.03 115.23 20.38 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.958 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.7 94.61 1.05 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.568 2.179 . . . . 0.0 112.096 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 p -76.17 5.5 6.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.564 0.697 . . . . 0.0 110.442 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.58 -25.64 68.33 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.263 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.7 mt -55.12 -50.95 59.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.46 -41.7 75.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.775 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -73.86 -34.89 64.66 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.49 -33.33 69.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.026 0.441 . . . . 0.0 109.921 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.718 HD11 ' HG2' ' A' ' 60' ' ' ARG . 7.8 tt -62.75 -36.4 82.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.359 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -61.9 -46.4 89.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.187 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -62.49 -53.95 47.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.4 mt -65.98 -46.24 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.664 -175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.51 0.29 60.89 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.294 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 -119.72 11.42 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.903 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.443 ' HA ' ' CE ' ' A' ' 23' ' ' MET . 2.9 tpt -145.4 81.33 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 67.84 -3.73 1.12 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.538 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -160.15 156.36 26.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -134.03 -163.68 1.4 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.48 166.56 18.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -132.21 -72.3 0.53 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.951 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.581 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 61.0 t -76.86 -57.25 1.21 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.817 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 73.0 Cg_endo -75.89 77.34 3.45 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.853 1.702 . . . . 0.0 112.164 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -88.43 112.71 23.24 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.453 ' HB2' ' H ' ' A' ' 33' ' ' MET . 3.2 m -103.48 -80.65 0.52 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.482 0.658 . . . . 0.0 110.238 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.453 ' H ' ' HB2' ' A' ' 32' ' ' SER . 3.8 ptm -90.5 -9.74 46.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.877 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.56 -22.47 66.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.845 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -102.56 -65.37 1.0 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.739 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.6 m -56.11 -52.3 64.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.986 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.436 ' O ' HG13 ' A' ' 41' ' ' ILE . 23.5 m -66.81 -41.62 87.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.697 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -61.99 -51.37 68.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.171 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.91 -39.86 90.96 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.487 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -44.65 97.81 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.15 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' HD23 ' A' ' 45' ' ' LEU . 80.0 mt -64.38 -47.43 89.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.653 0.264 . . . . 0.0 111.008 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 52' ' ' VAL . 86.0 mt -62.42 -42.75 99.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.024 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -67.45 -40.54 85.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.777 0.322 . . . . 0.0 110.273 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.562 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 77.7 t80 -59.15 -47.91 83.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.317 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 41' ' ' ILE . 3.3 mm? -60.03 -45.18 93.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.848 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -59.91 -42.45 93.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.618 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.52 -37.8 85.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 90.3 mt -56.79 -38.48 72.58 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.665 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.9 -52.4 0.43 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.801 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -87.23 126.1 63.75 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 121.152 0.501 . . . . 0.0 111.611 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.1 145.75 15.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.381 2.054 . . . . 0.0 111.708 175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 42' ' ' LEU . 30.8 m -81.07 140.25 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.176 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.501 ' HB2' HG22 ' A' ' 56' ' ' VAL . 3.6 m -90.55 119.21 69.1 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -64.1 -38.0 39.12 Favored 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.786 2.324 . . . . 0.0 113.462 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -69.98 -39.41 75.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 53' ' ' SER . 27.9 m -67.37 -26.77 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.018 0.437 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 53' ' ' SER . 86.9 t -68.67 -44.4 82.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.588 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 61.3 t -62.29 -42.04 93.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.09 -39.56 78.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.718 ' HG2' HD11 ' A' ' 17' ' ' LEU . 7.8 tpt180 -73.16 -34.34 66.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.296 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -58.42 -48.53 83.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.339 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 7.9 pt-20 -72.17 -26.4 62.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -82.12 -54.27 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.203 0.525 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.17 -25.83 47.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.879 -168.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 100.28 60.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.391 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.429 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 34.2 m0 -103.01 165.58 10.94 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 2.7 m-20 -71.91 137.78 82.41 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.695 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 45.7 Cg_exo -56.68 -44.62 43.65 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 123.177 2.585 . . . . 0.0 112.567 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 52.4 mp0 -63.83 -45.8 87.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.056 0.455 . . . . 0.0 110.291 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' VAL . 86.9 t80 -61.86 -54.58 40.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.369 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 23.4 m -58.05 -39.82 79.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.707 -177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.31 -46.41 73.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.928 -178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 61.7 mttm -66.94 -43.26 83.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.046 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.87 -36.19 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.822 0.344 . . . . 0.0 110.431 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.83 86.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.353 175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.95 96.73 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.091 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . 28.1 m0 -64.2 -49.19 72.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.02 79.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.376 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -59.04 -43.14 91.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.91 0.386 . . . . 0.0 110.138 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' HG22 ' A' ' 87' ' ' ILE . 66.8 mttm -65.23 -45.46 84.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.07 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' TRP . 85.6 t -58.99 -43.27 88.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.39 -29.63 65.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.4 p -89.74 -19.88 24.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.01 25.01 9.28 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.418 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -90.97 162.54 14.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 110.761 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -87.84 145.21 26.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.717 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 80' ' ' LYS . 33.7 pt -127.07 136.52 60.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.934 0.397 . . . . 0.0 110.407 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -86.84 138.54 31.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.888 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 90' ' ' LYS . 6.3 tt -126.45 161.02 33.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.539 ' N ' HG12 ' A' ' 89' ' ' ILE . 42.9 mmtm -74.42 44.43 0.2 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 171.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER 76.23 152.2 0.14 Allowed Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.016 0.926 . . . . 0.0 111.429 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.78 34.38 0.42 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 122.695 2.263 . . . . 0.0 112.065 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 91' ' ' ASN . 10.6 tp10 -103.52 161.47 13.85 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 74.31 -30.19 0.2 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.264 0.626 . . . . 0.0 111.457 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -77.66 86.02 3.97 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 166.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -83.77 172.03 12.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.783 -167.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -25.99 68.31 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.695 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -51.2 -53.66 32.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.132 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -68.73 -35.48 77.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.022 0.439 . . . . 0.0 110.248 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.16 -53.59 42.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.23 -38.17 76.31 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.986 0.179 . . . . 0.0 111.314 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -51.84 -60.69 2.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.63 0.729 . . . . 0.0 110.506 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.6 -38.17 83.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.111 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.31 -56.62 18.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.381 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.7 tt0 -64.79 -38.34 90.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.462 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -51.26 -43.24 61.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.522 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -83.06 -39.78 15.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.594 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 43.4 tp -61.56 -23.29 65.87 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.335 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 41.6 mt-10 -62.86 -22.55 66.77 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.623 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 71.2 m-70 . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.233 0.209 0 CA-C-O 121.118 0.485 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.7 106.56 18.86 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.245 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 89.2 t80 -90.87 96.38 10.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 4' ' ' PHE . 44.2 tttm 70.19 139.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.898 0.749 . . . . 0.0 109.942 -169.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.68 163.26 22.61 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.901 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -134.74 152.87 52.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 -171.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 p -62.09 111.09 1.8 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.33 175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.1 mtp -120.81 125.19 27.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.333 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.53 115.44 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.689 2.26 . . . . 0.0 112.293 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -77.23 2.12 16.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.83 92.06 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.663 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.58 -44.62 97.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.455 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.381 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.55 -33.31 75.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.459 -174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.643 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 10.9 mmpt? -75.45 -26.66 58.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.811 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.57 -40.39 84.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.38 0.61 . . . . 0.0 109.458 171.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.5 mm? -74.2 -14.83 61.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 11.9 t70 -69.01 -44.95 71.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -64.29 -64.29 0.92 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.708 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.0 -43.14 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.616 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.15 -9.54 80.62 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.985 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.03 -14.81 71.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.787 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.599 ' SD ' ' HA ' ' A' ' 34' ' ' ASP . 65.3 mtm -88.48 75.26 8.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.698 0.761 . . . . 0.0 110.368 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -100.02 10.31 41.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.926 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.96 54.49 1.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.518 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.7 m 57.62 31.22 20.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.101 174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.573 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . . . -64.83 112.92 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 110.141 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 m -165.06 -51.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' O ' ' HD2' ' A' ' 31' ' ' HIS . 56.4 t -72.98 139.69 80.02 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -30.23 96.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.853 3.036 . . . . 0.0 113.351 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.573 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -94.6 121.63 36.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -173.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -59.25 -67.45 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.254 0.549 . . . . 0.0 111.774 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -61.82 2.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.618 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.599 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -51.96 -68.56 0.16 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.979 -175.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 36.5 tt0 -62.09 -62.21 1.93 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -169.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -58.99 -47.37 85.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.368 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.2 m -75.22 -31.27 60.83 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.424 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.5 94.07 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.038 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.13 -43.4 82.34 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.078 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.597 ' CA ' ' HA ' ' A' ' 94' ' ' TYR . . . -63.9 -46.53 91.36 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.714 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.66 -47.53 90.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.522 0.201 . . . . 0.0 111.008 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.9 -38.6 86.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 111.208 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -66.59 -42.32 87.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.088 0.471 . . . . 0.0 110.269 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 54.2 t80 -66.16 -45.34 81.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.789 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.448 HD23 HD12 ' A' ' 48' ' ' LEU . 94.7 mt -60.85 -41.59 96.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.879 0.371 . . . . 0.0 110.862 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -50.49 -51.94 42.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.233 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -13.79 59.88 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.919 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 61.6 mt -73.43 -26.15 60.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.84 0.352 . . . . 0.0 110.292 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.88 -14.8 10.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.376 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.69 93.17 48.76 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.923 0.392 . . . . 0.0 110.629 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -90.97 146.21 3.67 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.091 2.527 . . . . 0.0 112.078 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.71 110.1 19.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.872 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 m -66.14 139.54 96.56 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.702 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.54 -28.08 53.47 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.034 2.489 . . . . 0.0 112.743 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -58.03 -44.41 87.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.211 0.529 . . . . 0.0 110.317 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.32 -38.03 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.307 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.33 -47.76 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.874 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.11 -49.68 83.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.983 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.66 92.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.548 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 1.4 tpt85 -69.39 -34.44 74.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.524 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.67 -50.21 68.5 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.275 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -73.25 -32.07 64.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.627 0.251 . . . . 0.0 111.407 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -72.09 -45.83 59.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.0 111.439 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 7.3 tp10 -82.75 -48.73 10.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.25 65.13 0.21 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.19 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.496 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 31.5 m0 -104.56 162.71 13.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.07 148.7 81.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.66 -35.09 66.74 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.156 2.571 . . . . 0.0 112.411 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 24.4 mm-40 -69.9 -46.74 64.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.704 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.08 -46.6 88.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.3 m -61.31 -44.78 96.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.191 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.99 -43.22 88.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.239 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 64.0 mttm -62.07 -53.57 53.57 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.1 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 53.0 t -59.38 -40.19 80.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.821 -177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.49 -32.92 74.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.07 -35.81 64.4 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.439 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 14.3 m0 -68.68 -49.35 59.69 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.18 -42.52 77.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.498 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.0 -58.42 6.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.324 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -66.22 -46.97 75.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.811 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.32 -43.66 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.565 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.59 -28.49 61.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.579 0.228 . . . . 0.0 111.22 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.9 t -67.25 -35.59 79.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.391 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.14 -3.44 8.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.63 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -91.28 103.9 16.5 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.137 0.494 . . . . 0.0 109.759 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -53.41 141.45 24.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.984 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 20.6 pt -124.36 113.15 35.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.531 0.681 . . . . 0.0 109.86 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.86 123.86 29.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.021 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.919 HG22 ' HB2' ' A' ' 91' ' ' ASN . 56.2 mt -66.42 -31.03 51.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.101 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? 62.29 21.55 12.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 122.271 1.034 . . . . 0.0 109.456 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 1.0 ' HB3' ' HD2' ' A' ' 92' ' ' PRO . 52.4 m-80 -148.43 -160.28 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 1.0 ' HD2' ' HB3' ' A' ' 91' ' ' ASN . 31.6 Cg_exo -43.37 86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.907 2.405 . . . . 0.0 114.14 168.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.559 ' HA ' HD12 ' A' ' 89' ' ' ILE . 19.0 mm-40 -63.99 130.14 42.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.883 173.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.597 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 96.8 m-85 64.63 -93.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.94 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER 169.85 -157.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.161 -172.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . 11.3 t -108.14 -175.78 2.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -41.12 88.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 -167.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 96' ' ' SER . 0.1 OUTLIER -53.46 -47.56 69.64 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -169.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.5 mtt -65.1 -45.3 85.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.402 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -58.68 -45.35 89.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.645 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -60.24 -44.58 95.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.431 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -64.61 -57.41 9.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.576 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.07 -46.76 87.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.704 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -65.42 -35.17 80.12 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.747 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.83 -38.73 91.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 0.0 110.821 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 tp -63.55 -34.11 77.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.304 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.93 -50.67 18.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.822 176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.1 -62.43 1.88 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.394 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -71.42 -59.94 2.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.286 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 . . . . . 0 N--CA 1.471 0.586 0 O-C-N 124.015 0.822 . . . . 0.0 111.569 175.776 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' PHE . 11.1 p . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -97.38 11.11 37.76 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -171.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' H ' HG22 ' A' ' 2' ' ' VAL . 42.9 t80 -166.9 138.6 3.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.447 0.165 . . . . 0.0 110.625 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.588 ' HE3' ' HA ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -70.39 122.26 19.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 175.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.71 170.88 13.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.937 0.398 . . . . 0.0 110.604 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -93.27 19.96 7.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.957 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -125.64 157.13 38.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.057 0.456 . . . . 0.0 110.419 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 ptp -140.96 157.87 66.27 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.536 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.0 118.13 4.87 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.896 2.397 . . . . 0.0 111.965 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 14' ' ' GLU . 8.9 t -131.35 148.84 52.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.138 0.494 . . . . 0.0 111.204 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -27.21 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.39 -37.6 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.612 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 14.0 mm-40 -76.72 -25.91 54.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.103 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -81.28 -30.61 33.97 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 19' ' ' PHE . . . -65.58 -36.17 82.98 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 171.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 57.1 tp -58.7 -41.02 85.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.323 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -58.29 -46.15 86.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.774 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 16' ' ' ALA . 57.5 m-85 -62.38 -50.74 70.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.868 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.35 -55.86 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.363 -173.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.95 29.3 5.84 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.222 -0.989 . . . . 0.0 113.26 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.05 -70.63 1.1 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.564 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 mmt -79.9 -50.64 10.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 60.49 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.649 176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t -89.64 167.35 13.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.313 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -71.96 88.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 0.0 110.569 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . . . -94.01 121.66 35.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.692 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.4 m -130.1 -47.37 1.11 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.542 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 15.5 m -74.34 173.62 6.32 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.248 167.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 51.5 Cg_exo -55.34 -19.89 23.6 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.262 1.974 . . . . 0.0 111.553 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.622 ' CD2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER 70.48 -167.17 0.16 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.348 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -95.9 -80.76 0.42 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 0.0 111.911 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.2 ttp -94.32 -17.01 23.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.544 0.688 . . . . 0.0 109.96 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.14 -21.29 66.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.218 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -93.45 -68.79 0.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.679 0.275 . . . . 0.0 110.825 -176.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -46.68 88.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.9 m -67.21 -36.61 82.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 0.0 111.033 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.94 89.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.525 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 31.7 mmtp -54.74 -48.0 73.11 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.564 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.12 -44.56 94.71 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.348 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.475 HG23 HD11 ' A' ' 103' ' ' LEU . 73.9 mt -61.05 -49.97 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.061 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.51 -44.62 93.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.429 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.42 -27.35 65.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.387 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -70.14 -36.52 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.044 0.449 . . . . 0.0 110.182 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 97.2 mt -64.15 -40.37 95.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.403 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -72.74 -25.0 61.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.65 -38.45 89.38 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.24 0.543 . . . . 0.0 109.897 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.44 -40.2 85.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.767 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.29 -26.81 3.67 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.97 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.91 104.7 54.24 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -92.32 -178.49 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.028 2.486 . . . . 0.0 112.081 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -109.83 121.35 62.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 56' ' ' VAL . 6.4 m -61.65 127.55 88.9 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.691 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 53.1 Cg_exo -53.02 -32.33 57.68 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.878 2.386 . . . . 0.0 112.544 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -55.99 -52.52 63.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.664 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 53' ' ' SER . 31.5 m -71.02 -24.19 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.772 0.32 . . . . 0.0 111.015 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.46 -45.49 88.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.126 176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 65.1 t -61.11 -48.99 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.646 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.57 98.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.949 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -61.81 -42.49 99.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.207 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -61.53 -47.63 89.47 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.48 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.9 -12.78 60.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.78 0.324 . . . . 0.0 110.814 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -85.8 -52.4 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -73.88 -27.34 61.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.959 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.37 48.21 1.45 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.532 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.489 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 40.9 m0 -83.26 153.74 24.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 67.2 t30 -63.17 127.9 91.6 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 4.9 Cg_endo -47.3 -43.82 25.61 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.867 . . . . 0.0 113.332 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.3 -37.1 79.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.766 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 74' ' ' VAL . 74.6 t80 -70.45 -53.36 16.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.164 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -58.16 -40.03 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.322 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.79 -46.91 88.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.535 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -67.41 -46.19 73.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.545 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 70' ' ' PHE . 69.6 t -60.33 -37.82 75.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.56 89.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.638 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.27 -35.12 69.58 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.899 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.544 ' O ' HG23 ' A' ' 81' ' ' VAL . 50.6 m0 -63.1 -54.13 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.64 -33.36 68.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.056 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -58.26 -50.29 74.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.162 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -81.27 -21.51 39.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.489 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.7 t -67.78 -38.27 79.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.144 0.497 . . . . 0.0 109.836 173.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.41 -44.33 36.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.239 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.3 p -75.55 -34.83 60.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.91 44.36 4.5 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.772 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -111.7 108.52 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 62.13 -141.22 0.44 Allowed 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.563 0.539 . . . . 0.0 110.671 174.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' C ' ' H ' ' A' ' 89' ' ' ILE . 37.0 pt 52.76 53.06 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.34 1.056 . . . . 0.0 112.22 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 3.4 pp -79.22 19.26 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.499 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 87' ' ' ILE . 1.1 tt 79.28 141.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.18 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -71.32 -40.94 70.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.566 0.698 . . . . 0.0 109.372 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -172.19 148.67 2.03 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.816 175.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.05 -37.81 93.74 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.453 2.102 . . . . 0.0 111.618 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.33 -97.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.43 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -142.49 24.22 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 111.116 -177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -72.25 107.39 4.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.0 m -99.34 159.93 14.65 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.277 -170.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 1.3 t -66.79 -28.59 68.51 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.0 -39.88 63.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.777 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.4 mtt -66.3 -42.23 88.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.086 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -59.7 -51.65 68.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.586 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 97' ' ' THR . 73.8 mt-10 -59.64 -42.02 91.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.13 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.449 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 22.1 mt-30 -56.22 -54.86 40.19 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.698 0.285 . . . . 0.0 111.155 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 107' ' ' VAL . 96.0 mt -60.76 -44.67 96.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.864 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -63.83 -41.9 97.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.865 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.48 -43.72 98.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.296 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 96.5 mt -66.54 -21.67 66.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' LEU . 98.6 t -71.8 -40.99 70.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.139 0.495 . . . . 0.0 109.91 173.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -72.3 -44.3 62.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.572 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.77 -23.53 65.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.685 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 85.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.635 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.053 0.454 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -83.02 -2.99 56.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.7 t80 71.29 -105.52 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.676 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 6' ' ' ASP . 86.5 tttt 177.73 168.2 0.69 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 5' ' ' LYS . 14.5 m-20 -56.58 109.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 169.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -75.55 -76.29 0.15 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.493 -173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -126.07 109.6 12.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.6 ttm -84.42 114.67 56.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.646 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.07 137.14 64.89 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.797 2.331 . . . . 0.0 112.114 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -77.52 85.35 3.89 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.563 0.697 . . . . 0.0 110.681 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.88 -38.4 88.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.583 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.5 mp -64.13 -40.54 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.128 0.489 . . . . 0.0 109.889 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.4 -50.64 72.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.15 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 28.1 mmtp -78.85 -18.51 53.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.69 77.87 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.641 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.1 mt -70.95 -22.41 62.22 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.183 174.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 18.4 t70 -67.48 -36.91 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 175.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -65.07 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.488 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.92 -74.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.519 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' A' ' 66' ' ' TRP . . . -95.36 46.96 1.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.373 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.08 -58.28 1.41 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.63 95.85 9.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.619 ' CG ' ' HA ' ' A' ' 66' ' ' TRP . 76.6 m-20 -116.21 144.71 43.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.464 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.509 HG21 ' CG2' ' A' ' 29' ' ' VAL . 12.4 t -164.54 -178.55 5.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.29 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 m -85.98 45.93 1.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.503 . . . . 0.0 110.579 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' ASN . . . -170.86 -151.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.385 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 69' ' ' GLU . 28.4 t -137.5 56.8 1.76 Allowed 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 25' ' ' THR . 31.3 t -46.09 -44.59 37.24 Favored Pre-proline 0 C--N 1.302 -1.481 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.056 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' HB2' ' OD1' ' A' ' 34' ' ' ASP . 81.6 Cg_exo -50.16 -37.95 49.69 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.462 1.441 . . . . 0.0 111.343 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.1 m170 68.18 -69.86 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.558 1.143 . . . . 0.0 111.968 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -92.56 -49.24 6.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.809 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.606 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.59 -27.71 28.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.332 -170.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -41.45 -54.17 3.18 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 124.097 0.873 . . . . 0.0 110.632 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.597 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . 33.5 mm-40 -59.09 -63.74 1.19 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.144 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.427 ' CB ' ' H ' ' A' ' 94' ' ' TYR . 19.9 m -62.14 -55.81 25.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.42 HG23 ' SD ' ' A' ' 99' ' ' MET . 90.9 m -69.14 -52.5 27.55 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -170.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' HZ3' ' A' ' 77' ' ' TRP . . . -75.48 -44.11 45.71 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 4.2 ttmp? -67.54 -33.59 75.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.799 0.333 . . . . 0.0 110.246 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.7 -50.42 66.3 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.314 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.15 -45.22 96.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.625 0.25 . . . . 0.0 111.102 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.8 mt -58.52 -44.83 89.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.941 0.401 . . . . 0.0 111.249 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 43' ' ' LYS . 9.8 mtpm? -69.92 -34.1 73.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.394 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -64.73 -42.2 95.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 110.117 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.43 -42.56 92.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.495 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -61.61 -35.83 78.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.606 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -65.56 -43.57 89.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.388 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.472 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.65 16.29 1.67 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.8 t -119.21 94.11 47.89 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.934 0.397 . . . . 0.0 110.671 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -93.02 152.19 2.63 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.886 2.391 . . . . 0.0 112.253 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 148.26 24.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.964 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.2 m -83.11 133.37 48.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.601 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 45.2 Cg_exo -56.87 -31.42 88.96 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.267 2.645 . . . . 0.0 112.519 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -52.59 -42.82 64.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.304 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -68.92 -38.65 78.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.414 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.43 -46.91 85.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.471 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 85.7 t -60.09 -44.26 94.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.498 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.77 88.73 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.121 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.641 ' HG2' HD13 ' A' ' 17' ' ' LEU . 13.0 tpt180 -65.38 -39.75 92.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.16 97.86 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.265 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 51.5 mt-10 -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.602 -0.352 . . . . 0.0 111.188 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.84 -46.09 26.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.4 -9.16 55.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.552 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.3 -65.3 1.58 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.819 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.619 ' HA ' ' CG ' ' A' ' 24' ' ' ASN . 35.7 m0 55.35 -167.27 0.1 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.07 0.548 . . . . 0.0 111.957 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.888 ' HB2' ' HB3' ' A' ' 70' ' ' PHE . 54.4 m-80 -93.48 123.4 60.38 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.45 -38.2 82.78 Favored 'Trans proline' 0 CA--C 1.526 0.106 0 C-N-CA 122.996 2.464 . . . . 0.0 112.628 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 2.6 tm-20 -80.45 -33.39 36.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.277 0.561 . . . . 0.0 110.015 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.888 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 77.5 t80 -73.27 -43.99 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.535 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.9 m -59.51 -35.62 74.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -69.59 -40.36 76.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.329 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.712 ' HB3' ' CZ2' ' A' ' 77' ' ' TRP . 63.2 mttt -54.76 -57.6 10.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.0 t -60.61 -37.46 75.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.06 -175.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.49 73.07 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.5 -44.1 51.42 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.15 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.712 ' CZ2' ' HB3' ' A' ' 73' ' ' LYS . 10.6 m0 -64.62 -49.25 71.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.979 0.419 . . . . 0.0 110.107 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.8 -34.41 74.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.743 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -59.6 -45.28 92.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.025 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -60.56 -49.03 79.19 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.427 0.632 . . . . 0.0 110.327 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 77' ' ' TRP . 61.9 t -60.77 -44.87 98.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.502 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.86 -32.1 61.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.64 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -77.45 -9.31 58.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 110.798 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.88 29.01 13.82 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.098 170.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.616 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -100.12 171.01 8.08 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 86' ' ' ARG . 13.0 ptt180 -119.44 132.83 55.88 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.8 pt -112.73 138.55 41.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.174 0.512 . . . . 0.0 110.901 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.16 116.65 17.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.708 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 89' ' ' ILE . 16.8 tt -77.48 89.86 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 122.502 1.144 . . . . 0.0 110.092 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 90' ' ' LYS . 17.3 pttp -67.62 -2.74 7.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.779 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.597 ' ND2' ' HB3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -160.12 88.35 1.88 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.13 0.491 . . . . 0.0 111.578 -177.347 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -96.35 29.15 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.523 2.816 . . . . 0.0 112.511 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -59.2 -55.52 33.82 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.606 ' HD2' ' HA ' ' A' ' 33' ' ' MET . 20.3 m-85 -99.45 35.67 1.91 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.39 -171.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HE2' HE21 ' A' ' 100' ' ' GLN . 10.7 t80 -116.1 82.87 1.85 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -74.09 160.53 31.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.838 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -30.86 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.734 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.549 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 43.7 t80 -49.34 -51.64 33.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.546 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 37' ' ' THR . 68.0 mtm -69.45 -39.14 77.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.502 HE21 ' HE2' ' A' ' 95' ' ' PHE . 73.4 mt-30 -61.88 -46.58 88.8 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.217 0.532 . . . . 0.0 110.117 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -66.23 -35.21 79.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.167 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 98' ' ' TYR . 57.5 mt-30 -59.11 -50.92 72.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.064 0.459 . . . . 0.0 110.37 175.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.48 -45.23 84.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.475 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -57.44 -42.39 82.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.908 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -69.23 -49.57 55.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.578 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 tt -62.94 -44.51 95.86 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.942 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.0 -32.48 58.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 110.415 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 32.5 tp -67.51 -59.22 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -32.72 69.99 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.713 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.401 171.13 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.286 0.565 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -140.48 112.52 7.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.303 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -99.25 105.61 17.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.522 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -76.89 104.18 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.01 -166.04 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.337 -173.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -116.76 99.83 7.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.094 -179.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.2 m -128.39 178.51 6.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.249 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -87.52 109.18 24.22 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 121.099 0.476 . . . . 0.0 110.025 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.76 -60.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.154 2.569 . . . . 0.0 114.401 -170.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.2 p -78.06 -6.57 55.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -171.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HA ' HD11 ' A' ' 106' ' ' LEU . . . -64.35 -46.62 82.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.2 0.524 . . . . 0.0 110.401 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 54.6 mt -70.52 -40.4 77.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.215 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.07 -39.77 93.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.91 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 48.4 tptt -68.71 -36.04 77.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.748 0.309 . . . . 0.0 110.61 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.2 -41.48 99.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.16 0.505 . . . . 0.0 110.27 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.528 HD13 ' HG2' ' A' ' 60' ' ' ARG . 92.0 mt -66.76 -32.7 74.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.687 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 7.4 t70 -57.49 -44.55 85.03 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.018 176.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.49 -41.85 98.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.01 177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -54.25 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.648 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.55 -54.16 30.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.81 -176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -111.28 4.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.904 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 62.6 mtt -109.21 -42.67 4.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 51.1 71.02 0.47 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.902 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -105.28 -78.44 0.57 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.966 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 t -102.04 4.25 39.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.293 0.568 . . . . 0.0 109.796 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.24 111.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.734 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 60.8 m -154.41 -52.57 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.18 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 51.3 t -109.15 -47.86 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.305 172.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 18.9 Cg_exo -67.68 110.54 2.13 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.415 1.41 . . . . 0.0 109.785 165.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 5.0 m170 -131.21 103.3 6.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.614 -172.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -104.19 -58.18 1.92 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 110.485 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 37' ' ' THR . 0.0 OUTLIER -87.4 -58.52 2.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.074 -171.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.36 -5.47 32.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.014 -169.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.679 ' HG3' ' CZ2' ' A' ' 77' ' ' TRP . 21.0 tt0 -103.19 -62.74 1.25 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.09 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.8 m -58.28 -55.78 30.54 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 33' ' ' MET . 41.3 m -70.91 -30.17 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.83 0.348 . . . . 0.0 110.868 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.74 99.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.424 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' HE3' ' CG ' ' A' ' 35' ' ' GLU . 92.3 mttt -58.88 -43.69 90.97 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.072 174.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 -44.38 97.87 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.594 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.418 HG12 ' HE1' ' A' ' 95' ' ' PHE . 55.5 mt -61.32 -47.43 93.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.042 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD22 HG11 ' A' ' 52' ' ' VAL . 82.5 mt -64.36 -40.29 95.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.091 0.472 . . . . 0.0 110.916 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.08 -34.23 76.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.461 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 76.3 t80 -65.62 -39.13 91.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.62 -44.18 96.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 110.623 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -62.62 -32.52 73.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.575 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.49 -34.46 72.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.305 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.3 mt -67.65 -41.68 83.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.353 175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.25 -50.22 0.47 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.734 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 m -87.47 121.24 71.25 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.224 0.535 . . . . 0.0 112.226 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.8 165.8 8.8 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.638 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HD22 ' A' ' 42' ' ' LEU . 8.9 p -107.03 147.79 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.45 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 13.8 m -102.16 137.05 19.35 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 27.0 Cg_exo -62.56 -24.79 75.31 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.241 2.627 . . . . 0.0 112.545 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -53.36 -45.92 69.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.825 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.84 -36.52 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.62 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 74' ' ' VAL . 66.8 t -64.0 -49.73 80.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.742 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.73 -46.0 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.763 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -48.06 83.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.528 ' HG2' HD13 ' A' ' 17' ' ' LEU . 20.8 tpt180 -66.4 -43.35 86.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.93 -47.08 91.3 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.429 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.13 -33.6 76.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.639 0.257 . . . . 0.0 111.418 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.97 -57.19 4.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.86 0.362 . . . . 0.0 111.19 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -70.52 -31.58 68.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.161 -170.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.66 45.03 1.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.964 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 37.8 m0 -85.65 131.43 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.449 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t30 -65.65 123.45 84.67 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 26.3 Cg_exo -30.11 -44.67 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.771 1 C-N-CA 125.748 4.299 . . . . 0.0 115.918 -176.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 1.4 mp0 -59.05 -35.19 72.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.98 0.419 . . . . 0.0 111.096 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 74' ' ' VAL . 57.4 t80 -74.92 -47.54 29.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.476 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 m -60.44 -39.8 88.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.879 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -62.41 -43.94 97.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.927 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -56.53 -58.75 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.167 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 31.8 t -59.65 -41.59 85.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.564 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.08 -39.07 88.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 0.0 110.438 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.08 -37.98 94.82 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.44 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.679 ' CZ2' ' HG3' ' A' ' 35' ' ' GLU . 11.1 m0 -66.43 -53.78 31.7 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.13 -40.29 64.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.986 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -55.24 -54.57 41.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.796 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 58.5 mttt -73.05 -39.3 66.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.418 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -42.21 92.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.541 0.21 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.49 -40.83 93.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.185 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -78.92 -9.22 59.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.12 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.57 39.39 41.54 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.217 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 80' ' ' LYS . 55.4 m-20 -98.61 152.16 19.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -69.38 149.72 48.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.053 0.454 . . . . 0.0 110.152 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 pt -136.39 166.03 27.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.589 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.89 102.43 14.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 89' ' ' ILE . 4.0 tt -103.28 -6.94 9.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.068 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 90' ' ' LYS . 3.8 tptp 66.11 -83.49 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.0 -169.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -153.26 126.86 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.21 -59.06 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.279 1.986 . . . . 0.0 111.467 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.68 ' HG2' ' HB3' ' A' ' 91' ' ' ASN . 27.7 mm-40 57.21 -81.38 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 172.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -85.08 53.44 2.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 41' ' ' ILE . 21.8 t80 -111.27 71.15 0.73 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.2 m -61.01 144.8 52.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.66 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.7 m -53.55 -38.18 63.6 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.523 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.23 -37.93 78.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.672 0.273 . . . . 0.0 111.231 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.2 mtm -75.56 -41.09 55.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.083 0.468 . . . . 0.0 110.397 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -62.35 -47.72 82.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.768 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 13.5 tp10 -69.39 -28.0 65.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.675 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -66.24 -49.08 68.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.337 0.589 . . . . 0.0 109.819 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.44 -43.6 98.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.238 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 34.6 tttm -58.86 -37.08 75.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.144 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 109' ' ' GLU . 35.5 tt0 -58.31 -54.67 44.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.521 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD11 ' HA ' ' A' ' 12' ' ' ALA . 6.1 tt -56.13 -45.3 79.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.364 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.73 -42.46 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.3 tp -66.58 -44.91 80.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.992 -176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 105' ' ' GLU . 52.7 mt-10 -49.15 -45.46 43.88 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.353 -172.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.515 0.198 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.05 -59.25 0.57 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.516 0.727 . . . . 0.0 111.811 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -114.75 109.98 19.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.259 0.552 . . . . 0.0 110.877 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -152.16 165.47 34.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.51 106.61 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.144 0.497 . . . . 0.0 110.595 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -88.53 141.67 28.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.203 -172.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 m 65.73 102.5 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 O-C-N 123.969 0.793 . . . . 0.0 111.436 177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' THR . 72.3 mtm -138.1 126.27 14.11 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.695 -177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 10.5 Cg_exo -71.44 29.35 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.201 2.601 . . . . 0.0 112.832 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' MET . 9.0 t -78.44 -1.17 32.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.589 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.27 -38.17 82.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.3 mt -63.28 -47.62 91.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.104 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.72 -36.76 84.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.495 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -66.85 -46.97 73.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.993 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.05 -41.26 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.101 0.476 . . . . 0.0 110.314 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' A' ' 60' ' ' ARG . 21.6 tp -66.79 -34.53 78.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.419 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.93 -42.31 97.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.119 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.13 -32.18 73.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.42 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.38 -65.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.15 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.92 -51.74 55.05 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.903 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.71 -117.17 4.97 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.482 -0.39 . . . . 0.0 112.785 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 ptm -165.28 117.87 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.069 0.462 . . . . 0.0 110.168 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -95.68 93.61 7.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.025 0.441 . . . . 0.0 110.662 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 t -78.8 83.15 4.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.617 0.722 . . . . 0.0 109.68 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t 70.41 -6.12 1.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.176 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.81 114.39 5.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.254 0.55 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 69' ' ' GLU . 3.3 p -141.11 -57.18 0.5 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.436 -175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.621 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 60.6 t -83.07 -54.83 0.53 Allowed Pre-proline 0 C--N 1.318 -0.774 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 90.6 Cg_endo -81.41 131.83 7.71 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.578 1.518 . . . . 0.0 111.462 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 26.4 m-70 -131.38 152.64 50.44 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 m -103.3 -80.97 0.51 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.312 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 10.4 ttp -109.34 -17.66 13.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.737 0.779 . . . . 0.0 108.907 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -79.96 -0.25 34.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.307 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 31' ' ' HIS . 3.5 tm-20 -102.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.782 174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 p -73.36 -62.68 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.827 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.9 m -62.17 -32.31 72.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.273 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.08 -46.02 89.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.836 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' HD3' HD12 ' A' ' 87' ' ' ILE . 58.4 mttp -57.0 -44.35 82.67 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.79 -49.08 82.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.644 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.01 -42.47 88.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.817 0.342 . . . . 0.0 111.061 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.53 -44.51 85.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.46 0.648 . . . . 0.0 110.237 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.608 ' HD3' ' HE1' ' A' ' 94' ' ' TYR . 57.9 tttp -71.29 -39.38 71.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.511 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 51.2 t80 -63.24 -38.95 93.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.29 -41.81 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.71 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 51.1 m80 -61.84 -36.05 80.06 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.077 0.465 . . . . 0.0 109.945 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 13.5 t70 -62.63 -51.13 68.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 89.4 mt -54.63 -44.06 72.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.429 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.594 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 144.6 -7.29 1.73 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.159 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.15 98.05 6.02 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-O 121.311 0.577 . . . . 0.0 110.951 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 72.6 Cg_endo -87.74 89.13 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.548 2.166 . . . . 0.0 112.447 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.4 129.6 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.997 174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -92.7 157.82 39.15 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.591 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 Cg_endo -52.04 -34.02 55.51 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.721 2.281 . . . . 0.0 112.349 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -50.31 -50.52 50.48 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.208 0.528 . . . . 0.0 110.878 174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.64 -37.51 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.466 -177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.46 -47.65 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 54' ' ' PRO . 85.9 t -62.01 -54.27 36.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.836 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HG2' HD11 ' A' ' 17' ' ' LEU . 13.9 tpp180 -65.4 -45.48 83.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.026 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.07 99.52 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.555 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.9 mt-10 -68.57 -26.18 65.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.56 0.219 . . . . 0.0 111.208 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -84.33 -46.46 11.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.69 0.281 . . . . 0.0 111.14 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -78.35 -26.2 46.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.859 0.362 . . . . 0.0 111.141 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.76 46.29 3.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.004 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 51.3 m0 -74.93 164.17 26.85 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.826 0.346 . . . . 0.0 110.489 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.475 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 57.8 t30 -69.91 127.85 92.18 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 82.4 Cg_exo -45.25 -47.67 12.35 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.15 2.566 . . . . 0.0 113.018 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 3.7 mm-40 -56.62 -34.18 67.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.857 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.421 ' O ' HG23 ' A' ' 74' ' ' VAL . 76.8 t80 -71.34 -59.57 2.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.05 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.414 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 24.7 m -56.8 -42.04 78.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.584 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -62.54 -49.9 73.48 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 111.118 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -72.73 -40.74 65.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.613 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' CZ3' ' A' ' 77' ' ' TRP . 96.0 t -64.19 -36.07 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.699 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.99 93.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.159 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.55 98.21 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.266 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.448 ' CZ3' HG22 ' A' ' 74' ' ' VAL . 27.7 m0 -65.98 -48.28 71.76 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.33 82.45 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.094 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -57.32 -48.53 78.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.176 0.512 . . . . 0.0 110.763 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.68 -40.5 80.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.457 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' TRP . 70.5 t -68.47 -35.15 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.589 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.64 -38.55 80.58 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -69.81 -21.05 63.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.308 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.66 35.53 9.23 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.14 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.3 -178.15 4.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.958 0.409 . . . . 0.0 110.348 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -111.26 138.45 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.6 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.532 HD12 ' HD3' ' A' ' 39' ' ' LYS . 39.2 pt -120.43 150.65 23.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.432 -172.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.26 101.71 9.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.249 0.547 . . . . 0.0 109.723 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.61 ' O ' ' HG2' ' A' ' 90' ' ' LYS . 1.4 tt -89.57 -71.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.076 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 89' ' ' ILE . 43.1 mmtm 175.66 -59.5 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 -172.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -169.52 139.59 1.73 Allowed Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.06 -178.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -67.79 24.18 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.114 2.543 . . . . 0.0 114.071 -171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 91' ' ' ASN . 36.2 tt0 -75.0 -26.19 59.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.608 ' HE1' ' HD3' ' A' ' 43' ' ' LYS . 98.4 m-85 67.43 -77.52 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.939 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.733 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 26.0 p90 -170.21 -173.76 1.57 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.651 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.5 m -75.89 155.06 35.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.926 0.393 . . . . 0.0 111.465 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -25.82 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.382 -175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -43.34 -56.43 3.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.276 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.733 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 2.1 mpt? -64.23 -44.77 90.82 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.063 -174.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG3' ' CE1' ' A' ' 95' ' ' PHE . 24.4 mt-30 -57.62 -49.66 75.71 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 -35.21 75.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.648 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.479 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 5.8 tp-100 -61.38 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.601 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 107' ' ' VAL . 10.0 mp -57.26 -39.55 75.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.725 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -57.77 -52.74 64.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.998 0.428 . . . . 0.0 111.482 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -26.33 65.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.633 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 86.5 mt -73.51 -31.65 63.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.643 0.259 . . . . 0.0 111.395 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 103' ' ' LEU . 29.0 t -90.03 -13.66 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 110.482 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.28 -31.78 72.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.395 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.73 -37.14 86.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.187 0.518 . . . . 0.0 111.353 175.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.8 t . . . . . 0 C--O 1.233 0.222 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -64.99 137.97 58.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 112.64 -166.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -98.37 104.48 16.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.811 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -87.05 -160.61 0.6 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.942 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -67.37 -174.64 0.41 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.36 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -76.57 75.95 3.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 0.0 110.652 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -101.66 106.67 17.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.264 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 88.3 mtp -141.21 71.39 27.52 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -96.2 -164.37 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.263 2.642 . . . . 0.0 112.7 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 14' ' ' GLU . 21.7 p 49.95 76.54 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.608 178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.16 -48.73 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.514 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.4 -30.53 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.588 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.782 ' HG2' HH22 ' A' ' 60' ' ' ARG . 3.6 tm-20 -65.87 -42.63 90.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.626 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 70.5 mmtt -75.08 -20.17 59.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.26 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.08 -39.34 86.78 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.748 HD12 ' HG2' ' A' ' 60' ' ' ARG . 4.0 mm? -65.61 -33.0 74.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.612 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.14 -36.63 80.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.252 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -64.2 -43.17 95.88 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.665 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.87 -56.79 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.708 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.46 -49.58 30.75 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.602 -178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.26 -71.71 2.75 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.998 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.528 ' HG3' ' H ' ' A' ' 24' ' ' ASN . 10.2 tpt -134.53 175.5 9.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -172.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' H ' ' HG3' ' A' ' 23' ' ' MET . 4.7 p-10 -69.24 168.51 14.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.069 0.462 . . . . 0.0 111.432 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 3.0 t -58.97 120.48 9.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.607 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -157.16 -50.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.54 -161.91 1.04 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.123 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.687 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 15.5 t -96.98 25.51 5.31 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.734 HG13 ' HD2' ' A' ' 30' ' ' PRO . 45.7 t 85.03 157.92 0.11 Allowed Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 113.467 -1.697 . . . . 0.0 106.522 -165.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.734 ' HD2' HG13 ' A' ' 29' ' ' VAL . 34.4 Cg_exo -30.53 -14.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 125.075 3.85 . . . . 0.0 116.847 173.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 29' ' ' VAL . 42.6 m80 86.78 -47.78 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.278 1.031 . . . . 0.0 110.871 168.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.9 m -83.69 -52.41 6.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.903 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.559 ' C ' ' HE3' ' A' ' 33' ' ' MET . 0.7 OUTLIER -51.48 -35.47 40.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.436 -1.711 . . . . 0.0 109.949 -175.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.26 -66.14 0.39 Allowed 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.405 1.082 . . . . 0.0 111.58 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 mm-40 -54.12 -64.69 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.472 -171.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 p -67.48 -42.8 82.38 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.415 ' CB ' ' SD ' ' A' ' 33' ' ' MET . 33.4 m -79.3 -53.33 7.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.5 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.842 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.75 ' HD3' HG12 ' A' ' 89' ' ' ILE . 87.2 mttt -64.57 -37.91 89.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.066 176.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.53 -50.28 69.38 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.342 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 47.9 mt -66.66 -45.41 88.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.508 0.194 . . . . 0.0 110.994 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 74' ' ' VAL . 79.4 mt -59.83 -45.85 91.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.627 0.251 . . . . 0.0 111.357 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -63.12 -44.26 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.893 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 58.4 t80 -61.28 -43.78 98.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.249 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 86.8 mt -62.14 -43.02 99.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.403 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.603 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 56.7 m80 -62.6 -37.71 87.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.488 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -64.95 -38.36 90.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.119 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 94.2 mt -66.4 -25.16 66.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.095 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.11 1.91 14.04 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.176 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.6 95.75 9.18 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.053 0.454 . . . . 0.0 109.968 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 77.2 Cg_endo -86.96 94.3 0.5 Allowed 'Trans proline' 0 N--CA 1.445 -1.362 0 C-N-CA 122.281 1.987 . . . . 0.0 112.76 -177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.79 117.13 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.499 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -99.41 162.06 22.55 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.471 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' O ' HG23 ' A' ' 58' ' ' VAL . 54.2 Cg_exo -53.06 -37.1 78.75 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.186 2.591 . . . . 0.0 112.955 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -56.74 -42.33 79.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.873 0.368 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.68 -41.16 91.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.9 -49.81 74.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.91 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 54' ' ' PRO . 57.7 t -63.06 -47.7 91.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.66 -44.76 93.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.782 HH22 ' HG2' ' A' ' 14' ' ' GLU . 5.4 tpp180 -66.16 -42.11 89.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.976 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.78 -36.88 81.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.176 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -71.79 -38.22 70.31 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.786 0.326 . . . . 0.0 110.672 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -63.32 -50.76 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.155 0.502 . . . . 0.0 111.233 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.579 ' OE2' ' HD2' ' A' ' 60' ' ' ARG . 63.0 mt-10 -87.21 -21.69 25.71 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 25' ' ' THR . . . 82.51 47.12 6.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.159 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -70.35 158.67 35.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.72 135.03 95.43 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.7 -24.69 23.97 Favored 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.677 2.251 . . . . 0.0 111.803 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.14 -53.05 62.36 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.917 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.671 ' HA ' ' CE ' ' A' ' 73' ' ' LYS . 51.8 t80 -71.52 -43.52 66.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.124 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 m -58.26 -41.62 84.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.795 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -69.57 -42.26 74.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.671 ' CE ' ' HA ' ' A' ' 70' ' ' PHE . 53.4 mtmt -56.24 -58.71 6.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.517 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 42' ' ' LEU . 54.2 t -62.92 -40.05 87.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.543 -174.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.63 88.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 110.516 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -65.19 -40.9 97.06 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.804 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.47 ' CE2' ' HE3' ' A' ' 39' ' ' LYS . 43.8 m0 -62.27 -44.59 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.121 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.41 96.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.62 -45.71 88.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.497 178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HD3' HG22 ' A' ' 87' ' ' ILE . 28.8 mtpp -61.62 -51.73 67.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 77' ' ' TRP . 19.5 t -67.96 -35.53 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.31 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.7 -33.76 72.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.9 t -79.18 -14.18 59.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.373 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.17 26.97 11.39 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.848 175.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -111.01 135.11 52.0 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -62.13 145.92 52.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.627 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' HD3' ' A' ' 80' ' ' LYS . 15.9 pt -103.61 129.99 54.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.5 pt? -68.12 115.37 7.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.484 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.75 HG12 ' HD3' ' A' ' 39' ' ' LYS . 25.1 mt -121.7 137.38 55.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -59.24 -41.26 88.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.408 ' H ' HG22 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 153.92 126.39 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 125.401 1.688 . . . . 0.0 109.19 166.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.16 -63.05 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.3 2.0 . . . . 0.0 110.943 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 68.23 -60.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.218 0.949 . . . . 0.0 112.545 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.97 6.89 23.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.812 0.339 . . . . 0.0 110.986 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -73.25 93.47 1.88 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.8 m -111.69 -170.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 0.0 112.875 -166.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.5 -54.85 19.11 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.502 -1.681 . . . . 0.0 113.827 -169.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -56.36 -40.37 74.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.341 0.4 . . . . 0.0 111.786 -170.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.3 mtt -66.28 -51.24 59.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.864 0.364 . . . . 0.0 110.743 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -66.0 -44.42 84.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.137 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -65.6 -45.57 82.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.856 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.416 ' O ' HD13 ' A' ' 106' ' ' LEU . 18.3 tp60 -56.46 -53.71 54.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.127 0.489 . . . . 0.0 110.617 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.0 -44.85 94.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.068 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -67.14 -34.75 78.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.174 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.68 -48.67 73.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.011 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 102' ' ' GLN . 10.1 mp -59.69 -37.22 78.22 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.2 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.2 t -74.76 -37.87 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.944 0.402 . . . . 0.0 110.69 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.1 tp -58.53 -49.22 78.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.649 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.85 -12.99 61.87 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.2 m80 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -175.917 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 120.713 0.292 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -70.93 138.23 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -150.61 -41.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.28 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm 71.53 165.64 0.29 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.054 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.85 26.48 13.31 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.573 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.75 106.34 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.754 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -140.4 111.09 6.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.476 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.3 mmt -95.95 131.67 28.57 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.907 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.49 31.43 0.51 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 0.0 111.515 176.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -85.09 84.66 7.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.842 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.21 82.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.813 178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.64 -32.31 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.465 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.531 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -71.55 -30.31 65.74 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.68 -35.17 76.87 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.568 HD12 ' HZ2' ' A' ' 66' ' ' TRP . 35.8 tp -61.01 -44.02 98.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.683 174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -63.23 -35.25 79.7 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.28 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' HE2' ' SD ' ' A' ' 99' ' ' MET . 1.2 m-85 -64.65 -47.18 79.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.59 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -87.97 -59.73 2.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 111.398 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.77 42.32 1.99 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.28 -175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.74 78.21 1.05 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.238 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.3 ttt 69.25 10.65 7.9 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.292 0.637 . . . . 0.0 110.56 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.07 82.4 3.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.843 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 66' ' ' TRP . 10.5 t -101.51 -12.5 18.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.728 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.5 t -108.88 102.81 11.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HA ' ' NE2' ' A' ' 31' ' ' HIS . . . -162.88 149.33 12.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t -177.35 -68.5 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.154 0.502 . . . . 0.0 109.739 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' A' ' 30' ' ' PRO . 60.0 t -68.3 140.19 92.73 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 173.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 30.6 Cg_exo -25.73 105.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 124.506 3.47 . . . . 0.0 113.572 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -96.79 167.94 10.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.268 -170.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 p -97.35 -79.86 0.45 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.722 0.296 . . . . 0.0 111.651 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' THR . 2.9 tpt -51.75 -62.28 1.73 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.747 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 70' ' ' PHE . 4.0 p-10 -75.4 -14.58 60.47 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.619 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 37.4 tt0 -102.62 -73.99 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.601 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 64.6 p -61.25 -39.18 89.38 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -172.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 33' ' ' MET . 57.6 m -70.15 -41.11 74.27 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.445 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.12 -36.68 84.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.502 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -58.18 -43.28 87.44 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -43.73 96.61 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.906 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 37' ' ' THR . 90.7 mt -59.03 -50.52 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.191 0.519 . . . . 0.0 110.455 176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.3 tp -57.67 -48.88 78.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.532 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -72.11 -29.85 64.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.568 -177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.436 ' HD2' HD12 ' A' ' 45' ' ' LEU . 72.9 t80 -63.77 -48.84 75.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.651 0.262 . . . . 0.0 111.168 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.436 HD12 ' HD2' ' A' ' 44' ' ' TYR . 8.2 mp -67.86 -32.09 72.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.689 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -66.34 -37.13 84.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.22 -36.66 84.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.275 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.35 -46.82 84.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.831 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 158.71 -55.49 0.36 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.369 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 m -93.23 113.48 60.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.097 0.475 . . . . 0.0 112.172 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.82 155.22 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.813 2.342 . . . . 0.0 111.772 174.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.93 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.1 m -83.44 149.15 57.21 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.42 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.19 -28.99 64.28 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.088 2.525 . . . . 0.0 112.195 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -46.17 -51.67 13.7 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.718 0.636 . . . . 0.0 110.569 174.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.529 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -63.27 -47.78 90.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.462 -177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 74' ' ' VAL . 57.8 t -58.04 -53.54 44.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.438 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -62.6 -41.51 92.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.33 76.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.201 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -68.36 -45.39 72.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.735 0.302 . . . . 0.0 110.285 176.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.63 -32.71 85.08 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.834 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -70.55 -46.01 64.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.218 0.532 . . . . 0.0 110.279 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -69.68 -50.47 43.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.493 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -85.44 -48.09 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.574 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.61 -59.67 0.69 Allowed Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.568 ' HZ2' HD12 ' A' ' 17' ' ' LEU . 34.7 m0 51.96 -104.57 0.19 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.284 0.564 . . . . 0.0 111.911 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.731 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 18.8 t-20 -171.61 131.64 0.77 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.68 -56.87 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.695 2.263 . . . . 0.0 113.275 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.63 -37.99 83.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.716 0.293 . . . . 0.0 110.911 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.731 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 61.1 t80 -64.68 -42.99 94.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.215 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.7 m -63.66 -40.99 98.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.435 . . . . 0.0 110.426 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -70.19 -37.49 75.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.25 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -52.58 -60.18 3.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 57' ' ' VAL . 24.2 t -61.45 -39.37 82.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.261 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.98 85.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.986 0.422 . . . . 0.0 110.585 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.95 -39.62 94.99 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.202 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.457 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 19.0 m0 -62.56 -48.34 79.89 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.82 -37.19 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.992 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.19 -53.04 61.91 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.091 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -57.18 -51.52 69.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -39.16 84.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.33 -176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.48 -33.49 71.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.957 0.408 . . . . 0.0 110.869 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -74.12 -19.39 60.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.222 0.534 . . . . 0.0 110.387 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.44 19.46 32.53 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.127 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.7 OUTLIER -96.89 164.96 12.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -103.03 148.04 26.2 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.158 0.504 . . . . 0.0 110.727 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.53 145.06 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.7 pt? -72.61 129.3 37.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.702 0.763 . . . . 0.0 112.051 -173.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.7 tt -135.26 1.73 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.591 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 90' ' ' LYS . 17.1 mtmt 66.05 -70.25 0.1 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.893 -173.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.469 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -161.5 136.87 5.66 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.961 -178.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 22.6 Cg_exo -63.84 78.51 0.15 Allowed 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 122.945 2.43 . . . . 0.0 112.715 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -81.82 -38.76 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.486 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -99.8 13.8 32.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.214 -170.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -117.7 96.03 5.2 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.46 0.648 . . . . 0.0 109.538 173.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 60.9 p -100.72 166.69 10.75 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.311 1.053 . . . . 0.0 112.197 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -45.89 -40.44 10.05 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.639 -2.073 . . . . 0.0 112.331 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -59.91 -47.36 86.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.939 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HE2' ' A' ' 19' ' ' PHE . 14.4 mmt -64.39 -45.25 88.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.205 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -60.34 -58.25 9.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.279 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 0.3 OUTLIER -60.05 -31.9 70.42 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.197 0.311 . . . . 0.0 111.788 -175.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -59.8 -58.24 9.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.541 0.686 . . . . 0.0 109.932 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.89 -37.46 87.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.454 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 84.1 tttt -54.59 -60.17 3.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.591 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -67.61 -27.02 66.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.466 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.95 -47.41 80.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.88 0.372 . . . . 0.0 110.596 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -77.75 -24.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.289 0.566 . . . . 0.0 110.54 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.3 tp -67.93 -17.16 64.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.269 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.54 -81.57 0.2 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.09 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.663 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 111.428 0.158 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -167.48 166.92 14.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.681 0.277 . . . . 0.0 110.61 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -99.27 25.41 6.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.174 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -120.66 143.1 48.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.059 0.457 . . . . 0.0 111.358 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -133.39 139.22 46.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.512 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.63 93.39 4.63 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.557 0.694 . . . . 0.0 111.209 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -77.59 102.73 7.14 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.558 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 26.2 ttt -139.76 -56.72 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -172.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 9' ' ' MET . 25.0 Cg_exo -64.0 -79.4 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.36 2.04 . . . . 0.0 112.518 -170.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.8 p 62.5 -47.83 0.18 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 172.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.99 -55.66 5.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mm -60.19 -46.57 94.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.901 0.381 . . . . 0.0 111.544 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' OE1' ' HB2' ' A' ' 10' ' ' PRO . 8.3 pt-20 -62.9 -35.44 80.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.277 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -79.27 -30.97 43.27 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.73 0.3 . . . . 0.0 110.435 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.07 -45.33 94.0 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.67 HD13 ' HG2' ' A' ' 60' ' ' ARG . 88.2 mt -68.61 -27.46 66.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.272 175.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -68.97 -42.02 77.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.886 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HZ ' ' OE1' ' A' ' 102' ' ' GLN . 36.9 m-85 -59.62 -53.14 61.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.337 174.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.7 mt -64.17 -44.48 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.836 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.33 47.24 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.606 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.57 51.1 4.18 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.945 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 26.8 ptt? -87.29 -3.58 59.04 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 122.689 0.396 . . . . 0.0 110.595 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.1 t30 66.39 -74.44 0.06 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.252 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -179.09 -30.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.7 t -73.39 -27.4 61.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.873 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.945 ' HB3' ' HB2' ' A' ' 23' ' ' MET . . . -76.67 112.43 13.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.67 0.748 . . . . 0.0 111.869 -173.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.409 ' CB ' HD22 ' A' ' 67' ' ' ASN . 68.4 m -162.24 -60.94 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.597 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 61.5 t -103.18 -58.41 0.09 OUTLIER Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.49 173.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 59.1 Cg_endo -74.86 129.8 12.82 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.56 1.507 . . . . 0.0 111.042 169.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 34' ' ' ASP . 12.0 m170 -125.21 76.07 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 m -54.21 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.688 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -24.59 34.94 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' HIS . 13.9 t70 -53.91 -60.32 3.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.701 -175.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -59.09 -43.27 91.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 111.472 -172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 m -68.06 -50.52 54.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.969 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 41' ' ' ILE . 53.7 m -73.29 -42.35 62.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.715 -174.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HG ' ' A' ' 42' ' ' LEU . . . -63.41 -48.91 75.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.636 0.255 . . . . 0.0 110.979 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.91 -34.23 77.48 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.727 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.24 -46.58 92.68 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.575 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 37' ' ' THR . 76.0 mt -59.02 -46.18 91.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.914 0.387 . . . . 0.0 110.488 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 38' ' ' ALA . 94.3 mt -58.16 -47.93 81.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.527 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 46' ' ' HIS . 89.7 mttt -68.25 -35.84 78.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.024 -179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE2' HD11 ' A' ' 48' ' ' LEU . 66.1 t80 -65.5 -48.83 71.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.407 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 84.5 mt -61.84 -38.38 87.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.978 0.418 . . . . 0.0 110.715 178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 41.3 t-80 -50.97 -51.45 52.58 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.45 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.0 -7.96 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -174.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 44' ' ' TYR . 74.5 mt -77.14 -36.24 55.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.56 4.08 13.72 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.347 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 43.9 t -129.42 93.17 36.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 110.773 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -92.27 162.79 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.198 2.599 . . . . 0.0 111.773 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.81 137.33 34.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.743 0.306 . . . . 0.0 110.794 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 56' ' ' VAL . 10.3 m -73.36 127.63 88.68 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.767 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 79' ' ' GLU . 23.4 Cg_endo -63.1 -29.08 74.32 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.577 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -53.06 -53.36 51.35 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.043 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 53' ' ' SER . 29.7 m -69.59 -26.07 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.556 -176.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.3 -41.01 80.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 54' ' ' PRO . 63.6 t -59.63 -54.19 37.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.187 177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.18 -47.38 86.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.328 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HG2' HD13 ' A' ' 17' ' ' LEU . 3.4 tpp180 -63.72 -44.13 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.554 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 66' ' ' TRP . . . -59.28 -47.61 89.97 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.199 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.4 -23.51 61.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.807 0.337 . . . . 0.0 110.807 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -80.04 -45.25 18.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.959 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' HD3' ' A' ' 60' ' ' ARG . 38.0 mm-40 -75.42 -17.07 60.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.893 0.378 . . . . 0.0 110.61 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.8 48.38 4.71 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.128 176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.542 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 49.5 m0 -70.72 -81.19 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.608 ' OD1' ' HD2' ' A' ' 68' ' ' PRO . 63.2 t30 166.18 130.79 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.608 ' HD2' ' OD1' ' A' ' 67' ' ' ASN . 40.7 Cg_exo -35.91 -48.05 1.06 Allowed 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.932 3.088 . . . . 0.0 114.403 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 22.4 mm-40 -69.85 -38.44 76.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -69.42 -52.29 28.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.735 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 m -59.5 -46.89 87.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.189 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -57.19 -54.66 44.24 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.75 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 49.7 mttm -63.81 -47.62 80.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -173.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.12 -39.56 82.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 110.92 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.81 92.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.06 -38.32 95.84 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.186 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.482 ' O ' HG23 ' A' ' 81' ' ' VAL . 25.6 m0 -65.17 -49.9 68.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.08 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.276 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HA ' ' HG3' ' A' ' 54' ' ' PRO . 9.2 tp10 -56.83 -51.7 67.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.887 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.505 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 88.1 mttt -70.21 -29.49 66.35 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.471 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 77' ' ' TRP . 78.5 t -71.98 -43.13 68.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.651 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.74 -43.86 75.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.045 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 p -70.13 -31.06 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.062 0.458 . . . . 0.0 111.001 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.74 26.54 19.57 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.998 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -95.33 0.93 54.14 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.861 0.839 . . . . 0.0 110.333 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 56.8 mtm-85 64.47 156.6 0.08 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.332 -1.758 . . . . 0.0 112.387 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.505 ' CG2' ' HB2' ' A' ' 80' ' ' LYS . 20.8 pt -119.02 17.63 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.212 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 68.4 mt 46.64 -151.35 0.08 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.975 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 tt -170.99 132.57 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.507 0.67 . . . . 0.0 110.554 168.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -95.08 -18.87 20.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.738 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -123.37 102.35 36.59 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.04 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.93 -26.61 58.91 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.355 2.037 . . . . 0.0 112.856 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.35 118.06 21.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.338 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -79.54 -77.7 0.17 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.24 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -173.23 168.73 4.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.611 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.0 t -54.86 139.99 38.23 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 122.378 1.085 . . . . 0.0 111.667 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 94.8 m -57.92 -21.88 45.91 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.698 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -60.15 -49.52 77.31 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.583 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -64.96 -28.73 69.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.714 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.09 -51.72 55.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -37.35 74.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.592 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.403 ' OE1' ' HZ ' ' A' ' 19' ' ' PHE . 29.6 tt0 -63.39 -53.24 55.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.734 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.47 -42.98 99.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.168 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -52.08 -55.88 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.928 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -70.71 -32.25 69.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.047 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.2 tp -59.01 -46.51 88.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.906 0.384 . . . . 0.0 110.12 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.9 -41.57 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.619 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.74 -41.2 90.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.217 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.85 5.48 11.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 112.042 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.009 0.433 . . . . 0.0 110.038 172.876 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -75.93 116.77 16.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.657 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -107.93 75.47 1.0 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -133.26 127.37 33.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.904 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.25 72.53 10.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.606 -170.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -167.78 156.15 9.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.798 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.9 t 71.03 14.5 6.79 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 111.258 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.417 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 82.2 mmm -130.49 112.06 16.54 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.003 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 3.5 Cg_exo -77.61 128.74 9.64 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 123.298 2.665 . . . . 0.0 111.67 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 14' ' ' GLU . 1.8 p -80.14 91.55 5.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.221 0.534 . . . . 0.0 111.418 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.24 -43.86 80.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.517 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.65 -36.86 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.637 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.564 ' HB3' ' HB ' ' A' ' 11' ' ' THR . 38.7 tt0 -70.89 -43.91 67.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.839 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -70.86 -31.42 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.296 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.67 -35.58 80.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.172 0.51 . . . . 0.0 110.212 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.33 -34.18 75.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.081 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -62.26 -41.04 98.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.053 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -73.55 -58.82 3.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 111.349 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.556 ' O ' ' HZ ' ' A' ' 70' ' ' PHE . 67.0 mt -72.09 -49.18 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.759 -172.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.66 10.63 8.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.263 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.53 70.89 2.92 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.428 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 26' ' ' SER . 22.2 ptp -61.5 -28.82 69.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.306 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.2 t30 64.29 -83.16 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.771 0.67 . . . . 0.0 111.278 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 m -99.4 10.5 41.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.394 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 23' ' ' MET . 42.3 t 66.21 55.94 0.85 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.856 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.27 133.27 41.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.057 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 43.8 m -126.39 -78.99 0.59 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.692 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.638 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 90.8 t -71.66 -60.53 2.48 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.099 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 88.6 Cg_endo -80.25 132.84 9.45 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.607 1.538 . . . . 0.0 111.362 172.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.439 ' HE1' ' HD1' ' A' ' 70' ' ' PHE . 5.4 m170 -126.78 139.61 52.99 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.6 m -95.67 -80.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 110.979 -176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.607 ' O ' ' HB ' ' A' ' 37' ' ' THR . 7.1 ptm -102.66 -14.91 16.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.959 0.885 . . . . 0.0 109.007 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -80.35 10.5 4.51 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.827 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.7 tm-20 -103.06 -73.35 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.479 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 p -76.37 -52.51 9.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.287 -175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 33' ' ' MET . 38.6 m -56.14 -46.21 79.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.684 0.278 . . . . 0.0 111.005 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.95 99.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 39' ' ' LYS . 34.6 ttmt -64.04 -38.45 91.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.431 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.17 -37.66 91.5 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.386 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.614 HG23 HD11 ' A' ' 103' ' ' LEU . 63.8 mt -59.12 -46.47 91.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.677 0.275 . . . . 0.0 110.646 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.43 -42.83 92.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -70.41 -36.5 74.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 65.9 t80 -67.97 -37.38 81.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 103' ' ' LEU . 89.0 mt -65.81 -35.05 79.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.792 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -62.0 -36.43 81.48 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 18.9 t70 -61.82 -37.96 86.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 45' ' ' LEU . 93.2 mt -72.91 -20.27 61.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.069 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 119.99 -32.88 4.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.65 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.9 108.2 33.3 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 0.0 111.867 -176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 94.4 Cg_endo -88.63 137.01 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 56.0 t -89.22 103.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.856 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.403 ' HB2' HG23 ' A' ' 56' ' ' VAL . 50.9 m -62.05 139.07 95.94 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' HG23 ' A' ' 58' ' ' VAL . 14.9 Cg_endo -58.43 -27.69 82.59 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -61.15 -42.41 98.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.232 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.452 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 21.4 t -65.48 -36.29 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.88 -47.96 91.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.189 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 54' ' ' PRO . 74.3 t -62.63 -44.12 99.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.357 177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.95 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.113 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 56' ' ' VAL . 3.7 mmp_? -67.1 -43.85 81.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.585 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -61.77 -32.49 81.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.51 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -78.74 -27.07 44.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.477 0.18 . . . . 0.0 111.46 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -81.71 -50.48 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.182 0.515 . . . . 0.0 110.602 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 27.6 mm-40 -83.68 -23.84 31.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.484 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.33 56.73 2.77 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.728 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.507 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 44.9 m0 -71.92 175.84 5.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.992 0.425 . . . . 0.0 110.635 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -82.8 154.57 68.01 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.316 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 72' ' ' LYS . 10.9 Cg_endo -54.79 -60.02 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.184 2.59 . . . . 0.0 112.579 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 28' ' ' SER . 59.6 mm-40 -60.46 -33.93 73.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.075 0.464 . . . . 0.0 110.96 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.556 ' HZ ' ' O ' ' A' ' 20' ' ' ILE . 10.5 t80 -65.55 -57.31 8.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.475 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 m -61.95 -39.54 92.45 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 110.819 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 68' ' ' PRO . 22.2 tttp -61.34 -57.18 13.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.554 -176.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.46 -47.44 67.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.073 -173.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 93.7 t -61.8 -39.66 84.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.609 0.242 . . . . 0.0 110.94 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.09 79.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.392 . . . . 0.0 110.417 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.73 -37.53 93.56 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.141 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.47 ' O ' HG23 ' A' ' 81' ' ' VAL . 17.4 m0 -68.93 -44.47 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.47 87.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.43 -53.09 56.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.639 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.63 -37.81 88.75 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.394 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 77' ' ' TRP . 93.1 t -70.1 -46.04 73.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.463 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.37 -44.33 83.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.545 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.0 p -67.06 -32.3 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.0 45.79 2.17 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.624 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.18 167.26 10.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -91.45 132.25 36.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.429 0.633 . . . . 0.0 111.073 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.18 90.49 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.499 175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.6 mp -70.7 110.89 5.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.493 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 tt -79.41 98.97 3.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.729 0.776 . . . . 0.0 109.715 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -67.1 -13.94 62.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.042 -175.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.95 90.48 5.4 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 121.41 0.624 . . . . 0.0 111.663 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.92 -67.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.421 2.08 . . . . 0.0 110.766 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 56.37 -81.16 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 170.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -86.2 24.49 1.33 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -98.15 103.9 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.509 ' HB3' ' HG3' ' A' ' 99' ' ' MET . 31.4 t -78.38 157.74 28.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.927 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 98' ' ' TYR . 14.3 t -65.97 -44.7 84.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.206 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.436 ' N ' HG23 ' A' ' 97' ' ' THR . 49.4 t80 -62.76 -27.12 69.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.889 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 96' ' ' SER . 61.2 mtt -64.32 -47.72 78.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -62.91 -50.01 72.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.938 177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 105' ' ' GLU . 48.0 mt-10 -59.22 -41.96 89.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.366 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.791 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -54.67 -55.95 24.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.155 0.502 . . . . 0.0 110.709 177.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.614 HD11 HG23 ' A' ' 41' ' ' ILE . 71.6 mt -60.62 -45.06 95.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.22 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -64.39 -47.63 78.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 101' ' ' GLU . 38.8 mm-40 -64.85 -34.1 77.56 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.763 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -58.51 -47.66 83.39 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.29 -38.73 78.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.672 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.41 -48.15 76.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.608 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.39 -29.43 69.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.899 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.8 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.044 172.012 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.157 0.504 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -101.25 73.91 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.83 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 60.7 -164.17 0.24 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.633 0.73 . . . . 0.0 112.609 173.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -93.06 111.51 23.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.102 -0.953 . . . . 0.0 108.775 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 7' ' ' LYS . 12.3 t70 60.04 -150.68 0.42 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 57.4 mtmt -89.82 15.88 9.02 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 122.115 -0.365 . . . . 0.0 110.468 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.4 p 52.2 -160.19 0.11 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.79 0.836 . . . . 0.0 111.53 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.453 ' HG2' HG22 ' A' ' 11' ' ' THR . 50.2 ttp -139.08 88.22 13.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.269 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -92.48 80.7 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.485 2.79 . . . . 0.0 112.452 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.453 HG22 ' HG2' ' A' ' 9' ' ' MET . 5.5 t -132.4 98.9 4.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.806 0.812 . . . . 0.0 110.705 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.72 -35.97 70.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.146 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.3 mp -64.72 -45.04 96.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.685 -175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -63.36 -39.85 95.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.752 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -75.18 -33.66 61.48 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.651 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.08 -41.45 99.42 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.522 0.677 . . . . 0.0 109.791 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 60' ' ' ARG . 25.0 tp -64.56 -38.93 92.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.859 175.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -66.04 -29.82 70.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.026 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.3 -52.0 60.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.745 0.307 . . . . 0.0 110.691 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.8 mt -69.13 -48.29 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.13 31.5 4.72 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.936 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.07 28.87 4.89 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.615 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -65.8 -35.98 82.22 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.6 m120 68.57 -44.29 0.51 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.619 0.768 . . . . 0.0 111.771 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.673 HG22 ' H ' ' A' ' 26' ' ' SER . 1.6 m -99.07 -152.45 0.41 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.673 ' H ' HG22 ' A' ' 25' ' ' THR . 15.4 m -103.44 97.62 7.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.89 0.376 . . . . 0.0 110.041 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HA ' ' NE2' ' A' ' 31' ' ' HIS . . . -76.92 139.78 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.849 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.9 m -160.81 -56.52 0.05 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.0 m -69.03 162.5 64.63 Favored Pre-proline 0 N--CA 1.438 -1.039 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.736 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.37 105.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.526 2.151 . . . . 0.0 110.947 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.558 ' NE2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -85.42 -172.89 4.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.335 -171.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.5 m -103.58 -80.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.2 tpt -57.48 -52.03 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.044 -175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -83.91 1.22 44.45 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.453 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -103.4 -77.44 0.57 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.387 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -63.3 -48.06 79.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -171.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.1 m -71.17 -30.67 66.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 110.552 -177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.51 -38.06 83.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.542 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -56.35 -44.64 80.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.384 174.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.43 -44.18 97.15 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.257 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 67.3 mt -66.2 -44.85 91.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.867 0.365 . . . . 0.0 110.864 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.4 tp -61.55 -37.7 84.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.701 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -66.33 -49.41 67.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.988 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' HD11 ' A' ' 48' ' ' LEU . 71.7 t80 -57.6 -44.75 85.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.575 -178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 94.4 mt -60.31 -47.98 83.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.618 0.247 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' CD2' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m80 -62.17 -36.77 82.86 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.751 177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.92 -32.83 73.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.114 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD11 ' CE2' ' A' ' 44' ' ' TYR . 81.1 mt -67.68 -16.72 64.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.268 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 107.37 1.45 35.33 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.109 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -105.46 98.04 15.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 46' ' ' HIS . 97.8 Cg_endo -84.0 104.88 1.1 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.232 1.954 . . . . 0.0 112.855 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 101.03 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.72 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 14.6 m -66.05 140.54 97.08 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.336 -177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 52.3 Cg_exo -55.75 -34.86 92.25 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.262 2.641 . . . . 0.0 112.506 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -54.93 -48.72 72.76 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.828 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.77 -38.43 81.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.275 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.88 -45.48 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.823 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 96.8 t -62.41 -49.08 85.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.944 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.76 94.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.12 0.486 . . . . 0.0 110.963 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HG2' HD11 ' A' ' 17' ' ' LEU . 10.3 tpp180 -66.96 -40.42 87.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.448 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.89 -40.7 99.21 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.375 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 36.8 mt-10 -68.14 -31.11 70.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.581 0.229 . . . . 0.0 111.206 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -76.16 -53.38 8.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.856 0.36 . . . . 0.0 111.267 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -69.84 -30.03 67.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.731 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.89 48.71 2.42 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.751 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.654 ' HB3' ' HD2' ' A' ' 70' ' ' PHE . 48.7 m0 -81.13 0.31 36.82 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.505 0.187 . . . . 0.0 111.505 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 93.1 m-20 72.94 145.05 0.11 Allowed Pre-proline 0 N--CA 1.466 0.358 0 C-N-CA 122.835 0.454 . . . . 0.0 111.02 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.29 -41.29 79.81 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.703 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 44.9 mt-10 -63.26 -56.05 19.79 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.657 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.654 ' HD2' ' HB3' ' A' ' 66' ' ' TRP . 89.7 t80 -60.67 -47.01 88.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.826 0.346 . . . . 0.0 110.631 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 31.1 m -58.78 -41.24 86.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.978 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.98 -43.49 95.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.779 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 67.9 mttm -62.52 -53.0 61.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.546 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 46.5 t -59.7 -41.48 85.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.958 0.409 . . . . 0.0 110.846 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 79' ' ' GLU . . . -61.42 -40.82 95.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.388 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -61.48 -42.41 99.76 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.393 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.546 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 15.2 m0 -62.13 -44.77 95.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.254 0.549 . . . . 0.0 109.572 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.43 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.58 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 75' ' ' ALA . 48.9 mt-10 -59.21 -48.14 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.354 0.409 . . . . 0.0 110.97 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.7 mtpp -60.97 -52.31 65.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.007 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 77' ' ' TRP . 62.1 t -61.38 -35.68 68.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.39 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.14 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.1 t -61.76 -48.26 81.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.453 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.77 -10.8 3.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 -87.75 107.39 18.62 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -58.07 156.67 9.09 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.653 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.54 141.42 18.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.285 176.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.75 111.75 24.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 110.763 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.589 HG12 ' H ' ' A' ' 91' ' ' ASN . 14.6 tt -91.78 140.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -94.28 -8.66 38.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.562 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.589 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.5 p30 -149.16 76.61 9.35 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 121.425 0.631 . . . . 0.0 111.297 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.05 -6.24 17.77 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.512 2.142 . . . . 0.0 112.477 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.55 -10.92 59.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 91' ' ' ASN . 67.1 m-85 -89.72 -18.23 26.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -89.1 91.64 8.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.0 p -86.7 173.35 9.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -66.09 -26.89 67.69 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.172 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -45.82 -49.48 15.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.808 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.34 -43.07 87.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.1 -46.45 89.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.508 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 97' ' ' THR . 38.2 mm-40 -55.16 -52.08 64.45 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 48.2 mt-30 -58.82 -54.04 51.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.993 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 107' ' ' VAL . 92.5 mt -59.28 -49.62 77.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.263 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.91 -46.29 91.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.041 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 6.2 tp10 -65.43 -31.51 72.65 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.54 -177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 83.3 mt -72.53 -29.71 63.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.844 0.354 . . . . 0.0 110.989 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 103' ' ' LEU . 82.1 t -78.11 -35.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.511 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.64 -42.42 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.081 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 2.3 mm-40 -81.99 12.67 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.672 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.321 -0.664 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.662 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 121.826 0.822 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -158.17 -46.05 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.974 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.1 t80 59.7 -83.28 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.986 0.804 . . . . 0.0 111.612 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 43.8 mtpt 63.17 106.16 0.03 OUTLIER 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.59 0.756 . . . . 0.0 111.868 -177.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.2 138.75 56.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.899 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 5' ' ' LYS . 61.6 mttp -137.18 -64.1 0.58 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.074 0.464 . . . . 0.0 110.347 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 t 176.42 -156.46 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -65.21 142.73 98.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 172.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.3 Cg_endo -55.9 112.57 1.1 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.594 2.196 . . . . 0.0 112.126 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.73 97.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.374 0.607 . . . . 0.0 111.774 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.09 -31.14 69.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.466 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -57.25 -56.72 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.989 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.21 -38.34 76.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.393 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 49.4 tptt -74.24 -34.18 63.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.715 0.293 . . . . 0.0 110.75 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 0.0 110.224 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 17' ' ' LEU . 3.9 mm? -64.58 -33.18 75.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.553 175.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -66.89 -39.68 87.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.811 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.89 0.376 . . . . 0.0 111.238 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -74.83 -46.92 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.33 -50.05 58.03 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.299 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.67 -8.2 6.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.203 -0.522 . . . . 0.0 113.574 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' A' ' 23' ' ' MET . 26.8 ttt 63.53 23.62 13.7 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.663 0.744 . . . . 0.0 110.312 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -133.03 163.15 29.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.648 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -125.08 -158.57 0.84 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.597 ' H ' HG22 ' A' ' 25' ' ' THR . 38.3 m 71.54 8.29 6.19 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.26 0.624 . . . . 0.0 112.185 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.63 89.23 3.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.066 0.46 . . . . 0.0 109.867 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' CD ' ' A' ' 69' ' ' GLU . 12.6 m -122.5 -51.92 1.94 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.784 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.635 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 21.8 t -114.6 -53.47 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.198 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 12.0 Cg_endo -91.97 86.55 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.259 1.972 . . . . 0.0 110.291 171.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.537 ' HD1' ' CG ' ' A' ' 34' ' ' ASP . 6.4 p80 -132.93 96.52 3.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.378 0.609 . . . . 0.0 111.143 -172.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 m -86.38 -14.99 41.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.786 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.485 ' O ' ' HB ' ' A' ' 37' ' ' THR . 4.3 tpt -60.99 -64.01 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.834 -177.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.537 ' CG ' ' HD1' ' A' ' 31' ' ' HIS . 11.4 p-10 -79.53 -26.95 41.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.136 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.01 -77.39 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . 13.2 m -71.27 -49.82 39.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.9 0.381 . . . . 0.0 111.505 -172.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 33' ' ' MET . 17.5 m -73.18 -55.18 6.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.864 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -68.11 -37.45 81.17 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 89' ' ' ILE . 4.4 ttmp? -67.33 -34.97 78.45 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.742 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.9 -42.23 99.58 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.473 175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 103' ' ' LEU . 69.6 mt -65.89 -47.76 84.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.913 0.387 . . . . 0.0 110.67 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.44 -44.57 92.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.912 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -69.96 -30.97 68.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 56.4 t80 -67.07 -46.15 75.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.151 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.89 -41.99 98.54 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.454 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.484 ' HB2' HG13 ' A' ' 81' ' ' VAL . 41.0 t-80 -50.21 -51.68 42.16 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.186 175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.81 -2.6 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.472 -175.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 64.3 mt -84.93 -21.83 29.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.218 0.532 . . . . 0.0 109.577 168.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.41 0.95 14.02 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.704 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.5 t -121.24 98.12 47.08 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.923 0.362 . . . . 0.0 111.106 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -82.84 157.87 15.87 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.918 2.412 . . . . 0.0 111.788 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -117.36 137.98 49.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.62 0.248 . . . . 0.0 110.622 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 24.5 m -85.0 144.43 41.53 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 53' ' ' SER . 23.8 Cg_exo -63.41 -32.9 71.24 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.103 2.535 . . . . 0.0 112.771 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -42.35 66.68 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 -177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.93 -47.84 91.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.72 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.5 t -64.03 -49.23 82.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.497 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -55.27 -58.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.488 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -30.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.551 -175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -67.86 -46.84 70.6 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.77 -34.69 90.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.98 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.05 -29.87 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.749 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -86.1 -49.78 7.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.555 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.07 -28.25 66.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.867 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.5 55.22 1.7 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.028 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 70' ' ' PHE . 44.5 m0 -81.37 -78.34 0.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.472 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 36.1 p30 175.45 160.79 0.41 Allowed Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.548 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 86.5 Cg_endo -79.89 8.69 3.9 Favored 'Trans proline' 0 CA--C 1.528 0.203 0 C-N-CA 122.046 1.831 . . . . 0.0 112.933 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 28' ' ' SER . 46.1 mt-10 -107.33 -69.66 0.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -71.54 -29.04 64.3 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.647 -174.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.8 m -59.62 -38.23 80.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.423 0.63 . . . . 0.0 110.198 175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -68.91 -35.81 77.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.882 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 74.0 mmtt -63.36 -56.81 13.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.329 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.551 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 42.2 t -59.66 -35.84 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.69 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.62 86.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.511 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.93 -37.71 92.36 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.362 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 21.9 m0 -66.0 -44.88 83.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.83 75.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.868 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -60.23 -50.29 74.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.423 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -63.55 -39.31 94.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.337 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.484 HG13 ' HB2' ' A' ' 46' ' ' HIS . 47.7 t -61.4 -51.14 76.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.313 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.92 93.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.76 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.4 t -65.39 -39.97 92.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.359 178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.92 6.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.701 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -100.94 -166.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.774 0.321 . . . . 0.0 110.468 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -94.6 154.77 17.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.92 0.391 . . . . 0.0 110.644 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.02 140.89 41.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.621 174.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -91.4 119.03 31.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.989 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.411 HG13 ' HD2' ' A' ' 39' ' ' LYS . 8.7 tt -112.36 151.72 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -96.47 -30.03 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.763 0.316 . . . . 0.0 111.081 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 15.0 m-80 -142.0 92.34 7.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.883 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.37 -22.52 18.59 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.464 2.11 . . . . 0.0 113.029 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.49 -5.32 59.3 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' ' 91' ' ' ASN . 8.6 m-85 -71.74 -20.06 61.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.01 0.433 . . . . 0.0 110.542 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -79.81 88.74 5.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 t -75.92 163.02 27.61 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.578 -171.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -31.17 69.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.74 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -60.08 -55.28 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.065 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.1 mtm -62.63 -36.53 83.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.906 0.384 . . . . 0.0 110.782 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.32 -50.9 71.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.213 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 46.1 mt-10 -73.27 -24.46 60.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.384 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.875 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.0 OUTLIER -65.63 -51.09 62.28 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.421 ' O ' HG23 ' A' ' 107' ' ' VAL . 98.7 mt -62.52 -42.31 99.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.14 175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 83.6 tttt -55.78 -47.36 77.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.213 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.58 -38.62 90.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 0.0 110.878 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 10' ' ' PRO . 28.5 tp -71.59 -44.09 65.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.828 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 103' ' ' LEU . 80.6 t -70.41 -27.38 31.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.775 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.92 -43.67 69.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.528 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -91.77 3.4 55.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.366 0.603 . . . . 0.0 110.623 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 121.258 0.551 . . . . 0.0 110.301 178.539 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.399 0.619 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.33 -39.63 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.698 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.94 97.07 8.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.464 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -122.61 23.73 9.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -40.27 110.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.913 -1.494 . . . . 0.0 112.249 -175.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -107.3 20.89 18.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.957 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.85 -167.72 1.93 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.546 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.6 ttp 68.56 98.4 0.04 OUTLIER Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.681 0.793 . . . . 0.0 111.184 -175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.7 84.07 1.82 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.883 2.388 . . . . 0.0 112.06 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 t -56.94 -22.39 37.48 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.641 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.44 91.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.067 0.46 . . . . 0.0 110.311 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.5 mm -76.93 -39.66 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.849 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.67 72.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.502 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 56.7 mmtt -76.29 -35.44 58.87 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.312 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.34 83.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.588 0.709 . . . . 0.0 109.113 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.758 HD22 HH11 ' A' ' 60' ' ' ARG . 23.4 tp -63.3 -37.12 86.03 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.252 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.31 -33.76 75.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.332 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.17 -40.51 78.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.471 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -88.15 -76.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.772 -174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.89 -4.94 81.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.748 -174.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.13 7.48 77.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.432 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -94.81 111.86 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.12 -156.99 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.06 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -86.96 41.67 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.262 -0.274 . . . . 0.0 110.875 175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 58.18 111.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.648 1.179 . . . . 0.0 112.106 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 70' ' ' PHE . . . -75.51 174.45 9.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.187 178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' A' ' 69' ' ' GLU . 28.2 p -155.19 -43.07 0.08 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.131 0.491 . . . . 0.0 109.935 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.556 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 28.3 m -66.16 170.64 5.03 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.745 170.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.556 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 39.6 Cg_exo -29.75 110.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.916 3.077 . . . . 0.0 112.662 174.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 19.6 m80 -83.73 162.8 20.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.755 -169.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 t -103.38 -80.52 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.084 0.468 . . . . 0.0 110.506 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.3 ttp -97.81 -29.75 13.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.51 0.671 . . . . 0.0 109.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 31' ' ' HIS . 9.2 p-10 -67.81 -8.31 34.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.145 -172.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.745 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 39.8 tt0 -102.51 -48.95 3.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 110.658 173.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.8 t -65.41 -48.48 72.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.697 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.8 m -64.82 -40.24 94.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.855 0.359 . . . . 0.0 110.267 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.61 -52.7 63.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.002 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -61.5 -28.88 69.62 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.195 0.521 . . . . 0.0 110.8 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.73 -49.9 52.0 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.382 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.667 HG12 HD11 ' A' ' 103' ' ' LEU . 63.7 mt -61.84 -43.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.618 0.247 . . . . 0.0 111.086 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.5 mp -54.97 -47.54 74.41 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.583 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.68 ' HE3' HD11 ' A' ' 87' ' ' ILE . 9.9 mtmp? -77.9 -25.84 48.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.312 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.533 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 53.0 t80 -65.15 -47.81 75.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -63.13 -40.54 97.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.223 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -50.94 -54.97 19.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.341 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.12 -18.83 60.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.526 -175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 57.6 mt -68.53 -27.29 65.97 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.6 6.17 10.64 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.583 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.39 93.19 43.62 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.758 0.313 . . . . 0.0 110.822 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.37 120.75 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.993 2.462 . . . . 0.0 111.838 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.31 138.66 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.299 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.93 147.46 38.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB3' ' HB1' ' A' ' 75' ' ' ALA . 50.2 Cg_exo -53.19 -36.0 75.63 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.397 2.731 . . . . 0.0 112.398 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -50.05 -47.3 53.45 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.316 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.0 -40.99 89.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.607 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 ' HB ' ' A' ' 74' ' ' VAL . 61.4 t -63.87 -45.92 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.456 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 71' ' ' THR . 67.4 t -59.99 -48.28 88.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.141 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.01 -42.8 89.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.439 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.758 HH11 HD22 ' A' ' 17' ' ' LEU . 14.6 tpp85 -67.79 -40.42 83.92 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.508 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.83 -37.14 93.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.479 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -62.66 -37.62 87.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.197 0.523 . . . . 0.0 110.574 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -73.03 -44.82 60.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.471 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.86 -30.03 32.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.81 57.28 1.84 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.067 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.753 ' HZ2' HD11 ' A' ' 17' ' ' LEU . 49.4 m0 -84.05 168.43 15.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 6.7 m-20 -61.83 123.58 77.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 167.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.91 -34.23 55.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.502 2.801 . . . . 0.0 113.82 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 26.5 mt-10 -64.73 -40.64 95.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 73.6 t80 -64.42 -50.97 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.142 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 58' ' ' VAL . 21.4 m -57.27 -41.23 79.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.936 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.44 -40.71 77.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.126 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.62 -50.14 68.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.077 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.599 ' HA ' ' CE3' ' A' ' 77' ' ' TRP . 52.1 t -60.22 -40.16 82.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 110.635 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 54' ' ' PRO . . . -59.59 -40.18 86.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.684 176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.9 -34.79 88.24 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.078 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.599 ' CE3' ' HA ' ' A' ' 74' ' ' VAL . 28.7 m0 -67.23 -47.58 70.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.7 87.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -58.95 -44.61 91.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 110.4 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -64.64 -45.79 85.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.635 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 77' ' ' TRP . 75.3 t -63.67 -40.64 89.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.028 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.37 -41.04 81.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.638 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.7 p -75.03 -16.63 60.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.149 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.54 33.03 6.33 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.53 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -109.98 163.99 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -89.27 156.57 18.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.516 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.68 HD11 ' HE3' ' A' ' 43' ' ' LYS . 21.8 pt -123.94 147.66 28.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 89' ' ' ILE . 6.6 tt -71.27 131.74 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 88' ' ' LEU . 13.5 tt -139.32 162.78 26.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -76.07 -53.18 8.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 110.723 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.76 140.3 31.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.68 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.2 7.11 4.58 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.326 2.017 . . . . 0.0 113.463 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -91.18 -16.33 27.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 77.44 -70.6 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.65 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.684 ' CE1' ' HB2' ' A' ' 99' ' ' MET . 40.8 p90 -162.82 -170.85 2.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.772 -173.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 95' ' ' PHE . 16.6 m -85.22 146.62 26.99 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.771 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 p -50.06 -36.9 30.93 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -38.68 57.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.596 0.236 . . . . 0.0 111.623 -173.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.684 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 6.2 mmt -65.76 -50.01 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.293 0.568 . . . . 0.0 110.225 -175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -71.14 -30.77 66.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.085 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.56 -32.74 74.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.358 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.556 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 8.6 tp-100 -70.07 -50.54 39.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 0.0 109.696 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.667 HD11 HG12 ' A' ' 41' ' ' ILE . 86.4 mt -52.85 -49.76 65.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.028 177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -59.51 -42.26 91.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.743 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 109' ' ' GLU . 35.4 tt0 -63.13 -39.9 96.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.572 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 102' ' ' GLN . 95.0 mt -62.54 -36.31 82.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.345 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.97 -43.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.67 -176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -78.62 -45.1 22.33 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 17.6 mm-40 -70.97 -75.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.059 -0.257 . . . . 0.0 111.033 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 121.835 0.826 . . . . 0.0 110.471 177.575 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 120.753 0.311 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -118.74 138.81 52.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.93 -11.33 19.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.9 pttt 40.89 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.211 0.944 . . . . 0.0 112.064 -175.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.16 81.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.22 -1.354 . . . . 0.0 113.551 -167.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.21 13.51 2.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.853 169.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.0 p 54.23 107.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.152 0.981 . . . . 0.0 111.938 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 mmt -53.57 115.95 8.89 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.779 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -87.53 -176.59 1.81 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.095 2.53 . . . . 0.0 111.95 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.6 p -83.54 159.46 21.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.784 0.326 . . . . 0.0 110.3 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.41 82.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 49.9 mm -65.58 -43.01 94.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.049 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -64.34 -33.27 75.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.659 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 36.2 mmtt -78.48 -31.07 47.63 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.202 177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.56 -41.86 99.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.275 0.559 . . . . 0.0 109.496 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 13' ' ' ILE . 62.9 mt -72.52 -27.61 62.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.436 177.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.6 -25.53 67.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.478 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -85.66 -48.25 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.272 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.2 mt -79.12 -37.49 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.32 -11.12 32.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.74 57.33 9.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.775 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.5 mmt -71.16 91.52 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.958 0.409 . . . . 0.0 111.077 -174.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 69.07 16.85 8.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.682 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.0 p -99.53 -0.71 40.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.591 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t 71.15 122.47 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.37 168.92 18.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.606 ' OG ' ' HB2' ' A' ' 69' ' ' GLU . 35.8 t 73.21 2.78 4.45 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.696 0.623 . . . . 0.0 110.943 176.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.635 ' HB ' ' HD3' ' A' ' 30' ' ' PRO . 53.8 t -138.62 -63.14 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.619 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 29' ' ' VAL . 81.6 Cg_endo -77.98 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.561 1.508 . . . . 0.0 112.399 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 34' ' ' ASP . 10.4 m170 59.16 24.25 12.61 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.467 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 m -66.83 -80.18 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.036 0.446 . . . . 0.0 110.166 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -93.1 -16.09 25.33 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.605 ' HB3' ' HA ' ' A' ' 31' ' ' HIS . 7.2 t0 -51.27 -45.57 62.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 112.913 -1.948 . . . . 0.0 111.315 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -99.9 -40.25 7.78 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.551 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.42 ' OG ' ' HB2' ' A' ' 92' ' ' PRO . 37.0 t -61.89 -62.04 2.07 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.933 -175.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 m -68.62 -36.29 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.915 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.25 -51.81 68.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.738 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HD3' HG12 ' A' ' 89' ' ' ILE . 95.2 mttt -62.98 -42.98 99.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.56 92.76 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 113.369 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 52.2 mt -68.91 -47.46 75.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.518 0.159 . . . . 0.0 111.372 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.18 -40.92 87.17 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -62.77 -41.34 99.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.939 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.431 ' CE2' HD11 ' A' ' 48' ' ' LEU . 67.6 t80 -73.1 -39.76 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.549 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 41' ' ' ILE . 92.8 mt -59.36 -46.18 89.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.804 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -64.22 -36.45 84.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.43 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.36 -41.47 97.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.634 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD11 ' CE2' ' A' ' 44' ' ' TYR . 88.5 mt -64.45 -37.86 89.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.803 176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.03 2.63 10.14 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.005 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.78 93.39 33.47 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.052 0.453 . . . . 0.0 109.813 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -91.26 157.13 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.941 2.427 . . . . 0.0 113.072 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.71 141.59 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.939 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.483 ' HB2' HG23 ' A' ' 56' ' ' VAL . 12.8 m -79.81 123.44 83.84 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 58' ' ' VAL . 43.7 Cg_exo -56.08 -38.1 95.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.076 2.517 . . . . 0.0 112.388 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -52.52 -50.66 62.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.155 0.502 . . . . 0.0 110.913 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 53' ' ' SER . 33.3 t -64.18 -35.6 74.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.342 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.33 -40.04 87.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.728 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 54' ' ' PRO . 90.8 t -62.23 -52.94 54.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.635 0.255 . . . . 0.0 110.458 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.91 -43.76 86.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.896 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HG2' HD13 ' A' ' 17' ' ' LEU . 7.2 tpp180 -64.1 -43.76 94.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' HA3' HG23 ' A' ' 71' ' ' THR . . . -60.53 -48.23 87.23 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.39 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 45.6 mt-10 -59.39 -33.23 70.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.135 0.493 . . . . 0.0 110.854 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -70.25 -48.92 54.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.547 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 66' ' ' TRP . 60.5 mt-10 -93.48 -3.79 52.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 0.0 111.388 -173.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.32 -70.63 0.54 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.597 ' O ' ' HB3' ' A' ' 70' ' ' PHE . 11.9 m0 56.31 -1.47 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 19.4 m-80 69.58 128.97 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 123.322 0.649 . . . . 0.0 110.489 -176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -49.45 -47.19 23.46 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 123.693 2.929 . . . . 0.0 114.335 -173.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.606 ' HB2' ' OG ' ' A' ' 28' ' ' SER . 55.7 mm-40 -69.56 -36.78 76.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.902 0.382 . . . . 0.0 110.852 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 66' ' ' TRP . 68.2 t80 -69.94 -49.07 55.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.382 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.447 HG23 ' HA3' ' A' ' 61' ' ' GLY . 21.1 m -53.6 -46.62 70.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.424 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.22 -46.03 68.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.067 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -65.06 -40.29 94.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 70' ' ' PHE . 96.4 t -61.82 -39.35 83.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.436 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.67 82.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.902 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.21 -40.58 87.7 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.089 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 81' ' ' VAL . 44.9 m0 -60.91 -54.49 44.4 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.11 73.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.004 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -56.41 -53.95 51.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.239 175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 46.0 mtpt -66.65 -35.93 81.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.262 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 77' ' ' TRP . 76.6 t -68.76 -46.17 79.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.052 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.67 69.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.758 0.313 . . . . 0.0 111.173 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.5 t -80.0 -18.12 51.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.747 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.81 45.8 15.9 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.901 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -95.95 16.3 18.16 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.032 0.133 . . . . 0.0 111.134 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 47.93 127.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 O-C-N 125.267 1.604 . . . . 0.0 113.953 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.1 pt -115.51 144.13 23.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.453 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.15 112.36 21.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.15 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -124.64 -43.45 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.413 177.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 67.31 -70.82 0.11 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 111.636 177.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.618 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -165.36 92.2 0.9 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.563 -175.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.5 ' HD3' HG23 ' A' ' 89' ' ' ILE . 61.1 Cg_endo -80.69 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.436 2.091 . . . . 0.0 112.69 -177.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 94' ' ' TYR . 13.8 pt-20 -156.34 24.92 0.35 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.038 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 53.3 m-85 73.25 -21.31 0.26 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.659 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 93' ' ' GLU . 18.1 t80 61.97 83.93 0.15 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -169.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 11.6 m -52.63 139.98 24.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.907 -169.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m -53.58 -41.99 67.14 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 112.979 -1.918 . . . . 0.0 112.329 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 35.5 t80 -61.04 -42.24 98.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.3 mtt -62.15 -50.7 70.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.931 0.396 . . . . 0.0 110.484 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -59.43 -46.63 88.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.896 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 104' ' ' LYS . 7.7 mt-10 -72.0 -27.36 62.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 98' ' ' TYR . 14.0 mm100 -59.01 -48.1 82.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.156 0.503 . . . . 0.0 109.74 173.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 107' ' ' VAL . 83.1 mt -68.3 -43.51 77.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.402 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.617 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 26.9 tttm -60.47 -50.04 75.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.13 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -69.55 -25.46 64.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.728 0.299 . . . . 0.0 110.682 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 48.3 tp -70.31 -45.71 65.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.471 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 103' ' ' LEU . 59.8 t -71.83 -25.54 24.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.337 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -60.09 -34.73 73.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.567 176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.65 -70.67 0.18 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 168.233 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -106.73 95.92 6.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.015 0.436 . . . . 0.0 110.502 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -85.53 -25.71 26.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.126 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -85.44 149.43 25.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.579 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 66.31 -168.76 0.2 Allowed 'General case' 0 N--CA 1.466 0.34 0 O-C-N 124.067 0.854 . . . . 0.0 110.001 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt 55.44 27.88 10.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.137 0.97 . . . . 0.0 109.287 -175.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 m -87.2 111.63 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.335 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -77.31 162.58 68.63 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -47.43 114.97 1.18 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.743 2.295 . . . . 0.0 112.33 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 p -84.38 85.82 7.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.481 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.77 -47.76 6.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.194 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 61.0 mt -63.12 -45.61 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.956 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -53.77 -54.83 32.63 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 94.9 mttt -67.62 -35.71 79.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.462 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.93 85.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 111.077 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 60' ' ' ARG . 85.5 mt -64.09 -47.22 80.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -13.58 56.79 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.855 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -64.59 -43.12 94.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.1 mt -74.32 -39.45 48.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.711 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 70' ' ' PHE . . . -54.79 -47.98 68.74 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.036 -178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.05 14.96 69.01 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.227 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 67.74 169.97 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.046 0.538 . . . . 0.0 111.455 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.4 108.13 11.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.212 0.529 . . . . 0.0 110.83 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 p -120.98 -171.19 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.707 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.9 t -73.38 173.05 10.13 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.86 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.54 -112.34 0.62 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 6.3 p -126.02 -13.85 6.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 28' ' ' SER . 23.2 t 109.1 -57.08 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 125.775 1.63 . . . . 0.0 111.321 -175.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.972 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 3.9 Cg_exo -74.0 86.97 1.21 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.326 1.351 . . . . 0.0 110.864 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -95.76 -76.85 0.49 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.473 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.7 m -103.98 -80.72 0.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.104 0.478 . . . . 0.0 110.721 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.2 ppp? -90.35 -12.15 38.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.946 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.972 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -65.03 -15.83 62.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.179 178.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -92.72 -55.18 3.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.28 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.471 ' HB3' HD11 ' A' ' 89' ' ' ILE . 14.3 m -71.27 -53.19 15.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.886 -174.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -62.75 -34.14 76.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.38 90.06 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.201 0.524 . . . . 0.0 110.132 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -64.0 -27.54 69.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.398 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.08 -55.04 23.96 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.736 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 HD11 ' A' ' 103' ' ' LEU . 66.4 mt -57.27 -43.65 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.245 0.545 . . . . 0.0 110.659 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 78' ' ' ALA . 26.6 tp -56.49 -47.74 78.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.458 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HZ2' ' HB2' ' A' ' 43' ' ' LYS . 9.9 mtmp? -72.83 -30.56 64.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.426 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 66.3 t80 -63.57 -37.95 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 HD12 ' A' ' 48' ' ' LEU . 94.2 mt -66.14 -38.92 89.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.279 176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -61.26 -34.54 75.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.293 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -78.07 -24.96 47.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 44' ' ' TYR . 93.6 mt -75.93 -32.25 59.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.314 0.578 . . . . 0.0 110.411 175.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.44 -18.11 8.84 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.319 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -122.83 93.42 48.4 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -95.37 158.32 1.61 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 123.065 2.51 . . . . 0.0 111.871 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.2 m -84.92 138.29 19.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 110.571 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 56' ' ' VAL . 23.8 m -83.03 149.24 58.68 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.39 -43.3 44.86 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.322 2.681 . . . . 0.0 112.733 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.17 -43.34 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.876 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 53' ' ' SER . 29.4 t -65.0 -36.39 77.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.174 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.69 -49.05 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.416 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.0 -45.55 96.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.76 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.73 -40.84 93.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.022 0.439 . . . . 0.0 110.72 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 17' ' ' LEU . 13.2 tpt180 -65.16 -46.12 82.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.409 177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.74 -42.37 99.4 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.035 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -58.51 -39.88 81.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.92 0.39 . . . . 0.0 111.084 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 63' ' ' GLN . 1.1 tm0? -83.02 -48.45 10.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.479 -177.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.33 -25.73 33.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.876 0.37 . . . . 0.0 111.463 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.81 -76.99 0.34 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 24.8 m0 54.2 -161.29 0.14 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.832 0.453 . . . . 0.0 111.625 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -124.26 140.23 34.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 -41.73 70.21 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.893 2.395 . . . . 0.0 112.775 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -66.86 -40.66 87.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.582 0.706 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.567 ' CE2' ' HA2' ' A' ' 21' ' ' GLY . 31.2 t80 -69.5 -53.06 20.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.409 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -58.29 -43.77 88.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.413 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -72.37 -34.44 67.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.741 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.76 -56.91 14.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.806 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -60.9 -35.47 65.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.064 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.2 86.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.048 0.451 . . . . 0.0 110.633 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.34 -37.83 62.84 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.073 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -61.44 -49.32 77.28 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.529 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -59.14 -38.09 78.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.915 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -58.95 -49.77 76.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.864 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -69.97 -37.24 75.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.107 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.7 t -67.47 -38.57 80.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.702 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.09 -30.2 66.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.082 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' OD1' ' A' ' 85' ' ' ASN . 17.2 m -87.81 -14.61 39.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.268 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.36 31.86 13.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.854 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 83' ' ' SER . 12.6 m120 -97.59 -171.65 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -108.95 135.32 50.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.206 0.527 . . . . 0.0 110.89 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.7 pt -109.0 119.64 58.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.806 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.67 122.61 14.54 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.054 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 36' ' ' SER . 16.1 tt -129.82 135.56 60.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.367 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HG3' ' OD1' ' A' ' 91' ' ' ASN . 17.5 pttm -76.01 -16.72 59.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -171.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.672 ' OD1' ' HG3' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -153.95 114.28 2.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.889 0.376 . . . . 0.0 110.399 177.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.68 80.92 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.138 2.559 . . . . 0.0 113.027 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.551 ' HG2' HD22 ' A' ' 91' ' ' ASN . 11.6 pt-20 -138.96 172.45 12.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.927 176.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -124.23 -80.92 0.63 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.723 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.656 ' HE1' ' HB2' ' A' ' 100' ' ' GLN . 0.6 OUTLIER 175.56 -176.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.951 -172.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 m -84.77 174.63 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.357 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -30.24 68.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.877 -177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -44.95 -55.08 5.81 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.622 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.89 -46.32 68.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.0 111.171 -176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.656 ' HB2' ' HE1' ' A' ' 95' ' ' PHE . 7.7 tt0 -60.57 -48.38 82.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.261 -177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.05 -35.18 79.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.928 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -54.12 -58.99 5.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.417 0.627 . . . . 0.0 110.033 175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 41' ' ' ILE . 94.3 mt -64.73 -39.68 94.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.911 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.74 -39.38 91.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.304 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.86 -26.56 57.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.928 0.394 . . . . 0.0 110.746 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.66 -36.95 81.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.473 HG21 HD13 ' A' ' 48' ' ' LEU . 55.8 t -77.53 -20.98 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.82 -18.76 64.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.44 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.02 -8.28 47.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.978 0.418 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 66.1 t60 . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.49 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -83.19 113.68 20.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -81.76 -25.5 35.27 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.803 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -138.76 130.43 27.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.946 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -135.29 145.81 47.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.207 -174.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 23.8 pttm -140.26 84.22 1.95 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.819 0.818 . . . . 0.0 110.241 172.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -82.97 132.3 35.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.503 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 90.1 mmm -63.48 110.76 4.0 Favored Pre-proline 0 C--N 1.331 -0.219 0 O-C-N 123.232 0.333 . . . . 0.0 110.46 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 9' ' ' MET . 4.7 Cg_exo -73.01 99.54 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.789 2.326 . . . . 0.0 112.562 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p -105.85 174.35 5.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.452 175.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.99 82.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.355 0.597 . . . . 0.0 109.779 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.4 mt -68.82 -44.23 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.06 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.09 -37.69 86.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.601 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 4.2 mmmp? -70.66 -26.35 63.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.838 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.15 86.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.227 0.537 . . . . 0.0 109.718 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.17 -32.33 70.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.088 174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 24.0 t70 -57.17 -32.66 66.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.718 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -78.7 -63.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.679 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.15 -68.96 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.067 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.95 -8.01 84.48 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.762 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.06 -16.94 80.33 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.332 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 25.4 ptp -103.59 97.78 7.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.839 0.828 . . . . 0.0 111.118 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.19 49.85 1.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -82.06 -168.94 2.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.133 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 p -84.59 -174.95 5.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.236 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 72.89 150.29 0.1 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 122.157 0.98 . . . . 0.0 111.906 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 20.0 m -139.82 -47.54 0.45 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.322 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.577 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 22.6 m -58.43 167.7 1.62 Allowed Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.127 167.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 29' ' ' VAL . 34.1 Cg_exo -22.33 105.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 124.87 3.713 . . . . 0.0 113.367 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -69.99 161.47 29.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.797 -170.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -75.53 0.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.536 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.463 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 6.8 ttp -96.64 -42.39 8.05 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -48.19 -45.71 34.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.541 -174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' A' ' 30' ' ' PRO . 26.2 tp10 -50.88 -66.3 0.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.187 0.518 . . . . 0.0 111.135 -175.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 t -70.2 -43.1 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.462 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 33' ' ' MET . 38.6 m -67.41 -42.66 82.89 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.62 87.08 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.479 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -56.96 -32.5 66.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.916 0.388 . . . . 0.0 110.693 174.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.45 -47.46 50.61 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.092 176.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.8 mt -59.94 -43.33 92.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.918 0.39 . . . . 0.0 110.736 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.0 mp -57.53 -39.56 76.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.142 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.504 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -69.2 -42.33 75.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.009 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -63.64 -48.45 77.22 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.375 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.569 HD21 HD23 ' A' ' 103' ' ' LEU . 72.8 mt -61.71 -48.36 81.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.458 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -59.65 -36.74 77.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.007 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.8 -40.59 88.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.89 0.376 . . . . 0.0 110.759 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 107' ' ' VAL . 94.1 mt -61.66 -30.1 70.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 177.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . 120.97 -0.09 11.75 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.928 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -102.05 97.89 9.18 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 49' ' ' GLY . 82.1 Cg_endo -83.3 127.12 4.43 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.379 2.053 . . . . 0.0 112.265 -176.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.538 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 41.4 t -75.33 101.47 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.857 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.444 ' O ' HG22 ' A' ' 56' ' ' VAL . 22.8 m -70.79 125.94 92.09 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.49 -23.04 62.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.648 2.232 . . . . 0.0 111.706 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -58.88 -54.08 51.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.14 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 53' ' ' SER . 34.1 m -70.42 -21.06 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.104 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.98 -49.3 69.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 69.4 t -62.03 -42.64 95.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.422 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.19 96.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.888 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.63 -37.54 87.92 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 177.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' HA2' ' CG ' ' A' ' 66' ' ' TRP . . . -60.18 -45.62 95.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.911 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 8.4 pt-20 -79.74 -20.41 46.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.82 -53.39 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.899 0.381 . . . . 0.0 110.142 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 60' ' ' ARG . 4.6 tp10 -73.73 -38.65 64.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 -173.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.91 62.22 0.56 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.973 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.469 ' CG ' ' HA2' ' A' ' 61' ' ' GLY . 24.8 m0 -98.52 160.66 14.13 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.426 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . 26.7 p30 -90.05 153.7 47.07 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 67' ' ' ASN . 4.9 Cg_exo -39.23 -60.41 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.613 3.542 . . . . 0.0 114.433 -174.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 4.6 mm-40 -61.21 -39.0 88.59 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.95 -44.76 84.1 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.812 0.339 . . . . 0.0 110.676 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.0 m -58.45 -48.5 80.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.386 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -77.42 -27.14 52.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.096 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.7 tptp -54.4 -66.26 0.43 Allowed 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.9 t -59.83 -40.94 84.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.892 -176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.97 96.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.967 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 80' ' ' LYS . . . -66.87 -40.79 93.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.47 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.443 ' O ' HG23 ' A' ' 81' ' ' VAL . 10.6 m0 -63.46 -50.79 68.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -58.91 -39.43 81.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.85 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -52.5 -49.85 63.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 52.0 mttm -71.98 -41.61 67.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.317 -176.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 77' ' ' TRP . 57.8 t -68.21 -39.65 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.269 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.0 -39.32 69.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.122 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.9 m -65.45 -27.99 68.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.98 23.04 5.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.863 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.554 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -93.1 -176.27 4.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -136.24 137.88 41.25 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.243 0.544 . . . . 0.0 110.738 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.32 125.48 74.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.613 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.14 110.2 16.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.415 0.626 . . . . 0.0 110.815 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.8 tt -86.59 -3.24 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.757 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 71.07 -52.05 0.68 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.817 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.3 OUTLIER -161.59 131.71 3.46 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.86 177.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 91' ' ' ASN . 37.0 Cg_exo -57.62 -66.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.739 2.293 . . . . 0.0 111.902 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 65.55 -72.5 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -78.15 5.7 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -168.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -87.18 102.85 14.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 p -94.56 169.58 10.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 -174.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 m -69.52 -32.4 71.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.694 -168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 102' ' ' GLN . 0.2 OUTLIER -56.19 -44.65 79.61 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.983 0.421 . . . . 0.0 110.166 -176.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.0 mtt -66.54 -49.36 66.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.366 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -61.03 -50.9 71.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.781 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.4 -47.96 82.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.445 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -54.49 -56.48 18.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.383 0.611 . . . . 0.0 110.736 -178.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.569 HD23 HD21 ' A' ' 45' ' ' LEU . 10.4 mp -67.8 -41.08 83.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.357 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -68.96 -34.01 74.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.144 -175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -65.74 -43.41 89.04 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.75 -42.9 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.127 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 48' ' ' LEU . 84.9 t -72.66 -32.19 40.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.121 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.3 tp -60.72 -20.56 61.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.01 -18.13 62.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.778 0.323 . . . . 0.0 110.775 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 . . . . . 0 C--N 1.325 -0.473 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.664 . . . . . . . . 0 0 . 1 stop_ save_